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Abstract 
Chronic Open Angle Glaucoma (COAG) refers to a chronic progressive condition that 
is characterised by damage to the optic nerve, resulting in peripheral visual loss that 
can progress to involve the fovea and central vision; subsequently causing blindness. 
COAG is reported to have a poor level of adherence to treatment due to its 
asymptomatic nature. In this study, a Glaucoma Expert Patient Programme (GEPP) 
demonstrated new ways of improving patients' experience and adherence to COAG 
treatment. The research has employed an Information-Motivation-8ehavioural Skills 
Model to understand the association between knowledge, motivation and behavioural 
skills in an attempt to improve adherence amongst recently diagnosed patients. 
Patient participation was at the heart of every component of the study. 
In this research, four Expert Patients were trained and supported to deliver an 
educational programme (termed the GEPP) to 25 recently diagnosed patients with 
COAG (Intervention Group) and then a comparison was made to 25 participants 
(Control Group) that were also recently diagnosed with COAG but did not receive the 
educational programme. Three pre and post educational programme validated 
questionnaires were used to measure patients' knowledge, satisfaction and 
adherence at baseline and then discern changes at 1 month and 6 months follow up 
to the GEPP intervention. Staff (N = 10), Expert Patient (N = 4), Intervention Group 
(N=10) and Control Group (N=10) semi-structured interviews were also conducted to 
obtain deeper insight into their experiences of engaging in the programme. Data 
analysis indicated IMPROVING AWARENESS was the main theme that emerged 
supported by three subthemes: knowledge, satisfaction and adherence. This research 
has taken the Patient-Patient relationship to a higher level. It is viewed that the Expert 
Patients' experience is crucial and valuable to improving the experience, knowledge 
and adherence of newly diagnosed patients with COAG. 
The GEPP delineated in this study provided insight regarding individuals' life 
experiences of living with and managing chronic complex glaucoma. Implications for 
practice relate to the development of tailored educational programmes. This research 
contributed new knowledge to improving the adherence practices of glaucoma 
patients. It also demonstrated the value of Expert Patients' experience and their 
contribution to assisting newly diagnosed patients in self-managing their COAG. 
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CHAPTER ONE 
Introduction 
The research explicated in this thesis was conducted in an attempt to understand the 
knowledge, experiences and actions of patients and health care professionals involved 
in managing COAG. This research provides a collaborative approach to designing and 
implementing an Expert Patient Programme and sheds light on the problems 
associated with managing COAG. The focus of my work has been to design, 
implement and evaluate a hospital based Glaucoma Expert Patient Programme 
(GEPP) for the purpose of improving the awareness, self-management skills and 
potentially concordance amongst newly diagnosed patient with COAG. 
1.0 Setting the Scene 
Chronic Open Angle Glaucoma (COAG) is the second most common cause of 
blindness and visual impairment registration in the United Kingdom (UK) (Burr et aI., 
2007). Though not curable, the progression of this all too common, disabling condition 
and can be averted through timely screening and prophylactic treatment. However, as 
I shall demonstrate, screening and treatment is not always timely and successful. The 
traditional medically led approach to managing COAG is not doing as well as it might. 
The problem of managing COAG is complex as timely screening and successful 
regimes of treatment depend on many factors, not least the actions of a wide range of 
health care professionals, carers and, most vitally, the actions of COAG patients. This 
research is an attempt to better understand the knowledge, experiences and actions 
of patients and health care professionals involved in managing COAG by devising a 
collaborative approach that is likely to improve concordance and quality of life. Thus 
the collaborative methodological approach of Action Research has been adopted to 
study how the collaborative practices of implementing an Expert Patient Programme 
sheds light on the problem of managing COAG to produce a better outcome. 
The Expert Patients Programme (EPP) is defined by the Department of Health (DOH, 
2001) as a self-management programme for people who are living with a chronic (Iong-
term) condition. The aim of such programme is to increase their confidence, improve 
their quality of life, and help them manage their condition more effectively. 
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The research presented in this work seeks to explicate the development and 
implementation of a specifically designed Glaucoma Expert Patient Programme 
(GEPP) and to unpick the reality of self-management in this particular chronic disease. 
The purpose of this chapter is to set the scene for the reader with three main areas 
highlighted. First, a focus on the increased prevalence of COAG and its' associated 
problems of concordance and healthcare costs. Second, the rise of active patients and 
self-management programmes in healthcare. Third, the rational for the research will 
be introduced, and finally some light will be shed on the history of Action Research. 
1.1 The Rise of COAG Associated Concordance and Health Care Cost 
People in the developed world have experienced the "epidemiological transition" 
where there was a shift in the disease burden from high rates of death from acute, 
parasitic, infectious diseases, and short life expectancy to longer life expectancy and 
high rates of chronic diseases (Harwood et aI., 2004; Cockerham, 2001). Globally, the 
World Health Organisation (WHO, 2002) estimates that 4.5 million people are blind 
due to glaucoma accounting for 12.3% of global blindness (Resnikoff et aI., 2004). In 
the UK, COAG is the second commonest cause for registration as blind (17.000 people 
approximately) and visually impaired (15.500 people respectively) (The Information 
Centre, 2006). In the UK, it also accounts for 11.6% of registrations over the age of 65 
years, although this is likely to be underestimated because of the way in which it 
causes blindness in patients with more than one pathology assigned to varying 
prevalence surveys, and because most blindness surveys do not consider subjects 
functionally blind due to severely restricted visual fields (King et aI., 2010). 
A SUbstantial increase in individuals affected with COAG and the subsequent costs is 
predicted over the next few years due to two primary reasons. First, by 2030 it is 
predicted in the UK that the population of all those under 44 years of age is set to fall; 
the 60-74 age group will rise by about 50% and the over 75 age group is likely to 
increase by 70% (Bootie, 2005). With an adult gradual onset, COAG is estimated to 
be present in around 2% of the population over the age of 40 years, rising to almost 
10% of those older than 75 years in white Europeans. The prevalence may be higher 
in people of black African or black Caribbean descent who have a family history of 
glaucoma (NICE, 2013). With changes in population demographics as people grow 
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older and living into their 70s and 80s, the number of individuals affected is to expected 
to rise (NICE, 2013; Rudnicka et aI., 2006). Secondly, the recent National Institute of 
Clinical Excellence (NICE) guidelines (NICE, 2011) have strongly advised community 
eye health services (Le. Optometrists) to refer all persons measuring an intraocular 
pressure (lOP) of >21 mmHg for assessment by an Ophthalmologist as compared to 
lOP of >25 mmHg in the past. This means all cases of suspected glaucoma will be 
referred to secondary care for confirmation of the diagnosis and treatment where 
necessary. This will inevitably increase' the number of cases being diagnosed with 
COAG (Vernon, 2011). Those most at risk include the socially disadvantaged with no 
family history of glaucoma, those with high lOP and those who do not attend an 
optometrist regularly (King et aI., 2010). 
Therefore, with this predicted increase in number of individuals affected and the 
subsequent costs, it is timely and essential to identify an effective strategy and self-
management programme that will help improve the quality of life of these individuals 
as well as minimising the burden of this condition on an already overstretched NHS 
services. 
Although glaucoma cannot be cured and damage already done to the optic nerve 
cannot be reversed, early treatment can slow down its progress, often by a course of 
eye drops that help to reduce pressure inside the eye. Early diagnosis can mean the 
difference between serious and permanent sight loss and indefinite good vision, which 
is one reason why regular eye tests are so important. Evidence suggests that people 
from underprivileged areas who have a lower occupational status and a lower level of 
education are more likely to present late for detection and treatment, significantly 
increasing their risk of permanent sight loss from this condition (Fraser et ai, 2001). 
Glaucoma is therefore one of the conditions that reflects health inequalities between 
different socioeconomic groups (Rudnicka et aI., 2006). A more collaborative approach 
to health care research of the processes involved in screening might well be able to 
address this inequality in health. Additionally, this research is aimed at raising the 
profile of COAG and increasing community awareness by utilising Expert Patients who 
may be able to promote the importance of screening to other members of their families 
who are at risk. This will, potentially, trickle through the community and they will be 
more aware of the disease and the help that is available. 
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Whilst the human cost of living with impaired vision or no vision at all can be immense, 
so too is the financial cost to the state. Reviewing the literature revealed very little 
attention paid to the financial cost of glaucoma. A review by Kobelt (2002), explained 
that as the disease affects mainly the elderly; there is considerably low investment and 
there is a lack of new treatments under development. A relatively old review conducted 
by Ethical Strategies Limited in 2003 estimated the annual costs for those registered 
as blind or partially sighted in England alone ranges from £1.4 to £2.9 billion (Grainger 
and Hutchinson, 2003). A more recent review based on the Royal National Institute 
for the Blind (RNIB) (2008) estimated sight loss cost of at least £6.5 billion and this is 
likely to increase as the number of people with sight loss increases with average costs 
per patient ranging from £7,239 to £17,246 (RNIB, 2011) per annum. 
It is therefore unsurprising that governments in the developed world are focusing on 
initiatives and models that seek to reduce this cost (Wilson et aI., 2005). Many of the 
most common chronic diseases unlike COAG are preventable, however, the trends 
and evidence available suggests that current medical model attempts to engage the 
public in changing lifestyle behaviours have not been successful (Wanless, 2002). In 
an attempt to fully engage the public, recent policies have heavily promoted the 
collaborative notion of the active patient. The key example of this is the Expert Patient 
Programme (EPP) (Department of Health, 2001), a lay-led self-management 
programme for generiC chronic diseases that enables patients with chronic illness to 
self-manage their conditions (Kennedy et aI., 2007) and thus be concordant with 
recommended treatment modalities. 
1.2 The Nature of the Problem 
As indicated in section 1.0 of this Thesis, COAG is a potentially blinding condition and 
the second most common cause of blindness and visual impairment registration in the 
UK (Burr et aI., 2007). It is usually asymptomatic until advanced and many people will 
be unaware there is a problem with their eyes until severe visual damage has 
occurred; hence it is often called the "sneak thief of sight". The term chronic means 
"over time" and in this condition pressure within the eye increases very slowly and 
painlessly. So slow is its progression that the brain is capable of adjusting to the loss 
of vision, so that no visual impairment is immediately apparent. By the time symptoms 
become apparent, it is often too late to reverse the condition (Rudnicka et aI., 2006). 
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By its nature, long term conditions like COAG require day-to-day management to 
prevent conditions worsening. This task falls far more to individuals and their family 
members than to health professionals (Vernon, 2011). There are 8760 hours in a year 
and the average person with COAG spends on average 3 or 4 hours a year with health 
professionals; that is less than 0.05% of the year (Alakeson, 2011). However, the 
current medical model and technologies have failed to provide a cure for COAG or 
even solutions for problems associated with its treatment. Furthermore, strategies 
attempting to encourage patients to comply with their treatment have not been 
successful. Writers in the field have argued that the solution is one that requires a 
different practice of health care, with new roles for the patients, for doctors and nurses, 
and for health services (Holman and Lorig, 2004; Lorig et aI., 2001). 
In the narrative that follows the reader is given a brief explanation of the current and 
culturally dominant model of health care in the NHS, which is best termed as the 
medical model or sometimes referred as biomedical model (Wade, 2009). According 
to its founding concepts, diseases, including mental illness are explained as 
abnormalities in the function of genes, cells, organs, and biological systems, caused 
chiefly by trauma, and neurophysiological dysfunction (Shah and Mountain, 2007). 
Treatment in this model generally consists of repairing and removing (surgery), 
attacking (antibiotics, anti-cancer agents), or modifying (hormone therapy) the entity 
causing the disease or trauma. According to Thomas (2004), the medical model is 
characterised by: 
• High cost and profitability 
• Sophisticated testing and vast range of therapies and drugs 
• Good short-term outcomes and fair long-term outcomes 
• High-tech research 
• Development of new knowledge 
• Difficulty addressing chronic disease. 
Although we have recently witnessed a new era of patient involvement and introduced 
Expert Patients, there are indications that there has not been a corresponding 
paradigmatic shift in the power that controls patient involvement or in the health 
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professions that still view patients as merely passive recipients of health care (Holman 
and Lorig, 2004). Numerous studies have been conducted on doctor-patient 
relationships. These indicate that patients continue to be reticent in sharing their 
viewpoints within the consultation (Britten et ai, 2004; Stevenson et aI., 2003). 
Collaborative initiatives like an Expert Patient Programme and self-management 
programmes that are promoted heavily by the government and believed to be effective 
in improving self-efficacy and self-management amongst patients with chronic 
illnesses still face a considerable resistance from health professionals towards this 
notion (Henderson, 2003). 
The aims of this study have been to design, implement and evaluate a disease-specific 
Glaucoma Expert Patient Programme (GEPP). The programme is hospital based in 
the sense that it intends to complement the advice and actions of health professionals 
working in the health service. The research explored the impact of this programme on 
newly diagnosed glaucoma patients, as it initiated behavioural changes and 
developed constructive self-management strategies based on sharing the knowledge 
and expertise of Expert Patients to motivate them to assume greater responsibility for 
their health care. 
1.3 Changing Terminology 
Patient adherence with chronic medical treatments is known to be far from ideal 
(Schwartz and Quigley, 2008). The terminology used to denote individuals' behaviour 
towards medication use has become more precise and empowering over time. Whilst 
this terminology will be discussed further in Chapter Two, it is appropriate to draw the 
readers' attention to some of the terms that are widely used. Although the term 
'compliance' is now well respected in the medical literature; it implies obedience to 
health professionals and reflects a paternalistic attitude. The term 'adherence' may be 
a better term and more precise but it remains slightly judgmental. 'Concordance', 
introduced in late 1990s is intended to remove the implication of submissiveness to 
health professionals and introduce a more collaborative approach to health care. It 
should be noted however that the majority of practitioners working within the field of 
ophthalmology and authors of articles and other texts related to ophthalmic research 
and ophthalmology predominantly use the term adherence (Amro et ai, 2011a, Amro 
et ai, 2012). 
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This study has explored how truly involved and informed participants can work to build 
a rapport and collaborate with health professionals to improve eye health outcomes. 
It has adopted a patient-centred approach that helps to move away from the traditional 
paradigms that view the patient as a mere recipient of doctor instructions. Using the 
appropriate terminology has been problematic; particularly in the medically dominant 
setting of Moorfields Eye Hospital National Health Service (NHS) Foundation Trust. 
As the term 'concordance' has not been fully recognised for use in this clinical setting, 
there has been a general lack of understanding of the implications of this term in 
comparison with terms like adherence and compliance. The Research and 
Development Committee at the Trust was in favour of using adherence as 
concordance is viewed as ambiguous and at times imprecise. Therefore, to save any 
further confusion and for clarity in this Thesis, the term 'adherence' will be used 
interchangeably with the term "concordance" throughout the Thesis to refer to patients' 
behaviour toward medication use. 
1.4 Contexts and Justification for the Research 
The epidemiological transition of healthcare from acute to chronic disease 
management has been encouraged by a growing recognition of the central role that 
individuals can play in managing their own health (Lorig at aI., 2001). This transition 
has led to a new focus on interventions that support self-management, such as the 
NHS Expert Patient Programme (EPP) (Sullivan, 2003). It has also strengthened the 
call for the need to change service arrangements and transform the NHS away from 
a professionally driven model of healthcare management to one that is individually 
tailored based on partnership between individuals, families and professionals (DoH, 
2008). 
One aspect of this desired change has been to encourage patients to become actively 
involved in the management of their condition (Holman and Lorig, 2004). The day-to-
day responsibility for chronic disease self-management is gradually shifting from 
health care professionals to the individual (DoH, 2005). Active involvement of patients 
could potentially result in better concordance to management and improved 
management of long-term conditions without increasing costs (Duffy, 2007). 
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Evidence indicates that between 30 and 50% of patients do not take their prescribed 
medication in full and that the annual cost of wasted drugs in the UK is around £100 
million (DoH, 2008). For decades, the traditional approach to patients with COAG has 
been primarily pharmacological and if unsuccessful, often combined with surgical 
intervention. Although useful, evidence shows that patients with COAG have one of 
the poorest levels of concordance. NICE (2011) indicate that involving patients and 
helping them understand how to manage their COAG could potentially improve 
concordance to medical treatment; allowing them to remain sighted for longer. 
The government commitment to promoting and embedding self-management 
programmes within the NHS was set out in a key policy document entitled: 'The Expert 
Patient: a new approach to chronic disease management for the 21 st century'; 
published by the Department of Health (DoH) in 2001. This document raises 
fundamental questions about the ability of such a programme to change chronic 
disease management in an organisation like the NHS. It also raises key questions as 
to whether a generic programme is suitable for all chronic conditions, or whether 
patients and health care professionals will engage and accept such a programme. For 
example, a national review of the Expert Patient Programme was conducted by the 
National Primary Care Research and Development Centre (NPCRDC) (Kennedy et 
aI., 2007) and raised concerns about its effectiveness. Several reviews and a Meta-
analysis commissioned by the Cochrane Collaboration have reviewed the 
effectiveness of the self-management programmes in various contexts and 
populations. 
The focus of my work has been to design, implement and evaluate a hospital based 
Glaucoma Expert Patient Programme (GEPP) for the purpose of improving the 
awareness, self-management skills and potentially concordance amongst newly 
diagnosed patient with COAG. This Thesis aims to show how effective the GEPP is in 
improving awareness, satisfaction and concordance of newly diagnosed patients. 
1.5 Methodological Account 
In this study three different methodological approaches were applied to three different 
stages, Ethnography, Action Research, and Mixed Methods. The Ethnographical 
approach was used to explore the issues arising from designing the GEPP, whilst a 
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collaborative Action Research approach was followed when examining the 
implementation of the GEPP. A Mixed Method approach was used when examining 
the effectiveness of the intervention and the issues arising from its delivery. 
Ethnography is a research approach that has traditionally been used to understand 
different cultures and in the first part of the study it guided the research process. Action 
Research on the other hand linked the research back to the aims and objectives of 
this study. 
Ethnography fits very well with action research because they both try to understand 
how a particular target group and a particular research work together (Alasuutari, 
1995). In contrast to the dominant biomedical model, it was important to consider how 
to explore forms of knowledge and the lack of it at times. Ethnography is an approach 
to research. It is not one specific method (like participant observation, or interviews, or 
surveys). In fact, it is a multi-method approach. I used a mixture of methods where 
appropriate to the situation and I adapted each method to the situation. To clarify, 
simple observation without being an active participant may not have been sufficient 
for exploring a situation where there is an obvious lack of knowledge and potentially 
'hidden' dissatisfaction. 
There is uncertainty over the use of action research with diverse claims for and against 
action research in a variety of contexts (Masters, 1995). Authors such as Kemmis and 
McTaggert (1988), Zuber-Skerrit (1992), Holter and Schwartz-Barcott (1993) claimed 
that American psychologist Kurt Lewin first used action research in 1946. However, 
McKernan (1991) argued that a number of social reformists used action research prior 
to Lewin. Despite the ambiguity of its origin, Kurt Lewin constructed the first action 
research theory in the 1940s (Lewin, 1948). Lewin envisioned action research as a 
cycling back and forth between ever deepening surveillance of the problem situation 
(within the persons, the organization, and the system) and a series of research-
informed action experiments. His original formulation of action research "consisted in 
analysis, fact-finding, conceptualisation, planning, execution, more fact-finding or 
evaluation; and then a repetition of this whole circle of activities; indeed a spiral of 
such circles" (Sanford, 1970:4). In Lewin's paper, he identified a framework for action 
research that proceeds "in a spiral of steps, each of which is composed of planning, 
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action, observing and the evaluation of the result of actions" (Carr and Kemmis, 
1986:8). 
However, a number of other people must take credit for their contribution in the 
development of action research over the years other than people who are reported in 
the literature (Gunz and Jacob, 1996). Jacob Moreno (1892-1974), a physician, social 
philosopher and poet who shared students with Lewin, reported the importance of 
integrating theory and practice by perceiving researchers as social investigators rather 
than just observers (Waterman et ai, 2001). With an increasing popularity over the last 
two centuries, action research has been used in a wide range of fields including 
organisational development (Coghlan and Brannick, 2005), education (Carr and 
Kemmis, 1986), community development projects (Reason and Bradbury, 2001) and 
health (Meyer, 1993; Waterman et ai, 2001). 
1.6 Study Population 
The population targeted in this research was relatively diverse, ranging from patients 
attending the clinics, relatives and carers, Expert Patients, administrative staff, nursing 
staff, Optometrists and Ophthalmologists. My broad criterion for inclusion was anyone 
who was involved in any capacity or role in caring for patients with COAG. On any 
given day, there will be between three to five glaucoma ophthalmologists, one or two 
optometrists, three to five nurses and two to three clerical administrators. On average, 
each one of the research site clinics attends to 50 to 80 glaucoma patients per day, 
with a large proportion of these patients being seen in the morning sessions. 
1.7 Research Site 
A critical step in this study was gaining entry into the area being studied (Burns and 
Grove, 1993). My second supervisor and clinical facilitator, a lead glaucoma consultant 
at Moorfields Eye Hospital NHS Foundation Trust Glaucoma Services, introduced me 
to people running and managing the glaucoma services in the trust. Of whom, a few I 
had worked with before in the A&E Department. They were incredibly supportive and 
gave me the time and space to get on with my study. I would not be that fortunate had 
I been an outsider conducting this enquiry. Further discussions and informal 
conversations made the purposes and methods of this study clearer to professionals 
running the clinic. I made it clear what the purpose of my observations and my 
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intentions in conducting this study were which made my period of observation a 
pleasant experience. 
1.8 Demographics of the Research Community 
The research was undertaken in the London Borough of Barking and Dagenham. The 
local population of the London Borough of Barking and Dagenham is growing at a 
significant rate. The latest estimate of the population of this Borough is 170,000 that 
represent an increase of more than 6,000 from the census figure of 163,944 in 2001. 
By 2020 the population is expected to reach 208,000, which is an increase of 38,000. 
According to the Barking and Dagenham Joint Strategic Needs Assessment (JSNA) 
of 2009, about 27% of residents in the Borough are from Black and Minority Ethnic 
groups in comparison with 12.5% the national average in England. I hoped that by 
selectively choosing a community where ethnic minorities are over represented, in 
comparison with the national figures and other neighbouring boroughs in London, that 
it would increase their chance of representation in the overall sample of this study. 
1.9 Economic Disadvantage and Low Levels of Education 
The levels of deprivation in this borough are quite high. Barking and Dagenham is the 
eleventh most deprived district in England (out of 354) and the sixth most deprived 
borough in London. Residents have the lowest average income in London. Barking 
and Dagenham's population has the fourth lowest literacy levels and second lowest 
numeracy levels in England. The borough has the lowest percentage of 16 to 74 year 
old residents with qualifications in London. 
Low levels of literacy make it more difficult to raise awareness regarding preventable 
Sight loss and educate people about healthy living. Economic disadvantage means 
that many people may face sight loss that could be avoidable by presenting to the 
Optometrist clinic and having a simple eye test. Free NHS eye tests and those with a 
family history of glaucoma are available to people receiving certain benefits, and free 
examinations are on offer for people over 60; yet cost still appears to dissuade many 
people from having their eyesight checked. 
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1.10 Research Question, Aims and Objectives 
This study has aimed to explore the concept of an Expert Patient Programme by 
designing, implementing and evaluating a glaucoma intervention programme for the 
purpose of improving newly diagnosed COAG patients' knowledge and concordance 
with treatment regimens. Expert Patients were trained and supported to take on the 
role of delivering a one-to-one intervention (educational programme) with newly 
diagnosed fellow glaucoma patients. 
The following is the specific research question addressed in this study: 
"Does development and implementation of a GEPP improve knowledge and 
concordance amongst newly diagnosed glaucoma patients?" 
The objectives of this research were: 
1. To determine through semi-structured interviews peoples' (Expert Patients, Patient 
Participants and staff) perception of the GEPP. 
2. To determine through questionnaires whether knowledge and concordance 
improved immediately following exposure to the GEPP. 
3. To determine overtime whether knowledge and concordance are maintained. 
1.11 Organisation of the Thesis 
The next chapter of this Thesis provides an overview of the challenge of COAG 
highlighting presentation and patient pathways, demographic and epidemiological 
trends, a meta-analysis of self-management programmes, clinical management of 
COAG and associated problems. Chapter three presents the themes from a literature 
review of self-management in chronic diseases. Drawn into this chapter is an analysis 
of strategies to promote self-management, theories and policies surrounding chronic 
conditions. An Adherence Model for the GEPP is discussed and the Information-
Motivation-Behavioural (1MB) Skills Model, as the theoretical framework for this study, 
is presented and critiqued. Then the work is presented in two parts in chapter four. 
Part One describes the Ethnographic approach that addresses the design of the 
GEPP. This is followed by Part Two in which collaborative Action Research as a new 
paradigm in social inquiry is explored alongside the Information-Motivation-
Behavioural (1MB) Skills Model for implementation of the GEPP. 
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In chapter four a detailed account of this inquiry and where I stand as an insider-
outsider researcher with experience as an ophthalmic nurse is provided as well as 
examining the effectiveness and interpretations from the intervention delivered. 
Chapter five presents the findings of the research from the perspective of designing, 
implementing and evaluating the study. Findings are presented qualitatively and 
quantitatively. An overall discussion chapter will be presented in chapter six including 
a reflection of the methodological approach and the empirical and theoretical 
contributions of the research. Finally, recommendations and conclusions will be 
presented in chapter seven. 
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CHAPTER TWO 
The Challenge of Chronic Open Angle Glaucoma 
2.0 Introduction 
This chapter is presented in three sections. The first section provides an overview of 
the nature of COAG as a chronic condition, the clinical features and presentation, 
patient pathways; epidemiological trends of COAG, treatment options and prognosis 
are also reviewed. The second section delineates and contrasts literature that provides 
examples of how self-management programmes are perceived and described within 
the bio-medical perspective in a meta-analysis. The last section explicates challenges 
faced by individuals affected by COAG and proposes an alternative "collaborative 
approach" to its management. This chapter concludes by summarising COAG, its risk 
factors and adherence to treatment regimens. 
Section I: Understanding COAG 
2.1 Definition of Glaucoma 
Glaucoma is a chronic degenerative optic neuropathy in which the neuro-retinal rim of 
the optic nerve becomes progressively thinner, thereby enlarging the optic-nerve cup 
(Ferri, 2012). To understand COAG better, it is important first to consider the functional 
anatomy of the eye and aqueous dynamics. 
2.1.1 Functional Anatomy of the Eye 
First the act of seeing (vision) is explained. Vision transpires in several steps. Light 
enters the eye through the cornea and the crystalline lens to the retina; the retina then 
'transforms' this light into electrical nerve impulses that the brain can process (refer to 
figure 2.1) (Kanski and Salmon, 2003). Once the light has been focused on the retina, 
it is absorbed by the retinal photoreceptors (the rods and cones) and the information 
transmitted to retinal ganglion cells (axons). All visual information is then sent as nerve 
impulses through the optic nerve to the part of the brain called the visual cortex. 
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Figure (2.1): The Eye: Adapted and Reproduced from the Department of Work and Pensions (2010). 
Retinal ganglion cell axons converge at the optic disc from where the optic nerve 
emerges; in other words, the optic nerve connects the eye with the brain (Flammer, 
2003). Now the visual system is able to put together images formed in each eye. 
Throughout the course of a lifetime, even a healthy person will lose some nerve fibers 
as part of the natural ageing process. 
2.1.2 Aqueous Dynamics 
The eye maintains its spherical shape because it is 'inflated' to above atmospheric 
pressure. The normal range of intraocular pressure (lOP) is between 10 and 21 
mmHg. Aqueous humour is a clear fluid formed by the ciliary epithelium through active 
secretion, ultra filtration and diffusion. The function of this fluid is to provide 
nourishment for the cornea and the lens whilst giving the eye its shape and contour. 
Aqueous initially passes into the posterior chamber between the iris and the lens then 
into the anterior chamber through the pupil. Then it leaves the anterior chamber into 
the trabecular meshwork and Schlemm's canal where it flows through collector (refer 
to figure 2.1 and 2.2) (Kanski and Salmon, 2003). 
Figure (2.2): Angle-closure on the right; on the left open-angle glaucoma: Adapted from QwikStep 
(2011 ). 
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This route accounts for 90% of aqueous drainage; the remaining 10% are drained 
through the ciliary body in the chamber angle into the venous system. A very small 
amount of the aqueous is also drained away through the corneal epithelium, iris 
vessels and vitreous humour (Kanski and Salmon, 2003). It is the abnormalities and 
imbalance between the production and drainage of the aqueous that leads to an 
increased lOP and to glaucoma. The exact mechanism that control and maintain the 
lOP within the normal range is unknown. 
2.1.3 Classification of Glaucoma 
The term 'glaucoma' covers a wide range of diseases having three things in common 
which are an optic neuropathy (Burgoyne et aI., 2010), visual field loss and irreversible 
blindness (Ferri, 2012). These ocular diseases may cause characteristic progressive 
changes in the optic nerve head, visual field loss, or both (Edgar and Rudnicka, 2007) 
which can progress to involve the fovea and central vision (Tielsch, 1996; RCO, 2004). 
There are a number of different types of glaucoma and these can be classified 
according to three main factors. These are: the appearance of the drainage angle 
(open or closed) which directly relates to the anterior chamber angle and the region 
for aqueous drainage as illustrated in figure (2.2), the presence of contributing factors 
that may raise the lOP and other conditions such as inflammation and nonvascular 
disease that may lead to secondary glaucoma. Chronic Open Angle Glaucoma is the 
most common form of glaucoma in the UK and therefore the remainder of this chapter 
and Thesis will focus primarily on this condition. 
2.1.4 Chronic Open Angle Glaucoma (COAG) 
COAG is the most common type of glaucoma in Western Europe. It is the leading 
cause of blindness in African-Americans in the United States of America (USA) and 
the second leading cause of blindness worldwide. It is estimated that 13.5 million 
people may have glaucoma and 5.2 million of those are blind. In the UK, it is 
responsible for 12% of blind registration (IGA, 2012) and 12.3% globally (Resnikoff et 
al.,2004) 
COAG has an adult onset, usually bilateral (although not always symmetrical) and 
produces characteristic changes in the optic nerve head or visual field with or without 
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an onset of increased lOP greater than 21 mmHg with an absence of underlying cause 
(RCO, 2004). Open-angle glaucoma means that when examining the anterior chamber 
angle, there is nothing that could block the aqueous humour outflow, but nevertheless, 
the lOP is elevated (Flammer, 2003). Refer to figure (2.2) for an illustration of the 
anterior chamber angle. 
In COAG, the mechanism of damage involves an increased resistance to aqueous 
outflow within the trabecular meshwork (a circumferential sieve-like structure through 
which 90% of the aqueous drains) so causing a rise in lOP (Flammer, 2003). This in 
turn influences retinal ganglion apoptosis: the rate of which is influenced by the lOP 
itself mechanically increasing pressure on the optic nerve head by compromise of the 
local microvasculature (MO, 2005). 
In COAG, the nerve cells and nerve fibers progressively die at a faster rate. As a 
consequence, the connection between the eye and brain, so crucial for vision, is 
gradually severed (Morgan, 2004). The eye at this stage still sees the light because 
the rods and cones are still working, but the transmission of visual information to the 
brain is interrupted (Hayreh, 2001). This is the core of the problem and is termed 
"glaucomatous damage". Hartmann as a long sufferer of COAG wrote in the British 
Medical Journal about her own journey as a patient and provided this definition: 
"When I try to explain what it's like not to see with glaucoma, I tell people to 
imagine a digital TV screen with pixels and to imagine that some of the pixels 
in an area have ceased to function. The entire picture still exists and moves, 
but there are areas that simply disappear from the screen. There is no 
shadow, no light, no colour--just nothing" (Hartmann and Rhee, 2006:738). 
2.2 Risk Factors for COAG Onset and Progression 
In recent years, substantial information has been added to our knowledge about risk 
factors for Chronic Open-Angle Glaucoma. Several studies have evaluated the cross-
sectional association between risk factors and COAG, whereas only a few have 
investigated the risk factors for the development of glaucoma and its progression 
(Boland and Quigley, 2007). 
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Risk factors for COAG are statistically associated with the development of COAG 
whereas prognostic factors for COAG are statistically associated with the progression 
of COAG. Neither risk factors nor prognostic factors establish causation. Prognostic 
factors for the progression of COAG have been explored in four large multi-centred 
clinical trials (Coleman and Miglior, 2008). The most consistent prognostic factors are 
older age and higher baseline lOP. Lowering lOP medically or surgically remains the 
only consistent strategy to slow the progression of COAG (Leske et aI., 2007). 
Identifying risk factors has preventive and therapeutic implications in COAG. With the 
absence of a way to prevent the development and progression of glaucoma, numerous 
investigators have studied the characteristics of individuals who have glaucoma, and 
based on those studies it became possible for them to identify several factors that 
seem to occur more frequently in glaucoma patients. Since there is a greater likelihood 
of these factors being present in someone with glaucoma, it is reasonable to assume 
that these are considered as risk factors for glaucoma. Some risk factors are 
immutable (genes), whereas others are variable and even amenable in the presence 
of strategies to modifying risk factors. The following table provide a summary of the 
main risk factors identified in the literature. 
Table (2.1): Risk Factors ofCOAG 
Risk Occular Factors 
Factors 
for 
COAG 
Demographic Factors -
SystemiC Diseases Risk 
Factors 
2.2.1 Ocular Factors 
Intraocular Pressure 
~, Optic Di~cCha~gE;s;"'-'~··~· ",~_. 
";"' ;, 
Visual Field Loss 
1"..: ~".~ y" _;,... ~:;',$ 
Short and Far Sightedness 
Age 
Socioeconomic Status, 
Alcohol Drinking and Smoking 
Ethnic Background 
't'" Familial Factors ~"'---'--'";':-'-;...:,-"" 
Diabetes 
Hypertension 
Currently several risk factors have been identified for glaucoma but as yet the 
underlying cause is not known. It is been suggested that a combination of risk factors 
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such as decreased blood flow to the optic nerve head and lOP levels that are too high 
in an individual may contribute to ganglion cell death (Morgan, 2004). 
2.2.1.1 Intraocular Pressure (lOP) 
lOP is a little like blood pressure in that there is not an absolute correct value but a 
normally distributed range of values (from 10-21 mmHg) with some normal individuals 
having lOPs outside these ranges (IGA, 2009). lOP is the main established factor, as 
the risk of COAG increases with increasing levels of lOP (Johnson et aI., 2003). 
Numerous experimental studies and clinical and epidemiological observations support 
the view that the higher the lOP, the greater the likelihood of glaucoma (Nemesure et 
aI., 2007). Epidemiological studies have compared the lowest and middle lOP groups 
and show an increase in COAG prevalence with increasing lOP as approximately six-
fold, and about 16-40 fold comparing the lowest and highest lOP groups as illustrated 
in table (2.1) (Sommer et ai, 1991; Mitchell et ai, 1996). 
Table (2.2): Prevalence estimates of COAG according to lOP. 
Baltimore Eye Study (Mitchell et ai, 1996) Blue Mountains Eye Study (Sommer et ai, 1991) 
lOP (mmHg) Prevalence of COAG lOP (mmHg) Prevalence of COAG 
(%) (%) 
16-21 1.5 12-13 0.9 
22-29 8.3 22-23 5.7 
~30 25 >28 39 
Recently, epidemiological studies have revealed the presence of glaucoma without 
raised lOP, and raised lOP without glaucoma, which has led to re-evaluation of the 
relationship between the two (Hatt et aI., 2006). Johnson et al. (1998) argued that the 
diagnosis of COAG cannot be made on the basis of lOP alone, but having an arbitrary 
cut-off of 21 mmHg increases the efficiency of case findings. 
2.2.1.2 Optic Disc Changes 
As COAG can occur in eyes with normal or raised lOP, there is increasing emphasis 
placed upon optic disc changes (RCO, 2004). This is a key assessment as it is a direct 
marker of disease progression. 
The greater the tissue damage at the optic nerve head, the more likely a future 
progression of nerve fibre loss; but whether this is a genuine risk factor is still debated 
(Flammer, 2003). Theoretically, it seems possible that an already damaged optic disc 
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could be more susceptible to increased IO~. Optic disc damage is assessed by 
examining the vertical ratio of the pale centre (cup) to the overall size of the disc. A 
small cup and a thick neuro-retinal rim (the darker part surrounding the cup) may give 
a ratio of 0.3 or less (normal) (RCO, 2004). A small number of people have a cup: disc 
ratio up to 0.7 but anything beyond that is definitely pathological (Tielsch, 1996). These 
measurements are not risk factors in an aetiological sense, but observation 
undertaken by an examiner will determine whether progression has occurred. 
2.2.1.3 Visual Field Loss 
Loss of visual field results from damage to nerve fibre bundles as they enter the optic 
disc. When a bundle of nerve fibres is damaged and lost, certain areas of the retina 
lose their innervations resulting in a visual field loss in the upper or lower half of the 
field. Such loss is initially only minimal but is gradually progressive and may eventually 
result in total blindness if the disease is not treated. There are different tests that are 
used widely in ophthalmic settings to assess patient's visual field, which will be 
discussed later on in this chapter. 
2.2.1.4 Short and Far Sightedness 
An eye may be normal-sighted (emmetropic), meaning no visual correction is required, 
far-sighted (hypermetropic) or near-sighted (myopic). Healthy hypermetropic and 
myopic eyes have the same mean lOP as emmetropic eyes (Flammer, 2003). 
However, since myopic eyes are, on average, larger than normal eyes, there is a high 
risk of COAG and other eye diseases independent of glaucoma. The association of 
COAG with myopia has been shown in several case-control studies {Johnson et aI., 
1998}. However, there is a potential for selection bias, because those with myopia are 
more likely to seek eye care and have a higher probability of being diagnosed with 
glaucoma compared with people without refractive errors (Tielsch et aI., 1994). 
2.2.2 Demographic Factors 
These are factors that can have a more or less pronounced influence on the intraocular 
pressure. These factors are discussed here. 
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2.2.2.1 Age 
Glaucoma is strongly associated with age and particularly so in COAG. Although 
children; even newborns, can suffer from glaucoma, it is very rare; most patients 
having an elevated lOP are over the age of 40 (Mitchell et ai, 2002). Throughout a 
person's lifetime, even in healthy eyes, there is a gradual rise in the lOP. This is due 
to the ageing of the trabecular meshwork, however, the production of the aqueous 
humour decreases during the same period, so the lOP rise is usually quite moderate 
(Azuara-Blanco et aI., 2002). For most COAG patients, the lOP starts to rise between 
the age of 40 and 50. In other patients, the lOP rises at a later age (Leske, 2007). 
In a meta-analysis, it was shown that the prevalence of COAG rose steadily with age 
and more steeply in Europeans than in other populations, but at all ages black 
populations have the highest prevalence estimates (Rudnicka et aI., 2006). Without 
treatment, the pressure continues to rise over the years. The exact nature of the 
changes in the eye related to age that also accounts for the development of COAG is 
not known (Johnson et aI., 1998). 
2.2.2.2 Socioeconomic Status, Alcohol Drinking and Smoking 
Eye problems like many other health problems are more prevalent in people living in 
relatively underprivileged areas (Reidy et ai, 1998). In addition, uptake of eye 
examination is low amongst individuals coming from unskilled socioeconomic groups 
(Wormald et ai, 1997). Hence, those who have the least material and psychosocial 
resources to cope with blindness may be at substantially higher risk of glaucoma and 
glaucomatous visual loss (Fraser et ai, 2001). Whether this is a reflection of the social 
class variations in the prevalence or incidence of COAG (Reidy et ai, 1998), or that 
those from less privileged circumstances present with different stages of 
glaucomatous disease remains unclear (Fraser et ai, 2001). Either way, it is a health 
inequality that needs to be addressed. 
Epidemiological studies are yet to show whether alcohol consumption and smoking, 
which are known to be associated with socioeconomic factors, have any evident effect 
on the prevalence of COAG (Quigley et ai, 2001). Bonovas et al. (2004) conducted a 
systematic review and a meta-analysis of four case-control studies and three cross 
sectional studies. They found that current smokers were 1.37 times more likely to have 
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COAG than non-smokers. More data from epidemiological studies is needed and the 
analysis should take into account risk factors that are related to socioeconomic status. 
2.2.2.3 Gender 
The relationship of gender to risk of COAG is inconsistent as men and women have 
the same lOP levels (RCO, 2004). The Farmingham and Barbados Eye Studies found 
that men had a significantly higher prevalence of COAG than women across all racial 
groups (Leibowitz et aI., 1980; Rudnicka et aI., 2006), whereas the opposite was found 
in Sweden (Bengtsson, 1981) and no association was found in Wales (Foster et aI., 
2002). Thus, gender is unlikely to be a major risk factor for COAG (Tielsch, 1996). 
However, Mitchell et al (2002) asserts that not only women commonly afflicted with 
normal tension glaucoma but also women with COAG and high lOP have a slightly 
higher risk of developing glaucomatous damage at a certain pressure level than do 
men. 
2.2.2.4 Ethnic Background 
Racial variations in the risk of COAG are an important part in the epidemiology of the 
disease (Tielsch, 1996). Although it is sometimes not easy to separate the influences 
of the prevailing socioeconomic conditions, nevertheless, patients of African ancestry 
often have a higher lOP and develop elevated lOP at earlier age (Leibowitz et aI., 
1980). The reason for the excess risk among persons of African descent is not clear, 
but it is likely to be related to an underlying predisposition (Tielsch et aI., 1994). 
Caucasians, on the other hand, suffer more frequently from pseudoexfoliation 
glaucoma particularly in the northern European countries. This study was mainly 
based in the East London borough of Barking and Oagenham. The population of Black 
and Ethnic Minorities in Barking and Oagenham has risen by 158% from 9,779 in 1991 
to 25,257, in 2001. These figures have almost tripled in recent surveys with rising 
levels of inequalities. 
Engaging affected individuals from Black and Minority Ethnic (BME) populations can 
be challenging. There are language barriers that can have an impact on affected 
individuals of Asian origin, to a lesser extent on individuals of Black origin. However, 
BME groups tend to have the health belief that of "doctor knows best" which in itself 
can be a challenge in treating COAG, not only because of increased prevalence, but 
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also in adherence to treatment. Therefore, by recruiting expert BME patients in this 
research, it further increases the potential to reach out to potentially disadvantaged 
groups. 
2.2.2.5 Familial Factors 
Family history is an established risk factor as the hereditability of COAG has been 
calculated from twin studies to be as high as 70-80% and 98% has been reported in 
monozygotic twins (Gottfredsdottir et ai, 1999). There is a clear inherited component 
in many individuals (lOP, aqueous outflow facilities and disc size are inherited 
characteristics) (AAO, 2005). In a Rotterdam study (Wolfs et ai, 1998) the lifetime risk 
of glaucoma was nine times higher in siblings and offspring of glaucoma patients than 
in siblings and offspring of controls without glaucoma. It showed almost twice higher 
incidence of COAG in those with a positive family history of COAG compared with 
those without a family history. In a similar study (Azuara-Blanco et ai, 2002), 
individuals who have a first-degree relative with glaucoma have greater risk of up to 
30% of developing the disease compared with controls. However, it is thought that 
there is incomplete penetrance and variable expressivity of the genes involved (Wiggs, 
2007). COAG is inherited as a complex trait with unclear understanding of the 
inheritance patterns. 
2.2.3 Systemic Diseases Risk Factors 
2.2.3.1 Diabetes 
While it is well documented that complications of diabetes can produce secondary 
glaucoma, the association of diabetes with COAG is inconsistent (Wilson et aI., 1987). 
Johnson et al. (2003) reported the conflicting evidence to whether there is any 
association or not; case-control studies have given relative risks (Mitchell et ai, 1996) 
while population-based studies have usually not found this association (Tielsch et ai, 
1995). 
2.2.3.2 Hypertension 
Systemic blood pressure has been related to COAG risk in several studies (Edgar and 
Rudnicka, 2007). Effects on ocular perfusion pressure mean that both systemic 
hypertension and hypotension have been implicated as risk factors for CAOG 
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(Graham, 1999). Although there is contradictory evidence from different studies (Leske 
et aI., 2001 a), there is considerable evidence that a reduction in blood pressure 
reduces the risk of COAG (Weih et ai, 2001). Other studies have related this risk to do 
with age as the majority of hypertensive patients are over the age of 40 to 50 whereas 
young hypertensive patients seem to be protected, while older ones have twice the 
normal risk of developing COAG (Johnson et aI., 1998). 
2.3 Socioeconomic Variations in COAG 
Socioeconomic status is measured by ascertaining education, income and occupation 
status. Current literature suggests consistent evidence for an association between 
lower socioeconomic status and late presentation with COAG. This inverse 
relationship between socioeconomic status and late presentation can be interpreted 
in different ways. Firstly, socially patterned differences in health seeking behaviours 
are likely to operate, and evidence suggests that regular sight testing is associated 
with higher social class as it greatly reduces the risk of late presentation (Fraser et aI., 
2001; Hoevenaars et aI., 2006). Secondly, other socioeconomic factors include 
education deprivation. Literature suggests it influences awareness of the disease and 
the need for regular sight testing. 
A Survey of Public Knowledge, Attitudes and Practices Related to Eye Health and 
Disease in the USA, knowledge of COAG was associated with having health 
insurance, higher income and higher education (Coleman and Kodjebacheva, 2011). 
Similar studies showed association between lower educational attainments with the 
lack of knowledge about COAG (Hoevenaars et aI., 2006; Gasch et aI., 2000). In the 
UK, people with late COAG were more likely to be from lower occupational classes, 
lack personal transportation, are less educated and rent rather than own their 
residences compared with people with early COAG (Fraser et aI., 2001). A recently 
published Rotterdam Study (Ramdas et aI., 2011) has claimed that socioeconomic 
status was not associated with the onset of COAG in a population-based prospective 
study. The findings of this study were inconsistent with the prior research and 
evidence, Coleman and Kodjebacheva (2011) commented that given that the 
Netherlands ranks number one in terms of equity in health care for all individuals 
regardless of income and education, these findings were not surprising. 
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By 2034, it is estimated that 23% of the UK population are expected to be age 65 and 
over, compared to 16% in 2009. The fastest population increase has been in the 
number of those ages 85 and over: the "oldest old". In 1984, there were approximately 
660,000 people in the UK over the age of 85. Since then the numbers have more than 
doubled reaching 1.4 million in 2009. By 2034 the number of people age 85 and over 
is projected to be 2.5 times larger than in 2009, reaching 3.5 million and accounting 
. for 5% of the total population. According to statistics carried out in 2008, 64% of blind 
and 66% of partially sighted people in the UK were age 75 or over. As people are 
clearly expected to live longer, so the incidence of age related sight loss due to 
progressive conditions like COAG will increase. 
2.4 Prevalence of Glaucoma 
There are many population-based surveys on the prevalence of glaucoma. 
Unfortunately many of the old publications do not differentiate between COAG and 
primary angle-closure glaucoma (PACG). However, the latter is far less common than 
COAG in the white population and those of European descent and therefore the 
estimates are likely to reflect mainly cases of COAG (Leske et ai, 2001 b). The following 
table (2.3) provides a summary of the trends of prevalence of glaucoma globally 
according to the ethnic group. 
T able (2.3 : Population-based prevalence of glaucoma by ethnic group Edgar and Rudnicka, 2007) 
Ethnic Age Sample COAG PACG 
origin Author (s) Year Name/location group size (%) (%) 
Black Mason et al 1989 St Lucia, West Indies 30-70+ 1679 8.76 -
Tielsch et al 1991 Baltimore, USA 40-80+ 2395 4.18 
-
Leske et al 1994 Barbados, West 40-86 4498 6.8 
-
Wormald et al 1994 Indies 35-60+ 873 3.67 
-
Behrmann et al 2000 London, UK 40-80+ 3247 3.08 0.59 
Rotchford et al 2003 Kongwa, East Africa 40-97 839 3.69 0.6 
Temba, South Africa 
Asian Awasthi et al 1975 Agra, India 30-70+ 3603 1.33 
-
Hu 1989 Shunyi, Beijing 40+ 3000 0.03 1.4 
Shiose et al 1991 Japan 30-70+ 8924 2.53 0.08 
Foster et al 1996 Hovsgol, Mongolia 40-89 942 0.53 1.49 
Jacob et al 1998 Vellore, India 30-60 972 0.41 4.32 
Foster et al 2000 Singapore 40-81 1232 1.79 1.14 
Metheetrirut et 2002 Bangkok, Thailand 60-104 2092 2.92 2.53 
al 2003 Aravind, South India 40-90 5150 1.24 0.5 
Ramakrishan et 2004 Tajimi, Japan 40-80+ 3021 3.94 
-
al 
Iwase et al 
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Eskimo Arkell et al 1987 Kotzebue, Alaska 15-70+ 1686 0.06 0.59 
White Hollows et al 1966 Frendale, Wales 40-74 4231 0.47 0.09 
Bankes et al 1968 Bedford, UK 20-80+ 5941 0.76 0.17 
Leibowitz et al 1980 Framingham, USA 65-75+ 2631 1.9 -
Bengtsson 1981 Dalby, Sweden 58-68 1511 0.86 0.13 
Ringvold et al 1991 Norway 65-89+ 1871 3.37 
-
Tielsch et al 1991 Baltimore, USA 40-80+ 2913 1.1 
-
Klein et al 1992 Beaver Dam, USA 43-75+ 4926 2.11 -
Coffey et al 1993 Roscommon, Ireland 50-80+ 2186 1.88 0.09 
Salmon et al 1993 Mamre, South Africa 40-70+ 987 1.52 2.33 
Dielemans et al 1994 Rotterdam, 55-75+ 3062 1.11 -
Leske et al 1994 Netherland 40-86 133 0.75 -
Hirvela et al 1994 Barbados, West 70-95 500 10.4 
-
Giuffre et al 1995 Indies 40-99 1062 1.22 
-
Mitchell et al 1996 Oulu, Finland 49-80+ 3654 2.38 -
Cedrone et al 1997 Castledaccia, Sicily 40-80+ 1034 2.51 0.97 
Wensoret al 1998 Blue Mount, Australia 40-90+ 3265 1.72 0.06 
Bonomi et al 1998 Ponza, Italy 40-80+ 4297 1.4 0.61 
Reidy et al 1998 Melbourne, Australia 65-100 1547 3.04 
-
Quigley et al 2001 Egna-Neumarkt, Italy 41-90+ 4774 1.97 0.1 
North London, UK 
Proyecto, USA 
COAG. Primary open angle glaucoma, PACG: Primary angle closure glaucoma 
The above table summarises the prevalence of COAG and PACG from some of the 
larger population-based studies. Although the methods of testing and sampling vary 
from one study to another depending on the criteria used for diagnosis (RCO, 2004), 
they give an idea of the relative prevalence in different populations. The prevalence 
as illustrated of COAG ranges from 0.03% in China to 8.76% in St Lucia; most of the 
studies in Table 2.1 are of people aged 30 years or more. The relative prevalence for 
COAG of those aged over 40 years in white people from Europe, America and 
Australia of comparable age groups is of the same order (Approximately 1-3%), 
whereas black populations of Caribbean origin have a higher prevalence in similar age 
groups. Currently the highest prevalence of COAG is reported in black populations of 
Caribbean origin; particularly St Lucia and Barbados (7-9%), with slightly lower 
prevalence (3-4%) in black populations of African origin (Leske et ai, 2001 b). More up-
to-date surveys have shown higher prevalence in Africa, with prevalence estimates up 
to 8% in Ghana (Ntim-Amponsah et aI., 2004). An even higher prevalence of up to 9% 
was found amongst African-Caribbeans, who originate mainly from West Africa where 
rates are elevated (Kosoko-Lasaki et aI., 2006). 
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Leske (2007) observed that prevalence rates tend to be higher in the most recent 
surveys in comparison to old surveys. This increase in the rates could be down to the 
increased awareness of people and so seeking expert opinion and screening tests. 
According to Leske's study of populations of 40 years and older, a prevalence of 
around 1-3% in Europe, 1-4% in Asia, and 2-3% in Australia was reported. 
An interesting observation in nearly all the population surveys is that approximately 
half of the cases of COAG detected at the time of the survey were previously 
undiagnosed. It comes as no surprise that COAG is the leading cause of irreversible 
blindness throughout the world, placing high emphasis on screening programmes 
(Johnson et aI., 2003). COAG accounts for most cases of glaucoma with around 2% 
of people older than 40 years having the condition, rising to almost 10% in people 
older than 75 years in white Europeans. As previously indicated in the UK, 
approximately 12% of blindness registrations are attributed to glaucoma (NHS 
Evidence, 2009). 
Epidemiology has made many crucial contributions to advance knowledge on COAG. 
Firstly, recent epidemiologic studies have documented the frequency and distribution 
of COAG in many populations as explained earlier. These studies have considerable 
scientific and public health implications (Leske, 2007). They show glaucoma 
disparities by ancestry, as well as the considerable amount of cases that remain 
undetected which is at least half in most studies (Wolfs et aI., 1998). Secondly, risk 
factor identification allowed the recognition of groups at higher risk and so provided 
strategies to target these groups for early detection, such as family members of 
glaucoma patients (Leske et aI., 2001 b). Finally, additional epidemiological 
contributions include the analysis of longitudinal data to identify factors predictive of 
progression of COAG. Identifying such factors will help in the management of 
glaucoma patients (Gordon et aI., 2002). 
2.5 Incidence of COAG 
There are fewer studies of glaucoma incidence. Farmingham and Ferndale prevalence 
studies gave a 5-year incidence of 0.2% at age 55 years, increasing to 1 % at 75 years 
(equivalent to 4 per 10000 per year and 20 per 10000 per year respectively) (Leibowitz 
et ai, 1980). Bengtsson (1981) reported 24 per 10000 per year in Sweden in those 
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over 55 years of age. In the Melbourne Visual Impairment study the incidence was 
reported at 12 per 10000 per year in those aged 60-69, 28 per 10000 per year in the 
70-79 age group and 82 per 10000 per year in those aged over 80 years (Le et ai, 
2003). 
Longitudinal follow up of the Barbados Eye Study (Leske et ai, 2001 b) showed a higher 
incidence amongst Black Caribbeans. The 4-year risk of COAG in black participants 
was 2.2%, which is equivalent to 55 per 10000 people per year. The rates were 1.2% 
per 4 years (30 per 10000 per year) in those aged 40-49 years rising to 4.2% (105 per 
10000 per year) at ages 70 years or more. 
2.6 Screening for COAG 
Glaucoma has long been regarded as a disease that fits well the criteria for screening; 
it has a long asymptomatic period; it is highly prevalent in the population and early 
treatment is probably more effective at preventing significant loss of vision (Tielsch, 
1996). In 2006 there were no formal glaucoma screening programmes with defined 'at 
risk' target populations in existence in any country as indicated by Hatt et al. (2006). 
A recent review of the literature reflects no change in this situation. However, a number 
of ad hoc strategies exist in some parts of developed countries. In the United States 
of America (USA), the American Academy of Ophthalmologists (MO) recommends 
screening in high risk groups as well as healthy adults, and more regularly as they 
grow older (MO, 2005). 
In the UK, the International Glaucoma Association (IGA) has made similar 
recommendations. Free sight tests are offered to persons over 40 years of age where 
there is a family history of glaucoma. However, this does not present a formal attempt 
to reach and test everyone at risk in the UK. It is perhaps better termed as opportunistic 
surveillance rather than screening (Wormald and Rauf, 1995). The British College of 
Optometrists provided guidelines on which tests should be used and when, but these 
tests are not enforced. According to the NICE guideline (2009), using screening criteria 
consisting of an lOP> 21mmHg and a vertical cup-disc ratio of> 0.4, only 60-70% of 
potential COAG patients will be identified. Until more accurate methods of mass 
screening are available, screening should be selective but thorough and should 
include visual field examination (Kanski and Salmon, 2003). 
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In summary, the current evidence suggests that screening tests can achieve high 
detection rates (sensitivity) approximately up to 80% according to Harper and Reeves 
(2000), but the false positive rates (this is the proportion of people without the disease 
with positive test results) are typically as high as 10-30%. This means that about 10-
30% of all people tested would be referred for further examination that adds more 
burdens on overstretched services (Fraser et aI., 2001). Furthermore, Vernon (2011) 
observed that if the NICE glaucoma screening guidance is followed, it is predicted that 
more people with suspect of COAG will be referred from primary care for management; 
more people will have optic disc imaging, and so more people will be treated for 
glaucoma and have surgery for the condition. 
In most Western societies, population screening for COAG is probably unjustified as 
there is no satisfactory screening test that has been identified as suitable for mass 
screening. Furthermore, the prevalence of COAG is generally low, so the yield from 
the screening will also be low which could be particularly tackled by restricting the 
screening to vulnerable groups, such as elderly or people with strong family history, 
and particularly those who are socially deprived. Finally, further evidence is required 
to establish a strong relationship between starting early treatment and a reduction of 
visual disability or impairment as current evidence suggests that treatment delays the 
deterioration of visual field by approximately 18 months only (Heijl et ai, 2002). 
The uptake of testing by the British population is variable and the less educated and 
more deprived communities and ethnic minorities are less likely to seek testing (Fraser 
et aI., 2001). Given the higher rates of COAG amongst Afro-Caribbeans for instance, 
collaborative educational programmes that raise awareness of the condition and target 
the high-risk groups could be the way forward for glaucoma screening. Improving 
patients and families understanding of the risks and hereditary element of glaucoma 
is also another way to increase the uptake of screening. 
2.7 Coping with COAG and Quality of Life 
The relationship between glaucoma as a disease and the experience of people who 
have been diagnosed with glaucoma provides a classic example of a potential gulf 
between 'medical' and 'social' models of care (Green et ai, 2002). The WHO (2001) is 
advocating for an integrated 'biopsychosocial' model that applies to all people 
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universally. In glaucoma, Levine (1987) observed the focus on the Quality of Life (QoL) 
of patients as a potential development that implies the merging of biomedical and 
socio-cultural paradigms with a shared scientific interest in evaluating care. Indeed, 
this concept directs more attention to the more complete social and psychological 
wellbeing of individuals and the relationships with others (Leplege and Hunt, 1997). 
This increased attention to QoL in health care over the past two decades has been 
greatly facilitated by a generation of user-friendly instruments to measure patient-
reported health status and related aspects of QoL (Hunt, 1997). The goal in this section 
is not to attempt a comprehensive overview of QoL, but to outline selected issues that 
are of relevance to COAG. 
Searching the literature has identified a number of well-documented tools that have 
been used to assess the subjective status of glaucoma patients. These tools are 
classified as generic instruments (SF-36, SIP), vision specific instruments (VF-14, 
NEI-VFQ, NEI-VFQ-25, and ADVS) and glaucoma specific instruments (GSS, 
COMTOL, GQL, and SIG). 
QoL is quite hard to define, and the impact of COAG on QoL is even harder to define 
(Aspinall et aI., 2008). Nonetheless, the ultimate goal in glaucoma management is the 
maintenance of patients' QoL through the preservation of vision. Therefore, an 
understanding of how COAG impacts on an individual is that QoL is central to its 
management (Goldberg et aI., 2009). 
COAG usually results in visual field defects in the individual's peripheral and 
occasionally central vision. Following the diagnosis, patients usually spend the rest of 
their lives attending an eye hospital and taking ocular anti-hypertensive drops on a 
daily basis. This could have a significant impact on their QoL for several reasons; firstly 
the diagnosis itself; as some people readily accept the diagnosis and are keen to seek 
information (Hartmann and Rhee, 2006). Others might find it hard to accept the 
diagnosis and disappear into the community only to return years later with a 
substantial deterioration in their visual function, whilst the majority fall in between the 
two extremes (Severn et aI., 2008). Secondly, the treatment of glaucoma that aims at 
decreasing lOP comes with many problems. The inconvenience of instilling one or 
more eye drops for the remainder of the individual's life, the experienced side effects 
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that discourage patients from instilling the eye drops, and the cost of the treatment 
(Nordmann et aI., 2003). Lastly, the insidious loss of vision and independence, given 
that regular hospital outpatient appointment reviews will be required. This could be of 
major concern for patients with COAG; particularly the elderly (Lester and Zingirian, 
2002). 
Having said this, the impact of COAG, like the disease itself, comes on very slowly 
over a period of 10 or 20 years and is usually associated with other medical conditions 
which make it even harder to know the cause of a specific symptom (Severn et aI., 
2008). Therefore getting an accurate account from a glaucoma patient about the 
impact of the disease may not always be easy. However, there are areas that could 
be potentially affected as a consequence of the disease which include impact on 
walking, reading and driving. 
2.7.1 Walking, Balance and Falling 
This is an important aspect of daily living that can be greatly affected by glaucoma. 
Vision is very important in maintaining balance, and studies have examined this 
connection by looking at how much individuals sway when they are standing still. 
Shabana et al (2005) found that glaucoma patients tend to sway a lot more than people 
with healthy eyes. It comes as no surprise that several studies have found that 
glaucoma patients tend to fall two to three times more frequently than individuals 
without glaucoma (Hassan et aI., 2007). Unfortunately, once a glaucoma patient 
reaches this level of difficulty, activities will have to be restricted to the minimum, or to 
consider using a walking aid that often marks him/her as disabled. This also could 
greatly impact on a glaucoma patient's quality of life and sense of independence and 
make him/her rely greatly on the help of others to perform their daily activities (Black 
et aI., 2008). With fewer numbers of patients who have personal transport, surely, this 
adds complexity for the glaucoma patient who now has to rely on public transport to 
get him/her to a clinic appOintment. Therefore, this research may have a profound 
effect on maintaining an ability to get around and overall quality of life. 
2.7.2 Impact on Reading 
Reading as a task primarily involves central vision. However, a study that looked at 
reading difficulties amongst glaucoma patients found that many people with glaucoma 
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express difficulty in finding the next line (Viswanathan et aI., 1999). This means that it 
may be glaucoma patients have no problem seeing what is in front of them, but to scan 
a page or search for specific information becomes difficult. Few studies exist that look 
at glaucoma patients who give up reading, although it is one of the most important 
vision-related activities and likely to have a huge impact on a patient's QoL (Aspinall 
et aI., 2008). 
2.7.3 Impact on Driving Ability 
Loss of peripheral vision will considerably undermine the ability to drive. Haymes et al. 
(2008) argued that relatively early glaucoma can make it difficult to see pedestrians 
on the road, while more advanced disease can infringe on central vision, with obvious 
consequences. Other studies suggested even healthier eyes with a great amount of 
visual field loss was associated with worsening driving outcomes (Szlyk et aI., 2002). 
Patients handle the issue of driving differently. Some will express the difficulties faced 
when driving and having more frequent accidents; some will manage to continue to 
drive safely, while others will cut back on driving or stop driving altogether (McGwin et 
aI., 2005). This can have a great effect on the individual's QoL especially with the 
elderly who sometimes have no one else to rely on for help getting to the shops, 
socialise or even attending their outpatient clinic appointments. It may have an even 
greater effect in cases where the patient is a taxi driver and supports his or her entire 
family and has to give up his or her driving or risk his or her life and that of others. 
There are legal guidelines in place to prevent patients who have lost more than half of 
the visual field in both eyes; all of this makes the impact of glaucoma on driving 
sometimes devastating (Freeman, et aI., 2006). 
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Section II: Meta-analysis of Self-Management Programmes in 
Chronic Conditions 
Meta-analysis is a scientific tool that can be used to summarise, appraise and 
communicate the results and implications of otherwise unmanageable quantities of 
research. It is of particular value in bringing together a number of separately conducted 
studies, sometimes with conflicting findings, and synthesise their results (CRD, 2001). 
In health care, with a constantly expanding amount of research and data to be 
considered by health professionals, Meta-analysis and systematic reviews become 
valuable tools for professionals who want to keep up with new evidence, gathering 
and synthesising evidence from reliable research to facilitate incorporation of research 
into practice (Higgins & Green, 2005). In the existence of uncertainty regarding the 
potential benefits or harm of certain new technologies or practices, meta-analysis and 
systematic reviews are of particular value in bringing together a number of separately 
conducted studies. They are essential to identify areas where the existing literature is 
insufficient, where gaps have arisen, and where further research is required 
(Kitchenham, 2004). 
Systematic reviews mayor may not include a statistical synthesis of the results from 
independent studies which is what meta-analysis does. The Cochrane Collaboration 
(2006) defined meta-analysis as the statistical combination of results from two or more 
separate studies, which generally aims to produce a single estimate of a treatment 
effect. 
The Cochrane Collaboration (2006) identifies three main reasons for undertaking a 
meta-analysis in a review. 
• To increase power and the chance the researcher can detect a real effect as 
statistically significant if it exists. 
• To improve precision of researcher estimation of treatment effect observed. 
• To answer questions not presented by individual studies to settle controversies 
ariSing from conflicting studies to generate new hypotheses. 
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2.8 Rationale for undertaking a meta-analysis: 
Undertaking this meta-analysis involved taking the findings from several randomised 
controlled trials of self-management programmes for patients with chronic diseases 
and analysing those using standardized statistical procedures. This helps to draw 
conclusions and detect patterns and relationships between findings which will enhance 
the precision of estimates of treatment effects, leading to reduced probability of false 
negative results, and potentially to a more timely introduction of effective treatments 
(Polit & Beck, 2006). 
Unlike traditional reviews, the purpose of this meta-analysis is to provide as complete 
a list as possible of all the published and unpublished studies relating to chronic 
diseases self-management. While traditional reviews attempt to summarize results of 
a number of studies, meta-analysis uses explicit and rigorous criteria to identify, 
critically evaluate and synthesize all the literature on a particular topic. It would reveal 
a new view of the efficacy self-management programmes. 
2.9 Formulation of Review Question 
One of the most critical issues in any meta-analysis is to formulate the right question 
that is focused, measurable and clear. Kitchenham (2004) pointed out that the right 
question in systematic reviews is one that is meaningful and important to practitioners 
as well as researchers. It should also lead to change in current practice or to increase 
confidence in the value of current practice, and identify discrepancies between 
commonly held beliefs and realities. 
In addition, a good understanding of the research question will guide the reviewer in 
choosing the right studies to be included as well as the data required to answer the 
question (Jackson & Waters, 2004a). The formulated questions of this analysis are: 
• Do different ways of involving patients with chronic conditions in the planning 
and implementation of health services succeed in improving the quality of 
health care services? 
• Do interventions that include empowering and enabling activities in their training 
programmes succeed in increasing people's awareness and readiness to 
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assume more responsibilities regarding their own health and wellbeing as well 
as health care services they receive? 
2.10 Identification of Studies 
The aim of meta-analysis is to find as many primary studies relevant to the research 
question as possible using an unbiased search strategy (Kitchenham, 2004). For this 
analysis, all randomised controlled trials that examine interventions that involved 
expert patients with chronic arthritis and aimed at improving their self-management 
skills as well as the services they receiving were identified. 
Randomised controlled trials (RCTs) are considered by many in the biomedical model 
to be the gold standard when addressing questions regarding effectiveness in 
healthcare; whereas other study designs are appropriate for addressing other types of 
questions (CRO, 2001). Researchers should consider what study designs are likely to 
provide reliable data with which to answer their questions. Because this analysis 
addresses questions about the effects of health care intervention from a biomedical 
perspective, it focuses primarily on RCTs. Many researchers in the medical field argue 
that there are two reasons why caution should be exercised in relation to including 
non-randomised studies in an analysis of the effects of health care. Both relate to bias. 
First, although it is possible to control for confounders that are known and measured 
using other study designs, randomisation is the only way to control confounders that 
are not known or not measured (Kunz & Oxman, 1998). Empirical evidence suggests 
that, on average, non-randomised studies tend to overestimate the effects of 
healthcare (Schulz, et aI., 1995). However, a systematic methodology review has 
shown that the extent and even the direction of bias in non-randomised studies are 
often impossible to predict (Kunz & Oxman, 1998). 
Second, although it is often difficult to locate RCTs and reviews that fail to include 
unpublished trials, they may be biased toward overestimating the effectiveness of an 
intervention (Oickersin, et aI., 1994). Consequently, researchers in the biomedical 
model believe including studies other than controlled trials in an analysis may require 
additional efforts to identify studies and to keep the analysis up-to-date. This might 
increase the risk that the results of the analysis will be influenced by publication bias. 
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2.10.1 Types of participants: 
This analysis included adult participants. Although it was intended to divide 
participants into age subgroups of adults, adolescents and children, only studies 
involving adults are included as studies involving the other subgroups are not 
assessable in published literature. 
Studies which target participants without an established chronic rheumatoid arthritis 
and/or chronic osteoarthritis that have been clinically confirmed have been excluded. 
Studies that target patients with compromised mentation, cancer patients who 
received chemotherapy, radiotherapy or any other therapeutic operation in the last 
year have also been excluded. 
2.10.2 Types of intervention: 
This analysis includes lay-led self-management education programmes for people 
with chronic arthritis. Interventions of interest are self management education 
programmes for people with chronic conditions. For the purpose of this analysis, these 
interventions are defined as structured programmes for people with chronic conditions 
which are judged to be primarily educational and address self-management of disease 
and where the majority of the course content was delivered by lay people. If health 
professionals participated as leaders they would have had a chronic illness and they 
would have adhered to the course manual. In addition, face to face education, in a 
group or as individuals have been included. 
likely components of self-management programmes are: 
• Prior training of lay tutors if appropriate 
• Education about the disease or condition 
• Education about lifestyle 
• Education on how to manage the condition and its symptoms 
• Skills training 
• Problem solving techniques 
• Self management-techniques 
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Interventions that are for people without established chronic conditions, for example, 
programmes that target people at higher risk of developing arthritis to encourage them 
to exercise were excluded. 
2.10.3 Types of outcome measures: 
Two main outcomes were identified, one primary and the other secondary. The 
Primary outcomes of the analysis are: 
• Health status: including patient self-rating quality of life, disability, pain, fatigue, 
psychological well-being. 
• Health behaviour. including exercise, cognitive symptoms management, and 
adherence. 
• Clinical improvement in examination findings as judged by observers, 
• Healthcare use: including doctors' visits, outpatient doctor visits, emergency 
room visits, hospital admissions and length of stay. 
• Self-care and self-efficacy. represents a person's confidence to carry out self-
management behaviour. 
The Secondary outcomes are: 
• Knowledge of the condition 
• Change in clinical exam findings 
• Quality of life measures 
• Communication with professionals 
• Cost of delivering programmes. 
2.10.4 Search strategies and studies identification 
It was necessary to determine and follow a search strategy that started with a 
preliminary search which aimed to identify existing reviews and assess the volume of 
potentially relevant studies. This therefore required identifying the search terms and 
key words that will give the maximum number of relevant studies (CRD, 2001). In this 
review the following electronic databases were searched. 
• Cochrane Central Register of Controlled Trials (CENTRAL) from inception; 
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• MEDLINE from 1997; 
• EMBASE from 1997; 
• AMED from 1997; 
• CINHAL from 1997; 
• Database of abstracts of reviews of effects (DARE) from inception; 
• National Research Register from inception; 
• NHS Economic Evaluation Database; 
• ProQuest from conception. 
Search strategies included MeSH and text word terms as appropriate. Table (2.4) 
illustrates the search terms that were used to search electronic databases and relevant 
journal articles and reports. 
Table (2.4): Search Terms 
Population Problem area Promotion Intervention type of study 
topic 
Patient$ Arthritis Self care Patient Randomised 
education controlled trials 
Consumer$ Rheumatoid Self efficacy Enabling Random 
arthritis allocation 
Client$ Osteoarthritis Self manage$ Empower$ Double blinded 
method 
Lay Long term Clin$ trial$ 
Volunteer$ Chronic disease Self monitoring Health Single blind 
information method 
Train$ Degenerative Self help Practice Clinical trials 
disease guidline$ 
Expert Ongoing health Self-efficacy Health Compare$ 
patient$ condition priority$ Comparative 
study 
Instruct$ Persistent illness$ Health Single or double 
or disease$ educat$ or treble or triple 
blind$ 
Skill$ Long term illness$ Effective$ 
or disease$ 
Expert$ Evaluat$ 
2.10.5 Consulting experts: 
Consulting experts in the field was helpful to identify relevant articles and ongoing 
reviews. For example, Cochrane Vision and Eye Collaboration were contacted for 
guidance regarding guidelines to follow in the effectiveness of systematic reviews. 
Subject librarians were contacted to formulate the research terms to be used. 
S6 
Reference lists of retrieved articles and published reviews on the topiC were searched. 
Appropriate journals were also hand searched. The reference lists of included studies 
for any additional studies not identified through electronic search were considered. 
Experts in the field for information on current, past or unpublished trials and relevant 
stUdies were also consulted. 
2.11 Methods of the Meta-analysis 
2.11.1 Assessment of search results: 
Potential studies that may possibly fit the "inclusion criteria" as defined in this protocol 
were assessed. Where a decision was made to include a potential study a full copy 
was obtained for further scrutiny. If any doubt arose on the eligibility of a study for 
inclusion, consultation with supervisors was sought to assist in decision-making. 
2.11.2 Data extraction and management: 
A data extraction form using some examples of eligible studies was developed. Data 
from all eligible studies were extracted independently. 
2.11.3 Assessment of methodological quality: 
The quality of reporting of each randomised trial was assessed mainly according to 
the quality criteria specified by Schulz, et al. (1995) and Jadad, et al. (1996). The 
following criteria were examined: 
1. Minimisation of selection bias: 
-Adequate randomisation procedure 
-Adequate concealment allocation. 
2. Minimisation of attrition bias: 
-Complete description of withdrawals/dropouts. 
-Intention-to-treat participants. 
3. Minimisation of detection bias: 
-Outcome assessor blinded to the intervention. 
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According to these criteria, trials were classified into three categories to inform 
sensitivity analysis. 
(A) All quality criteria met: low risk of bias. 
(B) One or more of the quality criteria partly met: moderate risk of bias. 
(C) One or more criteria not met: high risk of bias. 
2.11.4 Confounders within the groups: 
-Baseline health status (presence of other infections, conditions) 
-Gender 
-Age 
-Disease type 
The nature of self-management interventions may mean that different interventions or 
intervention components can be aggregated together. In order to evaluate 
effectiveness by specific intervention designs, interventions were classified carefully 
and sensitivity analysis was conducted to examine the following design factors: 
-Duration of interventions (how many sessions per week) 
-Setting of intervention (school, community, clinical, urban) 
-Lay or professional led interventions (level of training of lay) 
-Quality of volunteers' training (amount, type) 
-Individual versus group intervention 
-Type of intervention (support versus counselling, education versus training). 
2.11.5 Consumer involvement: 
The involvement of consumers, who are affected by the conditions listed above, or 
those who designed and administered interventions, was of central importance in this 
review. Self-management intervention is a complex concept that has diverse 
meanings that are dependent on the context within which it is used. 
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2.12 Data collection: 
Studies for inclusion in this analysis were independently extracted onto data extraction 
forms that included study methods, participants, interventions, outcomes, and adverse 
events. Any further data not included in these fields were extracted in specially 
designed section called "Notes". Over all data extracted were presented in table 
format. 
2.12.1 Data Synthesis: 
It is anticipated that the included studies have used different rating scales. The validity 
and reliability of each rating scale as supported by previous studies were assessed. 
However, the aim was to summarise data from studies collecting similar outcomes and 
using similar follow-up times. The heterogeneity of the interventions, the follow-up 
periods and the outcomes observed in the trials did not allow for statistical 
combinations of the study results. 
2.12.2 Table of included studies: 
Tables of the included and excluded studies were synthesised. Within each of these 
sets of tables, interventions were further grouped according to type of study, type of 
intervention and participant characteristics. Subgroup and sensitivity were conducted 
to examine the effects of specific factors. For example: 
1. Method of support: group, individual, online, telephone. 
2. Different chronic conditions. 
3. Differences in effect across socioeconomic strata and health equity. These 
were assessed by evaluating whether self-management interventions reduce 
health inequalities. Possible categories for defining socioeconomic 
disadvantages were considered: 
• Race/ethnicity/culture 
• Gender 
• Socioeconomic status 
• Occupation, if appropriate. 
Interventions were classified as: 
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1) Effective: interventions were considered effective for reducing inequalities in 
health if the improvements reported were greater for people from 
disadvantaged groups. 
2) Potentially effective: interventions were delivered only to people from 
disadvantaged groups, and show statistically significant and meaningful 
positive effects. 
3) Not effective: interventions resulted in improvements for people in advantaged 
groups but not for those in disadvantaged groups. 
4) Uncertain: intervention evidence is mixed or equally effective for people from 
both advantaged and disadvantaged groups. 
This analysis was subjected to the amount of information collected and provided 
by the authors. If sufficient demographic data were not available to address issues 
of inequalities then this was acknowledged. 
2.13 Description of studies 
This section collates the findings of studies included in this analysis in a structured 
way. It presents information about the studies characteristics (population, sample, 
interventions and outcomes), their design, quality and their effects to provide a deeper 
understanding of the evidence. 
2.13.1 Finding the studies 
The initial search yielded 700 references and abstracts, of which only 146 publications 
were found to be relevant because they included evaluative elements. The rest of the 
publications examined self-management programmes which were delivered by health 
professionals mainly and/or addressed other chronic conditions like asthma, diabetes, 
depression and heart failure. Amongst the 146 references, 53 studies required 
retrieval of the full article for scrutiny. Only 23 studies went through the data extraction 
phase, of which 18 studies were later excluded for methodological reasons, as they 
lacked a clear evaluation of the whole experience of patient participation in the 
programme. Checking reference lists revealed a further four relevant articles, and 
checking the reference lists of these revealed a further relevant article. By examining 
booklets of the scientific congresses in the field of arthritis a further five potentially 
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relevant articles were identified and obtained as full text copies, of which one study 
was included. 
Therefore, the total number of primary studies that were included was 6 as illustrated 
in figure (2.3). 
Figure (2.3): Studies selection 
Initial search results 
--_. 
Potentially relevant 
citations 
Did not meet the 
outset criteria 
Full text articles 
retrieved for evaluation 
Studies excluded on methodological 
and intervention basis 
Relevant studies went 
through data extraction 
Studies excluded after data 
extraction 
Studies included in 
the analysis 
Reference lists and booklets of 
scientific congresses included studies 
Total number of 
studies included in the 
analv~i~ 
2.13.2 Included Studies 
Six trials were included in this review. These were studies published by Lorig, et al. 
(1999a); Lorig, et al. (1999b); Barlow, et al. (2000); Dongbo, et al. (2003); Buszewicz, 
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et al. (2006) and Kennedy, et al. (2007) (refer to appendix 1 for full details of the 
included studies). These are summarised below and details are provided in the 
'characteristics of included studies' Table (2.5) by its country and study design. 
Table (2.5): Characteristics of studies included 
Author, year Study design characteristics Country 
Lorig , et al. (1999a) 
Lorig, et al. (1999b) 
Barlow, et al. (2000) 
Dongbo, et al. (2003) 
Randomised 
study 
Randomised 
study 
Randomised 
study 
Randomised 
study 
Buszewicz, et al. (2006) Randomised 
study 
Kennedy, et al. (2007) Randomised 
study 
controlled United States of America 
United States of America 
controlled 
controlled United Kingdom 
controlled China 
controlled United Kingdom 
controlled United Kingdom 
: 
Lorig , et al. (1999a) in a four-month trial followed by one year health-related outcome 
study, conducted a six week lay-led self-management arthritis programme for Spanish 
speaking participants. They tried to determine the role of self-efficacy in predicting 
health status for this population. In an attempt to reach Spanish speaking communities 
in which arthritis is the leading cause of disability, the Spanish Arthritis Self-
Management Programme (SASMP) was developed and evaluated as a first step 
toward remedying this problem. 
Lorig , et al. (1999b) in a six-month lay-led trial , based in northern California, examined 
the effectiveness of Chronic Disease Self-Management Programmes (CDSMP) 
designed for use amongst heterogeneous groups. They went further to explore the 
differential effectiveness of the intervention for subjects with specific diseases and 
comorbidities. All patients with a chronic condition were eligible to be included apart 
from patients with compromised mentation, cancer patients and persons younger than 
40 years of age. To ensure optimal responsiveness of the programme, Lorig and her 
team conducted two needs assessments through focus groups and based the content 
and methodology of CDSMP on the subject's particular needs. To measure 
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effectiveness Lorig and colleagues used the Mental Health Inventory 5 Scale (MHI-5), 
Quality of Life Short Form (SF-20) and Pain scale as outcome measures for success. 
Barlow, et al. (2000) examined the effectiveness of the Arthritis Self-Management 
Programme (ASMP) when delivered amongst UK participants in a pragmatic, 
randomised, controlled trial. Lorig et ai's arthritis handbook and ASMP were 
implemented and delivered by lay volunteers who have arthritis. All patients with 
chronic arthritis who were over the age of 18 years and able to complete 
questionnaires were eligible for inclusion. 
Dongbo, et al. (2003) in a randomised controlled trial, evaluated the effectiveness of 
a CDSMP based on five urban communities in Shanghai which have the heaviest 
burden of non-communicable diseases and the largest ageing population in China. 
Although Lorig's CDSMP was widely accepted and implemented in this research, there 
are parts which were deemed culturally inappropriate and replaced with culturally-
oriented components. Dongbo et al went further to design a Chinese culturally 
acceptable CDSMP and train lay-volunteers to deliver the programme. Patients less 
than 20 years of age and those with compromised mentation and cancer patients who 
were receiving treatment were excluded as well as patients for whom problems could 
be expected with compliance or follow up. This is a large scale trial that was published 
in English and French languages as well as Spanish. The study has not accounted for 
withdrawals and dropouts; neither the participants nor the data were blinded to the 
treatment assignment. 
Buszewicz, et al. (2006) conducted a randomised controlled trial to evaluate the 
clinical effectiveness of a Self-Management Programme for patients with arthritis 
amongst 74 general Primary Care Practices in the UK. Teaching sessions were based 
on self-efficacy theory and delivered by lay volunteers as well as health professionals. 
The research team used well established and validated clinical measures including 
the Quality of Life Scale (SF36), Arthritis Scale (WOMAC), Hospital Anxiety and 
Depression (HAD) Scale and Arthritis Self-efficacy Scale. Subjects' details were 
blinded to the research team apart from the trial manager and dropouts were 
accounted for. 
Kennedy et al. (2007) in a two-arm trial compared the clinical and cost effectiveness 
of a lay-led self care support programme amongst patients with a chronic condition in 
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community settings in England. This trial was conducted in parallel with a wider 
national implementation of EPP to explicitly model the relationship between cost and 
outcome. A nationwide recruitment programme was conducted in all 28 strategic 
health authorities in England, using no specific inclusion or exclusion criteria, beyond 
a self-defined long-term condition. An anglicised version of Lorig et aI's CDSMP was 
developed based on the theoretical model of social learning, and delivered by a trained 
pair of lay trainer or volunteer tutors. The team identified self-efficacy, reported energy 
and routine health service utilisation as primary outcomes with a cost-effectiveness 
analysis conducted alongside the trial. Kennedy et al took account of dropouts and 
concealed for allocation. 
2.13.2.1 Study population 
The characteristics of study populations are summarised in Table (2.6). Only studies 
of adults were included because in childhood and adolescence these illnesses are 
quite uncommon and only studies addressing this population were found. 
Table (2.6): Characteristics of the study population by age and gender 
Key: 1= Intervention group, c= Control group, M= Male, F= Female 
Author (Year) I. Age C. Age I. Gender (%) 
(mean) (mean) 
Lorig , et al. (1999a) 62.5 years 62.5 years 15% M, 85% F 
Lorig , et al. (1999b) 65.5 years 65 years 35% M, 75% F 
Barlow, et al. (2000) 57.3 years 59.1 years 15% M, 85% F 
Dongbo, et al. (2003) 64.21 years 63.8 years 26. 7%M, 73.3%F 
Buszewicz, et al 68.4 years 68.7 years 37% M, 63% F 
(2006) 
Kennedy, et al. (2007) 55.5 years 55.3 years 30% M, 70% F 
I 
C. Gender (%) 
19% M, 81% F 
36% M, 74% F 
17% M, 73% F 
30.9%M, 69.1% 
F 
37% M, 67% F 
30.4% M, 
69.6%F 
In addition, they create additional issues for self-management interventions, such as 
parent-child relationships, child development, puberty and education, which are 
beyond the scope of this review. This review is limited to randomised trials published 
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between 1998 and 2008 to capture the content and effectiveness of fairly recent 
interventions. 
All studies targeted adult people with an average age of 55.5 to 68.4 years of age in 
the treatment group compared to 55.3 to 68.7 years of age in the control group. Both 
men and women were targeted equally in all studies, however, although the messages 
were basically designed to target both men and women equally, all the studies 
included have significantly less male participants than females for reasons, which will 
be discussed later. Nonetheless, there was no significant difference between the 
percentage of male and female participants when comparing treatment and control 
group populations in each study. 
2.13.2.2 Sample and Withdrawals 
A total of 4410 participants were included in the 6 trials with 2439 (55 .3%) in the 
intervention group. The number of participants recruited varied widely from the 
smallest study (Lorig , et aI., 1999a) that included 331 participants with 219 (66%) 
allocated to the intervention group compared to the largest study (Lorig, et aI., 1999b), 
which included 1140 participants with 664 (58%) randomised to the intervention group. 
Comparability of different types of interventions is likely to be affected by the greater 
power of the larger studies to detect significant effects compared with smaller studies. 
The following table (2.7) describes the characteristics of studies included with their 
samples and recruitment procedure. 
Table (2.7): Characteristics of the Samples by Recruitment Setting 
Author ioN (completed) C.N Recruitment 
(completed) 
Lorig, et al. 219 (189) 112 (97) Not available. 
11999a) Total: 331 (286) 
-... 
..... 
Lorig, et al. 664 (558) 476 (390) Public announcements, GP offices, citizen ----
11999b) Total: 1140 (948) centres, coun!y referral. 
Barlow, et 311 (234) (241) 233 (189) GP practices, rheumatology departments -..... 
al. (2000) Total: 544(423) and public announcements. 
Dongbo, et 526 (430) 428 (349) Public announcement, clinic referrals, -.... 
al. (2003) Total: 954 (779) Community centres and interpersonal 
ll_ersuasion. 
Buszewicz 406 (294) 406 (325) Rheumatology Practices, through 
----
, et al. Total: 812 (619) analgesia prescription. 
(2006) 
Kennedy, 313 (248) 316 (273) EPP and peT staff, EPP webpage press .......... 
et al. Total: 629 (521) release. 
12007) 
-........ 
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Egger, et al. (1997) stated that loss to follow up withdrawal subjects may lead to the 
exclusion of patients after they have been allocated to treatment groups, which may 
introduce attrition bias. Lorig, et al. (1999a) study shows 86% of the intervention group 
completed the 4-month follow up compared to the same percentage of 86% in the 
control group. Lorig, et al. (1999b) trial shows 84% of the intervention group and 83% 
of control group completed the 6-month data collection period. However, Lorig et al. 
took full account of the (treatment-control) subjects not completing the final 6-month 
data collection, 1.2% - 0.8% had died, 3.4% -7.8% were too ill to continue, and 11.4% 
- 9.4% had unknown reasons for withdrawal. Barlow, et al. (2000) trial has 77.5% of 
the intervention group compared to 81.1 % of control group completing the 4-month 
follow up, with no account mentioned for the participants who failed to complete the 
follow up. 
Dongbo, et al. (2003) study has an almost equal percentage of participants in the 
groups who completed the follow up, with 81.7% of the intervention group and 81.5% 
of the control group completing the study. Taking a full account of subjects who failed 
to complete follow up, this trial has provided a good example of handling the loss to 
follow up. In total, 56 subjects in the intervention group and 69 partiCipants in the 
control group were identified. Of which 12 of the intervention group and 17 of the 
control group moved out of the area, 50f the intervention group and 10 of the control 
group were too ill to complete, 12 of the intervention group and 17 of control group 
refused to continue, 4 of the intervention group and 7 of the control group had died 
and 23 of the intervention group and 18 of the control group had an unknown reason 
to withdraw. 
Buszewicz, et al. (2006) had only 72.5% of the intervention group subjects included in 
the analysis compared to 80% of the control group participants. Nonetheless, they 
provided an account of the subjects who failed to complete the follow up as the 
following; 112 subjects of the intervention group compared to 81 of control group. Of 
Which 5 of the intervention group and 2 of the control group had died, 35 of intervention 
group and 23 of the control group withdrew for unknown reasons, and 72 of the 
intervention group and 56 of the control group had not responded with no further 
details given. 
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Kennedy, et al. (2007) had a differential attrition of 79.2% of the intervention group 
subjects completed the 6-month follow up sessions compared to 86.4% of the control 
group subjects who completed the same follow up. However, Kennedy, et al. (2007) 
could not provide a clear account of subjects who decided to withdraw. 
2.13.2.3. Participation rates and Follow up 
The time demand of self-management interventions could result in low participation 
and high rates of attrition. Analysis of participation rates is difficult because many 
studies fail to report them. However, knowledge of participation is important since it 
indicates the extent to which results can be generalised. All studies included in this 
analysis showed significantly high participation rates ranging from 72.5% to 86.4%. 
When comparing the participation rates of the intervention groups to the control groups 
across studies there is an insignificant difference. As previously noticed , self-
management interventions with greater intensity and longer duration had high attrition 
rates. The following table (2.8) describes the characteristics of the studies according 
to the duration of intervention and follow up as well as their participation rate. 
Table (2.8): Characteristics of duration of interventions and follow up 
Author (Year) Duration Follow-up Participation rate 
Lorig , et al. (1999a) Six weekly of 2 hour 4 months & 1(86%), C (86%). 
sessions 1year 
Lorig, et al. (1999b) Seven weekly 2.5 hour 6 months 1(84%), C (82%). 
sessions 
Barlow, et al. (2000) Six 2hour sessions 4 months 1(77.5%), C 
(81.1%) 
Dongbo, et al. (2003) Seven 2-2.5 hours 6 months 1(81.7%), C 
sessions (81.5%) 
Buszewicz, et Six sessions 1,4&12 I (72.5%), C (80%) 
al(2006) months 
Kennedy, etal. Six 2.5hour sessions 6 months 1(79.2%), C 
12007) (86.4%) 
Key: I=intervention group, C=Control group. 
Buszewicz, et al. (2006) study has the longest duration of intervention of 12 months in 
comparison to the other studies and it is evident that it has the lowest participation rate 
and the greatest difference between the intervention and control group. The factors 
leading to high attrition are clearly complex, but characteristics of individuals most 
likely to drop out should also be investigated to ensure the interventions are targeted 
most effectively. 
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2.13.2.4. Delivery 
All of the self-management interventions were delivered in a group setting. The 
arguments for using group intervention include reduced costs and the potential value 
of group learning. Individual interventions are often justified on the basis that the 
intervention can be tailored to individual needs, and they might be easier to integrate 
into clinical practice. Evidence on the effectiveness of group or individual delivery is 
scarce because comparisons across studies are confounded by many other variables. 
For example, Lorig, et al. (1999b) study, in order to assure the programme would be 
easily accessible to patients; it was held in multiple community sites including 
churches, senior and community centres, public libraries and health care facilities. For 
the convenience of patients, interventions were planned at varied times including late 
mornings, early afternoons, evenings as well as weekends. On the other hand, 
Dongbo, et al. (2003) considered the different local features of the five communities 
included in their study and accordingly adopted two delivery models. The first was a 
"commonly participatory model" in which communities were working alongside 
professionals and stakeholders in every step of the planning and implementation. The 
second was a "professional dominated model" where communities provided passive 
support to the programme. Kennedy, et al. (2007) interventions were delivered in non-
NHS premises while the other two studies Barlow, et al. (2000) and Buszewicz, et al. 
(2006 lacked a clear mode of delivery. 
There is research evidence that positive role model "lay leaders" with similar 
backgrounds and disease problems increase patients' self-efficacy or confidence in 
their ability to manage their disease (Lorig, et aI., 1999a). All the included studies with 
the exception of Buszewicz, et al. (2006) clearly identified the leaders who delivered 
the intervention. Lay leaders have the benefit of acting as role models and being less 
costly, but health care professionals are more able to address factual issues related 
to illness. Presently, little evidence suggests which approach is more effective. Two 
studies that made direct comparisons between lay-led and professional-led 
programmes showed no improvement in pain or disability with either approach but 
showed differential changes in other outcomes (Lorig, et aI., 1986). There is also 
insufficient evidence to show whether certain groups or professions are better placed 
to deliver self-management programmes. Nonetheless, training is an important 
determinant of effectiveness, particularly when complex skills such as cognitive 
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behavioural techniques are used. Information about training of course leaders was not 
commonly reported as illustrated in table (2.9). 
Table (2.9): Characteristic of Interventions Delivery by the Deliverer 
Author (Year) Individual Delivered by 
Lorig , et al. (1999a) 
Lorig, et al. (1999b) 
Barlow, et al. (2000) 
Group 
Group 
Group 
Dongbo, et al. (2003) Group 
Buszewicz, et al. Group 
(2006) 
Kennedy, et al. Group 
(2007) 
Limited information. 
Trained lay leaders (71%), students (15%) and 
(23%) health professional. 
Lay leaders who suffer arthritis. 
Trained non-health professional volunteer 
leaders. 
Unclear 
Lay volunteer trainers subject to quality 
assurance. 
2.13.2.5 Characteristics of intervention: 
The CDSMP and its anglicised version (the EPP) the Chinese version and the Spanish 
culturally adapted version all typically consist of a structured course of six (originally 
seven) weekly sessions lasting around 2 to 2.5 hours led by one or two trained 
facilitators. The evolution of self-management interventions has accompanied the 
power shift in health care services. It began as a system in which health care 
professionals were seen as experts and the patient as a passive recipient of care , to 
more collaborative care in which expertise is shared between the patient and 
professional to achieve the best outcomes. This trend has encouraged self-
management interventions to change from the provision of information to interventions 
that address problem solving and coping skills. 
In this analysis the intention has been to include interventions that assess the 
effectiveness of such intervention for chronic illnesses, in particular, the focus on 
arthritis. This illness has been chosen for many reasons: it has a high and increasing 
frequency with associated high costs to health services. Arthritis self-management 
interventions and research are well developed; reviews have revealed at least 100 
intervention studies of high quality, and it is possible to examine how the important 
69 
similarities and differences in the day-to-day management and consequences of 
arthritis compare with chronic eye conditions like glaucoma. 
Six RCTs were identified that address arthritis (rheumatoid arthritis and osteoarthritis), 
of which three studies Lorig, et al. (1999a); Barlow, et al. (2000); and Buszewicz, et 
al. (2006) were disease specific. The other three studies have focused on long term 
conditions with quite broad aims, but with a main focus on reducing pain and improving 
physical and psychological functioning. However these objectives affect a range of 
methodological and content issues which will be discussed later in this chapter. 
2.13.2.6 Theoretical framework of self-management programmes: 
The studies analysed were varied in the extent to which they explicitly stated the 
theoretical approach on which self-management interventions were based. 
Sometimes only components of a theory were mentioned (Le., self-efficacy) without 
definition of the underlying theory. Interventions fell into two main areas; self-efficacy 
theory, or an educational model expanded to incorporate other components such as 
social support, exercise and other skills. The following table (2.10) shows the 
characteristics of the studies with the topics that were covered in each self-
management intervention. 
Table (2.10): Characteristics of studies with topics covered. 
Author (Year) Self-efficacy topic covered. 
Lorig, et al. A culturally adapted format of all topics covered in the original version. 
11999a) 
Lorig, et al. Exercise, cognitive symptom management techniques, nutrition, 
(1999b) fatigue, sleep management, use of community resources, use of 
medication, dealing with emotions, communication, problem solving 
and decision making. 
Barlow, et al. Information about arthritis, self-management principles, exercise, 
(2000) cognitive symptom management, dealing with emotions, 
communication and contracting. 
Dongbo,etal. Exercise, cognitive symptoms management techniques, nutrition, 
(2003) fatigue and sleep management, use of community resources, use of 
medications, dealing with emotions, communication, problem solving 
and decision making. 
Buszewicz, et al. Unclear. 
(2006) 
Kennedy,etal. Sessions on relaxation, diet, exercise, fatigue, breaking the symptoms 
cycle, managing pain, managing medication and communication. (2007) 
Social learning theory (Bandura, 1977) has led the way to the use of problem solving 
and goal setting to enhance participants' self-efficacy and to encourage health related 
behaviours such as exercise, diet, joint protection, and techniques for cognitive pain 
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management in arthritis. Other studies focused on a cognitive behavioural approach 
to target pain and physical function and to improve coping in arthritis. Comparisons of 
different self-management interventions allow identification of components or 
approaches that might be more effective than others. 
In comparing the six different studies some changes were observed favouring the 
inclusion of training in coping skills and exercise as a way of reducing pain. This kind 
of comparison of self-management interventions has great potential for identifying 
active components and adjusting other components to make it more culture orientated 
as in the case of Dongbo, et al. (2003). 
2.13.2.7 Outcomes and Results 
The following table (2.11) presents all the studies by their outcomes assessed. The 
outcome measures most frequently assessed in these studies were self-report of 
symptoms. All the studies assessed more than one outcome; in addition, some studies 
included outcomes that had not been specifically targeted in their programme; which 
could dilute their overall effectiveness. To accurately assess a self-management 
intervention, it is important to link the outcomes measured to those targeted for 
change. 
Table (2.11): Characteristics of studies by the outcomes assessed. 
Author (Year) Outcomes assessed 
Lorig, et al. (1999a) Self-management behaviours, disability, depression, self-rated 
health, pain, self-efficacy and medication use. 
Health behaviour, health status, health service utilisation. 
Lorig, et al. (1999b) 
Barlow, et al. (2000) Health beliefs, cognitive-behaviour techniques, health status. 
Dongbo, et al. (2003) Health behaviour change, self-efficacy scale, health status and 
health care utilisation. 
Buszewicz, et al Quality of life, symptoms, physical and psychological well-
(2006) . being. 
Kennedy,etal. Self-efficacy scale, symptoms, health care utilisation. 
(2007) 
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a. Outcomes of the analysis 
All comparisons are reported at up to six-month follow up unless otherwise stated. The 
outcomes are: 
Primary outcomes measured 
o Health behaviours (Arthritis Self Efficacy "ASE") 
Stretching and strengthening exercise (minutes/week) 
Aerobic exercise (minutes/week) 
Cognitive symptoms management 
o Health status 
Self-rated health 
Disability 
Dietary habits 
Pain/physical discomfort 
Psychological well-being 
Energy/ Fatigue 
Health distress 
o Health service utilisation 
Medical Doctors and Accident and Emergency department visits 
Number of hospital stays 
Nights in hospital 
b. Secondary outcomes measured 
Communication with health professionals 
Social/role activity limitations 
Health care costs. 
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2.14 Discussion of outcomes 
Symptoms and functioning were common outcomes, with more than 40% of the 
studies showing some improvement in self-reported symptoms, as did a similar 
proportion for measure of disability. Previous reviews of the same outcomes in arthritis 
for example have generally reported that self-management interventions have a small 
but significant short-term effect, although the changes tend not to be maintained in the 
long term. In these studies, some evidence suggested improvements in pain beyond 
6 months, in one study, and for disability, in two studies. A greater effect on pain was 
identified for osteoarthritis, with four studies reporting some benefit. The reasons for 
the difference between the two forms of arthritis are unclear. Comparison is 
complicated because content of interventions tend to differ. 
Assessment of psychological wellbeing as an outcome is complicated by selection of 
participants. Although numbers with depression and anxiety tend to be higher than in 
the general population, many individuals recruited into self-management programmes 
might show little evidence of depressed mood or increased anxiety (Buszewicz, et aI., 
2006). Expectations that these outcomes will improve after a self-management 
intervention might be unrealistic. 62% of studies that measured psychological 
wellbeing reported benefits. All of those that used cognitive behavioural programmes 
and the one that is based on social learning theory recorded improvements in 
psychological wellbeing. 
Quality of life was assessed in only 29% of the studies analysed. Measuring quality of 
life is complicated by the fact that disease-specific instruments are widely used and 
their subscales are generally reported under symptoms, function, and psychological 
wellbeing rather than as a composite measure. For included studies, little effect was 
recorded for quality of life, which showed that the relationship between self-
management programmes and quality of life is still not well understood. The changes 
in behaviour needed by self-management interventions might constrain quality of life, 
but the absence of evidence of such deterioration in this analysis suggests that these 
interventions have no real cost to patients' quality of life. This necessitates the need 
for further research to understand the complex relationship between self-management 
programmes and quality of life. 
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Improvement of self-management behaviours, such as diet and exercise, or more 
cognitive behaviours, such as effective coping, is a prime focus of these types of 
interventions, but 50% of included studies did not assess behaviour changes. It seems 
that these studies assumed that a simple relationship exists between behaviour 
change and other outcomes, but this is extremely complex. This is illustrated by some 
studies where behaviour changed in the absence of changes in more clinical and 
symptomatic measures. Whilst other studies showed changes in clinical and 
symptomatic measures happened in the absence of behavioural changes. This clearly 
explains why there is no one to one relationship between behaviour and measures of 
symptoms and clinical state. 
Reduction in the use of health care is one of the possible economic benefits of self-
management interventions, and was the most frequently assessed outcome. The 
studies analysed were less likely to have an immediate effect on use of health care, 
since control of symptoms to restrict emergency visits was not the focus of these 
interventions. Nonetheless, improved self-management could change use of health 
care. Six studies examined such use for arthritis; two found some reduction in visits to 
health care professionals. 
One enduring issue for self-management interventions is the duration of any effect 
observed. Few included studies assessed outcomes for more than 12 months, and in 
those that did, many showed that benefits tend not to be retained at long-term follow-
up. Expectations of long-term effects from such interventions might be unreasonable 
because of the short-term nature of many interventions. Therefore, it remains 
important not only to examine whether people are able to adopt self-management 
behaviours in the long term, but also to devise techniques that can lead to long-term 
changes in behaviour. 
2.14.1 Methodological Quality of included studies. 
Based on the quality criteria described in the analysis methods section above and with 
particular respect to the context of this analysis, three studies were deemed to be of 
high methodological quality (Barlow, et aI., 2000; Buszewicz, et aI., 2006; Kennedy, et 
aI., 2007) where the other three studies appeared to be of intermediate quality (Lorig, 
et aI., 1999a; Lorig, et aI., 1999b; Dongbo, et aI., 2003). 
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2.14.2 Method of randomisation: 
Four of the six randomised controlled trials included provided adequate description of 
the way randomisation was conducted (Barlow, et aI., 2000; Dongbo, et al.,· 2003; 
Buszewicz, et aI., 2006; Kennedy, et aI., 2007), whilst Lorig, et al. (1999a), and Lorig, 
et al. (1999b) methods remain unclear. 
2.14.2.1 Allocation 
The concealment of allocation was adequate in three RCTs (Barlow, et aI., 2000; 
Buszewicz, et aI., 2006; Kennedy, et aI., 2007). The remaining three randomised 
controlled trials made no reference to allocation concealment (Lorig, et aI., 1999a; 
Lorig, et aI., 1999b; Dongbo, et aI., 2003). 
2.14.2.2 Blinding 
Full blinding of consented study participants to their allocation groups in studies that 
investigate behavioural changes is not possible, which questions the appropriateness 
of this criterion when examining interventions that improve participants' 
communication with health professionals (Vertigan, et aI., 2006). Although only three 
studies described adequate blinding (Lorig, et aI., 1999b; Dongbo, et aI., 2003; 
Buszewicz, et aI., 2006) the other three trials (Lorig, et aI., 1999a; Barlow, et aI., 2000; 
Kennedy, et aI., 2007) have collected outcomes by mail questionnaire which minimises 
the potential risk of blinding. 
2.14.2.3 Losses to follow up and withdrawals 
Follow up periods varied across included studies from 4 to 6 months with two studies 
following subjects to 1 year (Lorig, et aI., 1999a; Buszewicz, et aI., 2006). Losses to 
follow up information were reported in all included studies. Of those, four studies 
achieved follow up rates of more than 80% (Lorig, et aI., 1999a; Lorig, et aI., 1999b; 
Dongbo, et aI., 2003; Kennedy, et aI., 2007). While the other two studies have reported 
follow up rates of more than 70% (Barlow, et aI., 2000; Buszewicz, et aI., 2006). 
2.14.2.4 Intention-to-treat analysis 
Only one study reported analysis to be by intention to treat (Barlow, et aI., 2000). While 
Buszewicz, et al. (2006) used hot decking to impute missing data. The rest of the 
studies included (Lorig, et aI., 1999a; Lorig, et aI., 1999b; Dongbo, et aI., 2003; 
Kennedy, et aI., 2007) that reported carrying out an intention to treat analysis failed to 
present that in the results. 
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2.15 Results 
The results of this analysis are derived from six randomised controlled trials of lay-led 
self-management in adults with arthritis using Cochrane RevMan software. 
2.15.1 Primary outcomes of the analysis 
All studies in this analysis reported up to six-month follow up with an exception of two 
that were made on a one-year follow up. A test for heterogeneity was conducted if 
appropriate. 
2.15.1.1 Health Status 
1. Pain 
All the studies with a combined total of 3197 participants reported outcomes on pain 
with small heterogeneity (P = 0.10, 12 = 49%) between the studies. The results showed 
a statistically significant reduction in pain in favour of the intervention group at 6 
months follow up (SMD -0.34 (95% CI-0.55 to -0.13; Z = 3.19; P = 0.001) as illustrated 
in table (2.12). 
Table (2.12): comparing pain up to six month follow up with baseline 
Intervention Control Mean Difference Mean Difference 
Stud or Sub rou Mean SD Total Mean SD Total Wei ht IV, Fixed, 95% CI IV, Fixed, 95% CI 
Barlow (2000) -0.31 2.25 311 -0.24 2.49 233 26.4% -0.07 [-0.48, 0.34) 
Buszewicz (2006) -0.41 2.8 273 -0.22 2.65 291 21.4% -0.19 [-0.64, 0.26) 
Dongbo (2003) -0.04 2.38 412 0.34 2.31 326 37.6% -0.38 [-0.72, -0.04) 
Kennedy (2007) -2.77 18.67 237 -0.25 17.86 267 0.4% -2.52 [-5.72, 0.68) 
Lorig (1999a) -0.88 2.4 189 0.02 2.2 97 14.1% -0.90 [-1 .46, -0.34) 
Lorig (1999b) -2.6 19.4 561 -2.2 17.6 0 Not estimable 
Total (95% CI) 1983 1214 100.0% -0.34 [-0.55, -0.13) 
-100 -50 0 50 100 
Heterogeneity: Chi2 = 7.86, df = 4 (P = 0.10); F = 49% 
Test for overall effect: Z = 3.19 (P = 0.001) Favours experimental Favours control 
Two studies (Lorig, et aI., 1999a, Buszewicz, et aI., 2006) assessed pain on 12 months 
follow up with 260 participants reporting. Lorig, et al. (1999a) failed to provide enough 
results that estimation can be made. Buszewicz, et al. (2006) results failed to show 
any significant difference between the intervention and control group (SMD -0.38 (95% 
CI -0.92 to 0.16; Z = 1.37; P = 0.17) as illustrated in the following table (2.13). 
Table (2.13) : comparing pain up to 12 month follow up with baseline 
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Intervention Control Mean Difference Mean Difference 
~~~~~~~M~ea~n~S=D_T~o~ta~I ~M=ea~n~S~D_T~o~ta~1 ~W~ei~h~t~IV~, R~a~nd~0~m ,~9~5~o C=I ____ ~IV~, ~Ra=ndom~, 9_5~%_C_I ____ _ 
-0.49 3.23 260 -0.11 3.13 270 100.0% -0.38 [-0.92, 0.16] 
o 0 0 o 0 0 Not estimable 
Total (95% CI) 260 270 100.0% -0.38 [-0.92, 0.16] 
Heterogeneity: Not applicable 
Test for overall effect: Z = 1.37 (P = 0.17) -100 -50 o 50 100 Favours experimental Favours control 
2. Disability 
Five studies assessed changes in disability with 3106 participants using different 
instrument and scales with a reported substantial heterogeneity (P = 0.04; 12 = 60%) 
between studies. The results showed a very small statistically significant reduction in 
disability as a result of the intervention (SMD -0.05 (95% CI -0.10 to 0.00; Z = 1.82; P 
= 0.07). 
Table (2.14): comparing disability up to six month follow up with baseline 
Intervention Control 
Mean SO Total Mean SO Total Wei ht 
Barlow (2000) 0.01 0.34 31 1 -0.02 0.35 233 25.6% 
Buszewicz (2006) -0.28 8.55 279 0.11 7.58 311 0.1% 
Dongbo (2003) -0.07 0.28 412 0.01 0.32 322 30.2% 
Kennedy (2007) 0 0 0 0 0 0 
Lorig (1999a) -0.1 0.49 189 o 0.41 97 13.9% 
Lorig (1999b) -0.02 0.32 561 0.03 0.36 391 30.2% 
Total (95% CI) 1752 1354 100.0% 
Heterogeneity: Tau2 = 0.00; Chi2 = 9.96, df = 4 (P = 0.04); 12 = 60% 
Test for overall effect: Z = 1.82 (P = 0.07) 
Mean Difference 
IV, Random, 95% CI 
0.03 [-0.03, 0.09] 
-0.39 [-1 .70, 0.92J 
-0.08 [-0.12, -O.04J 
Not estimable 
-0.10 [·0.21, 0.01 ] 
-0.05 [-0.09, -0.01 ] 
-0.05 [-0.10, O.OOJ 
Mean Difference 
IV, Random, 95% CI 
-100 -50 o 50 
Favours experimental Favours control 
100 
Buszewicz, et al. (2006) reported changes on 12 months follow up but showed no 
significant difference between the intervention and the control group in terms of 
disability reduction (SMD -0.64 (95% CI -2.19 to .091; Z = 0.81 ; P = 0.42) as described 
in the following table. 
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Table (2.15): comparing disabil ity up to 12 month follow up with baseline 
Intervention Control Mean Difference Mean Difference 
~~~~~ __ M~e~an~S~D~To~ta~I ~M~ea~n~S~D_T~ot~al __ We~i ~h_t _1~V,_R_an_do_m~, 9_5~%~C_I ____ ~IV~, ~Ra~ndom~,9~5°~C~I ____ _ 
-0.75 9.64 268 -0.11 9.02 291 100.0% -0.64 [-2.19, 0.91) 
Total (95% CI) 268 291 100.0% -0.64 [·2.19, 0.91) 
Heterogeneity: Not applicable 
Test for overall effect: Z = 0.81 (P = 0.42) -100 -50 o 50 100 Favours experimental Favours control 
3. Fatigue 
Three studies (Lorig, et aI., 1999b; Barlow, et aI., 2000; Dongbo, et aI. , 2003) out of 
the six studies included provided data on self reported fatigue at 6 months follow up 
with substantial statistical heterogeneity (P = 0.07; 12 = 63%) between them. Results 
from these three studies showed a small statistically significant reduction in fatigue 
amongst the intervention group (SMD -0.29 (95% CI -0.57 to -0.02; Z = 2.13; P = 0.03) 
as illustrated in the following table. 
Table (2.16) : comparing fatigue up to six month follow up with baseline 
Intervention Control 
Mean SO Total Mean SO Total Wei ht 
-0.44 2.6 311 0.05 2.13 233 24.7% 
-0.35 2.7 411 0.09 2.52 326 26.0% 
-0.14 0.79 561 -0.02 0.75 391 49.3% 
Total (95% el) 1283 950 100.0% 
Heterogeneity: Tau' = 0.04; Chi' = 5.38, df = 2 (P = 0.07); " = 63% 
Test for overall effect: Z = 2.13 (P = 0.03) 
4. Depression 
Mean Difference 
IV Random, 95% CI 
-0.49 [-0.89, -0.09) 
-0.44 [-0.82, -0.06) 
-0.12 [-0.22, -0.02) 
-0.29 [-0.57, -0.02) 
Mean Difference 
IV Random 95% CI 
-100 -50 0 50 100 
Favours experimental Favours control 
Four studies (Lorig, et aI., 1999a; Barlow, et aI. , 2000; Dongbo, et aI. , 2003; 
Buszewicz, et aI., 2006) reported data on changes in depression with no heterogeneity 
between the studies (P = 0.60; 12 = 0%). The results of this meta-analysis showed a 
strong statistical significance effect on depression in favour of the intervention group 
(SMD -0.61 (95% CI -0.87 to -0.35; Z = 4.52; P < 0.00001) as described in the table 
below. 
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Table (2.17): comparing depression up to six month follow up with baseline 
Intervention Control 
Mean SO Total Mean SO Total Wei ht 
Barlow (2000) -1 2.94 311 -0.1 4 2.42 233 
Buszewicz (2006) -0.13 2.28 288 0.33 2.24 308 
Dongbo (2003) -1 .2 5.23 385 -0.66 5.17 308 
Lorig (1999a) -3.2 10.1 189 . -2.5 9.3 97 
Total (95% CI) 1173 946 
Heterogeneity: Tau2 = 0.00; Chi2 = 1.87, df = 3 (P = 0.60); 12 = 0% 
Test for overall effect: Z = 4.52 (P < 0.00001 ) 
34.3% 
52.9% 
11 .5% 
1.3% 
100.0% 
Mean Difference Mean Difference 
IV, Random, 95% CI IV, Random, 95% CI 
-0.86 [-1.31 , -0.41 ] 
-0.46 [-0.82, -0.10] 
-0.54 [-1 .32, 0.24] 
-0.70 [-3.04, 1.64] 
-0.61 [-0.87, -0.35] 
-100 -50 o 50 
Favours experimental Favours control 
5. Anxiety and Psychological well-being 
100 
Data were available on changes on anxiety from two studies (Barlow, et aI. , 2000; 
Buszewicz, et aI., 2006) with no heterogeneity between them (P = 0_72; 12 = 0%). 
Results of these studies showed improved anxiety levels which were statistically 
significant (SMD -0.53 (95% CI -0.85 to -0.20; Z = 3.19; P = 0.001) as in the following 
table. 
Table (2.18): comparing anxiety up to six month follow up with baseline 
Barlow (2000) 
Buszewicz (2006) 
Intervention Control 
Mean SO Total Mean SO Total Wei ht 
-0.94 2.87 311 -0.35 2.66 233 48.1 % 
-0.15 2.76 286 0.32 2.83 307 51.9% 
Total (95% el) 597 540 100,0% 
Heterogeneity: Tau2 = 0.00; Chi2 = 0.13, df = 1 (P = 0.72); J2 = 0% 
Test for overall effect: Z = 3.19 (P = 0.001) 
6. Health-related quality of life 
Mean Difference Mean Difference 
IV, Random 95% CI 
-0.59 [-1.06, -0.12] 
-0.47 [-0.92, -0.02J 
-0,53 [-0,85, ·0.20J 
-100 -50 o 50 
Favours experimental Favours control 
100 
Data on changes in health-related quality of life measures using the EuroQol (Brooks, 
1996) were available for two studies (Barlow, et aI., 2000; Buszewicz, et aI. , 2006) with 
a test for heterogeneity (P = 0.25; 12 = 26%). Although Barlow, et al. (2000) was unclear 
in the selection of intervention participants, results showed statistically significant 
improvement in the quality of life at 6 month follow up (SMD -0.07 (95% CI -0.11 to -
0.02; Z = 2.91 ; P = 0.004) as illustrated in the table below 
79 
Table (2.19): comparing QoL up to six month follow up with baseline 
Intervention Control Mean Difference Mean Difference 
Mean SO Total Mean SO Total Wei ht IV, Random, 95% CI IV, Random, 95% CI 
Barlow (2000) ·0.04 0.25 86 -0.01 0.24 78 28.6% -0.03 [-0.11, 0.05] 
Kennedy (2007) -0.14 0.35 313 -0.06 0.032 316 71.4% -0.08 [-0.12, -0.04] 
Total (95% CI) 399 394 100.0% .0.07 [.0.11 , -0.02] 
-100 -50 o 50 100 
Heterogeneity: Tau2 = 0.00; Chi2 = 1.34, df = 1 (P = 0.25); 12 = 26% 
Test for overall effect: Z = 2.91 (P = 0.004) Favours experimental Favours control 
7. Self-rated general health 
Four studies (Lorig, et aI. , 1999a; Lorig, et aI., 1999b; Dongbo, et aI. , 2003; Kennedy, 
et aI., 2007) reported changes in self-rated general health with little heterogeneity (P 
= 0.15; 12 = 43%). Meta-analysis of these studies showed strong significant inverse 
associations favouring the intervention group on 6 months follow up (SMD -0.16 (95% 
CI -0.24 to -0.08; Z = 3.83; P = 0.0001) as in the table below. 
Table (2.20): comparing general health up to six month follow up with baseline 
Dongbo (2003) 
Kennedy (2007) 
Lorig (1999a) 
Lorig (1999b) 
Intervention Control 
Mean SO Total Mean SD Total Wei ht 
-0.28 0.79 430 -0.03 0.72 349 29.4% 
-0.05 0.77 247 0.04 0.7 273 24.2% 
-0.33 0.86 189 -0.12 0.82 97 12.5% 
-0.09 0.72 561 0.02 0.69 391 34.0% 
Total (95% Cil 1427 1110 100.0% 
Heterogeneity: Tau2 = 0.00; Chi2 = 5.30, df = 3 (P = 0.15); 12 = 43% 
Test for overall effect: Z = 3.83 (P = 0.0001) 
8. Health distress 
Mean Difference 
IV, Random, 95% CI 
-0.25 [-0.36, -0.14J 
-0.09 [-0.22, 0.04J 
-0.21 [-0.41 , -0.01J 
-0.11 [-0.20, -0.02) 
.0.16 [-0.24, -0.08] 
Mean Difference 
IV, Random, 95% CI 
-100 -50 o 50 
Favours experimental Favours control 
100 
The same four studies that reported on health distress were statistically 
heterogeneous (P = 0.03; 12 = 72%). However, results showed no improvement in the 
intervention group (SMD -0.22 (95% CI -0.48 to 0.03; Z = 1.72; P = 0.09) as in the 
following table. 
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Table (2.21): comparing health distress up to six month follow up with baseline 
Intervention Control 
Mean SD Total Mean SD Total Wei ht 
Dongbo (2003) .0.24 1.01 386 .0.01 1.12 296 47.7% 
Kennedy (2007) -9.78 21.48 246 -4.75 20.58 270 0.5% 
Lorig (1999a) 0 0 0 0 0 0 
Lorig (1999b) .0.24 0.98 561 .0.07 0.97 391 51.8% 
Total (95% Cil 1193 957 100.0% 
Mean Difference 
IV, Random, 95% CI 
.0.23 [.0.39, -0.07] 
-5.03 [-8.67, -1.39] 
Not estimable 
.0.17 [-0.30, -0.04] 
-0.22 [-0.48, 0.03) 
-1 00 -50 o 50 100 Heterogeneity: Tau
2 
= 0.03; Chi2 = 7.12, df = 2 (P = 0.03); 12 = 72% 
Test for overall effect: Z = 1.72 (P = 0.09) Favours experimenlal Favours control 
2.15.1.2 Health behaviour 
The majority of studies reported health behaviours as outcome demonstrating the 
following: 
1. Exercise 
Four studies (Lorig, et aI. , 1999a; Lorig, et aI. , 1999b; Dongbo, et aI. , 2003; Kennedy, 
et aI., 2007) reported changes in the frequency of aerobic exercise with no 
heterogeneity (P = 0.80; 12 = 0%). However, results showed strong significance 
inversely associated in favour of the intervention group (SMD -19.49 (95% CI -28.25 
to -10.74; Z = 4.36; P < 0.0001) as illustrated below. 
Table (2.22) : comparing exercise up to six month follow up with baseline 
Intervention Control Mean Difference 
Mean SD Total Mean SD Total Wei ht IV, Random 95% CI 
Mean Difference 
IV, Random, 95% CI 
Dongbo (2003) -27.93 175.51 406 -2.68 136.51 319 
Kennedy (2007) -27.57 114.06 247 -3.74 110.04 273 
Lorig (1999a) -25.7 119.2 189 -17.5 130.2 97 
Long (1999b) -16 94.5 561 2 87 391 
Total (95% CI) 1403 1080 
Heterogeneity: Tau2 = 0.00; Chi2 = 1.01 , df = 3 (P = 0.80); I' = 0% 
Test for overall effect: Z = 4.36 (P < 0.0001) 
2. Symptoms management 
14.9% -25.25 [47.96, -2.54J 
----20.6% -23.83 [43.14, 4 .52J 
--8.0% -8.20 [-39.1 9, 22.79J 
56.6% -18.00 [-29.64, ~.36J 
100.0% -19.49 [-28.25, ·10.74) • 
-100 -50 o 50 
Favours experimental Favours control 
100 
Changes in cognitive symptoms management was obtained from three studies (Lorig, 
et aI. , 1999b; Barlow, et aI. , 2000; Dongbo, et aI. , 2003) and have substantial 
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heterogeneity between them (P < 0.0001; 12 = 91 %). Results of these studies showed 
a statistically significant increase in using various strategies and techniques in the 
intervention group (SMD -0.57 (95% CI -0.90 to -0.23; Z = 3.31; P = 0.0009) as 
described below. 
Table (2.23): comparing symptoms management up to six month follow up with baseline 
Intervention Control 
Mean SO Total Mean SO Total Wei ht 
Barlow (2000) -2.41 4.99 311 -0.23 4.2 233 13.3% 
Dongbo (2003) -0.37 0.95 391 -0.04 0.76 305 42.8% 
Long (1999b) -0.38 0.77 561 -0.07 0.73 391 43.9% 
Total (95% CI) 1263 929 100.0% 
Heterogeneity: Tau2 = 0.06; Chi2 = 22.12, df = 2 (P < 0.0001); 12 = 91 % 
Test for overall effect: Z = 3.31 (P = 0.0009) 
2.15.1.3 Healthcare use 
Mean Difference Mean Difference 
IV, Random, 95% CI IV, Random, 95% CI 
-2.18 [-2.95, -1 .41] 
-0.33 [-0.46, -0.20] 
-0.31 [-0.41 , -0.21] 
-0.57 [-0.90, -0.23] 
-100 -50 o 50 
Favours experimental Favours control 
1. General Practitioner and Accident and Emergency department visits 
100 
Five studies (Lorig, et aI., 1999a; Lorig, et aI., 1999b; Barlow, et aI. , 2000; Dongbo, et 
aI., 2003; Kennedy, et aI., 2007) examined changes in general practitioners visit with 
no heterogeneity between them (P= 0.92; 12 = 0%). These studies showed no changes 
between the intervention or control group in terms of attendance (SMD -0.00 (95% CI 
-0.28 to 0.27; Z = 0.01; P = 0.99) as illustrated in the following table. 
Table (2.24) : comparing GP and A&E visits up to six month follow up with baseline 
Intervention Control 
Stud or Sub rou Mean SO Total Mean SO Total Wei ht 
Barlow (2000) -0.19 1.48 86 -0.13 1.58 78 34.1% 
Dongbo (2003) -1.01 9.41 430 -0.84 7.76 349 5.2% 
Kennedy (2007) -0.42 3.01 243 -0.46 3.76 268 21 .8% 
Lorig (1999a) -0.06 2.9 189 -0.24 1.7 97 26.4% 
Lorig (1999b) -0.77 5.6 561 -0.54 6.3 391 12.5% 
Total (95% CI) 1509 1183 100.0% 
Heterogeneity: Tau2 = 0.00; Chi2 = 0.93, df = 4 (P = 0.92); 12 = 0% 
Test for overall effect: Z = 0.01 (P = 0.99) 
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Mean Difference 
IV Random, 95% CI 
-0.06 [-0.53, 0.41) 
-0.17 [-1.38, 1.04) 
0.04 [-0.55, 0.63) 
0.18 [-0.35, 0.71) 
-0.23 [-1 .01 , 0.55) 
-0.00 [-0.28, 0.27] 
Mean Difference 
IV Random, 95% CI 
-100 -50 o 50 
Favours experimental Favours control 
100 
2. Nights spent in hospital 
Changes in the number of days or nights spent in hospital were obtained from only 
three studies (Lorig, et aI., 1999b; Dongbo, et aI., 2003; Kennedy, et aI., 2007) with no 
statistical heterogeneity between studies (P = 0.72; 12 = 0%). Results showed no 
statistical difference between the intervention and control group (SMD -0.76 (95% CI 
-1.34 to -0.81; Z = 2.56; P = 0.01) as described below. 
Table (2.25): comparing nights spent in hospital up to six month follow up with baseline 
Intervention Control 
Mean SD Total Mean SD Total Wei ht 
Dongbo (2003) -0.55 9.6 430 0.44 6.72 349 25.6% 
Kennedy (2007) -0.04 6.19 246 0.3 7.69 272 23.6% 
Lorig (1 999b) -0.28 5.2 561 0.56 7 391 50.8% 
Total (95% CI) 1237 1012 100.0% 
Heterogeneity: Tau' = 0.00; Chi' = 0.66, df = 2 (P = 0.72); I' = 0% 
Test for overall effect: Z = 2.56 (P = 0.01) 
Mean Difference 
IV, Random, 95% CI 
-0.99 [-2.14, 0.16] 
-0.34 [-1.54, 0.86] 
-0.84 [-1 .66, -0.02] 
-0.76 [-1.34, -0.18] 
Mean Difference 
IV, Random, 95% CI 
-100 -50 o 50 
Favours experimental Favours control 
2.15.1.4 Self-efficacy to manage symptoms 
100 
Most of the studies included (Lorig, et aI. , 1999a; Barlow, et aI. , 2000; Dongbo, et aI. , 
2003; Buszewicz, et aI. , 2006; Kennedy, et aI., 2007) reported an improvement in 
participants' self-efficacy with substantial heterogeneity between studies (P < 0.00001 ; 
12 = 91 %). Meta-analysis showed significant improvements in self-efficacy amongst 
participants who received the intervention (SMD -2.31 (95% CI -3.50 to -1.12; Z = 3.80; 
P = 0.0001) as illustrated in this table. 
Table (2.26) : comparing self-efficacy up to six month follow up with baseline 
Intervention Control 
Mean SO Total Mean SD Total Wei ht 
Barlow (2000) -4.11 8.69 311 -1 .46 7.56 233 19.2% 
Buszewicz (2006) -1 .07 6.62 266 0.69 5.99 305 21 .5% 
Dongbo (2003) -0.52 2.11 376 0.17 2.67 301 25.1% 
Kennedy (2007) -12.71 18.32 237 -3.21 15.77 267 9.8% 
Lorig (1999a) -1.1 2.2 189 0.04 2.2 97 24.4% 
Total (95% CI) 1401 1203 100.0% 
Heterogeneity: Tau' = 1.44; Chi' = 42.33, df = 4 (P < 0.00001); I' = 91% 
Test for overall effect: Z = 3.80 (P = 0.0001) 
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Mean Difference 
IV, Random, 95% CI 
-2.65 [-4.02, -1 .28] 
-1 .96 [-3.00, -0.92] 
-0.69 [-1 .06, -0.32] 
-9.50 [-12.50, -6.50] 
-1 .14 [-1 .68, -0.60] 
-2.31 [-3 .50 , -1 .12] 
Mean Difference 
IV Random 95% CI 
-100 -SO 0 50 100 
Favours experimental Favours control 
2.15.1.5 Communication with health professionals 
Four studies (Lorig, et aI., 1999b; Barlow, et aI., 2000; Dongbo, et aI., 2003; Kennedy, 
et aI., 20007) reported changes in communication with health professionals. Results 
reported a small statistical significant improvement in favour of the intervention group 
but with substantial heterogeneity between the studies (P = 0.001; 12 = 81 %) as 
described in this table. 
Table (2.27): comparing communication with professionals up to six month follow up with baseline 
Intervention Control 
Mean SD Total Mean SD Total Wei ht 
Barlow (2000) -1 .42 4.38 311 -0.22 4.32 233 
Dongbo (2003) -0.04 1.24 396 -0.11 1.32 308 
Kennedy (2007) -2.78 26.07 236 1.9 26.08 267 
Lorig (1999b) -0.26 0.98 561 -0.11 0.96 391 
Total (95% CI) 1504 1199 
Heterogeneity: Tau2 = 0.08; Chi2 = 16.02, df = 3 (P = 0.001); 12 = 81 % 
Test for overall effect: Z = 1.38 (P = 0.17) 
2.16 Discussion 
16.5% 
40.2% 
0.7% 
42.7% 
100.0% 
Mean Difference 
IV, Random, 95% CI 
-1.20 [-1 .94, -0.46] 
0.07 [-0.12, 0.26] 
-4.68 [-9.25, -0.11] 
-0.15 [-0.28, -0.02J 
-0.26 [-0.64, 0.11] 
Mean Difference 
IV, Random, 95% CI 
-100 -50 o 50 
Favours experimental Favours control 
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This meta-analysis systematically analysed and evaluated 6 RCTs examining the 
effectiveness of self-management education programmes for patients with a chronic 
arthritis condition. Because there is no accepted universal definition of what 
constitutes a chronic self-management programme, all the studies shared a similar 
structure and components of an internationally reputed CDSMP that was designed by 
Kate Lorig and her team at the Stanford University of California. However, important 
cultural adaptations of the concepts, content and processes were made to the original 
programme in order to suit the communities receiving the intervention. For example, 
Dongbo, et al. (2003) adapted this programme to suit the Chinese culture. Lorig, et al. 
(1999a) made similar changes to adapt to Spanish speaking communities in the USA 
and Kennedy, et al. (2007) made the required cultural changes to anglicise the original 
CDSMP version. Nonetheless, a substantially statistically-significant heterogeneity 
was displayed between the studies in terms of reported outcomes and their effect. 
Only one study (Buszewicz, et aI. , 2006) reported changes on outcomes beyond six 
months, whilst the rest of the studies measured short term outcomes up to six months 
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and compared them to baseline data. Therefore, in this meta-analysis there were 
statistically significant short term outcomes of up to six months, but insufficient 
information to assess the sustainability of these positive outcomes beyond 6 months. 
The studies detected positive effects of self-management on reducing pain amongst 
patients who received the intervention and further evidence suggested they enjoyed 
improved psychological wellbeing and suffered less depression and anxiety. The 
currently available data did not show any significant evidence in favour of the 
intervention group compared to the control group to suggest improvement in disability 
or fatigue in general. 
Synthesis of the included studies suggests evidence associated with improved general 
self-rated health as well as improved health related quality of life amongst participants 
who received the intervention in comparison with participants who did not. There is 
also evidence suggesting that these interventions may be associated with short term 
reductions in health distress and increased use of cognitive symptoms management 
techniques. Patients in the intervention groups tended to exercise more frequently in 
comparison with the control groups according to the detected evidence. 
There is strong evidence from this meta-analysis that attending self-management 
programmes significantly improves empowerment and psychological self-efficacy to 
manage symptoms and conditions at 6 months follow up (P<0.0001). The currently 
available data did not show any significant effects of lay-led self-management 
interventions on service utilisation as it failed to improve the number of visits made to 
a general practitioner or emergency department; the number of days or nights spent 
in hospital. 
2.16.1 Health care costs 
Although Dongbo, et al. (2003) estimated the cost per patient of attending the 
program~e as 82.7 Chinese Yuan, there was only one study that reported a cost 
effective analysis. Kennedy, et al. (2007) reported the cost of attending the programme 
in the UK setting (£250 per participant) but complete information is not yet available. 
2.16.2 Generalisability and limitations of the meta-analysis 
As with all clinical trials, it is possible that participants in the studies may not be truly 
representative of the local adult population with arthritis, as people who take part in 
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clinical trials tend to be more committed and motivated. Although having motivated 
participants will not affect differences between the two groups, it may affect the 
generalisability of the results if self-management programmes are provided as a 
routine treatment. 
The studies were carried out in various developed countries (USA, UK and China), but 
there were no studies from developing countries. Although ethnicity was reported in 
some of the studies, there was not enough information to perform a subgroup analysis 
for ethnicity. However, there is no evidence to suggest that self-management 
programmes would not be suitable to be delivered to ethnic minority groups or in 
developing countries. It is also evident that these programmes if delivered to ethnic 
minority groups in a language that they are familiar with could still deliver the same 
benefits. 
This meta-analysis' primary objective was to examine the effectiveness of lay-led self-
management programmes with primary outcomes examining health status, health 
behaviours, healthcare use and self-efficacy. Although the analysis showed improved 
health status and health related quality of life, it failed to show similar results on the 
longer period of time as the included studies did not report any outcome beyond 6 
months except for two studies. Evidence from this review did not appear to reduce GP 
or healthcare resource use. 
Evidence from the data currently available is unable to identify whether disease 
specific lay-led programmes are more or less effective than generic programmes. It is 
also not possible to determine which components or aspects of interventions are more 
effective than others. This review did not examine which is more effective (lay-led or 
professionally-led) as it only included clinical trials that were lead by lay volunteers. 
This meta-analysis has several limitations in addition to those previously mentioned. 
The varie~ methodological quality of the originally included studies (High to moderate) 
is one of the limitations. Although meta-analysis methods allow for adjustments for 
study-level differences, the reviewer cannot take account of inherited biases from 
individual studies. A second limitation is the presence of possible publication bias, 
although this does not invalidate the findings, the findings should be interpreted 
cautiously. 
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2.17 Conclusion 
The 6 studies included in this meta-analysis provided evidence that arthritis lay-led 
self-management programmes for adults results in a clinically important impact on 
health status, improved health behaviours and increased self-efficacy to manage 
symptoms. No evidence was detected on long term improvement due to the lack of 
long term follow up and/or information on outcomes. It has been observed that 
providing additional education sessions on an annual basis or incorporating an 
education element in the services patients receive could result in long-lasting benefits 
to health and psychological outcomes. 
There is no evidence of an effect on healthcare use and resource utilisation. However, 
because of heterogeneity in interventions, study populations, follow up times and 
outcomes measured, data are still insufficient to give clear recommendations 
regarding the contents of self-management programmes in arthritis. 
There is no evidence to suggest which setting is more effective to deliver the self-
management programme; neither the person delivering the programme whether it is 
professional or lay volunteers. However, programmes that used the principles of 
empowerment, participation and adult learning are proved to be effective. 
For self-management interventions to have greater uptake, thought should be given 
to how and when they are offered to patients. Introduction and endorsement of these 
programmes at a physician visit will probably ensure higher rates of participation. It 
should also be recognised that as with medication, one therapy or programme might 
not be suitable for all patients. Identifying who benefits most from various self-
management interventions is an important addition to any assessment, and could lead 
to more effective targeting of resources. 
If self-management interventions are to be more widely adopted in health care, training 
in skills such as group facilitation, problem solving, goal setting and· cognitive 
behavioural techniques need to be enhanced. They are not usually part of most health-
care professionals' training. If these interventions are to be delivered appropriately and 
effectively, training in the skills needed by health-care professionals who deliver these 
programmes needs to be recognised and appropriate courses developed. 
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Clearly, meta-analysis has an important role in medical research, public policy, and 
clinical practice. Its use and value will likely increase, given the amount of new 
knowledge, the speed at which it is being created, and the availability of specialized 
software for performing it. However, the fundamental limitations of Meta-Analysis exist 
in, that only quantitative empirical research studies (RCTs) are used. Data will be 
typically found in articles or other publications and normally it is impossible to get the 
complete data sets. Two important restrictions result from this. The findings must be 
conceptually comparable and deal with the same constructs and relationships. 
Secondly the findings must be configured in similar statistical forms. And that is one 
of the biggest problems. 
Alternatively, this research in the following chapters will present a collaborative 
approach that takes into account patient experience and qualitative data that was not 
in the merit of this meta-analysis. 
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Section III: From Compliance to Concordance "the way forward" 
2.18 Introduction 
As stated previously in chapter one, usage of the term concordance in ophthalmic 
practice has yet to come to the force. Presently adherence is the term used. Patient 
adherence with chronic medical treatments is known to be far from ideal (Schwartz 
and Quigley, 2008). Research has demonstrated that approximately 9% of all 
prescriptions written across all therapeutic areas are never filled, especially at initial 
stage of treatment (Lash and Harding, 1995), which is a reflection on non-compliance 
with medication taking. The scope of this issue is enormous throughout chronic 
condition literature; diseases that are asymptomatic in nature like COAG are more 
prone to non-compliance and therefore poor adherence (Dimatteo et ai, 2002) with 
studies suggesting it could be as high as 80% (Olthoff et ai, 2005). Concordance as 
such becomes an impossibility in these conditions. 
Ocular hypotensive drugs are prescribed to patients with COAG to prevent the 
occurrence of glaucoma and minimise the visual field loss by slowing the progression 
rate of the disease in individuals with high lOPs and so preserving their vision 
(Nordstrom et ai, 2005). It is important that these drops are taken regularly on a daily 
basis for life (Gray et ai, 2009). Failing to do so, could be mistaken for the lack of 
effectiveness of treatment prescribed which might result in additional risks and costs 
because of more hospital appointments and diagnostic tests; switching to other 
medications and/or waste of unfinished pharmaceutical supplies, and ultimately 
advancing to subsequent surgical intervention (Bissell et ai, 2004; Hoevenaars et ai, 
2008; Gray et ai, 2009). In order for concordance to the medical regimen to become 
a possibility, patients must be willing to collaborate with healthcare professionals in 
their treatment and subsequently adhere to the medical regimen (Refer to section 2.10 
on changing terminology for clarification.). 
In the main, literature exploring glaucoma treatment adherence is vast, reflecting the 
variation in terminology used to describe it, interventions and strategies designed to 
tackle poor adherence, its barriers, and the way it is measured. Vermiere et al (2001) 
observed that during three decades of quantitative research into adherence 'non-
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compliance', more than 200 variables have been studied, but none can be considered 
as consistently predictive. 
2.18.1 Changing Terminology 
This section will not seek to review the literature; however, it will explore how terms 
that denote patient behaviour towards medication use have become more precise and 
empowering over time. Although the term 'compliance' has been used extensively in 
the medical model approach to refer to the extent to which patients' behaviours' 
correspond with providers' recommendations (Schwartz, 2005) and implies their 
obedience to physician orders, compliance views the patient as a passive recipient of 
instructions and directions of the superiorly experienced and knowledgeable doctor 
and reflects a paternalistic attitude. Unsurprisingly, this term has been abandoned by 
some (but by no means all) for a more precise and less judgmental term, called 
adherence (Gray et ai, 2009). Adherence in this sense is synonymous with compliance 
and has association with concordance as will be shown further on in this section. 
Adherence was defined by Lee et al (2007) as consistency and accuracy with which a 
patient follows a recommended medical regimen. Compliance and adherence 
according to Britten (2001) have provided an ideological framework through which 
doctors can express their ideas about how patients ought to behave. This framework 
has clearly justified blaming patients for not acting in accordance with doctors' 
instructions and expectations (Amro and Cox, 2011 b). 
Mead and Bower (2002) highlighted the limitations of compliance and adherence 
models in their application to health care relationships. The Independent Kings Fund 
report observed a "growing recognition" that the interests of those who provide health 
care do not necessarily coincide with the needs of those who use it. Where interaction 
with patients based on this model is viewed as an opportunity to reinforce instructions 
and expe~tations, instead, Bissell et al (2004) have advocated for a more collaborative 
approach and open space where expertise of both patients and health professionals 
can be pooled together to arrive at mutually agreed goals. In other words, health 
professionals should seek to develop "concordance" with their patients attending the 
service (Working Party, 1997). Concordance was introduced in the 1997 by the Royal 
Pharmaceutical Society of Great Britain and intended to remove the implications of 
patient obedience or submissiveness to physician's orders (Amro and Cox, 2011 b). 
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According to a multidisciplinary group of health professionals, academics and 
members of the pharmaceutical industry in the UK, concordance, as a new approach 
to glaucoma treatment and professional-patient interaction, has been defined as: 
"Concordance is based on the notion that the work of the prescriber and patient in the 
consultation is a negotiation between equals and the aim is therefore a therapeutic 
alliance between them. This alliance, may, in the end, include an agreement to differ. 
Its strength lies in a new assumption of respect for the patient's agenda and the 
creation of openness in the relationship, so that both doctor and patient together can 
proceed on the basis of reality and not of misunderstanding, distrust and concealment" 
Working Party (1997:8). 
The principles of concordance are not new (Britten, 2001), where it is increasingiy 
referred to in health services research. In contrast to compliance and adherence, 
William and Calnan (1996) noted that concordance fits neatly with the political 
landscape of the NHS in the UK and is congruent with ideas such as shared clinical 
decision making and patient-centeredness and collaborative care (May and Mead, 
1999). There are interesting studies that show the misunderstanding that arises 
between patients and doctors in the consultation around their treatment and the 
unvoiced patients' agenda in this consultation (William and Calnan, 1996). 
Nonetheless, there is a need for more empirical research that can shed light on 
concordance relevant to patients with chronic conditions like COAG (Bisse" et ai, 
2004). The research that is explicated in this study has not intended to foster 
concordance in the traditional sense, as it has not examined the doctor-patient 
relationship. The intervention explicated in this study has been associated with Expert 
Patient-patient interaction. Despite its eloquence, Justis (2010) has argued that the 
concorda':lce approach has not been widely adopted. Notwithstanding, this 
collaborative approach was important in harnessing the experiential knowledge 
patients gained in this study where they received the Expert Patient intervention, which 
seeks to empower them and improve their knowledge and skills in self-management 
of their condition. 
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Like concordance, persistence is another term, not synonymous with compliance or 
adherence that is still in use as it refers to the I~ngth of time from commencement to 
discontinuation of a prescribed treatment (Reardon et aI., 2004). For example, if a 
patient was prescribed a once-daily medication but actually takes the drug once every 
other day for an entire year; the patient would be 50% adherent and 100% persistent. 
For the purpose of this study, the term adherence is used throughout this Thesis and 
refers to gaps in the therapy whenever possible whilst persistence will be used to refer 
to continuous use of medication. As noted previously, the term concordance, 
preferable over other terms, was not used in the setting where the study was 
conducted. Healthcare professionals are more familiar with the terms adherence and 
compliance. To prevent confusion and a delay in approval for the research to proceed, 
by the Research and Development Committee, the term adherence has been used in 
questionnaires and application forms where changing the word to concordance proved 
problematic. 
2.18.2 Measuring Adherence and Persistence 
Assessing adherence and persistence accurately poses a significant challenge in 
glaucoma treatment (Schwartz and Quigley, 2008). Throughout the literature, there 
are three main techniques followed in measuring adherence. These are patient self-
report, monitoring devices and renewing prescription. 
\ 
2.18.2.1 Patient Self-Report 
Using a numerical scale that allows patients to mark along a scale where patients think 
their answers should be without being judgmental or leading questions is called patient 
self-report (Gray et ai, 2009). Although simple and inexpensive, self-report whether by 
self-administered questionnaire or by interview, tends to overestimate adherence 
(Kass et ~I, 1986). Although this technique is subjective to recall bias and the desire 
to please health professionals, Gray et al (2009) observed that self-report is the most 
utilised method for assessing adherence in glaucoma. Schwartz and Quigley (2008) 
draw attention to the selection bias of patients who are willing to complete a 
questionnaire or agree to be interviewed may demonstrate higher rates of adherence. 
Patients with poor adherence tend not to return for follow up and thus are unable to 
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participate in the study. In this study, a self-reported scale of 1 to 10 representing the 
times patients have missed their eye drops in the past four weeks has been used. 
2.18.2.2 Monitoring Devices 
In theory, an electronic monitoring device of dosing is considered the most reliable tool 
(Olthoff et ai, 2005). However, these devices cannot prove that a drop truly went in to 
the patient's eye or on the cheek, floor or in the sink (Schwartz and Quigley, 2008). 
These devices have advanced considerably in recent years where the device has 
become smaller and unobtrusive and more manageable to use (Hermann and 
Diestelhorst, 2006). However these devices are prohibitively expensive. It is viewed 
that it will be some time before more accurate and cost-effective devices are available 
for use (Gray et ai, 2009). 
2.18.2.3 Renewing Prescriptions 
This method is an objective estimation of adherence and persistence by assessing 
patients' continuity of the therapy (Schwartz and Quigley, 2008). Gray et al (2009) 
argued that this method provides accurate estimation of persistence; however, 
obtaining a repeat prescription of a particular drug does not necessarily mean that they 
will be used as prescribed or used at all. 
2.18.3 Barriers and Interventions to Improve Adherence 
Assessment of adherence barriers relies primarily on patients' attitudes and thoughts 
that are well located in the merit of qualitative research (Lacey et ai, 2009). Despite 
the recent call for further research relating to adherence with glaucoma therapy 
(Quigley et ai, 2006) and the growing acceptance and use of qualitative methods in 
human behaviours (Green et ai, 2002), there are few studies performed with in-depth 
qualitative perspectives (Taylor et ai, 2002). 
Adherence issues are complex. Tsai et al (2003) reported as many as 71 unique 
situational obstacles on patients in the USA. Tsai et al (2003) grouped the obstacles 
into four separate categories: situational/environmental factors (35 of 71; 49%), 
medication regimen factors (23 of 71; 32%), patient factors (11 of 71, 16%), and 
provider factors (2 of 71; 3%). For further details, refer to table (2.28). The taxonomy 
formulated in this study could be useful in assisting health professionals develop 
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individualised interventions that optimise patient education and problem solving 
regarding their health care. Another qualitative study by Taylor et al (2002) explored 
poor adherence amongst glaucoma patients and revealed that forgetfulness was the 
main reason for poor adherence. This was followed by an inability to instil eye drops 
even though patients thought they could, treatment side effects, complexity of 
treatment regimens, glaucoma knowledge and education, trying new treatment 
options and the cost of treatment. 
Table (2.28): Categories of barriers to adherence 
Situational/environmental factors Treatment regimen 
Accountability and lack of support Refill 
Major life events Cost of medication 
Travel/away from home Complexity 
Competing activities Change 
Change in routine Side effects 
Patient Factors Providers factors 
Knowledge/skills Dissatisfaction 
Memory Communication 
Motivation/health beliefs 
Co-morbidity 
A more recent UK based study by Lacey et al (2009) revealed the following barriers: 
lack of knowledge and education, lack of faith in drop efficacy, problems with drop 
instilling, forgetting drops, practical problems (running out of drops, failing to reorder 
them, medication packaging, side effects and cost), age and individual differences 
(phYSically unable to instil the drops, needing more assistance, forgetting drops in the 
elderly as compared to feeling depressed as glaucoma is an elderly disorder amongst 
younger patients). 
Based on the above barriers, numerous studies have set out to improve adherence of 
glaucoma patients to their treatment by improving one (or more) of the identified 
barriers. It would be impossible to review all these studies; instead, three main reviews 
(Olthoff et ai, 2005; van Dulmen et ai, 2007; and Gray et ai, 2009) that examined the 
evidence from these single studies will be considered in relation to interventions 
deSigned to overcome barriers. These interventions are: educational and 
individualised care planning, drug comparison, and reminder devices. 
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2.18.3.1 Educational and Individualised Care Planning 
These interventions are based on the belief that improving patients' glaucoma 
knowledge and their understanding of the condition will eventually improve their 
adherence levels. Patients receive basic information on glaucoma and available 
treatment regimens that then help patients to identify suitable times for instilling and 
storing eye drops. Examples of this intervention are Norell (1979) and Sheppard et al 
(2003). Educational interventions refer to cognitive didactic approaches where 
behavioural principles such as reinforcement and feedback are increasingly used 
(Leventhal et ai, 1997). To be effective, educational interventions have to be tailored 
to the patient's particular needs. This is in addition to the quality of patient-provider 
interaction and the way information is passed (van Dulmen et ai, 2007). 
2.18.3.2 Drug Comparison (Technical Interventions) 
Most adherence intervention studies in this domain are aimed at simplification and 
reducing the number of doses per day or reducing the number of different drugs in the 
regimen (van Dulmen et ai, 2007). Other studies compared the adherence levels 
amongst patients prescribed two different drugs (Gray et ai, 2009). Leventhal and 
Cameron (1987) argued that these technical solutions reflect the biomedical 
perspective of using medical expertise to find solutions for patients' problems without 
engaging with patients. 
2.18.3.3 Reminder Devices (Behavioural Interventions) 
These interventions are based on the fact that forgetfulness is the main barrier to 
adherence and shares the assumption that reminding patients to take their eye drops 
will improve their adherence. There are different devices being used: a cap attached 
to the bottle that digitally displays the time and the day of the week the container was 
last opened and when the last drop was taken (Gray et ai, 2009; Olthoff et ai, 2005). 
Other stu~ies have used a memory aid that provides an audible and visible reminder 
of when the drop was due (Laster et ai, 1996). In the USA, several studies examined 
the use of incentives in which patients were paid for taking their treatment. This 
showed improvement in adherence levels in most of the trials reviewed (Giuffrida and 
Torgerson, 1997). These interventions represent aspects of human behaviour theories 
where reminders can act as cues or stimuli and incentives as rewards. 
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None of the three reviews found any convincing evidence to advocate any particular 
intervention over the others; however, there have been reported significant yet small 
improvements in all interventions. Olthoff et al (2005) concluded that all the studies 
included in his review lacked a thorough behavioural theory basis. A conclusion shared 
by van Dulmen et al (2007) who added that further studies are needed to explore the 
theoretical components of these interventions. Gray et al (2009) did not find convincing 
evidence to recommend any particular intervention for improving adherence amongst 
glaucoma patients. This research, however, explicates a model that improves 
glaucoma concordance. 
2.19 Summary 
COAG is the most common form of glaucoma, with an adult onset in the early forties. 
Population-based studies have confirmed the markedly elevated risk of COAG among 
black Africans, although the basis for this excess risk remains unclear. Age and 
elevated lOP are the most well established risk factors for COAG across all population 
groups. Family history of glaucoma is also another major risk factor although this 
association has yet to be understood. Early detection and prompt treatment could save 
patients losing vision making glaucoma screening high on the public health agenda. 
Glaucoma treatments often produce side effects and frequently fail to address the 
psychosocial needs of people with COAG. A self-management programme may 
provide the answers to questions usually asked about glaucoma patients' 
understanding of their condition and adherence to their treatment regimens. An Expert 
Patient Programme approach has long been adopted by the DoH but not in relation to 
patients with COAG. Training programmes are being offered on various chronic 
conditions but again not in relation to COAG. Positive health outcomes and improved 
communications between patients and health professionals have made self-
managem.ent programmes popular across the world. This concept will be explored 
further in the following chapter. 
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CHAPTER THREE 
The Rise of Self-Management and Collaborative Health Care in 
Chronic Conditions: Policies, Theories and Analysis of the 
Literature 
3.0 Introduction 
This chapter explores the concept of self-management in chronic conditions and the 
policies surrounding self-management and the Expert Patient Programme. It reviews 
the strategies, models and outcomes of self-management. Theories of health 
behaviour change are also analysed with an emphasis on self-management and 
adherence. The chapter concludes by discussing the Information-Motivation-
Behavioural skills (1MB) model upon which the Glaucoma Expert Patient Programme 
(GEPP) of the study is based. 
3.1 The Rise of Self-Management: Self-Efficacy. 
The last century has witnessed an unprecedented demographic and epidemiological 
transition that has had a radical impact on health and health service provision in 
developed countries such as the UK (Taylor and Bury, 2007). The greater prosperity 
and the success of the pharmaceutical and medical technology after the Second World 
War have helped to create new public health challenges marked by the emergence of 
chronic conditions as the central health care issue (Holman and Lorig, 2004). In the 
1960s and 1970s, ideas associated with what is now known, as "self-management" 
was part of the new social movement in health. It challenged the existing medical 
practices and sought to establish new agendas and terminology around collaborative 
health care (Schiller and Levin, 1983). With an ever rising prevalence of chronic 
disease, at this stage, the impact of these diseases on patients' ability to engage in 
normal activities "physical functioning" was recognised. 
The Grounded Theory work of Strauss and his colleagues (Strauss and Corbin, 1998; 
Glaser and Strauss 1967) in the USA was instrumental in putting the everyday struggle 
of individuals with chronic conditions on the sociological map. In his work, Strauss 
emphasised the public health impact of chronic conditions and its implication for the 
development of health services that meet their needs (Strauss, 1975; Corbin and 
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Strauss, 1992). These insights were taken on by Bury (1982) in the UK, who conducted 
a study of rheumatoid arthritis (RA). He developed a framework in which he examined 
'disruptions of social relationships and the ability to mobilise material resources' 
among the chronically ill. It documented the 'before and after' character of life with a 
chronic illness, and dealt with three main stages of illness experience: Onset, and 
problems of explanation and legitimation, the impact of treatment and the development 
of adaptive resources (Bury, 1982). 
During the 1980s and 1990s, in a response to this growth of chronic disease morbidity 
and the consequent demand of health care, countries in the developed world began 
to align themselves closely with the sentiments of the new social movement in 
collaborative health care and its activities that were concerned with self-management 
(Newbould et ai, 2006). In this changing political climate, the Stanford Arthritis self-
management programme (a USA initiative run by Kate Lorig), found a new role for lay 
people that empowered and involved them in the care process in a participatory way 
(Holman and Lorig, 2004). Through the use of participative techniques such as 
modelling and action planning these programmes have fostered self-care amongst 
patients with chronic conditions (Taylor and Bury, 2007). This situation has created 
new roles and responsibilities for both patients and health care professionals where 
patients are expected to be an active and collaborative partner and assume greater 
responsibilities in the care process (Newbould et ai, 2006). 
These programmes are based on Bandura's social cognitive theory of behaviour, 
which emphasises the importance of self-efficacy in predicting successful behaviour 
change. It refers to the strength of a person's belief in their capabilities to produce 
deSignated levels of performance that influence events that affect their lives (Bandura, 
1994). In Chronic Disease Self-Management Programmes (CDSMP), self-efficacy is 
viewed as a mediating construct for behavioural change (Bandura, 1986). 
Self-efficacy is specific to a particular behaviour or situation, and is not usually 
generalised on other similar types of behaviours (Rogers, 2009). For instance, patients 
may feel high self-efficacy about instilling their eye drops on time, but feel far less self-
efficacy managing the side effects of their drops. In this sense, self-efficacy effects the 
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person's expectations of success and failure, and therefore, influences the person's 
selection of those behaviours, the effort expended on the behaviours; especially after 
experiencing failure (Michie and Abraham, 2004). In other words, patients who 
experience a further loss of visual field and/or deteriorated visual acuity, in spite of 
adhering to the treatment regimens, will presume the task is difficult and will not adhere 
to their treatment regimen, perhaps due to low self-efficacy. 
3.1.1 Self-Management: Definition and Conceptual Clarity 
Recognising what is known about self-management and identifying gaps in its theory 
and research will enhance a common understanding of this phenomenon (Lorig et ai, 
2005). To better understand this concept, first the key concepts of self-management 
will be identified. These include: chronic disease self-management skills are learned 
and health behaviours are self-directed; motivation and self-confidence (or self-
efficacy) are important determinants of an individuals' performance of self-
management; the social environment and health care system can support or impede 
self-management; and monitoring and responding to changes in the illness, 
symptoms, emotions and functioning improves adaptation (Wagner, 1998). Building 
on these concepts, and bearing in mind the complexity and multidimensional nature 
of this phenomenon, Von Korff et al (1997) provided a four dimensional definition of 
self-management as the following: 
• Engaging in activities that promote health, build psychological reserve and 
prevent adverse sequela; 
• Interacting with health care providers and adhering to agreed treatment plans; 
• Monitoring physical and emotional status and making appropriate management 
decisions on the basis of the results of self-monitoring; and 
• Managing the effects of illness on the patient's ability to function in important 
roles, emotions, self-esteem, and relationships with others. 
However, when analysing the literature of self-management, there was a considerable 
variation in the understanding of this concept across authors and programmes of 
research. Historically, self-management has been used in the chronic disease health 
care context to refer to three different phenomena; a process, a programme, or an 
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outcome (Ryan and Sawin, 2009). The process of self-management refers to the use 
of self-regulation skills to manage chronic conditions or risk factors (Bodenheimer et 
ai, 2002). This process requires learning self-management skills such as goal setting; 
self-monitoring; reflective thinking; decision making; planning for and engaging in 
specific behaviours; self-evaluation; and management of physical, emotional and 
cognitive responses associated with health behaviour change (Lorig and Holman, 
2003). The programme or intervention associated with self-management is designed 
by health care professionals for the purpose of preparing individuals with chronic 
conditions to assume the responsibility for managing their conditions and engaging in 
health promotion activities (Lorig et ai, 2001; Wagner, 2007). Self-management has 
also been used to describe outcomes achieved by engaging in the self-management 
process. Such outcomes include decreased pain, improving levels of activity, or 
improving adherence to therapeutic regimens (Adams et ai, 2007; Chodosh et ai, 
2005). 
Self-management is closely related, but distinct from concepts like self-care and 
patient education (Riegel et ai, 2007). A common theme in defining self-care and self-
management is that it is a hallmark of the management of all chronic illnesses (DoH, 
2002), and requires the acquisition of new knowledge and skills (Watt, 2000). Self-
care has been used to refer to performance of activities of daily living and engaging in 
health behaviours without the direct collaboration from a legitimate healthcare source 
(Clark et ai, 1991). 
Patient education, however, is often used interchangeably with self-management 
programmes or intervention (Ryan and Sawin, 2009). Patient education is a method 
of providing information which has been associated with outcomes such as increased 
knowledge, improving satisfaction, or to change individual preparedness to engage in 
healthy behaviours whereas self-management activities are designed to enhance 
changes in health behaviour (Lorig, 2003). 
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3.1.2 Strategies to Promote Self-Management 
Intervention programmes that were designed to promote self-management in chronic 
conditions in the literature have followed one or more of the following strategies: 
Information giving and self-management intervention programmes. 
3.1.2.1 Information Giving 
Historically, there is a general assumption that improving patient knowledge and giving 
information will lead to increased self-management skills. Heisler et al (2002) pointed 
out that for knowledge to develop; information should be presented in a clear manner 
and appropriately placed. The timing and form of the information is equally important 
with patients appearing to be most receptive of information at first hospital admission 
or when newly diagnosed (Sylvain and Talbot, 2002). Written materials in the form of 
leaflets, handouts, or even electronic forms of CDs or websites could potentially 
reinforce oral information (Kennedy, 1999). However compelling and necessary, 
information alone is insufficient to bring about changes in self-management 
behaviours (Gifford and Groessl, 2002). A similar view shared by Hoevenaars et al 
(2008) has concluded improving glaucoma knowledge would not necessarily improve 
patients' adherence levels. 
3.1.2.2 Self-Management Intervention Programmes 
Self-management education programmes aim to empower patients through providing 
information and teaching skills and techniques to improve self-care and interactions 
with health care services, with an ultimate goal of improving quality of life (Jordan and 
Osborne, 2007). These programmes can take generic or condition specific form and 
can be lay or professionally-led. Content may range from general guidance and 
support to a prescriptive content covering information, drugs, symptoms, 
psychological distress, social support, life style and/or communication (Sylvain and 
Talbot, 2002). Many programmes utilise a cognitive behavioural approach in an 
attempt to initiate new healthy behaviours and encourage behavioural change (Van 
Korff et ai, 2002). A" of these types of programmes will be addressed in later sections 
of this chapter. 
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3.1.3 Self-Management Programme Models 
The Stanford CDSM model, based on Bandura's theory of self-efficacy, has been the 
best researched and used approach to self-management (Lorig, 1996). Researcher 
Kate Lorig and colleagues at Stanford University found that participants reported that 
change in health status was associated with feelings of personal control rather than 
changes in behaviour (Lorig and Holman, 2003). Later studies confirmed that 
enhanced self-efficacy contributed to improvements in health status experienced by 
participants of self-management programmes. The key features of self-management 
programmes were teaching strategies that enhance self-efficacy. A set of core skills 
and knowledge that form the foundation of self-management programmes can be 
adapted to meet the individualised needs of participants appropriately. These core 
skills include 'problem-solving, decision-making, resource utilisation, forming of a 
patient/health care provider partnerships and taking action' (Lorig and Holman, 
2003:2). Therefore these core skills can be applied across a range of conditions 
(Holman and Lorig, 2004). 
The Stanford CDSM is a community group-based, six-week course, facilitated by lay 
leaders or health professionals (Lorig, 1996). Health professionals train course leaders 
to deliver the Stanford CDSM courses under license to the Stanford Education Centre 
in California. The Stanford programme was originally developed for arthritis, and has 
since been modified for people with a range of chronic conditions. The arthritis self-
management programme and generic CDSM programme course are conducted in a 
range of languages including French, Spanish, Japanese, Arabic, German, Chinese 
and many others. It has been adopted widely in almost all the developed countries 
with an increasing interest from developing countries (Amro et ai, 2010). 
The Flinders Model is a course that teaches health care providers the skills to promote 
patient self-management, based on a collaborative, motivational counselling 
framework (Flinders Human Behaviour and Health Research Unit, 2004). The course 
is licensed to Flinders University in Adelaide and provides a structured interview format 
and written tools for the health care providers to use with individual patients to assess 
self-management behaviours and personal barriers to self-care and to guide patient-
centred problem definition and goal setting. The model has been adopted widely in 
primary care and community health services (Wilson and Mayor, 2006). 
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In addition to the Stanford CDSM programme and Flinders Model, disease-specific 
health education programmes are conducted in hospitals and community health 
services such as the arthritis, asthma, diabetes and cardiac rehabilitation programmes 
that are well established in the UK (DoH, 2002). 
3.1.4 Self-Management Outcomes 
Kate Lorig's model of the CDSM in its generic form has followed particular criteria to 
best capture the impact of the interventions delivered. This criterion has been widely 
used in other studies (Lorig, 1996). In a Cochrane review, Foster et al (2009) reviewed 
16 RCTs that examined common chronic conditions and summarised all the outcomes 
that were measured in these studies at baseline and monitored over 6 months and 12 
months by some of them. 
Primary outcomes are: 
• Health status: including patient self-rating quality of life, disability, pain, fatigue, 
psychological well-being; 
• Health behaviour: including exercise, cognitive symptoms management, and 
adherence; 
• Clinical improvement: in examination findings as judged by observers; 
• Healthcare use: including doctors' visits, outpatient doctor visits, emergency 
room visits, hospital admissions and length of stay; 
• Self-care and self-efficacy: represents a person's confidence to carry out self-
management behaviour. 
Secondary outcomes are: 
• Knowledge of the condition; 
• Change in clinical exam findings; 
• Quality of life measures; 
• Communication with professionals; 
• Cost of delivering programmes. 
3.2 Policy Formation Related to Chronic Illnesses and Self-Management 
Policies concerned with the health care of chronic conditions, relate to normative 
lifestyles and desirable behaviours, which to an extent have been based on a "blame 
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culture", where individuals are blamed or held responsible for their illness (Rogers, 
2009). Whilst previous policies have focused on what patients should do to maintain 
their health, the new self-management policy approach is focused on what sort of 
person the patient should become (May, 2006). 
In the UK, whilst the Department of Health (DoH, 2004) acknowledged the impact 
chronic conditions have on the quality of life of patients and their families, this is often 
subsumed by the focus on resource issues within policy papers (Wilson and Mayor, 
2006). Considerable resources have been allocated to support and run such 
programmes. A major attraction for health care planners and policy makers has been 
the expectation that such courses will reduce the use of health care and will deliver 
long term cost savings (Wanless, 2002). Whilst the effectiveness of the self-
management programmes will be discussed in-depth later on in this chapter, it is 
appropriate to note at this stage that the challenge for policies is not only to ease the 
demand on resources, but also to improve the principles of patient participation, 
collaboration and choice. 
There are two main arguments that have driven the shift in policies toward increasing 
self-management and patient involvement in health care services (Coulter, 1999). 
First, it is a democratic and ethical right for the patients to be involved in decisions 
about their care and its organisation. Secondly, the evidence has supported the 
argument that greater patient involvement in the consultation and health care generally 
will improve their satisfaction with health care and more importantly may lead to better 
health outcomes (Griffiths et ai, 2007). 
3.2.1 An Overview of the Policies 
Following its election in 1997, the UK Labour Government planned a 10 year 
programme of major reformation and modernisation of the National Health Service 
(NHS). With the appearance of self-management programmes as a strategy to 
manage the high demand of health care in the USA in the early 1990s, new policy 
proposals were ready to be put forward. In December 1997, the DoH (1997) published 
the White Paper "The New NHS: Modern, Dependable" This paper set out to create 
Primary Care Trusts (PCTs), Strategic Health Authorities (SHAs), the National Institute 
for Clinical Excellence (NICE) and the Healthcare Commission (Rogers, 2009). It also 
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outlined the government commitment to supporting people with chronic conditions, 
and the subsequent DoH (2000) NHS Plan, a plan for investment, a plan for reform, 
made self-care one of five key building blocks of the new NHS. 
A further publication in 1999 of the White Paper Saving Lives: Our Healthier Nation 
set out the government's plans for public health improvement and to save lives, 
promote healthier living and reduce inequalities in health (Taylor and Bury, 2007). This 
new approach of self-care has on one hand emphasised the challenge of managing 
chronic conditions; on the other hand, it noted that to face this challenge " ... everybody 
should try to look after themselves better, by not smoking, taking more exercise, 
drinking less and eating more sensibly ... n (DoH, 1999a:3). 
On self-management, Saving Lives commented that "people with long-term health 
problems such as diabetes, epilepsy or arthritis are skilled at recognising warning 
signs when their symptoms are getting worse", citing the arthritis care programme 
developed in the USA by Kate Lorig (DoH, 1999a:11), the idea of the Expert Patient 
was introduced (DoH, 1999b). While recognising the contribution this programme can 
make in improving the care of chronic conditions, it announced the establishment of a 
task force to design a new Expert Patient Programme (EPP) led by Sir Liam Donaldson 
(Kennedy et ai, 2007). Sir Donaldson commented that in the past the 'wisdom and 
experience' of the patient had not been fully acknowledged by health professionals, 
and argued that EPPs will correct this failing, and that EPPs will become 'a centre 
piece of the NHS approach to chronic disease management in the 21st century' 
(Donaldson, 2003:1). Soon after the publication of the findings of the Expert Patient 
task force, the EPP was established (DoH, 2001). Section (3.3) will examine this 
initiative in detail. 
A subsequent publication that gave a direct link to the cost of health care service use 
was the Wanless Report (2002). This report marked out a 'fresh page' approach to the 
concordat between medical care, the patient and the state (Rogers et ai, 2009). 
Wanless described three possible future scenarios of health care service use in light 
of the increased burden of chronic conditions, and argued that the 'Fully Engaged' 
patient is the cheapest sustainable option (Wanless, 2002). The 'Fully Engaged' 
scenario will be exemplified by a high level of public involvement and taking more 
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control of their health and illness by better use of the health services (Wanless, 2002). 
He commented "Fully engaged and active patients benefit not only as individuals. My 
inquiry showed that encouraging and supporting self-care was one of a number of 
actions which could potentially save the economy billions of pounds ... patients remain 
far from fully engaged in their own care; opportunities are being lost and inequalities 
reinforced" (Rogers, 2009; The Wanless Report, 2002:7). 
The government responded to this report with a number of publications and initiatives 
that are increasingly focussed on self-management programmes and the care of 
people with chronic conditions (Abraham and Gardner, 2009). In 2004 the NHS 
Improvement Plan identified self-care as one of the new National Standards with 
almost 70-80% of patients with chronic conditions being helped by self-management 
programmes. The Plan stated that compared with other patients, Expert Patients 
report that their health is better, they can cope better with their condition, feel less 
limited in what they can do and are less dependent on hospital care (DoH, 2004). It 
set out the plan for the EPP to be rolled out by 2008 allowing thousands of people to 
take more control of their health and lives. 
It was followed by another publication 'Self Care: A Real Choice' (DoH, 2005). This 
paper highlighted self-care as one of the key building blocks for a patient-centred 
health service and as a key component of the collaborative model for supporting 
people with long term conditions. It reiterated that supporting self-care can improve 
health outcomes, increase patient satisfaction and help in deploying the biggest 
collaborative resource available to the NHS, patients and the public. This paper 
provided information for supporting self-care and the reasons why it is important, and 
suggested practical actions for health professionals providing self-care. It concluded 
that self-care represents an opportunity and challenge for the NHS to empower 
patients to take more control over their lives. 
The key White Paper 'Our health, our care, our say: supporting people with long-term 
conditions to self-care' followed in 2006 (DoH, 2006). It underlined the fact that the 
self-management of chronic conditions and the establishment of the EPP can be seen 
as part a wider policy framework for public health improvement and health service 
development. More recently the DoH (2011), in collaboration with the Expert Patient 
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Programme Community Interest Company (CIC), has developed a new tool that aims 
to stimulate demand for self-management courses that are both generic and disease 
specific. 
3.3 Expert Patient Programme (EPP) 
The EPP is explored throughout this Thesis and will be explicated primarily in chapter 
five. A detailed critique is developed in chapter six. Therefore, the purpose of this 
chapter is to trace the origins and the implementation of the EPP in the UK. 
As noted before, the UK government has promoted the initiative of Expert Patient 
Programmes (EPP) as they recognised the necessity of self-management skills in 
treating people with chronic conditions (Amro et ai, 2011 a). As previously indicated in 
this Thesis the concept of an Expert Patient Programme was developed in the USA 
as the Chronic Disease Self-Management Programme (CDSMP) (Kennedy et ai, 
2007). The work of Halstead Holman and Kate Lorig at Stanford University, have 
shown how useful self-management skills and self-efficacy can be in maintaining and 
improving patients' health behaviour and health status, whilst lowering health care 
utilisation (Smeulders et ai, 2007). 
In 1978, Lorig and colleagues started to develop and evaluate programmes for people 
with chronic conditions (arthritis). They avoided the traditional model of professionals 
educating patients (Lorig et ai, 1986). Using an innovative approach, Lorig trained lay 
volunteers that had chronic diseases with the skills to manage their own conditions 
(Squire and Hill, 2006). Her research demonstrated that six weekly education sessions 
lasting three hours, led by trained lay tutors, provided improvements in patients' 
communication skills with health professionals, symptoms and disease control and 
reduced healthcare service use. Against old comparisons, Lorig argued that the lay-
led model was attractive because lay educators were plentiful and relatively cheap 
and could help other people with the disease by modelling self-care more effectively 
than healthy professionals (Lorig et ai, 1999). Lorig found increasing evidence from 
research studies and from patients' associations that people have improved health 
and reduced incapacity if they take the lead themselves in managing their conditions 
with good support from the health services (Lorig et ai, 1993). 
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Based on Kate Lorig's model, the EPP shared the assertion: that people with chronic 
conditions are well placed to know how to cope with their conditions (Griffiths et ai, 
2007). The DoH therefore, has set up the EPP task force with strong representation 
from voluntary sector organisations including the Long Term Medical Conditions 
Alliance and Arthritis Care who have run self-management skills training courses in 
the UK since the early 1990s (Rogers et ai, 2009). Their contribution has been 
instrumental in promoting and disseminating the training, which formed the core of the 
EPP through a volunteer work force. In 2003, the EPP was established and promoted 
as a lay-led community-based (PCTs) chronic disease self-management programme 
involving two-to-three-hour six-weekly sessions led by lay volunteer tutors who 
themselves have a chronic condition (DoH, 2001). From 2003-2007 the EPP was 
piloted in about 98 per cent of Primary Care Trusts (PCTs) in which funding was 
received to train volunteer tutors and build networks round the country with the 
intention to widen access and make it available throughout the NHS by 2008 
(Tyreman, 2005). 
3.3.1 Lay-Led Vs. Professional-Led Programmes 
Health systems are shifting to models of care that are inclusive of patient involvement 
in self-managing their own condition and health care. Lay-led self-management 
education programmes for people with chronic disease are considered an effective 
way to promote increased patient involvement (DoH, 2001). A Cochrane systematic 
review conducted by Foster et al (2009) could not find enough evidence to advocate 
one programme (professional versus lay led) over the other. Previous work by Lorig 
et al (1986) suggested no difference in outcomes between lay or profeSSional-led 
programmes, but there was an obvious cost saving in lay-led self-management 
programmes. 
The EPP developed in the UK has attracted considerable public support and publicity, 
and consumers recognise that such programmes have the potential to provide them 
with a voice and better health outcomes (Tyreman, 2005). There are uncertainties, 
however, about the effectiveness of lay-led self-management education programmes 
in different populations, in different health care settings, compared with professionally-
led education programmes, and about the best modes of delivery (Griffiths et ai, 2007). 
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The EPP is designed to enable active patient involvement, is generally well defined 
and has a pre-determined structure. EPPs are distinct from simple patient education, 
skills training or even peer support interventions (Kennedy et ai, 2007). While 
interpretations of the term 'lay-led' may vary between different countries and different 
programmes, lay leaders are all trained and accredited and follow a self-management 
philosophy rather than a medical approach (Holman and Lorig, 2004). There are key 
differences between lay-led (or peer-led) education and professionally led education. 
Lay leaders commonly have a chronic disease and in disease-specific programmes 
they have the same condition; lay-led education may be less formal and facilitate more 
helpful discussion for participants; and lay-leaders may provide important and practical 
advice as they share their experience living with their condition (Lorig and Holman, 
2003). 
Much work has been undertaken in developing self-management skills for specific 
conditions and has resulted in a number of educational programmes led by 
professionals (Amro et ai, 2010). These programmes aim to improve participants' 
adherence with condition specific regimens. Gibson et al (2002) argued there is 
evidence suggesting unless participants in such programmes are empowered to take 
control of aspects of self-management that are the traditional province of health 
professionals, this type of approach then does not necessarily lead to improved health 
outcomes. 
The idea of empowerment and collaborative partnership as a vital element in patient 
self-management is the cornerstone of the EPP. Arguably, the most empowering 
aspect of the EPP is that it is not facilitated by a health professional but by a lay 
volunteer who has the same long-term conditions themselves (Wilson and Mayor, 
2006). The support and advice is supplemented by the coaching role of an Expert 
Patient who has had some training in running the programme. 
Having said this, Jordan and Osborne (2007) argued that contributing to the limited 
uptake of the EPP has been the lack of engagement by health professionals. Failure 
to effectively communicate with health professionals has resulted in difficulty in 
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recruiting a sustainable number of participants and ensuring access for traditionally 
marginalised groups 1. 
3.3.2 Generic Vs. Disease-Specific Programmes 
In the past ten years, the EPP has been developed and evaluated as a generic 
programme that individuals with many different types of chronic conditions attend at 
the same time (Kennedy et ai, 2005). Whether a disease-specific programme would 
have advantages over a generic programme remains an open question (Lorig et ai, 
2005). Evidence is lacking about which specific chronic diseases and in which 
population groups EPP's are most successful (Warsi et ai, 2004). Jordan and Osborne 
(2007) claimed that trials have failed to provide convincing evidence of the 
generalisability of the CDSM and EPP. They argued that one generic programme for 
all conditions clearly has limitations and fails to utilise other interventions. Additionally, 
they added that such a generic programme often has a great under-representation of 
men and ethnic minorities and advocated for a flexible collaborative approach to both 
delivery and programme content (Jordan and Osborne, 2007). 
The EPP in its generic form has targeted groups of patients with the most common 
conditions including: arthritis, asthma, back pain, diabetes, epilepsy, heart failure and 
multiple sclerosis, with an option of developing disease specific programmes in the 
future (DoH, 2001). However, Kennedy et al (2007) in the National Evaluation of the 
EPP commented that the generic form of the EPP has "reinforced the value and 
salience of pre-existing self-care activities rather than initiating alternative behaviour 
change ... so people who already saw themselves as good self-managers felt they had 
nothing new to learn" (Kennedy et ai, 2007:3). 
1 As empowerment processes are fundamental to the concept of patients' participation 
and collaboration; particularly in self-management programmes, the EPP 
implemented in this study was committed to involving patients in designing and 
running the project. Therefore, lay volunteers who had a long history of living with 
COAG were trained and equipped to deliver this GEPP. I have had the role of liaising 
with health professionals running the clinics in terms of identifying participants who 
could benefit from the self-management programme. 
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Whilst one can argue that chronic conditions have many symptoms that are so much 
in common, some participants found the programmes not to be engaging as they did 
not include disease specific advice that they could relate to (Kennedy et ai, 2007). It 
is noticeable, however, that chronic eye conditions are not included within the target 
groups at all. Patients with chronic eye conditions like COAG are facing far more 
challenges in their daily life. 
3.3.3 Effectiveness of EPPs 
Lorig's model of the CDSM was subjected to a number of evaluative studies including 
well-conducted randomised controlled trials (Rogers et ai, 2009). Results suggest that 
this model could improve participants' health status, reducing hospital bed days and 
could be delivered effectively by lay volunteers. Lorig's et aI's (1999) RCT also 
demonstrated significant improvement in self-rated health, pain, psychological well-
being and significantly less health service utilization amongst the intervention group. 
Nonetheless, a further RCT with a longer follow up raised questions on the 
sustainability of the effects of such interventions. 
Attracted by the success of the CDSM in the USA, Sir Donaldson asserted that the 
EPP would improve health status, slow the progression of diseases and reduce 
healthcare use (Donaldson, 2003). The DoH, with high expectations, has responded 
by investing £18 million so far in providing this programme across 300 PCTs in 
England (Griffiths et ai, 2007). 
With the great differences between the privately funded USA health care system, in 
comparison with state funded universally available on access NHS in the UK, 
questions were raised about the external validity of the self-management programmes 
developed in the USA (Taylor and Burry, 2007). With the lack of UK based evaluative 
studies to demonstrate its effectiveness, the DoH, through the National Primary Care 
Research and Development Centre in Manchester, decided to conduct a national 
evaluation of the EPP (Kennedy et ai, 2007). 
The evaluation examined two main components: running the self-management 
programmes and actions taken to mainstream the EPP within the NHS and link it to 
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other programmes and initiatives involved in chronic condition self-management. The 
evaluation took the form of a six-month follow up randomised controlled trial to 
evaluate the patients' outcomes and its cost-effectiveness, patients' personal 
experience with undertaking the EPP and a process evaluation of its implementation 
by the PCTs (Kennedy et ai, 2007) with 1000 participants from 245 EPPs. 
The results were not as positive as they had hoped, as the EPP has been heavily 
promoted as a way of reducing the use of acute health services (Griffiths et ai, 2007). 
There was a moderate increase in patients' self-efficacy, patients' confidence to 
change behaviour and their psychological health, and relatively small impact on the 
amount of energy people reported. However, there was no change in health service 
utilisation, the sum of General Practitioners consultations, practice nurse 
appointments, Accident and Emergency (A&E) Department attendances and 
outpatient visits (Kennedy, 2007). Further evaluative studies (Randomised Controlled 
Trials - RCTs) were also conducted and the results were even less glowing. Griffiths 
et al (2007) reviewed four UK based RCTs of lay-led self-management programmes 
(Barlow et ai, 2000; Griffiths et ai, 2005; Buszewics et ai, 2006; Kennedy et ai, 2007) 
which revealed little improvement in self-rated health and no decrease in the use of 
health care services. 
The CDSM and, its English version, the EPP, were originally developed for use in 
heterogeneous patient groups assuming that patients with various chronic conditions 
can learn from each other as they have similar problems and needs (Wilson and 
Mayor, 2006). An extensive body of literature that supports the efficacy of self-
management programmes that have been tailored to the particular needs of specific 
conditions has developed (Francis et ai, 2007). Smeulders et al (2007) evaluated a 
disease specific EPP led by a team of lay volunteers and professionals for patients 
with an implantable cardiovascular defibrillator. The results were positive and 
promising, with improvement in general self-efficacy expectancies, symptoms of 
anxiety and QoL. Another self-management programme that is diabetes specific and 
has a focus on controlling symptoms has been delivered to newly diagnosed patients. 
It has been shown to be equally effective and shown significant improvements in 
patients' self-management behaviours and health outcomes (Skinner et ai, 2003). 
Gifford and Groessl (2002) reviewed an HIV/AIDS self-management programme that 
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also showed equally positive findings. Furthermore, Lorig's et aI's (1999) arthritis self-
management programme, which has a focus on strategies that are required for 
patients to deal with pain and consequences of disability, was impressive with its 
findings. 
In their National Evaluation summary of EPP, Kennedy et al (2007) commented that 
there was a considerable demand for condition specific courses as participants 
expressed a need for specific condition information that was not included in the EPP 
in its generic form. They concluded that disease specific courses "provide a closer fit 
with the way the NHS currently provides care i.e. the NHS distinguishes between 
conditions and a generiC approach does not fit the current reality of the using services" 
(Kennedy et ai, 2007:4). In this context, Griffiths et al (2007) has offered an 
explanation as to why these programmes had more impact than the generic lay-led 
self-management programmes. They argued that these programmes are better 
targeted toward higher risk individuals who experience greater morbidity. A key feature 
of the success of these programmes was its correcting erroneous health beliefs and 
providing specific, clinical and relevant self-management plans for patients, and thirdly 
for cardiac and asthma programmes there was a structured exercise programme 
alongside the self-management advice (Griffiths et ai, 2007). 
A question yet to be answered is: To what extent chronic disease self-management 
programmes address health inequalities which arise when groups of people with 
reduced health status have needs which are not being adequately met? Generic 
programs are likely to meet the needs of those with sufficient personal, social and 
economic resources to make changes in their lives (Foster et aI., 2009). It is 
understood that without targeting and adaptation for groups with low socioeconomic 
status, low levels of education, literacy or from different cultures, self-management 
programs are not likely to reach or engage disadvantaged groups. Therefore, an 
important consideration for the transferability of self-management interventions is how 
well they have been adapted in considering the social determinants of chronic disease 
self-management and how effectively they are able to meet the needs of specific 
disadvantaged groups (Swerisson et ai, 2006). People from disadvantaged 
backgrounds are more frequently affected by chronic disease. Relevant social 
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determinants of health include income and education factors including literacy, culture, 
and access to social support, employment and health services (Swerisson et ai, 2006). 
Different cultural groups have diverse belief systems with regard to health and 
illnesses in comparison to the Western biomedical model of medicine. These belief 
systems may include different disease models and paradigms (e.g., Chinese 
medicine), various culturally-specific diseases and disorders, feelings about 
healthcare providers and seeking Westernized healthcare, and the use of traditional 
and indigenous healthcare practices and approaches (Vaughn et ai, 2009). Helman 
suggests that people attribute causes of illness to: 1) factors within individuals 
themselves (e.g., bad habits or negative emotional states); 2) factors within the natural 
environment (e.g., pollution and germs); 3) factors associated with others or the social 
world (e.g., interpersonal stress, medical facilities, and actions of others); and 4) 
supernatural factors including God, destiny, and indigenous beliefs such as witchcraft 
or voodoo (Helman, 2001). While westerners tend to attribute the cause of illness to 
the individual or the natural world whereas individuals from non-industrialized nations 
are more likely to explain illness as a result of social and supernatural causes (Vaughn 
et ai, 2009). 
In countries like the UK, healthcare is widely accessible by all regardless of income 
level or insurance status. Many aspects of culture can affect successful and effective 
treatment approaches including religion and spirituality, social support networks, 
beliefs and attitudes about causes and treatments, socioeconomic status, and 
language barriers (Matsumoto and Juang, 2008). There is no one perfect program that 
is culturally relevant for all involved; however, approaching self-management 
programmes from a culturally competent perspective should be paramount. 
3.3.4 Cost Effectiveness of EPPs 
Promoting effective self-management skills is an important factor in providing a 
patient-centred health care service (DoH, 2000). With providing self-care support to 
any patient with a chronic condition as the main aim; the EPP will have targeted over 
100,000 people in England by 2013. In the literature there is a large and expanding 
number of studies suggesting the effectiveness of self-management programmes in 
chronic conditions, however, little of this evidence addresses the cost effectiveness of 
these interventions (Wheeler et ai, 2003). In a budget-constrained NHS, it is important 
that the EPP is cost-effective as well as clinically effective. 
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Richardson et al (2008) conducted a RCT to assess the cost effectiveness of EPPs 
compared to a treatment as usual alternative. The results of this study were consistent 
with the evaluation of the CDSM based in the USA. In comparison with the usual 
treatment a lay-led self-management programme is likely to improve patient outcome 
with little impact on cost; therefore, it provides a cost-effective use of scarce resources 
(Richardson et ai, 2008): 
3.3.5 A Paradox of Patient Empowerment and Medical Dominance 
The importance of self-management in reducing the burden of chronic conditions is 
increasingly recognised and becoming evident in health policy (Kennedy et ai, 2005). 
Initiatives like the EPP have been promoted widely as part of long-term condition 
strategies. It recognises the role of patients in managing their conditions in a way that 
empowers them and promotes a sense of wellbeing (Wilson et ai, 2007). Drawing upon 
Bandura's self-efficacy theory (Bandura, 1986), if individuals feel confident that they 
can control their chronic conditions, the likelihood is they will be able to do so. 
However, despite it being led by lay volunteers, Wilson (2002) suggested that there is 
a number of underlying power issues within the EPP and the paternalistic health care 
service that have the potential to inhibit any sense of empowerment. 
Within the EPP, it was argued that power may be withheld from Expert Patients and 
participants in three ways (Gilbert, 2005). Firstly, patients may feel obliged to enrol in 
the EPP as suggested by health professionals. Secondly, participants accept the self-
management practices taught because the EPP may create benefits or bring an 
affirmative award. Finally, the EPP operates in an environment where self-
management is not only seen as a right but also as a responsibility. Furthermore, Fox 
et al (2005) expressed similar views and questioned whether all patients actually want 
to participate in self-management programmes like the EPP. 
The paternalistic approach to chronic conditions health care where health 
professionals make all the decisions about treatment and closely monitor the patient's 
progress is considered inappropriate in modern healthcare (Holman and Lorig, 2000). 
Instead, when health professionals engage in effective communication and support 
decision making and self-management actions they are enabling patients to optimally 
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manage their conditions outside of the health service setting (Kennedy et ai, 2005). 
Within the context of the EPP, Davidson (2005) identified the potentiality of an EPP 
reinforcing the medical paradigm rather than empowering participants. An analysis of 
the EPP policy by Wilson et al (2007:434) suggested that "it had a Foucaldian 
potentiality of medicalising self-care practices within an individual's previously hidden 
home life". Fox et al (2005) observed the EPP has been linked with the continuing 
language of disease and paternalism still present within the programme and 
questioned whether the EPP can empower patients when so heavily reliant on the 
medical model. A study by Wilson et al (2007) has echoed this concern as they 
indicated the EPP course content serves to reinforce an image of the Expert Patient 
as defined by the medical paradigm; however, they recognised a movement triggered 
by the EPP that has the potential to make a change within the NHS structure. 
Whilst not undermining the success and the potential of the EPP as a life-changing 
event (EPP, 2006) and its effectiveness in empowering participants (Barlow et ai, 
1998), the question remains whether this empowerment remains at the individual level 
or has developed at a community level with the potential of challenging the 
paternalistic structures of current practice. 
3.4 Theoretical Underpinning of Self-Management and Adherence 
In Chapter Two the changing terminology of compliance, adherence and concordance 
was examined. Based on the perspective presented in Chapter Two and the 
terminology used at Moorfields Eye Hospital NHS Foundation Trust in reference to 
patient behaviour toward medication use, the word "adherence" will be used 
throughout this section. Theories that explain the constructs of adherence will be 
examined in this section as well. 
Theories are essential in promoting an understanding of human behaviour, directing 
research and facilitating transferability from one health issue, geographical area or 
health care setting to another (Michie, et aI., 2005). However, early programmes that 
are related to self-management of different chronic conditions often lacked an explicit 
theoretical basis. In COAG, the problem of adherence remains a challenge for the 
medical professions and social scientists. Therefore, this section will provide a critique 
of the major theories that explain human behaviour and adherence while outlining an 
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alternative theory model that provides a contrasting framework to underpin self-
management and adherence in a glaucoma context. 
A review by Munro, et al. (200?) examined the empirical evidence and theories applied 
in changing behaviour interventions in relation to long-term disease self-management 
and treatment regimen adherence. This review revealed that certain theories have the 
potential to both improve understanding of behaviour change and contribute to the 
design of more effective interventions that promote collaborative partnerships and 
adherence. Several interventions have been designed to improve patients' treatment 
adherence, but few theories describe the processes involved in doing so (Michie, et 
aI., 2005; Olthoff et ai, 2005). With more than 30 theories of health behaviour change 
available, choosing the most appropriate theory when designing an intervention is far 
from an easy task (Munro, et aI., 200?). This is particularly problematic in the field of 
adherence to long-term medications, such as medications required to manage COAG 
where the cost of non-adherence is quite severe with an ultimate eyesight loss. 
Leventhal and Cameron (198?) initially classified five theoretical perspectives related 
to long-term treatment adherence: (1) Biomedical; (2) behavioural; (3) communication; 
(4) self-regulatory and (5) cognitive perspective. Recently a sixth domain, stage 
perspective, has emerged. Each perspective includes several theories, where the 
most commonly used theories are those within the cognitive perspective and the 
transtheoretical model of the perspective stage (Redding et aI., 2000). Each of these 
perspectives will be reviewed in the narrative that follows. 
3.4.1 Biomedical Perspective 
Patients in this perspective are viewed as a passive recipient of the doctors' 
instructions, where patients who fail to adhere is understood to be caused by patient 
characteristics like age and gender (Blackwell, 1992). Technological innovations to 
monitor adherence to medications, such as the "Unobtrusive eye drops monitor" are 
rooted in this perspective. 
A fundamental limitation of this perspective is that it fails to consider factors other than 
patient characteristics that may affect their health behaviours (WHO, 2003), for 
example, patients' perspectives of their own illness; psycho-social factors; socio-
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economical; environmental; and/or demographic factors. An attempt to incorporate 
these factors with the biomedical perspective produced a more integrated theory, the 
"bio-psycho-socio-environmental" theory, in which they attempted to consider the 
wider socio-environmental context (Ross and Deverell, 2004). 
However, the assumption that patients are passive recipients, while placing a greater 
emphasis on biomedical factors made this theory less popular and unlikely to 
significantly improve glaucoma patient medication adherence. Patients nowadays are 
more active and want to be part of decision-making; no longer receive and follow 
instructions passively. Van Dulmen et al (2007) commented that in spite of the many 
advances in adherence and adherence research amongst glaucoma patients, non-
adherence rates have remained nearly unchanged in the last decade. They concluded 
that these interventions and theories adopted by and large belong to this perspective, 
have failed to predict and explain non-adherence adequately. 
3.4.2 Behavioural Perspective 
This perspective includes behavioural learning theory (BL T) that focuses primarily on 
environmental factors as well as the teaching of skills to manage adherence (WHO, 
2003). The likelihood of a patient following a specific behaviour will partially depend 
on internal (thoughts) and external factors (environmental cues), while consequences 
in the form of punishments or rewards will discourage or encourage such behaviour 
respectively as illustrated in Figure 3.1. 
! ! 
Internal Antecedents External Antecedents 
"I should take my medication" "My mobile phone reminded 
me to take my medications' 
L-. r 
Behaviour 
Taking medicines 
+ 
Consequences 
Controlled lOPs, slow 
progress of COAG and 
side effects 
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Figure (3.1): Behavioural Learning Theory. 
Glaucoma adherence interventions of this theory tend to break down the complex 
behavioural changes into small steps that can be sequentially learned and reinforced 
by external reminders. Munro et al (2007) claimed that glaucoma interventions that 
are informed by this perspective such as patient reminders have been found to 
influence health behaviours and improve adherence. A meta-analysis conducted by 
Simoni et al. (2006) examining adherence to therapy concluded that interventions with 
cue dosing and external reward approaches derived from BL T were as effective as 
those without. Blackwell (1992) criticises BL T for lacking an individualised approach 
and for failing to consider factors that are not linked to immediate rewards but are 
influential to health behaviour change including past behaviour; habits; or lack of 
acceptance of the diagnosis. This perspective has also been criticised for regarding 
patients as passive and failing to consider patient empowerment. 
3.4.3 Communication Perspective 
Communication is understood to be "the cornerstone of every patient-practitioner 
relationship" (Ross and Deverell, 2004:56). This perspective suggests that improving 
communication between health professionals and patients will improve adherence, 
which can be achieved through patient education and health professional 
communication skills (Ross and Deverell, 2004). An example of an intervention 
informed by this perspective is one that aims to improve patient-professional 
interaction placing emphasis on the timing of the treatment, instruction and 
comprehension (Munro et aI., 2007). 
Reviewers examining the effects of interventions including communication elements 
have rarely examined the effects of communication on health behaviours specifically 
(Lewin et aI., 2001). In relation to this, two reviews showed that improved 
communication interventions led to improved communication in consultations, 
improved patient satisfaction with care and improved health outcomes (Lewin et aI., 
2001). However, these reviews also show limited and mixed evidence on the effects 
of such interventions on patient health care behaviours such as adherence (Munro et 
al.,2007). 
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A more recent study conducted by Friedman et al (2008) explored doctor-patient 
communication and its effect on glaucoma adherence. The findings supported the 
importance and the association between effective doctor-patient communication and 
improved adherence levels. The limitation of this perspective is that it fails to 
acknowledge attitudinal, motivational and interpersonal factors that might influence the 
reception of the information and its translation into behaviour change (Blackwell, 
1992). 
3.4.4 Self-Regulation Perspective 
This perspective proposes that it is necessary to examine an individual's subjective 
experience of health threats to understand the way in which the individual adapts to 
these threats (Leventhal et ai, 1992). According to this theory, individuals' illness 
representations of health threats that combine new information with past experience 
are key determinants of their behavioural and emotional response to illness (Edgar 
and Skinner, 2003). These representations guide their selection of particular 
behaviours for coping with health threats and consequently influence associated 
outcomes. This process of creating health threats and choosing coping strategies is 
assumed to be dynamic and informed by the individual's personality, religion and 
socio-cultural context (Leventhal et ai, 1992). Skinner et al (2003) identified five core 
elements that form our illness representation as illustrated in the following table: 
Table (3.1): Core elements of illness representation 
1. Identity: What is glaucoma? What symptoms are experienced? What is actually wrong? 
2. Cause: What caused my glaucoma? 
3. Timeline: How long will it last? 
4. Consequence: How will glaucoma affect me now and in the future? 
5. Treatment effectiveness: How good is my treatment at controlling or curing my glaucoma? 
Munro et al. (2007) suggested that this theory offers little guidance to the design of the 
interventions. With no meta-analysis available to examine its effectiveness, specific 
suggestions are still required as to how these processes could promote adherence. 
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3.4.5 Cognitive Perspective 
The cognitive perspective includes theories such as the health belief model (HBM), 
social cognitive theory (SeT), the theories of reasoned action (TRA), the theory of 
planned behaviour (TPB), the protection motivation theory (PMT) and the information-
motivation-behaviour skills (1MB) model (which will be discussed in Section 3.4.6.5). 
These theories share the assumption that attitudes and beliefs as well as expectations 
of future events and outcomes are major determinants of health related behaviours 
(Stroebe, 2000). They focus on cognitive variables as part of behaviour change and 
so propose that individuals will choose the action that most likely will lead to positive 
outcomes (Gebhardt and Maes, 2001). Munro et al (2007) argued that these theories 
have major weaknesses including: failing to address the behavioural skills needed to 
ensure adherence as well as giving little attention to the origin of beliefs and how they 
may affect other behaviours. Furthermore, it has been argued that these theories have 
failed to recognise the impact of other factors that may compromise adherence 
behaviour, such as power relationships and social reputation (WHO, 2003). As this 
research is based on the components of the cognitive perspective, it therefore 
warrants a detailed discussion. 
3.4.6 Stage Perspective 
This perspective includes the transtheoretical model (TIM) as its main theory. This 
theory hypothesise a number of different, discrete stages and processes of change, 
and reasons that people move through, relapse and revisit earlier stages before 
Success is achieved (Sutton, 1997). This model assumes that health behavioural 
changes are the result of a logical process, divided into five stages as illustrated in 
Figure 3.2. 
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Precontemplation ~ The individual has yet to consider a change 
possible or needed. 
Contemplation 
The individual grasps the problem and 
considers change 
Preparation 
The individual plans to act on the change within 
the ensuina month 
Action 
Contemplation and preparations are 
transformed into actual changes 
Maintenance 
L- The goal becomes sustaining behavioural 
chanQe and resistinQ relapse r-
Figure (3.2): Transtheoretical Model: Adapted from Sutton (1997). 
This theory has received criticism. According to Bandura (2004) this theory violates 
the three basic assumptions of stage theories. Bandura suggested that human 
functioning is too multifaceted to fit into separate and discrete stages. While Munro et 
al. (2007) praised TIM as a popular theory amongst practitioners; it has received little 
direct research support for its efficacy. The meta-analysis identified for this review did 
not offer direct support for this theory while another review identified that interventions 
that used the stage perspective were no more efficient than those not using the theory 
(Marshall and Biddle, 2001). In a glaucoma context, the barriers to adherence 
according to this theory are 'temptations' and the question framed here is: How 
tempted can an individual be to engage in an unhealthy behaviour across different 
challenging situations? 
3.4.6.1 Health Belief Model 
Whilst a range of other theories attempts to explain health behaviours and service 
utilisation, significant attention has been paid to this model in relation to self-
management (Hassell et ai, 2000). This model considers health behaviour change as 
a rational appraisal of the balance between the barriers to and benefits of the action 
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and the change as a whole (Blackwell, 1992). As illustrated in Figure 3.3, the 
individual's readiness to take a particular course of action is influenced by perceived 
risks and benefits from taking these actions which will be influenced by an individual's 
view of the seriousness of the condition, internal and external cues, self-efficacy and 
lastly modifying factors such as culture and gender (Hassell et ai, 2000). 
Perceived susceptibility: 
"I can see perfectly; 
No history of glaucoma" 
Belief In a personal :--.., health threat 
Perceived severity: r-+ "I will get over it" 
"Glaucoma can cause 
...... 
blindness if not treated" 
Health behaviour 
"If it gets worse I 
Perceived benefits: ~ will take the eye 
"The medication will make F drops" 
me better" Belief In 
~ effectiveness of V health behaviour 
Perceived barriers: "I am not sure if these 
"Eye drops sting and make drops are working" 
my eyes red" 
Figure (3.3): Health Belief Model: Adapted from Stroebe (2000). 
According to this model, demographic and socio-psychological and cultural variables 
influence both perceived susceptibility and perceived seriousness, and the perceived 
benefits and perceived barriers to change (Strecher and Rosenstock, 1997). 
Therefore, high perceived threat, low barriers (Le. side effect) and high perceived 
benefits to a certain action will increase the likelihood of the patient engaging in that 
action. In more simple glaucoma terms, if the health professional engages in a 
discussion with a glaucoma patient and explains the pros and cons of the condition, 
followed by the patient's decision regarding the treatment, the likelihood that this 
patient will adhere to his or her treatment regimen is very high. However, this model 
has been extensively criticised in failing to; first, provide significant correlation between 
health beliefs and professionally set self-care (Roberson, 1992) and second, 
determinants of health behaviours such as positive effect of negative behaviours and 
social influence are not included (Stroebe, 2000). While the HBM has insufficient 
explanatory power in self-management and adherence, social cognitive theory; 
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particularly self-efficacy, appears to provide a prediction of self-care (Strecher et ai, 
1986). 
3.4.6.2 Social-Cognitive Theory 
Unlike earlier chronic disease self-management programmes, Lorig's CDSM has a 
very clear theoretical model which is based on Bandura's social cognitive theory of 
behaviour. Lorig (1986) stated that the key predictors of successful behaviour change 
are confidence (self-efficacy) in the ability to carry out an action and expectation that 
a particular goal will be achieved. When patients succeed in resolving problems, which 
they have themselves identified, it enhances their sense of self-efficacy (Bandura, 
1977). This theory evolved from social learning theory and may be the most 
comprehensive theory of behaviour change developed so far (Redding, et aI., 2000). 
It hypothesizes a multifaceted causal structure in the regulation of human motivation, 
action and wellbeing as well as offering predictors of adherence and guidelines for its 
promotion (Bandura, 2000). While knowledge of health risks and benefits are 
prerequisites to health behaviour change, according to this theory, additional self-
influences are necessary for change to occur as illustrated in Figure 3.4. 
A person's beliefs regarding self-efficacy and abilities to self-manage their condition 
are among some of these influences, and they playa central role in behaviour change 
(Bandura, 2004). In summary, this theory proposes that behaviour change occurs if 
people perceive that they have control over the outcome, that there are few external 
barriers and that individuals have confidence and self-efficacy in their ability to execute 
the behaviour (Armitage and Conner, 2000). Nevertheless, Taylor and Burry (2007) 
argued that the extent to which self-efficacy is in fact a significant independent variable 
relating to self-management and adherence capabilities in the overall population 
remains unclear. They suggested that the degree to which high levels of observed 
self-efficacy are a direct cause, rather than a consequence of coping well with a 
chronic disease is also unclear. 
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Knowledge of health 
risks: r--. 
"What is Qlaucoma?" 
Benefits of change: 
"Taking my eye drops will f---' 
control the progression of r--., 
glaucoma" 
Self efficacy: Behaviour 
"I am managing my 
"I can take my eye drops" glaucoma and taking my 
eye drops" 
Outcomes expectations: 
---
"If I take my eye drops I will -..... 
not go blind" 
Facilitators and barriers: 
"It is easy to take my eye 
drops" 
,.-
Figure (3.4): Social Cognitive Theory: Adapted from Bandura (2000). 
Kalichman et al (2002) commented that self-efficacy serves as a proxy to behavioural 
skills and may not be as predictive of adherence to medication as a direct 
observational skill assessment. Stone (1999) criticised the wide ranging focus of this 
theory, and observed that this theory is often used only in parts due to difficulties in 
operationalising its components; thus raising questions regarding its applicability to 
intervention development. 
3.4.6.3 The Protection-Motivation Theory 
Health behaviour change according to this theory can be achieved by appealing to the 
patient's fears. Three components of fear arousal are suggested as illustrated in 
Figure (3.5): the magnitude of harm caused by the event; the probability of that event 
occurring; and the efficacy of the protective response (Rogers, 1975). This is the only 
theory within the cognitive perspective that explicitly uses the costs and benefits of 
existing and recommended behaviour to predict the likelihood of change (Gebhardt 
and Maes, 2001). This model may be appropriate for adherence interventions, as 
individuals do not consciously re-evaluate their routine behaviours such as taking long-
term medication. However, the impacts of social, psychological and environmental 
factors on motivation require further consideration (Floyd, et ai, 2000). 
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Perceived severity: 
"Glaucoma is a major 
-
cause of blindness" 
/ '\ 
Perceived probabilityl 
perceived Motivation to engage in 
susceptibility: preventive behaviour: 
"Many of my siblings "I should take my drops 
have got glaucoma, 1 as prescribed" 
could have it too' 
\.. ./ 
Efficacy of response: 
"Eye drops slow down t---the progress of 
glaucoma" 
Figure (3.5): Protection-Motivation Theory: Adapted from Rogers (1975). 
3.4.6.4 Theory of Reasoned Action (TRA) and the Theory of Planned Behaviour 
(TPB) 
According to the TRA and TPB, most socially relevant behaviours are under volitional 
control, and that a person's intention to perform a particular behaviour is both the 
immediate determinant and the single best predictor of that behaviour (Sutton, 1997). 
Subsequently, a person's intentions to perform behaviour are determined by their 
attitude and positive and negative beliefs of the outcomes of the behaviour. Behaviour 
is also influenced by subjective norms, including perceived expectations of important 
others, and the motivation for a person to comply with others' wishes. Sutton (1997) 
suggested that TRA and TPS require more conceptualisation, definition and additional 
explanatory factors. Stroebe (2000) argued that these theories are largely dependent 
on rational processes and do not allow explicitly for the impact of emotions and 
religious beliefs on behaviour. 
3.4.6.5Information-Motivation-Behavioural Skills (1MB) Model: 
Grounded in health and social psychology, the 1MB model asserts that self-
management and adherence as a health behaviour are determined principally by 
individuals' relevant information (knowledge), attitudes toward following treatment 
regimens (motivation) and abilities to perform necessary adherence and self-
management tasks together with a sense of self-efficacy (Behavioural skills). As 
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illustrated in Figure 3.6, these constructs are essential prerequisites for behavioural 
change but not necessarily sufficient in isolation (Fisher and Fisher, 1992). 
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Figure (3.6): Contribution of information, motivation, and behavioural skills to COAG self-management 
and health outcomes: Adapted from Fisher et al. (2003). 
The 1MB model was originally constructed to be conceptually based, generalisable 
and simple to promote contraceptive use and prevent HIV transmission (Fisher et aI., 
2003). Subsequently, it has been tailored and applied to numerous health promotion 
behaviours, with particular attention to adherence for treatment regimens in chronic 
conditions (Fisher and Fisher, 1992). Kalichman et al (2006) empirically examined the 
associations between the constructs of this model in changing behaviour. They 
commented that the 1MB model is particularly interesting because of the intuitive 
appeal that behaviour change requires; knowledge of the health implications of 
behaviour, the need to enhance motivation for behaviour change, and the requisite 
skills needed to enact behaviour change. 
The 1MB model is the only theory of this category that recognises the necessity and 
importance of a set of behavioural skills in initiating a positive self-management skill. 
Furthermore, it has other applications in health behaviour change as it provides a 
conceptual basis for analysis and insight into the determinants and dynamics of 
adherence to medical treatment behaviours (Fisher et aI., 2006). These two main 
advantages make this model particularly interesting and therefore adopted for this 
study. 
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3.5 Theoretical Underpinning of COAG Self-Management and Adherence 
As noted previously, there are over 30 psychological theories of behaviour change 
which are often fragmented with a contradictory evidence base and lacking a rigorous 
test to advocate one over the other. With the lack of published comparisons between 
theories to long-term adherence, it is vital to ensure the applicability of a chosen theory 
in the research context. Given the complexity of self-management and adherence 
behaviours to treatment in COAG (Stryker et ai, 2010), applying the appropriate theory 
helps understand and conceptualise this problem. Many interventions to improve 
adherence in chronic conditions are unsuccessful and sound theoretical foundations 
are lacking (van Dulmen et ai, 2007). 
In this section, the 1MB framework is employed to demonstrate the determinants of 
self-management amongst patients with COAG. The approach followed is 
collaborative in the sense that self-management is a collaborative effort where 
patients, providers and the service provided all contribute collectively. The success or 
failure of this effort depends on how well the collaboration works. This model has not 
received attention in chronic eye disease self-management; however, it has a 
considerable relevance to chronic disease management and adherence behaviours 
(HIV/AIDS viral therapy) (Amro et ai, 2010). Bearing in mind the uniqueness of the 
needs of patients with COAG; given this research is an action research study, it was 
imperative to gain a working knowledge of the validity of this model in an ophthalmic 
context and how to employ this model to meet the needs and expectations of glaucoma 
patients. 
Ware et al (2006) argued that models developed for use in a particular socio-cultural 
context cannot simply be assumed to be valid in another. They layout a schema of 4 
analytic questions that assesses the 1MB model validity in the new context. These 
questions will be explored to examine the validity of this model in a glaucoma context 
in the following narrative: 
Q1: Are the model's basic concepts relevant to the new setting? 
An important indicator of relevance of these concepts is its representation in the 
experience of patients involved. During the observation period of this study, patient 
interviews and observations were conducted. Information was represented in patients' 
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views as a basic understanding of their condition, treatment options, and prognosis of 
the condition and treatment side effects. Other statements of their commitment to 
taking their medication, confidence in the effectiveness of these medications and 
anticipated benefits of taking the treatment testified the motivational aspect of this 
model. Another common statement expressed by patients was whether they were 
instilling their drops correctly and timely, in addition to strategies followed to remind 
them of using these drops, which demonstrated mastery of adherence-related 
behavioural skills. 
Q2: Are basic concepts important to the new setting represented in the model? 
This question addresses whether new concepts should be added to this model. 
Answering this question requires appropriate understanding of the setting to be used 
in which to identify basic concepts of validity required but not presently included in the 
model. Two conceptual domains are particularly relevant and might increase the 
validity of this model, the social context and the cultural context. 
The social context here represents the organisation of social relations and 
interpersonal ties. Social structural barriers to adherence, i.e., family and significant 
others influence, do not appear in this model, or rather appear as a moderate 
influence, but they are considered to be of relevance in glaucoma adherence. As the 
majority of glaucoma patients are senior adults, inevitably they will rely on family 
members, friends and/or carers for support. 
The cultural context represents a set of norms, values, religious, ethical and meanings 
that shape an individual's behaviour and helps to make sense of experience. Culture 
as part of any society or community plays a role in shaping glaucoma adherence; yet 
culture does not figure in the 1MB model. This was represented in a particular case 
where a young glaucoma patient in his twenties refused taking any eye drops or 
accepting the diagnosis, and insistence on the part of the young man that "if I have a 
problem with my eyes the cure will come from GOD, not eye dropsn, and that he will 
seek the help of his church instead. 
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Q3: Are the meanings of the model's basic concepts accurate for the new 
setting? 
This question focuses on the indicators through which basic concepts in a model are 
specified. For example, the ability to perform necessary adherence skills is one 
indicator of the concept of behavioural skills. The use of reminders and cues is a 
relevant example that has been used extensively in glaucoma treatment. Socio-
cultural differences were present at this indicator level; for instance, a Muslim patient 
indicated the scheduled time of the morning prayers and evening prayers for taking 
his eye drops. Dinner preparation was relevant to other patients. 
Q4: Does the model capture the complexity of adherence and self-management 
in the new setting? 
As noted earlier, the challenge of adherence and self-management in glaucoma is 
widely acknowledged to be complex with many barriers and facilitators. The idea of 
developing a valid theoretical model of adherence offers a new opportunity to capture 
this complexity. The following section will examine the constructs of this model. 
3.5.1 The Construct of the 1MB Model 
As noted above, knowledge, motivation and behavioural skills are the main constructs 
of this model. Though essential prerequisites for behavioural change, they are not 
necessarily sufficient in isolation. 
3.5.1.1 Knowledge 
Past research has shown that information alone is an inconsistent predictor of health 
behaviour. However, when evaluated as part of the 1MB model, information has been 
a consistent predictor of health behaviour (Anderson et ai, 2006). To manage their 
condition, patients with COAG need knowledge, including basic information about their 
condition, screening, diagnosis, prognosis, treatment options and what they can do to 
maintain their vision and control their glaucoma. They need a clear understanding of 
their personal ophthalmic history, the treatment they are taking and why they are given 
this treatment, as this knowledge will serve as guides for personal actions. These are 
the main prerequisites for strong concordance as will be explicated later. 
Stryker et al (2010) in their study observed that half of the participants were looking 
for information about their glaucoma. However, non-adherent participants were less 
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likely than adherent participants to feel that they understood all the information they 
had received about their eyes. They also need to know how to contact health care 
professionals, ask questions and access care. However compelling and necessary 
information provision may be, information alone is usually insufficient to bring about 
changes in self-management behaviours; particularly as it relates to adherence and 
concordance. 
3.5.1.2 Motivation 'Improving Adherence with Medication' 
The second component, motivation, results from attitudes and beliefs about outcomes 
of adherent behaviour; significant others' support for the behaviour; and the patient's 
subjective perception of how patients with glaucoma might behave. According to this 
framework, motivation or readiness to change or sustain behaviour can be 
conceptualised as having two main components, both relevant to self-management 
approaches in chronic illnesses: importance and confidence (Fisher, et ai, 2006). 
Patients may be aware of the need for consistent use of the anti-hypertensive eye 
drops and they may consider this treatment as very important. However, Fisher et al 
(2003) pointed out that if the patient is lacking confidence they can manage side 
effects, remember dosing times and use medications appropriately but overall 
motivation will be weak. Conversely, other patients may be highly confident that they 
have the skills, support and tools to take their medications consistently, but they may 
not see the importance of doing so. In both cases, the patients are unsure about 
changing as they lack motivation, but for different reasons. Self-management 
approaches to each one should be targeted differently. 
3.5.1.3 Acquiring Necessary Behavioural Skills 
For information and motivation to translate into strong self-management, most patients 
require concrete behavioural skills that can be learned. practiced and adapted to 
environmental resources and constraints (Fisher et aI., 2006). These skills may be 
very specific technical skills, (such as instilling eye drops or using a drops reminder or 
cues), or may be broad self-management skills, (such as how to make an action plan 
to achieve a goal, how to communicate effectively with health professionals or how to 
find resources and social support). This conceptual framework suggests that 
behavioural skills are likely to be applied when they are practical and effective in 
addressing patients' most compelling disease management priorities (Fisher and 
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Fisher, 2000). According to this theory, a patient's satisfaction with the care they 
receive improves as the patient's sense of ownership and empowerment grows as a 
direct result of addressing the three main determinants of health outcomes. 
Moderating factors affecting adherence include psychological health, an unstable 
living situation, poor social support, and poor access to medical care. Although not 
developed to describe, predict, or influence glaucoma self-management behaviours, 
the 1MB model has strong implications for enhancing chronic disease self-
management and adherence behaviours (Amro et ai, 2011 a). The following section 
will explicate this adherence model. 
3.5.2 The Adherence Model for the Glaucoma Expert Patient Programme 
Adherence to long-term intraocular pressure (lOP) lowering medication is poor in 
patients with glaucoma, which is a significant factor in disease progression. Therefore, 
any educational or self-management programme for patients with COAG should 
address the issue of adherence to treatment regimens. Building on the Fisher et al 
(2003) 1MB model, Starace et al (2006) developed the 1MB model of adherence. This 
model demonstrates that adherence to a medical regimen has much in common with 
other complex health behaviours; therefore, adherence will occur as a function of the 
presence of a set of relevant information, motivation, and behavioural skills factors as 
illustrated in Figure 3.7 (Fisher et ai, 2003). 
According to this model adherence-related information is an essential prerequisite for 
consistent adherence and includes accurate information regarding one's specific 
regimen, potential drug interaction and side effects. Personal motivation includes the 
patient's attitude and beliefs toward potential outcomes and suboptimal adherence, 
whereas social motivation includes the patient's perception of support for adherence 
behaviours from significant others' wishes. Subsequently. glaucoma patients who are 
well informed about their condition, motivated to act, and possess the requisite 
behavioural skills to act effectively are more likely to adhere to treatment regimens 
and reap substantial health benefits. Conversely, patients who are poorly informed, 
unmotivated to act, and lack the requisite behavioural skills for effective adherence will 
likely be non-adherent to treatment regimens and will fail to realise its health benefits. 
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Although this model provides a good understanding of patients' behaviours regarding 
adherence, the relationship between adherence-related information and motivation is 
not assumed in this model. For example, there are cases where motivation does not 
imply correct information (e.g., the patient may be highly motivated to follow what he 
or she understands to be his or her prescribed treatment regardless of whether that 
understanding is accurate), nor does accurate information imply high motivation (e.g., 
one may be entirely accurate in understanding the requirements of his or her treatment 
regimen and still feel unmotivated to fulfil those requirements) (Starace et ai, 2006). 
According to this model, adherence behavioural skills include both objective ability and 
perceived self-efficacy for performing critical adherence-related skills. Examples of 
this include acquiring and self-administrating medications, incorporating treatment 
regimens into daily life, minimising side effects, seeking out new information when 
needed, and developing self-reinforcement strategies for establishing and maintaining 
adherence (Rollnick et aI., 2000). 
As illustrated in Figure 3.7, behavioural skills are directly related to adherence 
behaviour, whereas adherence-related information and motivation are related to 
adherence behaviour primarily through behavioural skills. Specifically, the 1MB model 
of adherence predicts that, to the extent that the skills required for adherence 
behaviour, behaviour skill will mediate the relationship between information and 
motivation and adherence behaviour (Fisher et aI., 2003). Consistent with the available 
literature, the 1MB model of adherence predicts that high levels of adherence will result 
in favourable health outcomes and that poor adherence will result in unfavourable 
health outcomes. Moreover, the model assumes that favourable or unfavourable 
health outcomes will affect subsequent levels of adherence-related information, 
motivation, and behavioural skills through a feedback loop (Fisher and Fisher, 1992). 
Finally, the model identifies several potential factors that may moderate (strengthen or 
weaken) the relationship between adherence-related information, motivation, 
behavioural skills, and adherence per se (Starace et ai, 2006). 
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ADHERENCE INFORMATION 
"About the regimen, correct 
treatment utilisation, adequate 
adherence 
"About side effects and drug 
interaction 
"About heuristics and implicit 
theories concerning adherence 
ADHERENCE MOTIVATION 
-Personal Motivation: 
Attitudes/beliefs about outcomes of 
adherent and non-adherent 
behaviour and evaluation of three 
outcomes. 
-Social Motivation: 
Perceptions of significant others' 
support for adherence and 
motivation to comply with significant 
other's wishes. 
f MODERATING FACTORS AFFECTING ADHERENCE 
"Psychological health (e.g. depression) 
"Unstable living situation 
"Poor access to medical care, services (e.g. medication supplies) 
ADHERENCE BEHAVIOURAL SKILLS 
Objective and perceived abilities (self-efficacy): 
*For acquiring, self-cueing, and self-
administering medication 
*For incorporating regimen into social ecology of 
daily life 
*For minimising side effects 
*For updating adherence related facts as 
necessary 
*For acquiring social support and instrumental 
support for adherence 
*For self-reinforcement of adherence over time 
ADHERENCE BEHAVIOR 
*Proper dosing: percentage of 
eye drops taken over amount 
prescribed. 
*Optimal adherence: 95% or 
greater adherence to dosing 
requirements of all anti-
hypertensive drops 
*Adherence levels over time 
HEALTH OUTCOMES 
"Visual field 
"Intraocular Pressure 
"Disc changes 
*Objective and subjective 
symptoms 
L ___________________________________________________________________________________________________________ _____________________________ ~ 
Figure (3.7): An information-motivation-behavioural skills model of therapy adherence (Adapted by Starace (2006) from the model developed by J. D. Fisher, 
et ai, 2003). 
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3.5.3 Empirical Support of the 1MB Model 
Beyond its established strength in predicting, understanding, and intervening to 
change HIV risk behaviours, the 1MB model is viewed as a generalisable approach to 
understanding and promoting health behaviours more broadly defined as examined 
earlier (Fisher and Fisher, 2000). In establishing the generalisability of this model, 
Fisher and Fisher conducted a review of the correlational research literature 
concerning socio-psychological factors linked to performance of diverse health 
behaviours. Fisher and Fisher (1999) found that in correlational research, information, 
motivation and behaviour skills elements are consistently related to health behaviour 
performance across diverse areas such as exercise behaviour, smoking cessation, 
breast cancer and cardiovascular health. In effect, there is considerable empirical 
support for the 1MB model's fundamental assumptions that information, motivation and 
behavioural skills in the model are critical determinants of health behaviour change 
outside the domain of HIV prevention (de Vroome, et aI., 1996). 
A further review was conducted by Fisher, et al (2006) in which they examined 
interventions that contain information, motivation and behavioural skills elements. 
They observed that interventions that included the three elements were more effective 
in promoting health behaviour change than interventions that lacked one or more of 
these elements. When comparing the strength of the three elements contents of 
interventions that had strong health behaviour change effects, versus those with weak 
effects, they observed that the former had greater information, motivation and 
behavioural skills related content in comparison with the latter (Fisher and Fisher, 
1996). Overall, the findings provide support for the 1MB model elements as 
determinants of intervention efficacy across diverse domains of health behaviour 
change including disease preventive behaviour, disease screening and detection 
behaviour and behaviour related to adherence to medical treatment. 
3.5.4 Critique of the 1MB Model 
The 1MB model provides a comprehensive conceptual approach to understanding the 
determinants of health behaviour and may constitute a generalisable methodology for 
interventions that promote health behaviour change (Fisher and Fisher, 1999). This 
approach has been supported in elicitation, experimental intervention, and evaluation 
research conducted with diverse populations that showed significant sustainable 
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positive changes. Results of such research are consistent with the 1MB model's focus 
on identifying and addressing deficits in health behaviour relevant information, 
motivation and behavioural skills as an effective means for promoting health behaviour 
change. Fisher et al (1998) added that given the relatively recent birth of the 1MB 
model, which was first published in 1992, it is not surprising that some areas of the 
1MB model-based research are somewhat sparse. Prospective studies of the 
determinants of health behaviour are fewer in number than cross-sectional and 
experimental intervention research, while much 1MB model based research is still in 
process and not yet widely available. 
A review in 2007 raised some questions about the role of the 1MB model's information 
construct, which appeared to be inconsistent in predicting patient health behaviours 
and adherence behaviour (Munro et ai, 2007). The model has speCified situations 
where information itself is expected to be a substantial contributor to health behaviour 
and adherence behaviours; perhaps in relation to concordance issues could be raised. 
Further questions have been raised regarding the relationship between the information 
and motivation constructs that sometimes seems independent whilst others are 
dependent. Fisher et al (1994) argued that the 1MB model's logic holds that well-
informed people are not necessarily well motivated to practice healthy behaviour or 
adhere to their treatment regimens, and vice versa. This has implications for 
concordance. 
3.5.5 The 1MB Concordance Model 
ACCOrding to the 1MB adherence model, provision of adherence support stresses the 
need to offer an individualized approach sensitive to patients' needs. Adherence is 
likely to be enhanced if the medical regimen fits pati~nts' lifestyle and beliefs; they 
understood the regimen and if their concerns have been addressed. Fundamental to 
this process is the provider-patient communication dynamic that occurs within a 
clinical encounter that can be theorized using this 'concordance' model (Refer to 
Figure 3.8.), adapted from the 1MB adherence model. According to this concordance 
model, for patients to be meaningfully engaged in their care, there is a requirement for 
them to have adequate information to participate as collaborative partners and to be 
Supported in self-managing their condition. Practical steps for shared decision-making 
include outlining the range of options, providing information in their preferred format, 
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checking understanding and exploring ideas to arrive at an agreed decision (Schneider 
et ai, 2004). Of critical importance here is that it is an agreed decision between the 
patient and the healthcare practitioner. 
The benefits of this collaborative concordance-based approach have been 
demonstrated in various settings, including improved adherence, increased patient 
satisfaction with care, reductions in the number of medications prescribed and in 
medication-related problems (Cox et ai, 2004). Patient-centred communicative 
behaviours that stress a collaborative approach between doctor and patient have been 
shown to be associated with stronger coping mechanisms, improved quality of life, 
quicker recovery, and enhanced functional status (Silverman et ai, 2006). 
Despite these benefits, the extent to which concordance is routinely incorporated in 
clinical consultations is unclear. As noted previously, the term concordance is rarely 
used and early observations have shown low levels of concordance activity. Schneider 
et al (2004) identified barriers include patient reticence and doctors' lack of skills to 
facilitate the process. Given the complexity of self-management and concordance 
amongst glaucoma patients associated with factors like drug-related tolerability and 
effectiveness, the model presented an opportunity to understand concordance and 
guide the design of intervention. 
3.6 Conclusion 
This chapter has explored the concept of self-management in some detail and mapped 
policy responses in the UK. The current views and literature surrounding the EPP were 
also examined in relation to its effectiveness and cost-effectiveness. Theories of 
human health behaviour have been explicated with an emphasis on self-management 
and adherence. This chapter has concluded with a proposed framework for the 
research that is underpinned by the 1MB model. Adherence and concordance have 
been shown as associations with the 1MB model. Many of the issues discussed in this 
chapter will be revisited later in the Thesis and discussed in-depth in the Discussion 
Chapter. In the chapter that follows, the methodology employed in this research project 
is described. The 1MB model is discussed in relation to how it has been applied in the 
EPP. 
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CONCORDANCE INFORMATION 
*Provision from health care professionals 
or Expert Patient, 
*About the regimen, correct treatment 
utilisation, adequate concordance to eye 
drops. 
*About side effects and drug interaction. 
CONCORDANCE MOTIVATION 
·Personal Motivation: 
Attitudeslbeliefs about outcomes of 
good concordance, initiating positive 
strategies and collaborative care. 
-Social Motivation: 
Perceptions of significant others' 
support for concordance. Motivation 
from significant others to initiate 
positive concordance strateQies. 
CONCORDANCE BEHAVIOURAL SKILLS 
Objective and perceived abilities (self-
efficacy): 
"For acquiring, self-cueing, and self-
administering medication 
"For incorporating regimen into social ecology 
of daily life 
"For minimising side effects 
"For engaging in collaborative partnership with 
care provider 
"For acquiring social support and instrumental 
support for concordance 
"For negotiating changing circumstance with 
care providers of adherence over time. 
MODERATING FACTORS AFFECTING CONCORDANCE 
·Psychological health (e.g. depression) 
*Unstable living situation 
*Professionals' attitudes toward empowerment and collaborative care 
*r.n!':t nf trA~tmAnt 
CONCORDANCE BEHAVIOR 
*Proper dosing: eye drops taken 
over amount prescribed. 
"Optimal concordance: taking 95% 
or greater of eye drops required. 
"Communication: establishing a 
mutual and collaborative 
relationship with care providers 
"Concordance levels over time 
'persistence' 
HEALTH OUTCOMES 
*Self-care 
*Self-management 
*Controlled lOPs 
*Slow prognosis of COAG 
*More Satisfaction 
1 _________________________________________________________________________________________________________________________________________ _ 
Figure (3.8): A modification of the 1MB adherence model to demonstrate glaucoma concordance (Adapted from Starace (2006), from the model 
developed by J. D. Fisher et ai, 2003) 
138 
4.0 Introduction 
Chapter Four 
Method 
The methodology for the research will be presented in three parts. Part one will 
describe the use of an ethnographic approach to develop the GEPP. Part two will 
describe the use of a collaborative Action Research approach to implement the GEPP. 
Part three will describe the mixed method approach associated with the evaluation. 
4.1 Methodological Account 
As previously indicated in the introduction chapter, this research took place in three 
glaucoma outpatient clinics in Moorfields Eye Hospital NHS Foundation Trust. Two of 
the clinics were outreach clinics that serve the area of east London (Barking and 
Dagenham), which is an ethnically diverse community with high levels of poverty. The 
third outpatient clinic was based at the main hospital building at City Road and serves 
a less diverse community with lower levels of poverty. 
In order to develop, implement and evaluate the intervention, the research team (The 
initial research team comprised a Consultant Ophthalmologist, the Nursing Research 
Lead in the Trust that is my City University London Supervisor, an Optometrist 
Research Fellow and myself) proposed the application of a mixed methodology 
(qualitative and quasi experimental quantitative design) comprising a before-and-after 
study involving action research. There was a strong belief held by the research team 
regarding the appropriateness of mixed methodology and the insight that potentially 
could be gained from engaging patients in designing and delivering the study through 
a collaborative approach. The Trust Research and Development Committee had a 
slightly different point of view where they preferred a large sample sized experimental 
study and a clear interest in supporting the undertaking of a Randomised Controlled 
Trial. It was evident to the research team that the data size required would be much 
larger than originally planned (approximately 1500 participants). The research team 
considered an ReT to be inappropriate. No preliminary research or pilot study had 
been undertaken and there was no evidence in the literature to support an RCT at this 
juncture. Therefore the team challenged the conduction of an RCT. Further meeting 
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with the Research and Development Committee resulted in an initial 'stale mate' and 
then a compromise. It was agreed the team would undertake a feasibility exploratory 
study comprising a before-and-after design in preparation for an RCT. The team 
regarded this as appropriate prior to undertaking a larger scale RCT. Once a decision 
was made that a qualitative and quasi-experimental quantitative component would be 
undertaken (that would be followed by an RCT), the Research and Development 
Committee approved the research. It should be noted that this study is the first nursing 
research project to be undertaken in the Trust. 
After data collection was initiated and following discussions with statisticians, the 
weakness of the before-and-after design in the absence of a control group was group 
in term of strengthening the validity when selected carefully, there was a risk of 
Occurrence of contamination that could have serious effects on outcomes and reduce 
the apparent effect of the interventions. In addition, I was focused on the action 
research processes and the intervention that was being delivered by the Expert 
Patients. Therefore, on completion of the intervention phase of this research, great 
efforts were made to recruit a non-contemporaneous control group of participants to 
match the intervention group participants with respect to the key characteristics of the 
geographical area, setting, gender, age, ethnicity and number of participants. It must 
be noted here that the Research and Development Committee did not approve the 
inclusion of a control group in the research. The Consultant Ophthalmologist took it 
Upon herself to fight for this addition to the action research project. 
The Trust Medical Statistician calculated the sample size for each group. The 
Research and Development Committee agreed that for the purpose of this 'preliminary' 
study (it should be noted that would be followed by an RCT) that 5 Expert Patients and 
25 clinic patient participants known as the 'intervention group' would be involved in the 
research. Following discussions with the Consultant Ophthalmologist the Research 
Development Committee agreed that an additional 25 patient partiCipants (control 
group) could be included. This was deemed sufficient to discern the effect of the 
GEPP. 
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4.1.1 Participants and Participation 
The development and implementation of the GEPP involved recruitment of three 
patient groups. First, an Expert Patient group who were experienced patients and 
received further training to deliver the intervention (The Ethnographic component of 
the research). Second, the patient participants group who were diagnosed with COAG 
within the last two years and were attending the clinic for their follow up care and 
received the intervention (The Action Research component of this research). The third 
group was a control group that did not receive any intervention other than the normal 
provision of information from the doctors and nurses but served the purpose of 
between groups comparison. 
All patients included in this study were patients that attended the glaucoma clinics 
under the care of the Glaucoma Consultant Ophthalmologist that has been supervising 
this study in the Trust. As stated previously recruitment took place in three different 
outpatient sites in this Trust where the Consultant Ophthalmologist was running clinics. 
The Expert Patient group was chosen according to criteria described in Appendix (2) 
although the criteria received further adjustments to suit our patients. Five patients 
who met the suitability criteria and agreed to take part were asked to attend training 
workshops. The clinic patient participants were recruited on the day they visited the 
glaucoma clinic. All patients that attended the clinic that met the inclusion criteria were 
invited to take part. Those who agreed were recruited. An information sheet was 
distributed and participants given time and space to decide whether they wished to 
participate. 
4.1.2 My Position as Researcher and Lead Investigator 
The Special Trustees of Moorfields Eye Hospital NHS Foundation Trust and the 
International Glaucoma Association (IGA) in the United Kingdom funded my post as a 
researcher to conduct this study. My remit has been to improve the knowledge, 
experience and the adherence to treatment of recently diagnosed glaucoma patients 
attending the outpatient clinics. As noted previously, I came to this research with 
extensive experience having worked in the Accident and Emergency Department of 
the hospital as an Ophthalmic Nurse Practitioner. During this time I have worked with 
the health professionals who are involved in running the outpatient clinics and know 
them on a professional and personal level. 
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During my working career in the Trust I have worked with glaucoma patients in all 
stages of their illness attending Accident and Emergency for various reasons including: 
being referred for their primary assessment by Optometrists or General Practitioners, 
reactions to eye drops, deterioration of vision, and/or being diagnosed on their visit for 
a non-glaucoma related eye problem. Over time I became concerned about glaucoma 
patients poor knowledge and concordance to treatment, which was the primary reason 
for my involvement in this research. My concerns became so great that I initiated 
discussions with one of the leading glaucoma consultants in the Trust, who worked in 
the Accident and Emergency with me. This consultant shared similar concerns 
regarding adherence and concordance amongst glaucoma patients. We wanted to find 
ways to involve experienced patients in the running of the service. Having both shared 
common concerns and ideas about improving the patients experience and involving 
experienced patients in improving the experience of other recently diagnosed patients, 
this Consultant was very supportive, prepared and willing to facilitate this research. 
In action research literature, there has been considerable debate about being an 
'insider' as opposed to 'outsider' action researcher conducting a particular inquiry. As 
an 'insider' the investigator has a formal role in the study setting and is usually in paid 
employment, whereas an 'outsider' has no formal role in the setting other than in the 
action research itself (Waterman et ai, 2001). I consider myself to be an insider from a 
staff point of view in the sense that I have known most of the people involved in running 
the outpatient clinics and 'being around' the clinics in either my clinical role or 
researcher role during the exploratory phase and the action phases of the research. 
Writers have taken different views as to which model of researcher is more successful. 
Titchen and Binnie (1993) suggested that the 'insider' model they used in their 
research was the most successful. Meyer and Batehup (1997) having worked within 
the setting before called themselves 'insiders' although later on as management 
changed they felt like an 'outsider'. In a comparison, Waterman et al (2001) observed 
that 63% of outsider action researchers reviewed have been successful in achieving 
their aims as compared to 30% of insider action researchers. They also observed that 
both roles have their advantages and disadvantages as summarised in Table (4.1). 
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Table (4.1): Insider or outsider action researcher: Adapted from Waterman et al (2001). 
~~~~--~~--------------~--~--~---Perceived positive aspects Perceived negative aspects 
Insider action researcher: Familiarity clouded understanding 
Improve understanding of context Conflicting commitments causing delays 
Enhance credibility with participants Participants disclosed information reluctantly 
Challenge barriers to change Limited access to confidential information 
Increase commitment to the study Perceived as owning the data 
Sustain change Generating feelings of vulner~a~bi_lit...LY ___ ---! 
Outsider action researcher: Difficulty in understanding context 
Bring fresh perspective to issues Time-consuming 
Lead to empowerment of participants Lack concern for long-term outcomes 
Have more to gain {e.g. higher degree). 
Titchen and Binnie (1993) have advocated for what they called a 'double act' where 
one researcher was an outsider (researcher) and the second was an insider (change 
facilitator). Whatever stance taken, Ruth (2002) stressed that reflexivity and critical 
self-awareness are essential to help question biases from whether an individual is an 
insider or an outsider. In that sense I also considered myself as an 'outsider' having 
not worked in the glaucoma outpatient clinics before and being unfamiliar with the 
practices followed. Subsequently, I could bring a fresh perspective to examining 
issues. As an 'outsider' in the glaucoma clinics, it made me conscious that it is not 
easy for an 'outsider' to be present. I felt that some senior nurses involved in leading 
these clinics found my role threatening from the way they responded to my presence. 
4.1.3 Steering Group 
A steering group was established to monitor the research . The steering group was 
intended to include a patient representative right at the beginning of the planning phase 
of this study. However, due to the delay in gaining ethical approval for the study and 
as we were required to provide a detailed account of the plan of this research, it meant 
there was limited input from a patient's perspective at this stage. The original steering 
group comprised of The Nursing Research Lead at the Trust (City University London 
supervisor), Glaucoma Consultant Lead (second supervisor), Optometrist Research 
Fellow (Senior Lecturer in the Department of Optometry at City University London) and 
myself. The steering group oversaw the research in its initial phases of seeking access 
to the Trust outpatient clinics and the exploratory phase. 
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The role of this group has evolved and changed from one stage to another. In the early 
stages it played a primary role in seeking the approval of the Research and 
Development Committee at Moorfields Eye Hospital NHS Foundation Trust and getting 
the research through the strict scrutiny of the National Research Ethics Service 
(NRES). It has met regularly to obtain updates on issues like the study design, the 
tools to be used, the outcomes to be measured, Expert Patient recruitment and the 
content of the training programme for example. 
Steering group members were experienced professionals and had been involved in 
different research projects in the past. As noted previously, there was no significant 
patient input at the early stages of this research; particularly in issues related to the 
Trust's Research and Development Committee approval and the subsequent NRES 
approval. 
4.2 Stages of This Study 
This study had three phases which are to an extent, connected with one leading to 
another. The following figure (4.1) presents a flow chart of the development of the 
different phases of this study from a methodological perspective. 
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Figure (4.1): Methodological Flow Chart 
Stages and Phases of the Study 
Designing the 
GEPP 
Recruitment of the 
Intervention Group 
Assessment of the 
Intervention Group 
Ethnography 
Recruitment of the 
EPs 
Employment of the 
1MB model: EP 
delivering the 
intervention 
Training of the EP 
Re-enforcement of 
the EP teaching and 
learning 
Mixed Method 
Application of the 
1MB model 
Recruitment of the 
Control Group. 
Assessment of the Control 
Group 
Interviews with Staff and 
Expert Patients 
4.2.1 Exploration Phase (Ethnography) 
This phase was an intense period of involvement for the various key players and lasted 
6 months. During the ethnographic 'pre-innovation phase' (Meyer, 1993), I spent two 
shifts (8 hours each) a week in the first month to get to know the staff involved in 
running the glaucoma services closely and to conduct my observation tasks. In this 
phase, I made formal and informal presentations of the study proposed, emphasising 
the importance of its collaborative aspects. It was important to engage staff working in 
these clinics and encourage them to contribute, at an early stage, to building a picture 
and proposing possible solutions to the problem of adherence. I was surprised at the 
amount of trust that had already been built and the level of interest the staff showed in 
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this research and how much they were prepared to participate in the study and be 
interviewed which was rather refreshing and encouraging at this stage; particularly in 
light of my feelings about how some senior nurses had regarded my presence initially. 
Concurrently, I was engaged in discussions and frequently met with the Research and 
Development Committee staff to seek permission for this study and to obtain the 
necessary ethical approval from the Moorfields Eye Hospital NHS Foundation Trust. 
Data were generated in this phase to explore the nature of the problem and the focus 
of the study using different data sources consisting of reflective field notes based on 
my observation, gathering the views of the multidisciplinary team involved in running 
these clinics, views of patients attending the clinic and their comments on the service 
received. During the course of this phase, the research had input from other groups at 
different stages including patients, nurses, doctors, optometrists, researchers and 
outpatient leads. The following were involved at specific stages of this inquiry: 
Ethnographic Phase 
Expert Patients (n=5) 
Nurses (n=5) 
Outpatient Clinic Nurse Managers (n=2) 
Doctors (n=3) 
Research Lead (n=1) 
Medical Statistician (n=1) 
4.2.2 Implementation Phase (Action Research) 
This phase started once the Expert Patients training had finished. This Thesis 
describes the use of a collaborative Action Research approach by presenting the 
different cycles involved in the implementation of the GEPP; starting with the 
recruitment of the Intervention Group and delivering the GEPP by the Expert Patients 
and similarly recruiting the Control Group. This phase will be discussed in detail in Part 
II of this chapter. 
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4.2.3 Evaluative Phase (Mixed Method) 
This phase is an on-going phase that started at early stages of this study and continued 
throughout. Various data collection tools where used to evaluate the effectiveness of 
the GEPP including field notes, Expert Patient interviews and questionnaires, 
intervention and control group questionnaires and semi-structured interviews. Staff 
interviews will be discussed in detail in the last part of this chapter. 
4.3 Part I: Ethnography 
Part I is presented in this section and will explore the methodological decision made, 
along with an account of why ethnography was appropriate for developing the GEPP. 
This section commences with an account of the preparations and experiences that 
preceded the development of the GEPP and training programme, followed by 
implications and results from the meta-analysis conducted. The chapter concludes 
with a brief discussion component of the training programme (workshops) for the 
Expert Patients. 
A closer look at the literature reveals that under the qualitative umbrella there are 
several approaches that share many characteristics but have distinct disciplinary and 
intellectual traditions and customs (Fetterman, 1998). Each approach is embedded 
within a research community and has its own criteria for judging trustworthiness and 
merit (Silverman, 2006). In this study three different methodological approaches were 
applied in three different stages. An ethnographical approach was used to explore the 
issues arising from designing and implementing the first part of the GEPP, whilst a 
collaborative Action Research approach was used when implementing part two of the 
intervention and part three explores the issues arising from its delivery. In the following 
section, the empirical support, rationale for using ethnography and its main 
characteristics are presented. 
Ethnography fits well with action research because they both attempt to understand 
how a particular target group and a particular project work together (Alasuutari, 1995). 
Ethnography is an approach to research (LeCompte and Schensul, 1999). It is not one 
specific method (like participant observation, or interviews, or surveys). In fact, it is a 
multi-method approach. Moreover, ethnographic approaches integrate different 
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methods into one holistic study (LeCompte and Schensul, 1999; Atkinson et ai, 2001). 
I could not carry out and analyse a survey, for example, separately from interviews or 
in isolation from the diaries or field notes that I wrote. So I tried to look at all the 
knowledge and experiences together in relation to each other. Action Research links 
the research back to the aims and objectives of the study that will be discussed in the 
following chapter. 
4.3.1 Rationale and Definitions 
Describing this part of this study, as ethnography does not simply refer to the methods 
used for the research, which was participant-observation in three different settings, but 
also to the epistemological choices and the ethical commitments of the research. In 
contrast to the dominant biomedical model, it was important to consider how to explore 
knowledge associated with self-management of glaucoma and the lack of it at times. 
Ethnography, with its origins in the anthropological studies of 'others' seemed an 
obvious choice for the study of patients with COAG. In particular, simple observation 
without being an active participant may not have been sufficient for exploring a 
situation where there is an obvious lack of knowledge and potentially 'hidden' 
dissatisfaction. 
An ethnographic approach to exploring complex conditions (Le. COAG concordance) 
provides rich understandings of the context and enables effective interpretations of 
knowledge and information (Atkinson and Hammersley, 1994). Ethnography literally 
means to "write a culture" and can be distinguished from other forms of qualitative 
research by its focus on culture (Walcott 1994). It is often defined as the learned social 
behaviour or way of life of a particular group of people (Fetterman, 1998) and 
traditionally based on long-term engagement in the field of study (Le., Glaucoma 
outpatient clinics and its community.). 
Culture informs what people think and do, which forms the lens through which 
explored the experiences and the daily running of the outpatient clinics. Within a 
changing NHS, Edwards (2007:19) proposed that ethnography is an empirical method 
for studying "the experience of work at the point of production", where observation can 
generate important details and data. Geertz (1973) on the other hand, argued the value 
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of ethnographic research in the exploration of health care cultures that contrast with 
the dominant biomedical model, are, to a large extent, that they are internally validated. 
A key method is participant observation, where the ethnographer participates in the 
community and the setting being studied yet retains an analytical or observational 
position so that through reflection and analysis the ethnographer can describe and 
interpret the subject of the study (Wolcott, 1994). An ethnographer looks for patterns, 
describes local relationships, understandings and meanings which will help formulate 
and design a project based on the observed and felt needs of people (Hammersley, 
1992). Throughout the study field notes based on my observations were kept. Details 
of my activities in the clinics have already been given, though other activities were also 
undertaken with the primary aim of collecting data. As the clinics were occasionally 
short staffed I was called upon to cover for their nursing staff shortage, so I wore my 
nursing uniform and had an active role attending to patients as part of the nursing 
team, which was an even better opportunity to bring me closer to my observation task. 
As a non-participant observer at times I was not content to observe and participate 
marginally in the everyday activities of running of the clinics, but instead sought to learn 
those activities by putting them into practice. The goal of this active participation (which 
is also recommended by Schwartz and Jacobs, 1979: 248-53) is not to become like 
the 'natives,' but rather to gain better understanding of their practices. Therefore my 
role in this phase varied from being a non-participant observer to a participant 
observer. 
Some contemporary researchers share the early anthropologists' belief that in order 
to understand the world 'firsthand', the researcher must participate themselves rather 
than just observe people at distance. This has given rise to what is described as the 
method of participant observation. In a very general sense, Atkinson and Hammersley 
(1994:249) described "all social research as a form of participant observation, because 
we cannot study the social world without being part of it. From this point of view, 
participant observation is not a particular research technique but a mode of being-in-
the-world characteristic of researchers". I particularly enjoyed being a participant 
observer as it brought me closer to patients where their views were important for my 
data collection. As Silverman (2006) summed up, it also allowed me to pursue what 
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people actually 'do', leaving what people say they 'think' and 'feel' to the skills of the 
media interviewer. 
For example, I was attending to a 45 year old driver who was diagnosed with glaucoma 
two years ago and prescribed antihypertensive drops to be used until his next visit. He 
failed to attend the next few visits as he was travelling; eventually attended after two 
years of not using the prescribed drops. There was a progressive visual field loss and 
he could potentially lose his job as a result. I could not help but spend substantial time 
with him understanding what went wrong; which I would not be able to grasp if I was a 
mere observer. 
Prior to immersing myself in the culture (the fieldwork), I identified individual 
'informants' who were willing to interpret the outpatient culture from their perspective. 
These people were work colleagues and as this study unfolded became friends who 
gave me the support and confidence to complete this study. These informants were 
helpful in not only answering questions and queries I have raised, but they also brought 
to my attention certain issues which subsequently helped in formulating the final 
question and designing the GEPP. 
The process of examining practices and behaviours of a group or community implies 
that ethnography is field-oriented and naturalistic (Fetterman, 1996). In an attempt to 
get immersed in the culture and balance insider and outsider perspectives, I remained 
in the clinics for a considerable amount of time, observing, interviewing and 
participating in health care provision. 
This activity required taking an extensive amount of notes. Initially the amount of data 
was overwhelming and at times hard to make sense of. As a first time ethnographer I 
found myself bombarded with information and felt an urgent need to take notes all the 
time. Then my intuition started to playa greater role in deciding which data needed to 
be collected and when to document it and how. I know that it was important to maintain 
objectivity as a researcher and avoid "going native" (Burns and Grove, 1993). Data 
generated during this period has helped to uncover issues that were addressed in the 
GEPP and determined the direction of this study. 
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The notebook I kept with me was helpful in making an entry of my observation 'ideas 
and thoughts' as they occurred. I felt my notes could become relevant to the progress 
of the research with interpretations and reflections added. This varied from a comment 
made by a patient or an action taken by one of the nursing staff involved or even a 
telephone conversation with a patient. Often there was limited time to make a full entry. 
Occasionally I wrote a phrase or a word so that my memory would be triggered when 
more time was available to make a full entry. My one-hour commute train trip home 
was always handy in summing my day and going through my field notes that were 
written up the same day. 
Patients' views were recorded differently. Initially I asked patients questions about their 
thoughts of the consultation and the care they received. Their answers were insightful 
in assessing how satisfied or dissatisfied they were and what they valued and 
remembered most, but it left me with copious amounts of field notes which were not 
necessarily helpful in observing what actually went on in the conSUltation. Additionally, 
it was almost impossible to compare the field notes from one patient to another as their 
responses were quite varied. As I was going through my field notes I felt: 
"Very frustrated and uncertain about what I should be asking and 
recording, As my field notes are piling up on my desk I know I am doing 
something wrong. There has to be another way of doing this" 
"Reflective Diary" 
As I became more confident in recording patients' views, I developed a list of closed-
ended questions to be asked of all newly diagnosed patients that had either a yes or 
no answer (refer to appendix 1). In this way I could avoid collecting a large amount of 
field notes that did not allow comparisons or draw any conclusions. Patients were 
asked whether they were given information about the diagnosis, medication use and 
future visits and any further comment they would like to make. These notes allowed 
views of the patients and their levels of knowledge to be captured and recorded to 
inform future decisions regarding the content of what would be an Expert Patient 
training programme. In this phase, field note entries were recorded covering the 
following activities: 
• Observation of the MDT including Ophthalmologist, Optometrist, Nurses and 
Clerical staff. 
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• Records of meetings with patient participants. 
• Records of information meetings with participants. 
4.3.2 Research and Ethnography Aims 
As mentioned earlier the overall research question for this research can be formulated 
as follows: "Does the development and implementation of a GEPP improve knowledge 
and concordance amongst newly diagnosed glaucoma patients?" 
The aim of the explorative phase 'ethnography' is to take a holistic approach to the 
subject being studied and to look at the whole social setting and relationships and 
subsequently try to contextualise these in wider contexts (Bryman, 2001). The purpose 
of the ethnographic part therefore, was to explore the complete range of patient-
professional interactions and the processes involved in service provision at the 
glaucoma service, including: 
• The immediate circle of health professionals and the team involved in running 
the service, how they are organised, how they carry out their work, how the 
project fits into their daily activities; 
• Patients, their everyday lives with this condition and ways of doing things, 
interaction and communication with health professionals, their views on service 
provided, expectations and satisfaction; 
• The wider social context (e.g., social divisions and socioeconomical variations 
related to the condition and the service received and language issues), 
• Social and environmental structures and processes beyond the patients and to 
some extent the health professionals running the service. 
4.4 PartiCipatory Observation in Detail 
My fieldwork role as an ethnographer was a process of 'observation through 
partiCipation'. This has ranged from being a complete observer to complete participant 
depending on the situation I was experiencing. As an observer many insights were 
gained from listening to consultations with professionals and feedback from patients, 
interactions with patients' relatives and carers, listening to telephone conversations, 
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observing relationships between professionals and listening to personal tales and 
experiences. 
For this intervention to complement the care provided in the outpatient clinic, it was 
essential to understand and examine the health care provided for patients attending 
the clinic. It was also critical for the success of this research to build rapport with the 
staff running the clinics and to understand my role in this research and what exactly I 
was trying to achieve. Having worked in the Trust for seven years and having a good 
working relationship running the service has allowed me to closely observe the running 
of the clinics over four weeks. As data were generated it became clear that there was 
inconsistency in the care provided. On an ordinary day, as the clinics were getting 
busier and waiting times getting longer, patient encounters with professionals tended 
to become brief and to focus mainly on basic questions, i.e., what eye drops are you 
taking? Do you have any allergy or medical condition? Any problems with eye drops? 
To overcome this inconsistency, it was essential to get a sense of the scope of the 
problem as the data generated became messy and hard to comprehend. Therefore, I 
designed a checklist of questions (Table 4.2) that presumably covered what was 
discussed in consultations with the professionals. It comprised the following: 
Table (4.2): Observation Checklist. 
GLAUCOMA 
What is glaucoma? Was the condition explained to you? Yes 0 No 0 
Was treatment given? Yes 0 NOD 
Why they were given? Yes 0 NOD 
For how long to be used? Yes 0 No 0 
Where to get a repeat prescription if needed? Yes 0 No 0 
Self-management and self-care? Yes 0 No 0 
FUTURE VISITS: 
Prognosis of glaucoma if untreated? Yes 0 No 0 
Tests and procedures to be carried out on future visit? Yes 0 No 0 
OTHER ISSUES: 
Family screening? Yes 0 No 0 
Driving? Yes 0 No 0 
Thirty patients were asked the above questions as they were leaving the clinics to 
establish an idea of the quality of the consultation they received. The aim of this 
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exercise was to identify issues that needed to be addressed in the intervention. The 
data extracted from this checklist were analysed based on the 1MB model as follows 
in figure (4.2): 
Figure (4.2): Observation data analysis based on the 1MB model. 
-Glaucoma Explained 
-Was treatment Given 
-Why treatment given 
-For how long 
-Where to get repeat 
prescription 
-How to manage side effects 
-Self-management skills 
-How to instil eye drops 
-Prognosis if left untreated 
-Impact on QoL (driving 
and reading) 
-Routine test and 
procedures 
-Family screening 
To reveal the cultural knowledge entrenched in the outpatient clinics a number of 
enquiry techniques were utilised. As mentioned earlier, ethnography entails the use of 
various techniques to capture rich and deep inSight (Fatterman, 1998). In addition to 
observation, interviewing was another technique used frequently throughout this 
ethnography. It ranged from the form of spontaneous, informal conversation, to more 
formally arranged, in-depth interviews and short surveys. 
For instance, the health professional interviews were primarily in the form of informal 
conversation. For most it was a welcomed opportunity to talk about their own 
experience and difficulties they were facing running the clinics and the changing 
culture of the NHS. To an extent they indicated they were not only speaking to a 
researcher conducting a study, they were also sharing it with one of their colleagues 
to Whom they could relate. 
154 
4.5 Planning the GEPP 
This phase actually started at the beginning of this research. However, it continued 
throughout the study. At times I had difficulty in separating the ethnography from the 
action research. It was during this early stage that a number of action research cycles 
began to emerge as spirals of activity that led to the development of the innovation 
and preparation for implementation of change. Each cycle was planned to comprise a 
period of planning, acting, observing, reflecting and re-planning with the primary aim 
of involving partiCipating patients and staff through a variety of actions to initiate the 
GEPP. Although this sounds like a one-dimensional activity, the reality was far more 
complicated and at times confusing. 
Data collected in the exploratory ethnographic phase identified that staff involved in 
the outpatient clinics recognised that the care provided was patchy and fragmented. 
live examples from my observation also raised questions about how informed 
glaucoma patients attending the clinics were about their conditions and treatments 
prescribed. The poor level of knowledge and adherence amongst clinic attendants that 
has emerged from this research has confirmed this and will be discussed later. 
Although this could be partially contributed to difficulty in retaining information by newly 
diagnosed patients, despite being given sufficient information, the benefits of the EPP 
are therefore, to provide additional opportunities for reinforcement of key information. 
RaiSing the profile of the GEPP was initiated and included undertaking local, regional 
and national presentations on how the GEPP was developing as well as presentations 
in tutorials running in the Trust on a weekly basis. Further consultations with 
professionals involved in self-management programmes and patient support groups 
that involve recruiting and training volunteers were undertaken. An example is Dr. Alan 
Simpson and his extensive work with patients with mental illness which involved 
training and supporting them to gain more control over their lives and resume and lead 
a more independent and productive life. Governmental organisations and charities 
involved in similar work were consulted, for example, the International Glaucoma 
ASSOCiation (IGA) was instrumental in their input and support in shaping the content of 
the Expert Patient training programme. Key internal stakeholders views on how the 
training and the intervention should be developed were sought. More importantly, 
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potential Expert Patients were very insightful and encouraging as they shed light on 
their own valuable experiences with glaucoma when asked what they would have 
wished to happen when they were diagnosed. 
The Steering Group, overseeing the design and implementation of the GEPP, was also 
involved in discussions with the Moorfields Eye Hospital Research and Development 
Committee on the design of the study, sample and outcomes to be measured. The 
drive behind establishing this group was to resolve difficulties encountered by the 
Research and Development Committee and subsequent ethical approval as well as 
overseeing the research as a whole. 
4.6 Development of the GEPP 
In designing the training programme many considerations were taken into account. 
First, based on the results of the meta-analysis and lessons learned from Kate Lorig 
et ai's research and subsequently the recommendations of the Department of Health 
EPP the skeleton of the programme was built. The 'felt needs' as expressed by the 
Expert Patients and other fellow patients interviewed during the exploratory phase 
added a patient perspective to the programme. 'Felt needs' are needs perceived by 
patients who have COAG that have been expressed in their own words during 
interviews regarding things they thought were important to them but were not 
addressed during their consultations in the clinic. 
This is a fact that I was keen to illustrate, right at the beginning of this research. My 
. intention was to put patients' needs and their participation at the heart of this inquiry 
even though their input was limited at earlier stages in the research when the process 
of gaining ethical approval was initiated. Additionally, bearing in mind the uniqueness 
of COAG, suggestions made by professionals involved were taken into account as to 
the type and amount of information to provide the Expert Patients without 
overwhelming them with the task they were about to undertake. 
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Figure (4.3): Flow Diagram of the GEPP (blue represents ethnography and red represents 
AR) 
Formulation of Research Project 
Preliminary Design 
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I 
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I 
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'-
I 
Recruiting Expert Patients By Glaucoma 
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As illustrated in the flow diagram (Figure 4.3), this work began with formulating the 
research and writing the proposal for the purpose of obtaining ethical approval. Then 
it went through an observation period "ethnography" to understand the practices of the 
glaucoma clinics. In trying to understand the current situations and practices and 
improve them, many questions needed to be answered and further ones to be 
formulated. Therefore, the study took a new methodological approach. A collaborative 
action research process was employed in this part of the research , as the research 
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proceeded through a spiral of planning, action taking, data collection, analysis· and 
critical reflection. These activities reflect the collaborative nature of this research that 
is explicated further on in this chapter. 
4.6.1 Meta-analysis: Lessons Learned 
In preparation for the research and with a lack of glaucoma specific self-management 
programmes in place, a meta-analysis was conducted in an attempt to examine 
successful examples of self-management programmes for different chronic conditions 
including arthritis, diabetes mellitus, heart disease and hypertension. An example of 
these programmes is the Department of Health generic "Expert Patient Programme". 
This phase began by undertaking a literature review of self-management programmes 
designed and delivered by Expert Patients to chronically ill patients with a view to 
applying them in an ophthalmic context as discussed in the previous chapter. The 
result of the meta-analysis was consistent with available evidence and literature that 
Chronic Disease Self-Management Programmes are effective in improving patient 
health outcomes for chronic diseases such as arthritis, hypertension and diabetes. The 
findings from the meta-analysis also demonstrated improvement in some indices 
including health status, health outcomes and increased symptom control but were not 
statistically significant. These improvements occurred within the first six to eight 
months and were not monitored thereafter. Based on this meta-analysis there were no 
definite answers to the shape and content of the GEPP. However, there were plenty 
of lessons learned from Kate Lorig et aI's (1999) CDSM model and the self-
management training programme they developed. The following are elements 
associated with successful programmes that can be incorporated into the GEPP. 
4.6.1.1 Follow up 
The majority of studies conducted in this context have followed their subjects over a 
time series (baseline, one to three months and six months). Though some 
experimental studies went beyond six months and followed patients up to 1 year. It 
was deemed sufficient in most studies to follow up to six months to ensure that such 
an intervention is sustainable. In this study, in addition to the questionnaire used to 
evaluate participants' responses, semi-structured interviews were conducted to obtain 
a deeper insight into the patient experience with the GEPP. 
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4.6.1.2 Mode of Delivery 
An intervention mode of delivery has varied amongst studies. Some studies have 
trained health professionals running the service to deliver the intervention, while the 
majority sought a more participatory and empowering approach to train volunteers to 
, 
deliver the intervention. Programmes that have used the principles of empowerment, 
participation and adult learning have been proved to be the most effective. In my study 
it was essential to get participants involved in this enquiry. Recruiting and training 
volunteers, though more difficult and time consuming, has added a patient perspective; 
something often overlooked when conducting such an inquiry. 
4.6.1.3 Outcomes Measured 
The primary and secondary outcomes measured in the majority of self-management 
programmes have been generic in nature. They measure the impact of these 
programmes for patients with varied chronic conditions. Outcomes measured include: 
• Health Behaviours (Self Efficacy) 
Stretching and strengthening exercises, aerobic exercise, and cognitive symptom 
management. 
• Health Status 
Self-rated health, disability, dietary habits, pain/physical discomfort, psychological 
well-being, energy/fatigue, and health distress. 
• Health Service Utilisation 
Medical doctors and Accident and Emergency Department visits, number of hospital 
stays and days in hospital. 
These measures, though relevant, would not reflect the impact of the glaucoma 
intervention, envisaged for the present research. It was recognised that as with 
medication, one therapy or programme might not be suitable for all patients. This is a 
fact that shifted the argument to weather disease-specific programmes are more 
desirable to address the unique issues that face patients with chronic eye conditions 
like glaucoma. Subsequently, several meetings were held with my supervisors to 
decide how best to choose outcomes that when measured are sensitive to and able to 
reflect the impact of the intervention. Of which, level of knowledge, 
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motivation/satisfaction and behavioural skills essential for concordance were chosen 
as outcomes measures based on the 1MB model constructs. 
4.6.1.4 Setting 
Based on the meta-analysis, there was no evidence to suggest which setting is more 
effective to deliver the self-management programme; however, for self-management 
interventions to have greater uptake, thought should be given to how and when they 
are offered to patients. My view was that introduction and endorsement of these 
programmes at a clinic visit will probably ensure higher rates of participation. 
Therefore, it was agreed that this intervention would be delivered at the hospital 
outpatient setting to complement the care provided by professionals and fill the gaps 
where professionals failed. This required a good understanding ofthe current practices 
and the running of the clinics to ensure smooth delivery of the intervention. 
4.6.2 Uncovering an Alternative Theoretical Perspective 
As discussed earlier (refer to Chapter Three), reviews of interventions that target 
adherence and concordance amongst glaucoma patients indicate that with very few 
exceptions, interventions have not been based on well-articulated and well-tested 
behaviour change theory (Olthoff et ai, 2005) and further have not demonstrated a 
significant impact on patients' adherence behaviour. Some of the interventions that 
have been reported to be effective have had significant methodological shortcomings. 
They have demonstrated positive effects only within a relatively brief time frame after 
intervention and may have critical limitations associated with self-selection of 
participants, use of select and not necessarily representative teachers, limited 
generalizability of effects, and limited potential for widespread application. 
Interventions reviewed in the meta-analysis fell into two main areas; self-efficacy 
theory, or an educational model expanded to incorporate other components such as 
social support, exercise and other skills. Glaucoma, unlike the other conditions 
reviewed in this Thesis, is asymptomatic in nature and therefore has one of the poorest 
rates of concordance in comparison with other chronic conditions. A review of research 
has indicated that interventions of an educational nature have been particularly 
successful in improving concordance levels amongst glaucoma patients (Olthoff et ai, 
2005). 
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It was necessary to discern a theoretical model that explains and addresses the issue 
of concordance in depth. With the similarity (asymptomatic and non-apparent need for 
treatment) between the concordance of HIV/AIDS sufferers and glaucoma patients' 
concordance, the 1MB model was selected as the framework that the ethnographic 
component has been founded. 
The present research applied the Information-Motivation-Behavioural Skills (1MB) 
model (Fisher and Fisher, 1992, 2000) (described in chapter three) which is a well-
established conceptualization for modifying behaviour with demonstrated intervention 
efficacy (e.g., Fisher et ai, 1994; Carey et aI., 1997; and Fisher and Fisher, 2000), to 
design, implement, and evaluate the GEPP. 
According to the 1MB model, glaucoma concordance information, motivation, and 
behavioural skills are the fundamental determinants of positive health outcomes and 
preventive behaviour. Information that is directly relevant to glaucoma self-
management and concordance and easy to apply in an individual's social setting is an 
initial prerequisite of successful self-management programmes. Motivation to engage 
positive self-management behaviour, including personal motivation (favourable 
attitudes toward awareness and adherence) and social motivation (perceived social 
support for these attitudes), is a second prerequiSite and determines whether well-
informed individuals will be inclined to act on what they know concerning glaucoma 
self-management and adherence. Behavioural skills necessary for performing self-
management specific acts and a sense of self-efficacy for doing so, are a third critical 
prerequisite and determine whether even well-informed and well-motivated individuals 
will be capable of enacting glaucoma concordance behaviours effectively. According 
to the 1MB !"Tlodel, to the extent that individuals are well informed, highly motivated, 
and skilled, they are expected to initiate and maintain strong self-management patterns 
of glaucoma adherent behaviour. 
4.6.3 Development of Expert Patients Training Programme 
It was apparent at this stage that the intervention with the Expert Patient must be a 
proactive educational programme with additional practical skills that would enable the 
glaucoma patients' participants to assume greater responsibilities and playa central 
part in managing their condition. This fitted very well with the principle of the 1MB model 
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which considers knowledge, behavioural skills and motivation as the main 
prerequisites and constructs of improving concordance amongst patients with chronic 
conditions like COAG. However, each one of these constructs is not enough in 
isolation to achieve self-management. . 
The GEPP and more specifically the training programme for the Expert Patients 
consisted of interactive activities that were designed to address each one of the 1MB 
constructs (refer to Figure 4.4) including glaucoma information, motivation and 
concordance, and behavioural skills. 
/ 
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Management .. 
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Figure (4.4): Contribution of information, motivation, and behavioural skills to COAG self-management 
and health outcomes: Adapted from Fisher et al (2003). 
4.6.4 Expert Patient Recruitment 
Patients with established COAG attending glaucoma clinics at Moorfields Eye Hospital 
NHS Foundation Trust were invited to assess their knowledge, compliance and 
satisfaction with the treatment they received as well as assessing their suitability to 
become an Expert Patient using an adapted criteria developed by the DoH (refer to 
Appendix 2). All efforts were made to ensure the representation of the chosen sample 
to the targeted population attending the clinic. Patients identified as having good 
knowledge and vast experience with COAG and capable of delivering the intervention, 
were invited to take part in the training programme designed, based on the 1MB model, 
to particularly boost their preparedness and findings of this phase were fed into this 
cycle of the action research. 
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Five Expert Patients were recruited and given the recruitment package and time (up 
to one month) to carefully read and consider the information provided. Upon their 
agreement to participate in the research, a signed informed consent form was obtained 
from each Expert Patient. At this stage a demographic instrument was completed as 
well as identification of dates to attend a training programme that was provided by the 
research team. 
o Inclusion criteria for the Expert Patient 
Patients who have been using the service over the last 10 years or more were eligible 
to take part in the study as an Expert Patient provided they: 
a) Had COAG for more than 10 years; 
b) Were aged 25 years or more; 
c) Were able to complete a questionnaire and comply with instructions; 
d) Agreed to participate in the research by signing the consent form. 
o Exclusion criteria: 
a) Under the age of 25 years; 
b) Had COAG for less than 10 years; 
c) Difficulty understanding or communicating in the English language; 
d) Unable to fully understand and comprehend the consent form. 
4.7 Delivering the GEPP to the Expert Patients by the Research Team 
The GEPP is a group educational programme designed to inform, motivate, and 
improve skills of people living with COAG who wish to become better self-managers 
"Expert Patients". A training programme was provided to orientate the Expert Patients 
to the learn,ing and teaching strategies required for interacting with patients. The 
programme was highly interactive with very little passive learning. It incorporated the 
following topics: 
• Discussing questionnaires; 
• Expert patients and self-management in the NHS; 
• Glaucoma: developing further understanding of the condition; 
• Behavioural skills: guidelines in instilling eye drops; 
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• Motivation, confidence and concordance; 
• Health coaching: coaching relationship stage by stage; 
• Coaching and learning strategies; 
• Motivational interviewing; 
• Scenarios and role-play. 
Specific discussions were held with the Nursing Research Lead at Moorfields Eye 
Hospital NHS Foundation Trust and Lead Glaucoma Consultant to decide on the role 
of each one of us would take in delivering the training and other logistic details. The 
main focus of this training was providing the training in an array of COAG self-
management areas while maintaining a core focus on using anti-hypertensive eye 
drops as well as enhancing patients' understanding of their condition. As the research 
unfolded and Expert Patients became involved, the Glaucoma Specific Self-
management Programme (GEPP) was developed. 
4.7.1 Discussing Questionnaires 
Although Expert Patients showed a considerable understanding of their condition, it 
was essential to explore this understanding and build on the Expert Patient strengths 
to boost their confidence. The Expert Patients were asked to complete the 
questionnaire intended to be completed by Clinic Patient Participants to assess their 
own level of knowledge and satisfaction in glaucoma management. The reason was 
to ensure all participants were familiar with the questions and appropriate answers. 
4.7.2 Expert Patient and Self-management in the NHS 
An Expert Patient is a patient who is an expert in his or her own right in the skills of 
how to cope with COAG. Expert Patients have comprehensive knowledge of their 
condition, confidence and experience in working in partnership with health 
professionals. 
Although there was some degree of consensus regarding Expert Patients' increasing 
power, some authors believed that this modification did not imply de-
professionalization of physicians, or censuring of the dominant biomedical knowledge 
(Fox et ai, 2005). According to these authors, greater knowledge among patients 
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regarding their state of health or disease did not directly imply loss of physicians' 
authority nor conforming to the medical model by being 'good' or doing the 'right thing'. 
In fact the EPP is likely to bridge this gap and help in the reformulation of the patient-
physician relationship. In other words, the value of the Expert Patients is not in being 
a surrogate for ensuring compliance with the medical model or counter posing the 
decision-making powers of physicians, but in empowering newly diagnosed glaucoma 
patients to feel in control of their destiny and acknowledging their choices. 
4.7.3 Glaucoma: Developing Further Understanding of the Condition 
An interactive group workshop was designed by my supervisor and myself to provide 
information about different areas related to glaucoma, such as what glaucoma is, the 
prevalence of glaucoma, how the eye works, different types of glaucoma, the treatment 
available, and other related information. To manage their condition, COAG patients 
need basic information about glaucoma, prognosis, treatment, and the risks 
associated with poor concordance. Knowledge goes beyond basic information giving. 
Patients need to understand their personal ophthalmic history, knowledge of their eye 
drops and frequency, when and where to seek help when needed and to be 
encouraged to ask questions, and compare results of Intra Ocular Pressures and 
Visual Fields each visit. In the training programme the Expert Patients learned how to 
assist participants complete questionnaires and identify areas where knowledge was 
lacking. A well-validated 29 true-false items instrument was used to assess the Expert 
Patients' knowledge of glaucoma (Hoevenaars et ai, 2006) (refer to Appendix 3). It 
assessed issues including eye drops use, intraocular pressure reading, visual field 
loss,' and other related information. This questionnaire was also used to assess the 
Intervention and Control Groups participants' level of knowledge. This was followed by 
assessment of motivation and adherence. 
The Glaucoma Ophthalmologist Consultant explained basic anatomy and physiology 
of the eye so as to familiarise participants with the terminology used in glaucoma health 
care. Routine eye examinations in the glaucoma clinic as well as therapeutic 
procedures including laser treatment and surgeries were explained. Visual aids were 
used to demonstrate deteriorations that occur as a result of glaucoma. 
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4.7.4 Behavioural Skills: Guidelines in Instilling Eye Drops 
Behavioural skills that are essential to promote good understanding and ensure safe 
administration of eye drops were assessed. The Expert Patients were asked how they 
administer their eye drops; then provided with the appropriate technique to instil eye 
drops and use aids when necessary. The 1MB framework provides another dimension 
in assessing patients' confidence in their abilities to change perceptions and 
concordance toward glaucoma, and the importance of doing so. For instance, a patient 
who underestimates the risk of poor concordance and the potential loss of sight is likely 
not to follow the treatment regimen in spite of being knowledgeable. As COAG is 
common amongst elderly patients with noticeable difficulties in dropping eye 
medications, ~urther arrangements have to be made to ensure safe and effective 
administration, i.e. involving a family member in the care of the patient if appropriate· 
or to notify the team if the patient continues facing difficulties in dropping their eye 
drops. 
4.7.5 Motivation and Adherence 
Motivation is a fundamental determinant of concordance and adherence to treatment 
regimens and readiness to change behaviour. It reflects two main components: 
importance and confidence. On the one hand, patients may be confident that they are 
able to manage their treatment and take eye drops consistently, but they cannot see 
the point of doing so. On the other hand, patients may be aware of the need to take 
their eye drops, but lack the confidence in doing so. In both cases patients will have 
poor concordance but for two different reasons that should be addressed accordingly. 
In this case ensuring that patients possess the necessary behavioural skills is 
essential. 
Anti-hypertensive drops adherence and motivation were assessed with two multi-item 
scales. Eye drops adherence was measured with a self-reported form listing the 
number of times patients forgot to use their eye drops in the last four weeks. Each 
Expert Patient was asked to use a scale of 1 (once) to >10 (more than ten times) to 
assess their adherence (refer to Appendix 4). For the other multi-item scale they were 
asked to assess their level of satisfaction with the treatment regimen and eye drops 
use including the effectiveness of the treatment, ease of administration, side effects, 
eye appearance on a scale 1 (extremely satisfied) to 5 (extremely dissatisfied) (Day et 
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ai, 2006) (refer to Appendix 5). The point of asking the Expert Patients to complete 
these questionnaires was to familiarise themselves with the questions and the choices 
to choose from. The same tools were used to assess each group at the conclusion of 
this study (refer to part III). Finally behavioural skills were addressed. 
4.7.6 Health Coaching: Coaching Relationship Stage by Stage 
A health coaching model (Berry, 2007; Abraham and Gardner, 2009) was employed 
that provides principles, techniques and guidance so that Expert Patients knew which 
techniques to use with a patient at any point during the intervention being taught. 
These techniques take into account the patient's learning readiness, perceived 
importance and confidence in making recommended behaviour changes. Expert 
Patients were taught how to form a partnership with fellow patients in the clinic where· 
patients define their own goals, and identify what is needed to bridge the gap between 
where they are now and where they want to be. Planning a strategy that is flexible and 
gives fellow patients a framework in which they can identify steps and stages to work 
on to achieve their main goal were discussed. Expert Patients were trained to help 
fellow patients break their main goal into smaller manageable goals with a daily actions 
list that they can perform consistently to achieve their goal. The process involves: 
• Knowledge; 
• Empowerment; 
• Action Plans; 
• Monitoring and reviewing. 
4.7.6.1 Knowledge 
This is the first stage of coaching in which the Expert Patient assesses the level of 
knowledge participants have and covers information that patients lack. Patients have 
to understand the risk factors, targets, treatments and side effects available for their 
condition to be able to set their own daily actions. The aforementioned was 
incorporated into the Expert Patients training. 
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4.7.6.2 Empowerment 
Expert Patients were taught how to persuade fellow patients to engage with health 
professionals collaboratively and ask questions that are important to enable patients 
to understand their condition and play an active role in the service and care they 
receive. For example, the Expert Patients were taught to encourage patients to ask 
questions about their visual acuities, Intra-Ocular Pressure readings and/or visual field 
performance. The Expert Patients were taught how to encourage patients to report any 
side effects of drops and discuss altering their doses if appropriate or consider 
changing their drops. 
4.7.6.3 Action Plans 
The Expert Patients were taught how to negotiate a developmental plan with fellow 
patients that describes the target goals in simple but SMART (specific, measurable, 
achievable, realistic and time-based) terms. In this activity the patient is supported in 
considering options and how to work out a plan to achieve their goals. 
4.7.6.4 Monitoring and Reviewing 
When reviewing coaching progress, I considered not only progress in relation to patient 
development and goals, but also the quality of the relationship and the process that 
enabled this to happen. Expert Patients were taught that the monitoring stage is a 
continuous stage throughout the course of action and starts at the end of each session, 
at a designated point within the period of the relationship and at the end of the 
relationship with the fellow patients. Expert Patients were taught they should discuss 
briefly with the patients how they felt the session went and whether it met their 
expectations. 
4.7.6.5 Scenarios and Role Play 
Since it was unlikely that examples of self-management would be in place, scenarios 
were created (refer to Appendix 6) in which different self-management skills (e.g., 
understanding their condition, instilling their drops and complying with their treatment, 
physiological and activity monitoring and care-related information) would become 
embedded in the patient's care structures. 
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The scenarios were based on 'felt needs' as expressed by Expert Patients and Tole 
play by the Expert Patients themselves whilst allowing other Expert Patients and the 
research team to provide feedback. The scenarios were built around sensitive issues 
that professionals face in their daily care of patients. For example, compliance with 
eye drops, terminology, driving vehicles, glaucoma, side effects of eye drops, and 
instilling the eye drops were considered. Interactive feedback techniques were used 
to allow participants to draw on their own experience whilst allowing other participants 
to feedback. The following is an example of the scenarios used in the training: 
Scenario 1: Compliance 
Patient: 
A 58-year-old taxi driver was diagnosed with glaucoma 3 months ago. He was· 
prescribed a beta-blocker to be applied topically twice a day. On the next visit his wife 
says he is not taking the medications regularly. The patient does not think it is important 
to do so and thinks it is enough to do it once a day or just twice a week. 
Expert Patient: 
Drug non-compliance is a common problem. Avoid confronting the patient as the 
patient may deny it. Instead begin by asking if he has problems with the eye drops 
such as breathlessness or any problems applying them such as arthritic or rheumatoid 
hands. Then explain to him about deterioration of visual fields and the risk of blindness 
and losing his driving license. Suggest discussing alternatives with the doctor rather 
than not using the drops. 
In this workshop, Expert Patients were thoroughly trained to deliver their respective 
intervention content before proceeding with the intervention. In addition to training on 
the delivery of the GEPP intervention, which included lectures, small group interaction, 
and extensive role play and other exercises, the GEPP training also included intensive 
exposure of Expert Patients to techniques previously demonstrated that facilitate and 
influence the learning of fellow glaucoma patients such as health coaching and 
motivational interviewing. Before the training began, Expert Patients were required to 
demonstrate mastery of intervention delivery to a pre-set criterion. Based on the pre-
set criteria assessment, five Expert Patients were retained for the workshops. 
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A great emphasis has been placed on the knowledge and educational aspect of the 
workshops when recruiting and training the Expert Patients. To reiterate, to be deemed 
ready to deliver the intervention, Expert Patients were required to demonstrate a 
substantial understanding of glaucoma, excellent communication skills and abilities to 
motivate and encourage participants. Based on the 1MB model (refer to figure 4.5) the 
Expert Patients Training Programme workshops were designed to take place over two 
days in a modern venue and covered the following topics: 
1) Knowledge 
2) Behavioural skills 
3) Motivation/Satisfaction. 
Figure (4.5): Contents of Expert Patient Training Programme based on the 1MB Model. 
-Glaucoma Aeteology 
-Terminology 
-Treatment Options 
-Progno~is 
-Screening 
-Glaucoma impact on QoL 
-Common side effects. 
-How to manage side effects 
-Self-management skills 
-How to instill eye drops 
-Repeat prescription 
-Use of medication aids and 
reminders 
-Coaching and motivational 
interviewing techniques 
-Scenarios and Role play 
-Patient-Professional 
communication 
-Oecsion-making skills 
The actual training delivered by the research team to the Expert Patients group will 
be discussed in detail in the following chapter as a cycle of the action research. 
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4.8 Compilation of Expert Patient Glaucoma Booklet 
As part of the ethnographic component of the research, a 20 page booklet was 
designed that explained in simple language the main issues glaucoma patients may 
want to know about their condition. It was produced with input from the International 
Glaucoma Association (lGA) for the purpose of ensuring glaucoma patients had 
understanding of their condition and how to adapt to life with such a chronic condition. 
Although the language used is very simple, a glossary section has also been included 
to define medical terms used in the management of glaucoma. 
This booklet was given to the Expert Patients as a reference to refer to once they 
finished the training workshops. A copy of this booklet was also given to all patients 
participating in this study including the intervention and control group participants. 
The final version of this booklet comprised of: 
• What is Glaucoma? 
• Causes 
• Types of Glaucoma 
• Who is at risk? 
• Patient pathway and diagnostics 
• Treatments 
• Eye Drops 
• Driving and Glaucoma 
• Self-management and Glaucoma. 
This booklet provided much needed information for newly diagnosed patients who are 
sometimes sent home without any written information to read at their own 
convenience. 
As outlined above, the booklet incorporates information. about patient pathways and 
the diagnostic tests that are carried out on every visit to the clinic and rational behind 
doing so. Eye drop instilling is a critical issue in glaucoma concordance. Guidelines for 
instilling eye drops are demonstrated with photographs and side effects of eye drops. 
Explanations of the non-apparent indication for using eye drops are also presented in 
simple language in the booklet. In addition skills that are essential for self-managing 
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glaucoma are presented to encourage patients to take control of their condition. Quality 
of Life issues that might be affected by glaucoma are also presented in simple 
language. 
4.9 Section Summary 
This section has presented the ethnographic approach that was used to address the 
phases and steps taken in developing the intervention and designing the training 
programme for the Expert Patients. It was important to keep an open mind and be 
flexible when approaching and delivering the training. As the Expert Patients grew in 
their roles and became more confident, there were adjustments to the way the 
intervention was delivered to the intervention group as will be discussed in the action 
research section, Part II. The following section will present part two of this study. Using 
a collaborative action research approach, the delivery and implementation of the 
interventions will be explicated. 
4.10 Part II: Action Research 
The second part of this study used a collaborative action research approach to 
implement the Glaucoma Expert Patient Programme (GEPP). This approach has 
ranged from "technical collaborative" in the early stages of this study and progressed 
to a "mutual collaborative" approach. In this section, the underpinning philosophy and 
an introduction to action research is presented. The aim and objectives of the study 
are explained, including the details of methods used for data collection and analysis, 
action research cycles are discussed and the methodological qualities and rational for 
its use with its ethical considerations are considered. 
4.10.1 Collaborative Action Research 
Action research has been used increasingly in different disciplines including 
community projects, education and health care (Hart and Bond, 1995). Many authors 
and researchers have used the term action research in various ways. To illustrate this, 
Reason and Bradbury (2001) reviewed phrases used interchangeably in chapter titles 
including: "participatory action research", "emancipatory action research", "pragmatic 
action research", "co-operative inquiry", "appreciative inquiry", "community action 
research", "action inquiry", "educational action research", "transpersonal co-operative 
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inquiry" and "collaborative action research". Whilst these terms describe 
characteristics of action research and identify the essence of action research and the 
personal preferences of the philosophical paradigms that support it (Hope and 
Waterman, 2003; Munhall, 2011), inadvertently, they contribute to the confusion of 
classifying within the field of action research (Holter and Schwartz-Barcott, 1993). 
Action research is considered to belong to a variety of schools. Within the 
constructivistlinterpretivist school of thought, action research is viewed as a method of 
gaining access to participants' understandings and meanings of their situations (Hope 
and Waterman, 2003). Within the critical theory school, action research is recognised 
as a method to address ideological and power related issues in a particular situation 
(Kemmis, 2001). 
A more recent and stronger addition is within the participatory paradigm school as it 
recognises the collaborative aspects of the action research method within an 
ecological context (Reason and Bradbury, 2001). This paradigm focuses on a concern 
for carrying out research that is with, for and by people and communities, rather than 
on them whilst putting peoples' participation and engagement at the heart of enquiry 
(Meyer, 2006). A feature that made this participatory paradigm very appealing was that 
it allowed patients to contribute in the design, delivery and evaluation of this 
programme. Its merits have been working with participants to identify problems in 
practice, implement solutions and to monitor the process and outcomes of change 
(Meyer, 2000a). The increased use and acceptance of action research as a legitimate 
form of enquiry according to Meyer (2000b) reflects its importance in understanding 
the complex factors in health care settings with a view to changing and improving 
practice. 
The last three decades have seen action research evolving from a technical 
experimental approach to a more mutual and collaborative approach; then into an 
empowering and professional ising action research approach within nursing research 
as it seeks to achieve the status of a research-based profession (Holter and Schwartz-
Barcott, 1993; Hart and Bond, 1995; Munhall, 2011). It also has been noted that the 
humanistic qualities of action research appeal to nurses who embrace action research 
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as a collaborative enquiry rooted in reflective practice and as a natural fit for what 
nurses have been doing and continue to do (Hart and Anthrop, 1996; Shelton, 2008). 
Nonetheless, many nursing researchers have realised the potential in action research 
to develop a transformative shift in nursing's culture whilst introducing innovation and 
facilitating change in practice (Waterman et ai, 1995). There are numerous examples 
in the literature where action research was employed in health care research to 
generate knowledge and produce change. These examples include research that 
addresses professional issues (Kelly et ai, 2002), producing change in hospitals and 
clinics (Parsons and Warner-Robbins, 2002; Shelton, 2008), assessing and improving 
education (Walker et ai, 2001) and improving practice based upon patients' insight and 
experiences (Olshanky et ai, 2005) as well as healthcare providers' feedback (Mitchell 
et ai, 2005; Reid-Searl et ai, 2009). 
These examples demonstrate a change from a philosophy of doing things to people, 
to working with and supporting and enabling them to identify their own needs and 
facilitate formulation of strategies that will meet those needs. An emphasis on the 
importance of participation in the action research process is consistent with the 
emphasis in NHS policy to increase the active participation of service users in their 
care. Action research being used in health research has the potential to playa role in 
achieving the goals of the NHS as well as developing innovative practices and services 
over a wide range of healthcare situations (Waterman et ai, 2001). 
The. methodological approach of collaborative action research was chosen as a 
suitable method for this research, in which participation was perceived as a means to 
an end; an educational process necessary to achieve change. However, in response 
to the political nature of conducting nursing research in the Trust, where clearly 
identified steps are a requirement for the approval of this study, meant a need for a 
shift in approaches. In the early stages of this study there was limited patient 
participation and input on how the research was designed and measurement of 
outcomes termed "Technical collaboration". However once the ethics and research 
and development committees approved the study, the approach shifted from the 
technical type, to a greater recognition of the patient participants' role as active players 
in the process. A more mutual and collaborative approach was employed to engage 
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the Expert Patients in the processes of delivering the intervention according to the 
individual needs of the newly diagnosed COAG participants. 
4.10.2 Definitions and Philosophical Perspective of Action Research 
Considering the history of action research, it is not surprising that there are differing 
definitions in the literature (Waterman et ai, 2001). In health care, action research has 
many applications as diverse as HIV/AIDS education in Tanzania, prisoners in 
Malaysia, improving care in nursing homes in Australia and the USA and NHS 
hospitals in the UK (Hughes, 2008). Therefore, it i~ understandable that there is no 
single definition or an agreed way of how to employ action research. For example, 
Kemmis and McTaggert (1990) provided an action research definition that includes the 
major components of an action research methodology including its ability of not only 
achieving a specific goal, but also generating new knowledge by studying the process 
of change. For the purpose of this study their definition of action research is used: 
"a form of collective self-reflective inquiry undertaken by participants in 
social situations in order to improve the rationality and justice of their own 
social or educational practices, as well as their understanding of these 
practices and the situations in which these practices are carried out" 
Kemmis and McTaggert (1990:5). 
Hart and Bond (1995) on the other hand, devised a typology of action research that 
categorises the range of approaches to action research including: experimental, 
organisational, professionalising, and empowering. They set out criteria of seven main 
characteristics including: it has an educative base, it deals with individuals as members 
in groups, it is problem focused, it involves a change intervention, it aims at 
improvement and involvement, it involves cyclic processes and it is founded on 
collaboration. The strength of the typology presented by Hart and Bond (1995:38) is 
that it was developed to be " .. . able to retain distinct identity of action research while 
spanning the spectrum of research approaches ... " it identifies explicitly characteristics 
of action research, clarifies action research types while avoiding problems associated 
with narrow definitions (Waterman et ai, 2001). 
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In a large scale commissioned systematic review of action research by the English 
Department of Health Technology Assessments Research and Development 
Programme, Waterman et al (2001) provided a comprehensive definition of action 
research as: 
"Action research is a period of inquiry, which describes, interprets and 
explains social situations while executing a change intervention aimed at 
improvement and involvement. It is problem-focused, context-specific and 
future-oriented. Action research is a group activity with an explicit critical 
value basis and is founded on a partnership between researchers and 
participants, all of whom are involved in the change process. The participatory 
process is educative and empowering, involving a dynamic approach in which 
problem identification; planning, action and evaluation are interlinked. 
Knowledge may be advanced through reflection and research, and qualitative 
and quantitative research methods may be employed to collect data. Different 
types of knowledge may be produced by action research, including practical 
and propositional. Theory may be generated and refined, and general 
application explored through cycles of the action research process. n 
(Waterman et ai, 2001 :11). 
Whilst this is a lengthy definition, it does include the wide variety of approaches in 
healthcare action research. Most definitions in any discipline will incorporate three key 
elements: 
• Its participatory nature, whereby researchers, practitioners and patients work 
together in directing the course of change and the accompanying research. 
• Its democratic impulse, whereby all participants are seen as equals, have a voice 
in the process and are empowered to change the contexts in which they work 
together . 
• Its simultaneous contribution to social science and social change (of knowledge 
which is argued to be more meaningful to practice) (Carr and Kemmis, 1986; 
Greenwood and Levin, 1998; Meyer, 2000b; Waterman et ai, 2001). 
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Authors like Carr and Kemmis (1986), Reason (1994) and Hart and Bond (1995) have 
identified key characteristics of action research. After scrutinising all the 
characteristics, Waterman et al (2001) identified two main criteria as fundamental to 
action research and these have been included in their definition. These were: The 
Cyclic Process and The Research Partnership, which are described below. 
4.10.2.1 The Cyclic Process 
The action research project described in this chapter essentially proceeds through a 
spiral of cycles of problem identification including reflection, planning, implementation 
of change and monitoring, and evaluation, which leads to identification of new 
problems, planning, action and evaluation and so on (refer to figure 4.6). Each of these 
activities is systematically and self-critically implemented and interrelated (Masters, 
1995; Waterman et ai, 2001). 
Specifying 
learning 
Exploring 
general findings ( 
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Reviewing tl"/e 
consequences 
& ) Diagnosing 
Research 
into 
action 
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\ 
Action planning 
Selecting 
interventions 
Action taking 
Implelnenting change 
Figure (4.6): Illustration of the cyclical process of action research adapted for the GEPP 
project, from Susman and Evered (1978). 
East and Robinson (1993) argued that the increasing popularity of action research 
presented as a cyclical process in nursing research might be partly attributed to its 
similarity with elements and phases of the nursing process. However, as with the 
nursing process, I found applying the action research steps not always as 
straightforward as they appear on paper. It is with planning the actions and 
preparations for the intervention stage of the cycle where this research has been most 
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challenging. As stated previously, during the planning phase, particularly, there were 
some logistic challenges that limited patient input and participation. 
4.10.2.2 The Research Partnership 
Action research, unlike traditional research, involves those who are being studied, 
whether they are practitioners or clients, as co-researchers (Waterman et ai, 2001). It 
considers participation as fundamental to an overarching aim to promote more 
democratic research practices, where participants perceive the need and importance 
of change and are willing to assume an active part in the research and the change 
process (Meyer, 2000a). Waterman et al (2001) argued that participation in action 
research turns the conventional research wisdom of neutral and independent 
researchers on its head. Traditional research that relies on controlling variables when 
dealing with human beings in complex organisations, have failed to address 
uncertainty, complexity, instability, uniqueness and value conflict (Greenwood, 1984). 
4.10.3 Why Action Research? 
Action research as a methodology provides a real opportunity for professionals and 
researchers, who are trying to acknowledge and respect the contributions that 
potentially can be made by service users, to become jointly involved in the research 
process. Action research is a means to discern new knowledge; particularly for those 
frustrated by traditional research methods based on quantitative analysis and control. 
Indeed, the challenge of COAG provides a classic example of the need for a 
collaborative approach. In relation to the patients' experience, their experience of 
managing their COAG should not only be acknowledged, but also the findings studied 
so that they can be integrated within the service to improve the way services are 
provided. Through the collaborative approach it becomes possible to engage with 
professionals and patients to improve the experience of newly diagnosed glaucoma 
patients. 
Pietroni (1998) argued that conventional health research has been helpful in detecting 
trends within populations and the physical process involved in disease progression. 
However this research methodology does not itself address the patient experience 
from the patients' perspectives. Hughes (2008) observed that the so-called "Gold 
Standard" of RCTs has failed to provide an insight into such problems and falls short 
178 
in defining and supporting credible effective practice. More than 200 variables have 
been studied in RCTs addressing glaucoma, but none can be considered as 
consistently predictive of adherence/compliance (Vermiere et ai, 2001). These 
methodologies (conventional and RCTs) have failed to address the requirements of 
service users who do not engage in the scientific discourse. Therefore it has not 
addressed issues associated with the patient experience. The more collaborative 
approach of action research that engages patients as well as professionals will 
potentially provide a better understanding of the issues associated with the patient 
experience; particularly in relation to adherence and concordance in glaucoma self-
management. 
Health professionals and service users face problems and challenges in their daily 
practice that require systematic and rigorous examination that cannot be made sense 
of through conventional methods of positivist scientific medical scrutiny. Rather, it is 
evident that service users have been viewed as passive and relatively powerless 
consumers of knowledge that is passed down to them. Thus, it became evident to me 
there was a necessity to develop an active rather than passive research tool that 
involved patients alongside professionals in a positive and ethical process of raising 
awareness so that adherence and concordance in self-managing COAG could be 
achieved. 
In addition, in health care practice, with the ever increasing gap between the aims of 
practice and theories that supply them, many practitioners have found in action 
research a philosophical approach to bridge this gap by drawing on patients and 
practitioners' involvement and experiences. As Schwartz and Walker (1995) observed, 
there is a growing separation of the management of professional work from the work 
itself, creating a need for better understanding of health care service delivery. Owen 
(1993) observed that in British nursing research, action research has increasingly 
attracted considerable attention and is perceived as a highly compelling way of 
bridging the gap between theory, research and practice (Owen, 1993). It has also been 
advocated as a method that empowers nurses through the supportive collaboration of 
researchers and the researched (Webb, 1989). 
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It is from these notions where the "new paradigm" unconventional research comes into 
place and is partly constituted by action research in health care practice. It is the active 
engagement and passionate involvement of all participants in an action research 
inquiry that makes action research so recognised in bringing to life the people and 
purpose for which the research is designed. 
Professor Waterman and colleagues proposed five reasons for choosing action 
research. These were found in 48 British reports and are: 
• Action research is about encouraging stakeholders to participate in making 
decisions about all stages of research, or empowering and supporting 
participants (most common reasons); 
• Action research solves practical, concrete or material problems, or evaluates· 
changes (frequent reasons); 
• Action research contributes to understanding knowledge or theory; has a 
cyclical process including feedback, and/or embraces a variety of research 
methods (reasons associated with the research process); 
• Action research educates; 
• Action research acknowledges complex contexts, or can be used with complex 
problems in complex adaptive systems (quarter of reasons) (Waterman et ai, 
2001 ). 
4.10.3.1 Generating Knowledge and Understandings 
Central to all research is the generation of new knowledge, and action research is no 
exception (Hart and Bond, 1995). However, action research generates knowledge that 
is directly related to people lives, work and practice (Holter and Schwartz-Barcott 1993; 
Meyer 2000b). Indeed it is the philosophy underpinning action research that educates, 
liberates, empowers, supports and emancipates research participants that makes the 
knowledge generated of great relevance and importance (Hart, 1996). 
In their review, Waterman et al (2001) observed that generation of knowledge, 
theoretical and practical, is considered by half of studies reviewed as important. More 
importantly, there has been an emphasis and priority given to the personal and 
professional development of participants. This research is no different. It is a tailored 
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self-management programme designed to be delivered by Expert Patients to newly 
diagnosed glaucoma patients. Participants' development and empowerment has been 
crucial for the development and implementation of this research as patients have been 
involved in most phases of this process. Straight after receiving the approval, Expert 
Patients were invited to comment on the content of the intervention and the mode of 
delivery as part of the planning phase. Interactive sessions were held where Expert 
Patients engaged in role-play and scenarios designed to boost their confidence in 
interacting with patients appropriately. Participation generated great interest amongst 
Expert Patients in the research and established a constructive relationship with myself. 
This relationship has grown stronger and has enhanced a sense of ownership and 
empowerment amongst Expert Patients that has solidified their commitment to the 
successful completion of this research. 
4.11 Research Aim and Question 
As stated in Part I of this chapter, this research is the first of its kind to be undertaken 
in an ophthalmic context. Considering the degree of flexibility in answering the 
research questions, action research was determined to be the method of choice for 
Part II of the research as it enables adaptation to changing circumstances as the 
research process unfolds. Action research methodology is a vital, dynamic and 
relevant approach to enhancing change. It is argued that action research methodology 
is a way to bring about sustainable services that evoke human flourishing (Koch and 
Kralik, 2006). 
The overall research question for this research can be formulated as follows: 
"Does the development and implementation of a GEPP improve knowledge and 
concordance amongst newly diagnosed glaucoma patients?" 
The objectives of this part of the study pursued in order to answer the research 
questions are: 
1. To determine through semi-structured interviews peoples' (Expert Patients, 
Patient Participants and staff) perception of the GEPP. 
2. To determine through questionnaires whether knowledge and concordance 
improved immediately following exposure to the GEPP. 
3. To determine overtime whether knowledge and concordance are maintained. 
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Given the complexity of this inquiry, a variety of quantitative and qualitative methods 
were used at different stages to gather data that formed the cycles of the action 
research processes and eventually provided the findings of this research. Methods 
used were mostly of a qualitative nature including observation, individual semi-
structured interviews, focus groups and reflective field notes. Additionally, 
questionnaires were used to measure before intervention and after changes to 
participants' levels of knowledge, satisfaction and adherence. Issues arising during 
different stages were fed back to Expert Patient participants and the Steering Group. 
4.12 Participants and Participation 
As Noted in Part I of this chapter, this study took place in three glaucoma outpatient 
clinics in Moorfields Eye Hospital NHS Foundation Trust. During the course of this 
study the research had input from different groups at different stages as explained 
earlier. Additional to the groups involved in the ethnography phase, the action research 
phase has involved two more participants groups; Intervention Group (n=25) and 
Control Group (n=25). 
It was not feasible to include all members of staff involved in running this service in 
this inquiry. Therefore only people whose patients were at the heart and focus of this 
inquiry were involved. It was primarily designed around the patients felt needs 
expressed and delivered by Expert Patients. Their participation and input was 
paramount to the success and completion of this inquiry. 
4.12.1 Intervention Group 
A total of 25 clinic patient recruits that met the inclusion criteria on their clinic visit were 
included in the study if they agreed to participate. 
o Inclusion criteria for clinic patient participants 
a) Diagnosed with COAG within the last two years: as this is the period where 
patients need knowledge and support most. (During the first visit the patients 
are overwhelmed with the amount of information given by clinic staff and 
understandably their anxiety levels are expected to be high. Therefore, little 
knowledge is retained); 
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b) Aged 18 years or over: COAG is uncommon in childhood and most common 
amongst adults over the age of 40. In addition, only adult patients over the age 
of 18 years attend these clinics; 
c) Agreed to be interviewed to obtain essential demographic information and 
complete a glaucoma knowledge questionnaire prior to receiving training by an 
Expert Patient; 
d) Agreed to be contacted on the next visit (6 months follow up in the clinic) and 
by phone once (1 - 3 months after the initial contact) for monitoring purposes 
and to complete the following questionnaires: glaucoma knowledge, medication 
compliance and satisfaction with the treatment; 
e) Agreed to participate in the research. 
o Exclusion criteria: 
a) Diagnosed with COAG longer than 2 years; 
b) Under the age of 18 years; 
c) Unable to fully understand the patient information and/or consent form; 
d) Unable to comply with study follow up to 6 months. 
4.12.2 Control Group 
A total of 25 newly (up to two years) diagnosed patients with COAG attending the same 
outpatient clinics as the intervention group were invited to take part in this research as 
a control group. The same inclusion and exclusion criteria as the Intervention Group 
were followed when recruiting the Control Group. They were asked to complete a set 
of four different questionnaires including a demographic questionnaire, knowledge 
questionnaire, satisfaction questionnaire and adherence questionnaire. These 
questionnaires were repeated on 1 and 3 months and 6 months. Patients were given 
the opportunity to ask questions about the questionnaires and the study in general, 
though they did not receive any intervention other than the regular information that is 
provided by the doctors and nurses in the clinics. 
4.12.3 Involvement of Expert Patients 
The participation of Expert Patients was crucial to the success and the completion of 
this research. It was a delicate situation that needed a sensitive and flexible approach 
that would ensure their preparedness and commitment to this unusual role they were 
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about to take. This required striking a strong partnership between me as a facilitator of 
the research and the Expert Patients who would deliver the intervention and work with 
fellow patients. Efforts were made to ensure enough training and constant support was 
provided so as to boost their confidence and make them feel at ease engaging with 
other patients. Collaborative mechanisms included frequent meetings and informal 
contacts with the Expert Patients as to changes that needed to be made and data to 
be collected on the basis of emerging findings. These meetings, most of the time, 
included the Expert Patients and myself. We discussed the progress of the research 
and their progress and they raised issues that had emerged either in the research or 
themselves. 
Following delivery of the workshops I met regularly with the Expert Patients to reinforce 
consistency of intervention delivery and to deal with any implementation issues. 
Intervention fidelity and consistency were high across all interventions. The 
interventions were designed to be relatively easy to apply in existing care practices 
followed in the clinic settings. The Moorefield's Eye Hospital NHS Foundation Trust 
Research and Development Ethics Committee approved all intervention procedures. 
The Expert Patients lived in different areas of the city and some of them led a busy 
life. Therefore, it was critical to arrange for their attendance around their busy work 
lives and commitments. Allocating each Expert Patient to a particular outpatient clinic 
closer to where they lived was imperative to make the most of the time they dedicated 
to this research. It was also important to look after their welfare and in a sense not to 
exhaust them. For instance, on a particular day the Expert Patient chose either a 
morning or an afternoon session and attended for no more than 3 to 4 hours. Expert 
Patients w~re always asked if they were feeling comfortable to start their session. I 
asked them to let me know the day before if for any reason they could not attend. For 
example, one of the Expert Patients had a fire in her house during the night. Everything 
was burned and she had to be hospitalised for a few days due to minor injuries and 
then had to be relocated to an emergency accommodation. We had to put her part of 
the research on hold, for almost two months, before commencing her role again in the 
research. 
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4.13 Delivering the GEPP to the Intervention Group by the Expert Patients. 
The second cycle of this research started on completion of the Expert Patient training. 
As indicated previously, each Expert Patient was allocated to one particular outpatient 
clinic on a morning or afternoon session according to their availability. The Expert 
Patient delivered each session during the patients' visit to the clinic whilst they were 
waiting to be seen by the ophthalmologist. 
The idea behind such an intervention supports the notion of patient-to-patient 
interaction where the newly diagnosed patient will benefit from the vast experience 
shared by the Expert Patient. Lorig and Holman (2003) argued that self-management 
programmes delivered by lay volunteers have shown favourable results in comparison 
to professionally led programmes. 
Twenty-Five clinic patient participants were recruited and received the intervention 
whilst attending their routine clinic visits. I approached all the participants and 
explained to them the idea of the research and provided them with an information sheet 
to help them make an informed decision whether to take part in the research. Those 
who agreed were asked to read and sign the consent form, then to complete the 
demographic questionnaire. Clinic Patient Participants were then introduced to the 
Expert Patient as a patient having glaucoma for many years and attending the same 
service. The participants were assured that this session would be conducted within the 
time usually spent waiting (usual waiting time is one to two hours) to be seen by the 
Ophthalmologist. This helped to eliminate any distraction that could impact on the 
quality of the discussion as the patient felt at ease because they were not missing their 
turn whilst they were with the Expert Patient. 
Each session started with the Clinic Patient Participants completing the knowledge, 
satisfaction and adherence questionnaires respectively in the presence of the Expert 
Patient and myself. This was followed by a few questions and casual conversation with 
the Expert Patients so as to build rapport with the participants. The session ideally 
lasted between 30-45 minutes. However, some sessions lasted more than an hour. In 
cases where patients were having problems instilling their eye drops, the Expert 
Patient demonstrated the right technique of doing so and asked the participants to 
perform the same technique which was time consuming at times. In other cases where 
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participants had certain health beliefs that the Expert Patient had to challenge, a very 
constructive conversation continued for close to 80 minutes. However informing and 
essential, due to time constraints doctors and nurses have in seeing patients through 
the clinics, it is unfeasible to hold such a lengthy conversation with each patient. This 
is where the GEPP has been effective and makes a difference. The Expert Patients 
have the time to interact with the Clinic Patients whilst the Clinic Patients are waiting 
to be seen. 
Depending on the time spent with each participant and availability of patients who were 
interested in taking part, recru itment of Clinic Patient Participants took place over a 
period of 3 months. Each Expert Patient was expected to deliver the intervention to 5 
to 6 patients. However at the beginning of the research, one Expert Patient withdrew 
from the study, which meant the other three Expert Patients had to deliver the 
intervention to 8 or 9 participants. The following Figure (4.8) presents a flow chart of 
the stages of this study. 
Figure (4.7): Phases of GEPP Flowchart 
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4.13.1 Reflective Field Notes and Feedback from Expert Patient 
During the implementation phase, informal discussion with the Expert Patient 
participants and the training team were recorded . Reflective field notes based on 
Expert Patients' actions, performance and feedback were kept. Field notes were 
recorded throughout this phase and continued until the end of follow up with the 
186 
participants. Frequent discussions were held with staff involved in running the clinics 
to obtain their opinion of the study as it unfolded. 
After every session the Expert Patient spent with the Clinic Patient Participants, I would 
reflect on that session with the Expert Patient. We considered things we could improve 
or adjust to make efficient use of the time spent with the Clinic Patient Participants. 
Examples of such adjustments included changes in the environment to minimise 
distraction levels. Keeping the patient's clinical notes with me was another example, 
as Clinic Patient Participants frequently asked to see their visual fields results once 
they understood what the visual field was and why they were required to undertake 
this particular test routinely when attending the clinic. 
4.14 Trustworthiness of the Action Research Process 
Quality in action research and qualitative methods in general has created an extensive 
debate. Some writers suggest that the quality of action research can be judged solely 
on the 'professional judgement' of the action researcher (Rolfe, 1998). Other authors 
have called for judging the quality of action research against an approved checklist. 
Guidance is clearly needed to give the new nurse action researcher a structure within 
which their work can be developed (Meyer, 2000b). Waterman et al (2001) have 
offered specific guidance (questions) for funding agencies, policy makers, ethics 
committees and researchers for assessing action research proposals and projects 
within the present healthcare climate. However how extensive this guidance is followed 
may be questioned. 
As a new action researcher I found these questions helpful in enabling me to look at 
the cycles of this research in a different way and look for ways to improve the progress 
of this research. My 'professional judgement' was not at its best and not completely 
developed when the study was initiated, therefore I found it reassuring to critically 
reflect on the guidance and ask myself these questions. During the planning phase, 
this guidance helped me to provide clear answers to the Research and Development 
Committee who were in favour of conducting an RCT. The following list shows the 
questions that Waterman et al (2001) compiled and I reflected upon: 
1. Is there a clear statement of the aims and objectives of each stage of research? 
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2. Was the action research relevant to practitioners and/or users? 
3. Were the phases of the research clearly outlined? 
4. Were the participants and stakeholders clearly described and justified? 
5. Was the relationship between researchers and participants adequately 
considered? 
6. Was the research managed appropriately? 
7. Were ethical issues encountered and how were they dealt with? 
8. Was the study adequately funded/supported? 
9. Was the length and timetable of the research realistic? 
10. Were data collected in a way that addressed the research issue? 
11. Were steps taken to promote the rigour of the findings? 
12. Were data analyses sufficiently rigorous? 
13. Was the study design flexible and responsive? 
14.Are there clear statements of the findings and outcomes for each phase of the 
study? 
15. Do the researchers link the data that are presented to their own commentary and 
interpretations? 
16.ls the connection to an existing body of knowledge made clear? 
17. Are the findings transferable? 
Murphy et al (1998) and Waterman (1998) identified a number of practices that can 
enhance the validity of qualitative research and provide the reader with detailed 
information needed to evaluate the trustworthiness of the findings. Meyer (2000a) 
added that, whilst acknowledging subjectivity and the inherited problems of validity in 
action research, one should not seek objectivity but instead demonstrate freedom from 
bias. Hope and Waterman (2003) highlighted that validity in action research revolves 
around: 
The dialectal movement between action and reflection .... as a 
consequence, needless vagueness and ambiguity is reduced, but 
amplification and deepening of the research focus is enhanced' (Hope 
and Waterman, 2003:125). 
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This will include the different ways participants were involved in data collection and 
analysis, the processes used to feedback findings and a clear account of how findings 
were subsequently refined. These practices have been followed closely in this study, 
and a detailed description has been given on the methods used for data collection, 
analysis and the impact of an action research approach. These descriptions have 
been underlined by reflexivity; particularly in relation to my role as an action researcher 
and the Expert Patients. 
Titchen (1995) highlighted in action research that it is critical to be aware of using your 
own beliefs and values consciously through a high level of self-awareness and 
simultaneously representing the experience and evaluation of those participating in 
the research. This can be achieved through reflexivity and field note keeping as part 
of challenging oneself in light of differing opinions. This has helped me immensely in 
attempting to use a critical perspective when approaching issues arising. Such a 
perspective recognises the identification and subsequent exploration of tensions and 
contradictions within oneself and in the field study (Waterman, 1998). 
4.15 Section Summary 
The second part of this study presented in this chapter has explored issues arising 
from designing, and implementing a glaucoma self-management programme GEPP. 
The study is located in the participatory paradigm that incorporates inquiry that is with, 
for and by people and that privileges practical and theoretical knowledge. In an inquiry 
of this nature, participants were collaboratively involved in research activities and 
decision making that has previously been viewed as being in the domain of the 
researcher alone. An in-depth relationship between study participants and myself was 
necessary for such practical knowledge to emerge. 
4.16 Part III: Mixed Methods 
The third part of this chapter describes the mixed method approach associated with 
the evaluation and interpretations of the GEPP. For the purpose of presenting this 
Thesis the evaluative phase is presented here but the reality is it was an on-going 
process starting toward the beginning of the research. An array of data collection tools 
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where used to evaluate the effectiveness of the GEPP including field notes, patient 
interviews and questionnaires. 
4.16.1 Background and Definitions 
Historically, the decision as to whether a qualitative or quantitative method would best 
answer the central questions of a study would be dictated by the hypotheses or 
research question. A sound research project would require using the most appropriate 
method(s) at the appropriate time (Morse and Field, 1995). 
The interest in mixed method design has grown over the years as questions related to 
healthcare have become more complex. Mixed method research combines elements 
from both qualitative and quantitative paradigms to produce converging findings in the 
context of complex research questions (Lingard et aI., 2008). The surge in mixed 
methods use in health care research is viewed by some noted researchers as 
recognition of some of the inherent limitations and strengths of both qualitative and 
quantitative approaches (Tashakkori and Teddlie, 2003). Many scholars argue that the 
demands of an increasingly complex health care system and the needs of both health 
practitioners and patients have long called for new approaches to health service 
research (Clark, 2000). 
Combining the two research methods (qualitative and quantitative) in health care 
services research is by no means a straight forward procedure, with large amounts of 
literature that consider the conceptual and pragmatic feasibility of mixing multi-
methods (Sofaer, 1999). Several definitions of mixed methods in health care are 
available in the literature. Morse and Field (1995) argued that it is more than simply 
collecting qualitative data from interviews or multiple types of quantitative data from 
questionnaires and surveys. It should start with gathering evidence based on the 
nature of the research question and theoretical orientation. Whilst Johnson et al (2004) 
explain it is the intentional integration or combination of qualitative and quantitative 
data to maximise the strengths and minimise the weaknesses of each type of data. Of 
the many definitions available in the literature and for the purpose of this Thesis, mixed 
methods research will be defined as a methodology that: 
1) Focuses on research questions that call for real life contextual and cultural 
understandings; 
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2) Employs quantitative research to assess the magnitude and frequency of the 
constructs and qualitative research to explore the meaning and understanding 
of constructs; 
3) Intentionally integrates or combines methods to draw on the strengths of each; 
and 
4) Frames the investigation within philosophical and theoretical positions Creswell 
et al (2011). 
The incorporation of qualitative research methods is increasingly seen as a valuable 
and necessary component of health care research that intends to improve health care 
service (Rundall et ai, 1999). Robbins (2001: 27) a noted ethnographer, argued that 
"rigorous qualitative research can provide the 'why' behind statistically significant 
differences", Qualitative research, as discussed earlier, has been increasingly used for 
the rich descriptions of the context and that of complex phenomena (Kaufman, 1994). 
Sofaer (1999:1101) argued that qualitative inquiry allows for "Initial explorations to 
develop theories and to generate and even test hypotheses while moving toward 
explanations". Crawley et al. (2000:2518), a noted quantitative researcher, stated that 
"qualitative research is needed to clarify and improve the knowledge of health care 
professionals of the demographic, socioeconomic, psychosocial, and medical factors 
that influence decision regarding patient care". In contrast, as Denzin and Lincoln 
(1994:4) put it "the quantitative approach emphasises measurement and analysis of 
causal relationships between variables, not processes", 
4.16.2 Mixed Method Design 
The study described in this section is a mixed method of sequential exploratory design. 
According to Creswell et al (2003) this design is characterised by the collection and 
analysis of qualitative data followed by the collection and analysis of quantitative data. 
Priority is given to the qualitative aspect of the study and the findings of the two phases 
are then integrated in the interpretation and evaluation phase. 
This part of the Thesis will present the integrated mixed methods design used to 
explicate the findings and the interpretations of this inquiry, Throughout this study, 
evaluation and reflection were on-going starting as early as June 2009 and continued 
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until January 2011 when data collection ceased. Data collected included but are not 
limited to: Expert Patients' actions, feedback and views on the progress of the research 
and their experience, Clinic Patient Participants views and learning and interviewing -
staff about their thoughts on the research step by step. This added to the accumulative 
data that was being fed back during the process of doing the research. My analysis 
therefore of this action research was on going. 
4.16.2.1 Field Notes 
Fields notes were produced from attending frequent meetings with the Consultant 
Ophthalmologist running the clinics, my research supervisor and subsequent 
interviews with staff involved in the clinics. Field notes made from observing Expert 
Patients role play in the training days helped me to comment on their performance and 
further evaluate how engaging and effective they were in delivering the intervention. 
Further notes were taken during the delivery of the intervention. For instance, on one 
occasion in one of the busy sessions in a clinic, three glaucoma teams were working 
at the same time. It was overcrowded with limited space for staff to attend to the 
patients. The project team involving the Expert Patient and myself moved to the 
canteen. After the session started I observed that a clinic patient participant was 
distracted by the noise in the background and soon realised this environment was not 
fit for purpose as it had a lot of distraction with people coming in to get something to 
eat. I had to find another site for the Expert Patient to deliver the intervention. This 
twist in the process and subsequent changes illustrates how important flexibility in the 
method and approach used must be. 
Comments and feedback made by Patient Participants on the performance of Expert 
Patients and their thoughts regarding the research were taken in form of field notes. 
These comments have provided insight into the overall evaluation of the Expert 
Patients' delivery and their suitability for this role. 
4.16.2.2 Expert Patients Interviews and Questionnaires 
Semi-structured interviews were used to capture the views of Expert Patients on their 
experience and the role they played in this research. Expert Patient involvement in 
chronic eye diseases is a particularly under-researched area where participants' views 
are not known. Therefore, getting a sense of the predominant views of their 
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experiences was essential. Further interviews were employed toward the end of the 
research to gain more insight into how beneficial they felt the intervention was. 
All interviews were tape recorded and transcribed verbatim. In addition, three 
questionnaires were used to assess knowledge and understanding of glaucoma 
compared to baseline data obtained prior to their training. The questionnaires were 
approved by the Research and Development Committee and validated which made it 
impossible to alter any of the contents of the questionnaires. 
4.16.2.3 Intervention Group Participants Interviews and Questionnaires 
The impact of the intervention was measured in two ways, completing a set of three 
questionnaires and the second in semi-structured interview. Of the questionnaires 
used, two were well validated and gained Research Committee approval. The third 
questionnaire was extensively used in measuring glaucoma patient adherence and 
also gained Research Committee approval. The first questionnaire assessed patients' 
knowledge and understanding of glaucoma; designed by Hoevenaars et al (2008). A 
few minor changes were made to make the language more applicable to British 
patients. It measures improvements on level of knowledge and how much information 
patients gained and whether the GEPP helped them to better understand their 
condition and treatment. The second questionnaire assessed patients' satisfaction 
with the treatment regimen and the service they received. It was designed by Day et 
al (2006). A few minor changes were made to the layout to make it more reader friendly 
with a bigger font size for ease of reading. This questionnaire assesses, for those 
patients who gained knowledge of their condition, whether the GEPP made any 
difference to their level of satisfaction. The third questionnaire, a self-report adherence 
level to treatment regimens, measured whether knowledge improves satisfaction and 
adherence levels. 
Baseline data were collected from all participants on the recruitment day prior to 
receiving the intervention with an Expert Patient by completing the pre-designed and 
piloted questionnaires. Follow up data. were obtained by completing the three 
questionnaires at patients' clinic appOintments at 1 and 3 months as well as 6 months. 
If this was not possible, the questionnaires were sent in the mail for the participants to 
complete and return to me. The questionnaires used are composed of closed 
questions which is acknowledged may not provide in-depth data. Extra space was 
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provided for patients who were willing to comment on the questionnaire and their 
experience. Expert Patients also completed these questionnaires prior to the training 
received and at the end of this research. 
The time used to complete questionnaires was troublesome for a few patients whose 
ability to read is impaired due to glaucoma. Expert Patients helped patients, when 
needed, by reading out loud questions to the patients and providing explanations that 
did not influence their answers. A few patients found completing the questionnaires on 
recruitment time-consuming. This made them reconsider their decision to take part in 
the research. For example, on one occasion a clinic patient participant withdrew from 
the study as he found completing the questionnaires too time-consuming. 
Of the 25 participants, 10 were randomly selected to be interviewed so as to shed 
more light on their experience with the GEPP and how it helped them to better cope 
with their COAG. The interview took anything between 20-40 minutes and covered the 
following issues: 
• Experience with COAG, 
• Quality of Life and COAG; 
• Their views on the running of the clinic and staff; 
• The delivery of the GEPP (convenience, relevance and usefulness); 
• The 1MB constructs (knowledge, satisfaction and concordance) 
• Self-management and coping skills developed; 
• Things they would like to change and improve in service and in the GEPP. 
4.16.2.4 Control Group Participants Interviews and Questionnaires 
The control group completed the same set of questionnaires mentioned above on their 
visit to the clinic on baseline, on 1 and 3 months and 6 months. To measure for 
changes over time the control group was recruited concurrently with the third follow up 
of the intervention group data collection. Although there has not been any indication of 
changes taking place to the practices followed in the Trust clinics than before the study 
began, since this study took 18 months to complete, it was seen as important to 
measure for any potential changes with the intervention group and compare it with the 
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control group. Of the 25 participants, 10 participants were selected to give their 
feedback and views in semi-structured interviews. The interview covered the following 
issues: 
• Diagnosis and patient pathways; 
• Experience with COAG; 
• Experience with the service and staff involved in running the service; 
• Importance of constructs of 1MB (Knowledge, satisfaction and concordance); 
• Things they would like to improve or to see improved. 
4.16.2.5 Staff Interviews 
Staff interviews were held at different stages in this study. For example, at the 
exploration phase, interviews were conducted to gain views on practices followed in 
the clinics, content of the training programme and so forth. A member of staff who has 
been involved in running educational programmes highlighted problems encountered 
in her experience and ways of overcoming them. These problems were examined 
carefully with the Consultants and Expert Patients when designing the GEPP. At the 
end of the study, two Lead Nurses running the clinics were interviewed to reflect on 
the patients' recruitment period and the Expert Patient intervention. These interviews 
were more focused and structured. 
4.17 Methods of Data Analysis 
As mentioned earlier, findings described in this study were collected using a mixed 
method approach including the following: individual semi-structured interviews, focus 
group interviews, observation, field notes and questionnaires. Qualitative data 
provided information and understanding on process and implementation of the Expert 
Patient Programme, whereas quantitative data collection instruments measured for the 
impact of the GEPP, sustainability of the GEPP over time, and trends in the findings. 
In this study, data were collected continuously throughout the various phases. The 
emerging findings were pondered for meanings and interpretations as well as 
prompting further data collection or adjustments on the planned actions. As I grew in 
confidence and became more experienced these mini-cycles became a more naturally 
conducted series of processes. 
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4.17.1 Thematic Analysis 
During the exploratory phase in each of the outpatient clinics, a qualitative assessment 
describing and assessing health care practices followed. In this phase, the work of 
Susman and Evered (1978) functioned as a guide in the procedure of thematic 
analysis. The same procedure was used for the qualitative evaluative phase of the 
research. This procedure involves a cyclical process consisting of three stages in 
which each informs the direction of the other. 
Stage One, describing, begins with the process of data collection and serves as a 
means of linking the work with the remaining analysis. The process includes 
engagement and familiarisation with the data as it is transcribed from a verbal form 
into a written form. It also includes reviewing all the thoughts that involve field notes 
and discussion memos regarding the possible direction of the data analysis. Stage 
Two, organising, begins the process of arranging data collected into codes in marginal 
notes. This consists of using a data-driven approach to identify codes in the marginal 
notes. Codes are simultaneously identified during the organising stage and explored 
to identify underlying patterns that lead to the formulation of linking concepts and 
constructs. Stage Three, connecting, involves the search and creation of themes from 
the concepts and constructs identified in Stage Two by noting connections between 
codes. In this stage, the data are translated into themes' about the elements and 
components of the glaucoma self-management programme in order to present the 
research findings in a meaningful way with clear distinctions between themes. 
Thematic maps of the data presenting a summary of the main themes and patterns 
will be explained in detail in the following chapter. Table 4.3 shows a working example 
of the way themes were constructed to reflect the 1MB model. 
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Table (4.3): Qualitative Analysis worked example according to Susman and Evered (1978). 
Marginal notes: (Codes) 
Know - Knowledge 
Things to do - Knowledge 
Knowing - Knowledge 
Accept - Motivation 
Consequences - Motivation 
Follow instructions - Behaviour 
Happy - Motivation 
Take drops - Behavioural 
Concepts (Leading to constructs) 
Statements from Interviews: (data driven 
narrative) 
"By knowing things you accept them 
quickly"IG07. 
"So I want to know if there is anything I can do 
to stop me from going blind" IGOS 
"So the more info I get the more likely I will 
follow the instructions and the happier I am" 
IG04. 
"It (knowledge) motivates me to take my eye 
drops on time knowing what the 
consequences are" IG03. 
(IG = Intervention Group Participant) 
Know+ things to do + knowing = Knowledge 
Consequences + Happy + Accept = Motivation/Satisfaction 
Take drops + follow instruction = Behavioural Skills 
Constructs 
Knowledge 
Motivation/Satisfaction 
Behavioural Skills 
Main Themes (1MB Model) 
+ + 
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4.17.2 Descriptive Quantitative Statistics 
Data extracted from the patient group (Expert, Intervention and Control) 
questionnaires were coded and entered onto statistical software SPSS (Version 18.0). 
Each patient was given a code and individual score for questionnaires completed. The 
Demographic data questionnaire in addition to the three previously mentioned 
questionnaires have provided ordinal level data which when entered into SPSS 
allowed for making comparisons between baseline, first follow up and evaluation when 
merging the three data sets. Non-parametric tests were used to compare groups 
including Mann-Whitney U Test and Wilcoxon Signed-Ranks Test. The aim of the 
statistical analysis was to identify changes on the scoring of each patient throughout 
the study and establish trends throughout the data. Any comments made by 
participants on the questionnaire have been treated and analysed as qualitative data. 
A statistician has examined the data set for any missing data or errors made during 
data entry and analysis. Expert Patients, Intervention and Control Groups participants 
were assigned a unique identification number (not their hospital number) so that they 
cannot be identified. 
4.18 Ethical Considerations: A Summary 
In preparation for seeking ethical approval, my supervisors and I were engaged in 
discussions with the Research and Development Department at the Trust to obtain 
their approval and support for the research. Moorfields Eye Hospital NHS Foundation 
Trust is a predominantly medical institution with very little if any recognisable nursing 
research contribution. There were conflicting interests amongst the Trust Research 
and Development Ethics Committee Panel (which approves all research prior to review 
at the main Ethics Committee) on the way the stu~y was designed, the contents of the 
training programme and the way the study would be evaluated as previously indicated. 
It was agreed this study would be a mixed methodology (qualitative and quasi 
experimental quantitative design) comprising a before-and-after study involving a 
collaborative action research where outcomes would be measured on one, three and 
six months follow up with a view toward a large scaled RCT in the future. The Research 
and Development Department had a growing interest in using Quality of Life (QoL) 
measurement and their level of anxiety amongst participants in this study as outcomes 
to evaluate the effectiveness of this programme. However, it was agreed that QoL and 
anxiety questionnaires would not capture the effect of this intervention, which is 
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improving concordance, and level of knowledge of glaucoma patients. Therefore QoL 
tools and tools that measure anxiety were not used. 
4.18.1 Ethical Approval 
Ethical approval to undertake the research was granted by the Moorfields Eye Hospital 
NHS Foundation Trust and the Whittington Hospital Research Ethics Committee. Prior 
to Trust approval, NREC approval was obtained. This is a process in which NREC 
ensures that the rights, safety, dignity and wellbeing of research participants are 
protected, and facilitates ethical research that is of potential benefit to participants, 
science and society. In addition, approval to undertake the research was granted by 
the City University, London Senate Research Ethics Committee and indemnified for 
£3,000,000. 
4.18.2 Consent Form 
Crucial to the ethical conduct of research is informed consent. All participants in this 
study were adults over the age of 18 and able to give an informed and considered 
consent to participate. Prior to any data collection, participants involved in this study 
were given information sheets. One sheet was to inform Expert Patients and one sheet 
was for other PartiCipants (refer to Appendix 7 and 8 respectively) and participants 
were asked to indicate whether they understood: 
• The purpose of the research; 
• How the data collected would be used; 
• Who the researcher was; 
• How the research would be conducted; 
• How confidentiality would be maintained; 
• That participation was voluntary and that they could withdraw at any time 
without fear of any adverse consequences. 
Once a patient felt confident and willing to take part in the study, a consent form was 
signed with one copy given to the patient, one kept in the participants' medical records 
and one kept in the Trust Nursing Office. The patients' General Practitioners were 
informed in writing that their patients were involved in the study. 
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4.18.3 Confidentiality and Anonymity 
Data provided by individuals as part of the research study were safeguarded and 
remained confidential to the research team and were used only for the purposes of the 
research. Unless agreed in advance with the research participants, individuals 
providing data were not personally identifiable in any outputs that arose from the 
research. All information was collected and stored in accordance with the requirements 
of the Data Protection Act (1998). All measures were taken to protect patient 
confidentiality and anonymity. However, where Expert Patients were involved with the 
other fellow patients in the clinics, the ethical issues became more complex. Although 
participants gave informed consent, it was relatively unclear how the study would 
unfold as recruitment progressed. This is a common occurrence in action research; 
therefore, each situation as it arose was considered and the best interests of Expert 
Patients as well as clinic participants were maintained. 
Meyer (2000b) noted that confidentiality and anonymity are potential problems to be 
explored with participants in action research projects. It is likely that in action research 
researchers will talk about things that might be personal or confidential. It was 
important to discuss how much of the discussion that took place in team meetings with 
the Expert Patients was to stay inside the group and what was permitted to be 
conveyed to others outside the team. Since this study involved Expert Patients 
interacting with fellow patients in the clinics, I could not control what participants said 
to each other in the field and as such, vulnerability of individuals could have become 
an issue. Anonymity and confidentiality may be compromised by the fact that the 
Consultant Ophthalmologist and I can be easily associated with having worked in the 
glaucoma service during recruitment and data collection. Therefore, many people 
within the organisation and within the same service reading the finished Thesis may 
be able to identify the key players and Expert Patients in this study. 
4.18.4 Objectivity: Influence on the Research 
The issue of objectivity is challenging for researchers. The researcher's status as an 
insider or outsider will provide opportunities as opposed to constraints to the success 
of the study. On the one hand, as an insider researcher, there is the risk of 'taken-for-
granted assumptions' remaining unchallenged and, on the other, how the 'strange' 
world encountered by the outsider researcher is engaged with and made intelligible 
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(Hockey, 1993). As an insider researcher I was an active observer of the events and 
the phases of this study unfolding. Having spent the last seven years working at the 
Trust I developed a good understanding and appreciation of the context of the study 
in a way that is not open to an outsider researcher. Insights and sensitivity to things 
both said and unsaid and to the culture operating at the time of the research are all 
potentially available for me as the insider researcher. 
As stated previously, in preparation of this study I was allowed to observe and work in 
the glaucoma service which enabled me to short cut much of the mutual familiarisation 
phase necessary to seek out common ground, and establish a positive research 
relationship. I knew and was known to the staff involved in running the clinics and 
would be involved in facilitating the recruitment and delivery of the intervention at later . 
stages. Such a position was a privileged one which was essential to the success of 
this study. It also helped me to anticipate problems before they occurred. For instance, 
one of the sites where we planned to recruit half of our sample was extremely crowded 
and occasionally staff used poorly equipped rooms due to lack of space. I expected 
this would be an issue I would have to deal with, and thusly made contingency plans 
to use another site to recruit patients, which required some logistic preparation. 
4.19 Conclusion 
This chapter has presented the approach followed in designing, implementing and 
evaluating the GEPP. This study is located in the collaborative paradigm that 
incorporates inquiry that is with, for and by people and that privileges practical and 
theoretical knowledge. In an enquiry of this nature, participants were collaboratively 
involved in research activities and decision making that has previously been viewed 
as being in the domain of the researcher alone. 
The aim and objectives of this study, along with details of the methods used for data 
collection and analysis, and quality assessment issues including ethical considerations 
have been comprehensively provided in this chapter. The following results chapter 
describes the final phase in which general findings will be explored. 
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CHAPTER FIVE 
Exploring Findings from Designing, Implementing and Evaluating 
the GEPP 
The following chapter is presented in three main parts. Part one presents the findings 
from the ethnography conducted in the exploration phase. Part two presents the 
findings from implementing the GEPP through action research methodology which 
includes demographic findings from the Expert Patient Group with its action cycles. 
The third part of this chapter provides the detailed mixed methods evaluation of the 
implementation and effectiveness of the GEPP. 
5.0 Introduction 
It may be remembered from chapter 3, that the GEPP is based on the 1MB model 
(Fisher et ai, 2003). The primary causal mechanism of this programme is changes in 
the main constructs (Knowledge, Motivation/Satisfaction and Behavioural Skills) which 
is likely to lead to changes in self-management behaviour and subsequently improving 
health outcomes which in this case is better COAG concordance. 
Self-management programme evaluation has rarely used a qualitative approach. 
Instead it has heavily relied on experimental design to provide assurance of how 
effective these programmes have been. The GEPP, however, has been evaluated 
using a mixed methods design. The quantitative findings reflect trends and show how 
participants' learning processes have evolved. and been maintained during this 
programme. The qualitative findings extracted from semi-structured interviews and 
other forms of data collection provide a picture of the participants' responses to the 
illness itself and to the GEPP. As noted previously, the sample size of this study was 
relatively small and therefore, results should be cautiously interpreted. 
5.1 Ethnography Results 
Designing the GEPP required a great understanding of the problem of COAG as a 
chronic debilitating condition. It also required an understanding of the daily running of 
the glaucoma service and patient pathways, the needs of glaucoma patients; 
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particularly at early stage of diagnosis. Furthermore understanding had to extend to 
the perspectives of patients and professionals in relation to how much of their needs 
and care is being met in the clinic, how best to fill gaps in expectations and needs and 
the constraints that healthcare providers are likely to face. . 
5.1.1 Context Issues in Managing COAG in Outpatient Clinics 
Unlike many countries round the world, the UK's NHS is experiencing an increase in 
the proportion of elderly people living well into their 80s and 90s. These demographic 
changes have led to an increased demand for health and social care services to be 
redesigned to ensure they can meet these demands. Like most other chronic 
conditions, COAG incidence increases with age; with the majority of patients attending 
the glaucoma clinic being in their 60s 70s 80s. One clinician stated: 
"As you can see most patients attending the clinic are elderly who are either 
hard of hearing or with limited mobility or other health conditions... So it 
does take longer time and more efforts than if you are dealing with younger 
patients ... " (OP01). 
(Refer to Table 5.1 below for key of the numerical codes). 
Table (5.1): Key to numerical codes. 
OP Ophthalmologist/Optometrist 
NM Nurse Manager 
ON Ophthalmic Nurse 
EP Expert Patient 
IG Intervention Group 
CG Control Group 
Social factors are driving the changing perceptions and changing expectations which 
mean that an increasing number of older people rightly want choice and control over 
the care they receive and the services they use, including the location in which this 
takes place. Service redesign to ensure person-centered planning and self-directed 
support will be vital to delivering a personalised service and maximising people's 
choice and control, thereby meeting these expectations. 
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"Unlike years ago, patients nowadays are more aware of their rights and so 
you find them asking questions and wanting to know why you're doing this 
and why you're doing that ... n (NM01). 
One clinician added: 
"I personally like it when patients start asking questions and weighing 
options when it comes to treatment regimens ... lt means they are interested 
and most likely they will take things on board ... " (OP02). 
Despite the increased pressure on staffing as a result of this noticeable increase in the 
age and number of patients attending outpatient clinics, the staffing level has remained 
largely unchanged and is likely to remain so. Subsequently, NHS leaders have 
advocated for meeting these demographic changes by developing innovative models 
of care for older people to satisfy the demand. 
" .. . As you know only two staff nurses are employed full time in this clinic, 
the rest of them are either part time or working somewhere else and just 
doing over time ... " (NM02). 
5.1.2 Under Pressure and Patient Pathways 
The glaucoma outpatient clinics start running at 7 every morning and run up until five 
o'clock in the evening. They are generally very busy clinics and most often would be 
over booked so as to meet the large numbers of patients referred to the Trust. Early in 
the, morning the nurses prepare the clinics, the clerical staff check the list of patients 
and update the team on the numbers of attendees and whether there are any 
cancellations or changes that may disrupt the running of the clinics. On arrival patients 
are registered by clerical staff; then soon after are seen by an ophthalmic nurse for an 
initial assessment, which includes a brief history and visual acuity assessment, and 
determination of what tests need to be done on the day. Then most often the patient 
will be called to have a visual field test done by a technician or Healthcare Assistant. 
Shortly after that the patient will be called again to have an Intraocular Pressure test 
and his pupils dilated so he/she can be examined by the Ophthalmologist. 
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As mentioned earlier, as the clinics were getting busier and more patients were waiting 
for assessment (whether initial assessment by nurses or final consultation with the 
ophthalmologist or optometrist); there was an increasing pressure on the team to 
speed the flow of patients. This has increased the workload on the staff and put clear 
time constraints on staff. Consequently, consultations were getting shorter in duration. 
From the staff point of view, with the limited spaces available, it meant at times two 
nurses were seeing two patients at the same time in the same cubicle. For instance, 
on one side of the room a nurse was examining patient eyes using the slit lamp and 
on the other side of the room another nurse was assessing the visual acuity of a 
patient. When asked what they thought of that, a nurse replied: 
"You can see how long some of the patients have been waiting for. 
Unfortunately we can't expand the space we have here, so we try to 
make use of every possible space to speed things up and get the 
patients through" (ON01). 
Other nursing staff expressed a similar view: 
" ... Even if we can get more staff, there is no space for them to see 
patients. We only have three cubicles for doctors and two cubicles for 
nurses and that is not enough given the number of patients we see 
here on daily basis" (NM02). 
Lack of space is a persisting problem in the Trust outpatient clinics; in particular the 
glaucoma outpatient clinics. With an ever increasing number of patients, the 
comments made above applied to one particular site (Upney Lane site) and to a lesser 
extent to the main glaucoma clinic at City Road. The leading glaucoma consultant 
running this clinic is well aware of the situation. There is a plan to relocate the clinic to 
a near site which can accommodate the increasing numbers of patients. OP01 added: 
"In our last meeting I raised the issue of space and I am aware of a plan to 
relocate to another site nearby ... We will be able to employ more staff to 
cope with the workload of this clinic" (OP01). 
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On other sites like City Road, the problem of limited space is more prominent, and the 
prospect of expanding is very difficult due to the aging building at City Road which led 
the executive board at the Trust to consider relocating the entire hospital. These plans 
were mentioned in one of the clinician comments: 
''The lack of space has always been an issue at Moorfields ... We know the 
building is very old and cannot accommodate the increasing numbers of 
patients ... This is the case in all services at Moorfields ... " (OP03). 
When asked if this issue impacts on the quality of care and patient experience in the 
glaucoma clinic, OP02 commented: 
"To some extent it does ... We recently opened a new branch at Loxford 
Clinic ... rooms are larger ... pleasant waiting area ... patients are full of praise 
and they keep saying it feels like a private clinic ... So in a way it does make 
them happier ... " (OP02). 
The staff in all the outpatient clinics included in this study were under pressure to cope 
with the workload and large numbers of patients attending. 
"We never have enough time; because there is not enough staff ... 1 think 
that is one of the main problems. We know what we need to do and how we 
can do it but physically we have not got the time to do it, and we know for a 
fact that we're not doing enough for the patients. We don't tell them 
everything; not out of negligence, but because of the lack of staffing and 
time to spend with them" (NM03). 
This aids the argument of positive associations between better staffing and better 
patient outcomes. The evidence of the impact on quality of consultation and supporting 
self-management and organisations of having too few nurses is clearly visible in this 
quote. Therefore, the EPP could bridge these gaps and complement the care provided 
by professionals. 
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From a patient point of view, for some, it felt quite uncomfortable to be seen with 
relatively limited privacy. As this patient put it: 
" ... At times it is (the clinic) chaotic and you don 't feel at ease at all ... " 
(CG02). 
For other patients who are more claustrophobic the experience was quite unpleasant 
because of the small spaces and dark rooms. As this patient put it: 
" ... It feels like you have been shovelled in a cupboard .. . " (CG03). 
5.1.3 Quality of Consultation and Care Provided by Professionals 
This research assessed the quality of the consultation and the information shared with 
patients attending the clinic. A checklist (see Table 4.2) was designed for this purpose 
in which I asked thirty patients a set of questions as they were leaving the clinic to 
establish their level of knowledge and understanding of their condition. The data 
extracted from this checklist were analysed based on the 1MB model as follows: 
-Glaucoma Explained 
-What treatment Given 
-Why treatment given 
-For how long 
-Where to get repeat 
prescriptions 
-How to manage side effects 
-Develop self-management 
skills 
-How to instil eye drops 
. -Prognosis if left untreated 
-Impact on QoL (driving 
and reading) 
-Routine test and 
procedures 
-Family screening 
Figure (5.1): Observation data analysis based on the 1MB model. 
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5.1.3.1 Knowledge 
Of the 30 patients questioned, more than half (53.33%) indicated that they did not 
"receive an explanation of their condition" by health professionals and/or "were not 
sure what glaucoma is". 76.7% of participants said they were "given treatment to be 
used until the next visit but did not know how to use it properly". The rest (23.3%) said 
they were not "given any treatment at this stage" or that they were "not sure they were 
given treatment". For example, when asked was treatment given? A clinic patient 
answered: 
"I am not really sure. He (Ophthalmologist) looked at my eyes and said 
we will give you drops to use every day. Then he spoke to someone and 
she looked at me and said I am not sure if you need them (eye drops) 
and that was it, nothing was said after that" (CG04). 
For those patients that received treatment the question asked was, whether it was 
explained to them what the treatment was for and why they must use the eye drops. 
Of those responding two thirds (65.2%) indicated that they "did not know" or were "not 
sure why the treatment was given". One third (34.8%) of the respondents were "not 
sure how long the treatment" was to be used. More importantly, one third (39.1 %) of 
respondents did not know what to do if they ran out of drops or "where to get a repeat 
prescription". A further question often asked between professionals on the 
effectiveness of the treatment in preventing further damage was if it was to be taken 
exactly as prescribed. Some patients realised the reality of COAG, that sometimes it 
cannot be controlled even if the treatment is taken exactly as prescribed and the lOP 
is lowered. As this patient expressed: 
"I kno'w I have glaucoma and have high pressures in my eyes hence I am 
taking the eye drops to keep the pressure low. But the doctor I saw last time 
told me that even though I am taking my drops and being careful I could still 
develop some further damage, which I don't understand. Why? Or if there is 
anything more I can do to stop further damage" (CG07). 
This reflects some of the uncertainties surrounding the effectiveness of the treatment 
and the impact that it could have on concordance when managing COAG. 
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5.1.3.2 Motivation/Satisfaction 
When asked about the importance of treatment and the consequences of not strictly 
following the treatment, only one third (36.7%) of patients seemed familiar with the 
seriousness of the consequences of not using their eye drops and leaving their 
glaucoma untreated. In particular, they were not aware that as the glaucoma 
progresses they are likely to develop visual field defects; whereby their ability to drive 
will decline and that subsequently they will have to give up driving. More than two thirds 
(73.3%) of those who responded were not informed about this consequence. 
• Case Study (From Field Notes) 
This is the case of a 55 year old male taxi driver (drives for living). He was diagnosed 
with advanced COAG and advised to take eye drops for the next few months and to 
return for review in three months. This gentleman didn't attend for three consecutive 
visits and subsequently was discharged from the service. Two years later he was back 
in the clinic after being referred back by his GP, and as he explained he understood 
that the drops were to be used for one month only. He went abroad for a few months. 
On this visit, the visual field test showed a progressive field loss that potentially will 
limit his ability to drive and loss of his main source of income. This was terrible news 
that was not expected and not well received by this gentleman. It will essentially have 
a significant impact on this gentleman and his family's main source of income. Perhaps 
this could have been prevented had this gentleman understood the importance of 
taking the eye drops and potential damage that could result if ignored and if he had 
come back for his review. Without pointing the finger at who is to blame, there was an 
evident breakdown in communication. It may be that a language barrier was an issue 
that was not addressed. The patient may well have been told everything but 
unfortunately he did not understand it. 
5.1.3.3 Self-Management and Behavioural Skills 
When asked if patients knew about a set of self-management skills that are essential 
for patients to know about in order to help self-care for their glaucoma, only (23%) of 
the participants were familiar with the skills and thought they were able to self-care for 
their condition. Amongst respondents only 3% were told about self-management skills 
and the rest indicated that nothing was mentioned about self-management skills. When 
asked about genetic testing for the condition, amongst respondents (86.7%) indicated 
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that they were "advised to get family members screened for glaucoma"; particularly 
those "over the age of 40". 
One essential skill when managing COAG is the ability to instil eye drops correctly. 
Asking patients to demonstrate instilling eye drops is a subject that tends to be 
overlooked. 
• Case Study (From Field Notes) 
This case presents a 65 year old lady who had been diagnosed with COAG over the 
last two years during which she did not attend her appointments on three occasions. 
The patient only attended one follow up appointment. I took interest in this case and 
phoned the patient asking her the reason for not attending and convinced her to attend 
a specially arranged appointment the following week. Fortunately this time she 
attended. As this lady tends to travel often she doesn't remember to get repeat 
prescriptions, and if she does she tends to forget to take her eye drops with her. She 
has very limited knowledge of COAG and the potential damage it carries with it. After 
a long discussion with this lady I asked her if she can instil her eye drops confidently, 
she hesitantly answered: 
"Sometimes I get them in my eyes and sometimes on my cheek" (lG 14). 
During demonstration, in 9 out of 10 try's the patient instilled the drop on her lid or 
cheek. This case represents a lack of knowledge/skills and led to the lack of interest, 
not attending appointments and subsequently not using the eye drops correctly and 
potentially risking her sight. A lengthy conversation followed on how to use the drops, 
to carry them when travelling and how to use a Drop Aid. I asked this lady to return 
following two weeks of practice. When I saw this lady again she was a confident and 
happier lady because she was doing the right thing to save her sight. This patient is 
mastering the dropping far better now as she said: 
"Now I don't have that constant guilt in me that I am ignoring the advice and 
now that I am doing the right thing I feel so much encouraged to visit the 
clinic to see what my pressures are like and how I am doing" (IG 14). 
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5.1.4 Expressed Patient Needs 
Analysis of the interview data found that the majority of patient respondents, as 
explained earlier, lacked an understanding of their condition and therefore, had plenty 
of unanswered questions and doubts that were not addressed by professionals. During 
this ethnography I asked participants what information and skills they considered as 
essential for self-managing their condition. The answers were varied and personal to 
some extent, however, there was general consensus that basic understanding of the 
condition that is being treated, why it is treated, prognosis if not treated, what they need 
to do to help their condition, glaucoma and quality of life and driving were the main 
themes. Skills they also wanted to learn include: instilling eye drops, how to minimise 
side effects, how to remember using their drops and getting/need for repeat 
prescriptions. Additionally, a few participants; particularly those of a younger age were 
finding it difficult to accept this condition due to some doubts they had that were not 
addressed. Therefore, they were more reluctant to use their medications. 
As noted previously, this research set out to explore the issues arising from the 
development, implementation and evaluation of a new and innovative Glaucoma 
Expert Patient Programme (GEPP) in an outpatient setting. In the narrative that 
follows, the findings of the before-and-after GEPP intervention in the three main 
constructs; knowledge, motivation/satisfaction and behavioural skills (adherence), 
amongst the three participant groups (Expert, Intervention and Control) will be 
presented. This will involve explication of qualitative and quantitative data. Qualitative 
data is articulated in participants' narratives and the quantitative data from the 
questionnaires delivered on 1 st and 6th months follow up is analysed and depicted 
descriptively. 
5.1.5 Expert Patients: Understanding and Respecting Roles 
When building a multidisciplinary team it is essential to understand and respect 
individual roles as this may impact communication and contribute to poor teamwork. 
Therefore, once ethical approval was granted to start recruiting patients, it became 
essential to explain to professionals running the outpatient clinics the role of the Expert 
Patient and what we would be trying to achieve during this study. Brown and 
Greenwood (1998) indicated that a lack of recognition from team members about an 
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individual's contribution to the whole could leave a feeling of demoralisation. 
Subsequently, there could be the potential for failure of the programme. 
The Expert Patients' role was central to the completion of this study and to the delivery 
of the intervention. The role was carefully clarified and explained to staff involved in 
this study. Initially, as one of the nursing staff commented in one of the focus groups: 
"So we don't have to explain anything from now on to patients, Expert 
Patients will be doing all the talking" (ON03). 
This comment prompted me to clarify that the research was only an exploratory study 
at this stage and Expert Patients would not take away any of the traditional 
responsibilities of the health professionals for providing high quality care. The. 
outpatient clinic manager commented: 
"Even though there will be an Expert Patient on site speaking to other 
patients, this should not affect the usual running of the clinic and the care 
we provide our patients. The liaising will be directly between Raed (I) and 
who is in charge on the day" (NM01). 
One of the inclusion criteria to become an Expert Patient was to have been diagnosed 
with glaucoma for more than 10 years, as with time patients are likely to gain more 
experience and become knowledgeable about issues that face the glaucoma patient in 
their daily life. One of the Expert Patients commented: 
"I think it was important to receive this training as I discovered that there 
are things I don't know about glaucoma even after 20 years of having it. 
Alsoit prepared me what to expect from patients and what sort of questions 
they ask" (EP04). 
The training programme intended to prepare the Expert Patients to deliver the 
intervention. I thought the training went well and Expert Patients were motivated and 
excited about their involvement in this research. 
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"The training went quite well. Participants were very engaged and enjoyed . 
most of it. Though / think we needed more role play sessions to give 
participants more opportunity to practice more. n (Field Notes- August 
2009). 
One of the Expert Patients commented on the training programme: 
"The role plays were excellent. The venue was very pleasant, and the 
presenters were very knowledgeable and friendly" (EP01). 
Another Expert Patient added: 
"Having been diagnosed a few years ago, / found that the training and 
discussion were helpful to me to understand the problem of glaucoma n 
(EP02). 
A booklet designed for the research was also helpful in enforcing the information given 
in the clinic and also provided the patient with something they could read at their 
convenience. 
As one of the participants said: 
"/ really wanted to know more (about glaucoma) but did not know where to 
find information so I just 'Googled'it and read there ... But some time ago I 
found a good leaflet here in the waiting area (Clinic) so / took it home and 
read it" (eG07). 
One of the Expert Patients suggested, producing a DVD to incorporate issues outlined 
above. It should present the potentially damaging and sight threatening complications 
of glaucoma and would be far more effective in reaching all disadvantaged groups. 
"/ thought a short video on glaucoma on a DVD that the patient could 
share with family and carers would be helpful and their involvement 
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might be crucial in ensuring that the patient complies with their 
treatment" (EP01). 
5.1.6 Enhancing Self-Management 
As discussed earlier, the time spent with the patients was limited with professionals 
and so it was essential for the Expert Patients to be motivated to deliver the intervention 
to fellow patients to self-manage their condition. Whilst health professionals were likely 
to mention patient education groups and associations like the International Glaucoma 
Association (IGA), they utilised written information such as an explanatory sheet on 
what glaucoma is if available. Ophthalmologists used long-term prognosis as a 
motivation strategy whilst nurses were more likely to engage in more active teaching if 
they had the time. A nurse manager commented: 
" .. . since we opened this branch and I am the only nurse running the clinic 
and that is several months now ... I used to spend a lot of time going through 
different aspects of self-managing glaucoma with patients ... but here it is 
very difficult to speak to people much about glaucoma as most of the time I 
have too much to do ... " (N MO 1 ). 
She added: 
"I can't see something better than someone who is actually experiencing 
the problem, have family and people and connection to do with glaucoma 
and have to use drops and been through pathways of glaucoma. The best 
. person possible to speak to another patient is a patient who is being 
diagnosed with glaucoma" (NM01). 
A City Road clinic manager commented: 
" ... 1 am occasionally involved in sort of one-to-one sessions with glaucoma 
patients having trouble managing their conditions. Unfortunately I often have 
to come out and cover for other nurses or the clinic is over booked and we 
have many patients waiting. Then my priority becomes to attend to those 
patients waiting to be seen ... " (NM03). 
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Patients rarely mentioned any experience of being taught by professionals on a one-
to-one basis, however, the one exception is when the City Road clinic manager is 
running her teaching sessions. Apart from these rarely run teaching sessions, there is 
no other condition specific group education to enhance self-management. In fact only 
a few of the professionals involved in the study could actually describe the Department 
of Health Self-Management programme or suggested to any patient the EPP. 
In contrast, Expert Patients had clear ideas of strategies to enhance self-management 
amongst patients with COAG. They knew what helps and what doesn't, what is 
essential to know what is not as one of the Expert Patients commented: 
" ... It is the practical daily tips of living with glaucoma, how not to forget your 
eye drops, where to store them, how to fit them in your daily activity of doing 
your shopping, cooking your dinner; getting ready for bed. That is what will 
make the difference and what will help most ... " (EP02). 
5.2 Action Research Findings 
In this part of the chapter, data generated from the implementation of the GEPP and 
action research cycles involved will be presented. 
5.2.1 Recruitment of Intervention Group 
Recruiting participants for the intervention group required the presence of myself and 
the Expert Patient in the clinic. On any particular session, I would come to the clinic an 
hour before the first appointment; assess all the clinical notes of the patients on the list 
of that day, decide who is eligible for participation and who is not, and then make my 
own list of participants and potential participants. We did not always have clinical notes 
of patients on site, so until I asked a patient a few questions I would not be able to 
decide if he/she was eligible. Then before the clinic started I would meet with the Expert 
Patient and plan our day around the appointments of potential participants. As soon 
as the patients arrived at the clinic I approached them and introduced myself and told 
them what the study was about then asked them if they would like to take part in the 
study. I always offered them time and an information sheet to consider and to help 
them make up their mind before committing to participation in the study. Patients tend 
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to spend between 1 to 3 hours per visit, so that gave me enough time to recruit the 
participants and for the Expert Patient to deliver the intervention without causing the 
participants any unnecessary delays. Once a patient considered the information sheet 
and agreed to take part, the consent form was completed and then he/she was 
introduced to the Expert Patient who normally waited in a separate room to deliver the 
intervention. 
The recruitment procedure seemed like a straight forward procedure, but following the 
inclusion criteria meant we could only recruit newly diagnosed patients with COAG. 
This meant fewer patients met our inclusion criteria. In other words, there were 
occasions when we (I and Expert Patient) attended the clinic to recruit participants but 
after considering the clinical notes of patients found none of them met the inclusion 
criteria which meant four hours were spent without any recruits. On other days, I made 
my list of potential participants but none of them agreed to take part, which meant 
spending four hours at the clinic and not recruiting any participants. This was 
particularly frustrating for one of the Expert Patients who had to travel over an hour on 
the train to get to the clinic. She voiced her frustration and commented: 
lilt's a shame that we cannot decide before hand if there are patients who 
are eligible to take part or whether they are willing to take part, as this could 
save us a lot of time instead of travelling miles ... 1t feels like a wasted 
opportunity ... " (EP01). 
For other Expert Patients this was not an issue as they lived locally and coming to the 
clinic as a volunteer was always a gain for them. They got to meet the professionals 
who usually looked after them when they were attending for their glaucoma 
appointment. 
As most glaucoma patients attending the clinic were elderly, they were often 
accompanied by relatives (Le .• son or daughter) and/or siblings. It was important to 
allow both the patient and carer or sibling to decide. with the patient whether to 
participate. At times patients were keen to get involved and the carer was not as keen. 
The decision at the end was to not to take part. 
On a particular case I wrote in my field notes: 
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" ... When I approached Mr. X to invite him to participate, he was quite keen 
to get involved and he liked the idea and wanted to learn more about 
glaucoma. To my surprise, his daughter who was reading a magazine, 
turned to me and said 'no my dad knows everything and does not want to 
learn more, do you dad?' ... " (Field Note). 
A lack of space was one the main problems we faced during recruitment. At times I 
had to cancel the entire day as there was no free space for us to use to speak with 
participants and for the Expert Patient to deliver the intervention. One of the outpatient 
clinic managers commented: 
"In this clinic, we have a terrible lack of space and sometimes we have to 
share the same cubicle, so I think you will find it difficult to find the space 
that you can use for recruiting patients. Maybe you should try other 
outpatient clinics .... " (NM02). 
5.2.2 Intervention Group Experience with COAG 
This section will present the data illustrating the experience of the intervention group 
participants of living with COAG. The majority of the narrative begins with the pre-
diagnosis phase, optometrist and General Practitioner referral and the pathway 
followed at the Trust. The effect on life and quality of life will be conveyed and the 
section will conclude with narrative on how participants reacted to being diagnosed 
and strategies to cope with COAG. 
5.2.2.1 Diagnosis; Shock, Denial and Validation 
Receiving a diagnosis for many participants was a complete shock as often they did 
not have any signs or symptoms prior to being diagnosed. 
lilt was a bit of shock really, you know. I saw my optician for new glasses 
and the next thing I am here with glaucoma. I still don't think I have any 
problem with my eyes ... you know. I can see perfect and have no pain or 
anything ... " (CG06). 
For others it was confusing and worrying that they were unable to decide whether they 
have COAG or not 
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"I didn't really know anything about it before they told me. The optician was 
not sure what he saw and here in the clinic they are still not sure if it is 
glaucoma. So the whole thing is confusing and not right" (CG01). 
"Well that is the thing. They told me at the beginning that I have not got 
glaucoma. Then the next visit they said you do have glaucoma and we will 
give you some eye drops to use. Then another doctor saw me and said no 
(there is no glaucoma) but nothing has been confirmed as yet" (eGOS). 
For younger patients, being diagnosed with glaucoma was not only shocking but a. 
reality they denied and found unacceptable. 
"You know it's been 18 months now since I was first referred; now they are 
saying that I have glaucoma and I should take these eye drops for life or I 
go blind ... You know I am still 28 and none of my family had it ... I don't 
believe what they saying ... It's all confusing" (eG06). 
eG06 added: 
"I have faith in Jesus and if I have glaucoma, Jesus will heel my eyes not 
. these eye drops. If anything they made my eyes worse" (eG06). 
For others, the diagnosis was something they predicted and the diagnosis brought a 
sense of relief that it could be controlled by taking eye drops and that they were not 
going blind. 
III didn't find it shocking to be honest, because both of my two sisters had it, 
the younger and the older sister, I am the middle one. So I knew I would get 
it at some point. I think I am even lucky. I didn't get it as early as they did ... " 
(CG07). 
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"I think I was lucky that they probably picked it up early and I have very little 
problems in terms of you know, controlling the pressures with the drops" 
(CG03). 
5.2.2.2 Adapting and Adjusting "Quality of Life" 
It is widely accepted that during the first two years of life with any chronic condition 
patients tend to develop strategies of coping. The diagnosis is considered to be a 
disruptive event in some cases and to a lesser extent to others as COAG is largely 
asymptomatic and patients do not experience any symptoms at this stage unless it is 
discovered very late. 
The impact of COAG varied between respondents but at the very least the glaucoma 
would have some impact on their life plans. For many the thought of losing their vision 
and becoming blind was frightening and terrifying whilst others spoke of their 
experience with COAG as part of life's journey. 
The majority of participants involved in the interviews considered COAG as a non-
disruptive event and hardly noticed any changes apart from taking their eye drops on 
a regular basis and coming to their clinic appointment every six months. 
"I think I have very little problems with managing my glaucoma. I come for 
regular appointments to which ever clinic I am meant to be coming, and 
every time they say the pressure is well controlled and there is no damage 
at the back of my eyes ... apart from having to do the drops every night I don't 
think it (COAG) has affected my life a lot" (CG03). 
For working participants, COAG has not limited their ability to continue working as 
participants added: 
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"It has not really affected my life at all. I am still working full time and I am 
driving as usual, go swimming every now and then and you know no 
problem at all" (IG02). 
" ... though I have noticed that before this (being diagnosed) I would be 
looking at the tele without my glasses and see clearly, but now I am finding 
it a bit blurry when looking at the tele without the glasses ... " (IG04). 
"I am still doing my shopping and driving although I am 68, so I would say 
that it (COAG) has not stopped me from doing my usual things and going 
out and about, though I only had it (COAG) for 10 months" (IG02). 
Managing the condition and the daily use of the eye drop/drops was considered by the 
majority as hard work and the reward they got for the effort was the sense of control 
when they had a low reading of lOP and so minimising the damage to their eyes. For 
others the eye drops had troublesome effects that made it almost impossible to 
continue using the eye drops. Many symptoms were reported as having impacted on 
their outlook and quality of life. 
III am still doing the drops but I am not sure if they are doing much to be 
honest ... as they make my eyes very gritty crusty and red especially in the 
morning which is something I never had before ... But the doctor says they 
seem to be working and controlling the pressure" (IG02). 
"I didn't have any symptoms at all until I started using the eye drops ... that's 
why I was not very convinced at the beginning" (IG01). 
For other respondents the appearance of their eyes was very important and strictly 
taking their eye drops meant they would have red and crusty eyes; something they 
were prepared to tolerate: 
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" .. . the inconveniences of doing these drops for all this time ... as you can see 
my eyes are always gritty and red, you know my colleagues at work keep 
asking what's wrong with your eyes. Or are you alright? It is really annoying" 
(CG06). 
" .. . my eyes were absolutely fine until I started putting them drops, what they 
called, Travatan or something like that. You know when I drop them in my 
eyes they sting like mad ... and look at my eyes they are always red, very 
crusty and I really don't think these are doing me any good" (CG06). 
Some patients were offered alternative eye drops to try, but the side effects seemed 
to be no better: 
"/ told the doctors last time that the eye drops didn't agree with my eyes as 
they sting a lot ... They said they would like me to try some other drops to 
see if it improves things ... They gave me a new drop but if anything it is 
worse" (IG03). 
In terms of long term adjustment to their conditions, Expert Patients were trained to 
identify coping strategies developed by participants. As the GEPP is planned to be 
delivered within the first two years of being diagnosed the chances are all participants 
will be at an early stage of trying to integrate the illness into their lives. The most 
common form of management technique described by participants was the use of 
medication, however, Expert Patients were able to elaborate on any other self-care 
practices they may have tried so as to be considered in the intervention delivered to 
the patients. 
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5.2.2.3 What will happen to me? Am I Going Blind? 
Many respondents reported going through a period of anxiety regarding the 
effectiveness of the treatment they were taking and considered the future of their eyes, 
they simply kept asking: 
"Am I going blind?" (IG01, 03, 04; CG04, 06, 12). 
For the majority who follow the treatment regimen and attend their appointments the 
answer will be 'no'. For some unfortunately, the answer will be 'yes'. If COAG is 
discovered in the late stage and patients do not strictly follow their treatment, there is 
a strong chance that they will go blind at some point. 
"Ever since my mom went blind because of glaucoma, I am always 
frightened the same thing will happen to me and I won't find anyone to look 
after me .. .it is scary though" (EP03). 
5.2.3 Delivery of the GEPP by Expert Patients (Employment of 1MB Model) 
Unlike other generic EPPs the GEPP in essence incorporated individual needs as 
expressed by participants and an intervention that was delivered by Expert Patients 
accordingly. As discussed previously, prior to each session I provided the Expert 
Patient with a brief ophthalmic history for each participant in addition to participants' 
responses on the knowledge questionnaire to be considered in the shape of the 
intervention to be delivered. Nonetheless, maintaining a consistent intervention that 
addressed the three main constructs of the 1MB model; knowledge, motivation and 
behavioural skills was equally essential. That meant for knowledgeable participants, 
the focus was more on behavioural skills and the motivation necessary to achieve 
concordance. For less knowledgeable participants it was important to provide factual 
information that may contribute to improved concordance. 
5.2.3.1 Complementing Existing Self-Management Routines (Knowledge 
and Coping Strategies) 
It was essential for the intervention not to disrupt the coping mechanisms participants 
had initiated. Instead it had to complement them and provide further practical tips that 
will enhance their coping and self-management. 
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One of the Expert Patients commented during the training: 
"I think we should be vel}' careful not to sound judgmental and critical of the 
participants' way of coping. Instead we should complement that and share 
our experience and ways of self-managing ... " (EP01). 
Often these coping strategies needed some adjustment; it was vital that this adjustment 
was planned and approved by the participant and that the participant understood the 
justification for doing so. 
One participant commented after completing a session with an Expert Patient: 
" ... 1 struggled at the beginning to get the drops in my eyes, and then I started 
looking in the mirror to get the angle right ... sometimes it went in and 
sometimes it didn't ... she (Expert Patient) gave me this little dropper which 
seems vel}' easy to use ... 1 will definitely tl}' it and see how it goes ... " (IG03). 
As can be seen, the participants had attempted to manage their condition; sometimes 
using a trial and error approach in an attempt to find a way that worked for them. 
The Expert Patient acknowledged the efforts made by the participants and added: 
" ... there is no point of me saying you've got to do this and that .. .il's like 
we're back to square one ... unless we both (participants and Expert Patient) 
agree as to what needs to be done and how to achieve our goals ... " (EP04). 
Other participants appeared to be searching for different self-management practices to 
help them manage their condition on a daily basis. The GEPP was timely and gave 
them answers and tips they needed. 
One participant commented: 
" ... 1 tl}' to remember putting the drops in, but to be honest I tend to forget 
them quite often, she (Expert Patient) suggested to put the drops either in 
the toilet next to my toothbrush so they are there in front of me so I 
remember or next to my bedside table so I can see them when I am in 
bed ... you see I never thought of that..." (IG06). 
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Personal experience with glaucoma was related to participants by the Expert Patients 
during the intervention. For example, the importance of family member screening as a 
way of early detection of glaucoma was explained. An Expert Patient commented: 
"/ used to come to the clinic with my mom before she died, and they always 
told me to get my annual check-up with the opticians ... On one occasion the 
optician told me that my pressures were up and he need to refer me to 
Moorfields ... 1 knew it then, that's it, / am getting the same thing ... so / tell 
every participant / work with this story so they remember to do the same 
with their siblings ... This is the only way they would know that they have 
it..." (EP03). 
Another Expert Patient added: 
"/ had to give up driving as a result of glaucoma, which is something / really 
miss a lot. So / tell every participant that ... you know some people are driving 
for a living and have to give it up. That can be a bit of problem ... unless we 
tell them that they probably wouldn't know ... " (EP01). 
A participant who drives a lorry for a living commented: 
"l knew glaucoma affects your ability to drive ... but / didn't know how ... as / 
have perfect vision ... 1 didn't know losing the peripheral vision would stop me 
from driving ... " (IG11). 
5.2.3.2 Maintaining Consistency (Motivation and Behavioral Skills) 
To avoid any variations in the intervention delivered by the Expert Patients to different 
participants, it was vital to cover the main constructs of the 1MB model based on the 
individual needs of participants. Whilst maintaining· the focus of improving the 
knowledge amongst all participants, it was equally important to consider barriers and 
behaviours that impact concordance. For example, a young educated participant had 
been diagnosed with glaucoma and had not been keeping his appointments or taking 
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his eye drops regularly given the fast progression of his glaucoma. After a long 
conversation with one of the Expert Patients, this is what the EP had to say: 
" ... this young gentleman is vel}' knowledgeable and understands his 
condition vel}' well ... the problem is he doesn't believe he has 
glaucoma ... He is only 27 years of age and has no family histol}' of glaucoma 
and so does not take his eye drops ... After a long chat with him, he 
understands that not taking the eye drops if anything will make the situation 
worse and he will subsequently pay the ultimate price ... 1 draw a lot on my 
personal experience with glaucoma and how ignorant 1 was at the 
beginning ... He listened to me and was like ... what you're saying actually 
make sense ... "(EP01). 
I had the chance to speak with this gentleman afterwards and he said the following 
about the Expert Patient: 
" .. . she was vel}' informative and vel}' reasonable ... 1f someone has been 
through this and telling me at the end of the day they are the one who lost 
their sight...1 think 1 buy that and listen to what she says ... although 1 don't 
believe what the doctors are telling me here ... but 1 don't want to go blind 
either ... " (IG13). 
This gentleman found it difficult to accept the reality of his condition and may well 
subsequently have a surgical procedure to reduce his lOPs before it is too late. The 
Expert Patient conversation will definitely help him accept the situation and he may well 
accept having a Trabeculectomy (surgery) if the eye drops continue to be an issue for 
him. I reflected on this interaction and wrote in my field notes: 
III am impressed with the flexibility the Expert Patient has shown and the 
ability to change some of the beliefs this gentleman was holding toward 
glaucoma ... ft was apparent that a lack of knowledge was not an issue ... She 
moved to the next 1MB construct which is motivation, she identified that he 
has poor motivation and confidence ... She addressed that and then ensured 
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he is holding the necessary behavioural skills to achieve concordance" 
(Field Note). 
Communicating such conversations to the health professionals caring for this 
participant will alert the Ophthalmologist to the situation who may be able to alter the 
course of treatment or the direction of treatment all together. 
The 1MB model provided not only comprehensive guidelines on understanding the 
issue of concordance; it also ensured a consistent delivery of the intervention and 
enabled Expert Patients to address barriers to concordance. 
5.2.3.3 Re-enforcement of the Expert Patients Teaching and Learning 
(Sustainability) 
The first and second follow ups were an opportunity to reinforce learning acquired from 
the intervention. Although the findings will be presented in detail in the mixed method 
section, for clarity I mention that participants were asked to comment on the 
intervention they received. I took this opportunity to answer their questions and validate 
the teaching delivered by the Expert Patients. To incorporate feedback into the results 
I left a section in the questionnaires for participants to comment on the performance of 
the Expert Patient. Most participants were full of praise and wanted to speak to the 
Expert Patients again. Many thought some of the tips given worked for them. 
The following are a few of the comments made by participants from the Intervention 
Group on their follow up visit: 
" ... this is a very good idea especially for elderly people who can't find 
information anywhere else .. .it could save them their sight knowing how 
dangerous glaucoma is" (IG01). 
liMy wife has glaucoma as well ... 1 didn't really know much about glaucoma 
and I keep asking her as we help each other to put the drops in ... 50 it is 
useful for everyone to know about their conditions and find someone you 
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can speak to ... 1 wish my wife was here. She could have appreciated this 
session a lot" (IG02). 
"I think this is a vel}' good idea. Sometimes I feel like talking to someone 
who is experienced and been through what I am going through now ... and 
to find out how other people are coping with this condition ... The lady (Expert 
Patient) is vel}' knowledgeable and helpful" (IG03). 
Participant IG22 who was accompanied by her son who is also a glaucoma sufferer 
commented: 
"this is a great idea, we both have been patients for years and we never had 
the opportunity to sit with someone and spend the time as we did today 
talking about it (COAG) and how it could affect our Iives ... For example, we 
never understood why they do the visual field evel}' time we come to the 
clinic or what the eye pressure reading should be ... Thank you for the 
opportunity and for her (Expert Patient) efforts" (IG22). 
" ... 1 hated the visual field test ... 1 never knew why they were doing it ... 1 call 
it the torture chamber ... but now (after the session) it all makes sense and I 
asked them to see the results and then when they compared it to what it 
was last time ... you know it is really reassuring to know that things are not 
getting any worse ... " (IG19). 
"You know I never knew what my pressure readings were ... but after this 
session I understand what the pressure means and what it should be ... Now 
they told me the pressures are down to 16 and 12 which is normal ... lt is nice 
to know that I am doing a good job and the drops are working for me ... " 
(IG23). 
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It is evident from these comments that participants often wanted to know and learn how 
to assume greater responsibility about how to manage their condition. The Expert 
Patients gave them a starting point and a platform to build on. 
5.2.4 Recruitment of the Control Group 
The control group findings are presented in comparison with those of the intervention 
group in the mixed method section below. For clarity 25 participants were recruited in 
the control group of which 10 participants were interviewed. 
5.3 Findings From the Mixed Methods Evaluation 
Obtaining baseline data was an essential step to determine how knowledgeable and 
motivated these two groups were post intervention. This section serves the purpose of 
comparative evaluation between each group before and after intervention and 
between groups comparison. It presents the three time series of the quantitative 
findings from participant groups including: Expert Patient Group, Intervention Group 
and Control Group. Simultaneously findings from the interviews conducted with 
selected participants of the groups will also be presented. 
5.3.1 Expert Patients Group 
Four patients who met the inclusion criteria and showed commitment and enthusiasm 
to participating in this research were recruited . The following sections describe their 
demographic data and the results. 
5.3.1.1 Demographic Data 
Three of the participants were of white ethnicity and one was of black ethnicity as 
illustrated in figure (5.2) below. 
Figure {5.2 : Ex ert Patient by Ethnicity 
Ethinicity 
• White 
• Black 
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Although I had hoped to recruit an Expert Patient of Asian ethnicity so as to reflect the 
diversity of the community served in this research, it was not possible to find a 
participant that meet the inclusion criteria. 
Three out of the four have a high school qualification whilst the fourth has a 
postgraduate qualification and long experience in coaching young entrepreneurs as 
illustrated below in figure (5.3). 
Figure (5.3 Ex ert Patient b Education 
Education 
• High School 
• PostGraduate 
Half of the Expert Patients have a family history of glaucoma as shown in figure (5.4). 
Figure (5.4): Expert Patient by Family History_ 
Family History 
5.3.1.2 Pre-Intervention Findings: 
The baseline data for the Expert Patients Group were obtained directly after 
recruitment and prior to the training provided. 
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1. Knowledge (Appendix 3) 
Although the Expert Patients were considerably knowledgeable and knew the ins and 
outs of the clinics, it was important to assess the impact of the training/intervention as 
well as their learning gained through this research. Therefore, their level of knowledge 
was assessed on baseline before getting involved in this study. The mean on baseline 
was (23.25) and the SD was (2.5). 
An Expert Patient commented: 
"I think it was important to receive this training as I discovered that there are 
things I don't know about glaucoma even after 20 years of having it" (EP04). 
2. Motivation/Satisfaction (Appendix 4) 
As the Expert Patient group has been attending the clinic for over 10 years, their ideas 
and views of the treatment received have been formed. Therefore it is expected there 
will be minimal change if any when comparing the baseline results with the follow up 
results. The mean was (35.5) whilst the SD was (8.347). 
3. Adherence (Appendix 5) 
The Expert Patient participants were not using any eye drops regimens as they had 
surgical procedures; therefore it was not possible to measure for adherence. 
5.3.1.3 Post-Intervention Findings 
The same outcomes were measured again on the completion of the study and the 
findings were as the following: 
1. Knowledge (Appendix 3) 
A follow up assessment was conducted on completion of the intervention. As expected 
the results revealed a small improvement, the mean was (23.25 on baseline and 26.5 
on follow up). The SD was (2.5 on baseline and 1.91485 on follow up). Using Wilcoxon 
Signed Ranks Test at 0.05 probability showed a p-value of (0.066) which is not 
statistically significant. The following figure (5.5) demonstrates this change. 
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Figure (5.5): Line Chart of Expert Patient Kn~wledge 
CII 
30 ~-------------------------------------------
25 +----~.::-----~~~~~---~~-;;~;;~~~~--­- -------20 +-------------~~~~-----------------------
5 15 +--------------------------------------------u 
I/) 
10 +--------------------------------------------
5 +--------------------------------------------
o +---------~----------._--------_.----------~ 
1 2 3 4 
Number of Patient 
- Besline 
- FUl 
The above line chart represents the small change in Expert Patients' knowledge. The 
blue line represents the level of knowledge on baseline whilst the red line represents 
the knowledge after the completion of the intervention. All Expert Patients' knowledge 
has marginally improved. 
Expert Patient evaluation of the knowledge gained from the GEPP was also measured 
through semi-structured interviews and they commented: 
"I learned a lot from this project .. . lots of information at the beginning of the 
project and I think more importantly the life experience of patients and how 
they coped and managed their glaucoma .. . " (EPO 1 ). 
"Having been diagnosed a few years ago I found that the training and 
discussion were helpful for me to understand the problem of glaucoma" 
(EP02). 
" ... 1 knew a bit before about glaucoma .. . and learned a lot during this 
project ... ft is great to know the problem with your eyes and that I am not 
going blind like my mom, as I always thought" (EP03). 
When asked whether the training and the information gained were useful, an Expert 
Patient suggested: 
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"The training was very good but in my opinion was not sufficient to get 
enough day-to-day problems sorted such as informing the DVLA and 
insurance company ... " (EP02). 
2. Motivation/Satisfaction (Appendix 4) 
Motivation and satisfaction of the Expert Patients comprised of two main parts. First 
their satisfaction with the treatment and experience with the running of the clinics and 
the health care they received in the clinic. This was measured using the satisfaction 
questionnaire (refer to the questionnaire in the appendix 4) by comparing their baseline 
responses with those at the end of the study. The results were analysed using SPSS 
18 software and showed the following: The mean was (35.5 on baseline and 35.5 on 
follow up) whilst the SO was (8.347 on baseline and 8.34666 on follow up) and 
expectedly the p-value was 1.000 using the Wilcoxon Signed Ranks Test. This 
demonstrated no significant change. 
Secondly, Expert Patients were asked in an interview to comment on their satisfaction 
and involvement and how motivated they felt during this project. The following are 
comments made by the Expert Patients: 
"/ think our commitment to seeing this project through was an indication of 
the belief we hold that this is really a worthwhile project and does make a 
difference ... " (EP01). 
11 •• .1 really enjoyed my time during this project .. . coming to the clinic where / 
always received treatment and being part of the team and to make other 
people's experience a better one was very encouraging ... You know coming 
here and chatting to B.H (clinic manager) and nurses and doctors was really 
nice ... lt makes you see things from a different perspective ... " (EP03). 
" ... unfortunately / was only able to attend patients in Upney Lane which 
really has very limited space and is quite claustrophobic at times .. .1 only 
saw three patients although / was hoping to see more ... It was really 
brilliant ... " (EP04). 
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5.3.2 The Intervention Group 
The intervention group included 25 newly diagnosed patients attending the clinic within 
the first two years of being diagnosed. The participants were randomly chosen once 
they met the inclusion criteria and completed the consent form. 
5.3.2.1 Demographic Data 
Whilst maintaining the representation of the sample, all efforts were made to recruit a 
sample that reflects the demography of the community in which this study was 
conducted. Of those recruited, 48% were of white origin, 40% were of black origin and 
12% of Asian origin as illustrated in figure (5.6) below. 
Figure (5.6J: Intervention Group by Ethnicity 
Intervention Group (Ethnicity) 
• White 
. Asian 
• Black 
Previous studies have linked poor concordance to patients with low educational 
accomplishment. The following figure (5.7) illustrates the level of education amongst 
participants in this group. 
, 
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Figure (5.7): Intervention Group by Education 
------
Intervention Group (Education Level) 
• below high school 
• High School 
• Undergraduate 
• Postgraduate 
Family history is considered a primary motive for the general public to seek medical 
attention and attend screening tests. Out of the 25 participants 40% have a family 
history of glaucoma as illustrated in figure (5.8). 
Figure (5.8): Intervention Group by Family History 
Intervention Group (Family History) 
As mentioned earlier this group of participants has been diagnosed with COAG within 
the last two years. Of those 40% were in the first year of diagnosis and rest of the 
group were in their second year of life with COAG as illustrated in the following figure 
(5.9). 
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Figure (S.9tlntervention Group by Years of Diagnosis ___ _ 
Intervention Group (Glaucoma Diagnosis) 
5.3.2.2 Pre-Intervention Findings 
1. Knowledge (Appendix 3) 
One of the outcomes to assess the impact of this intervention was the level of 
knowledge which has been assessed prior to receiving the intervention using a true 
and false validated questionnaire. On Baseline the mean was (20.40) and SD was 
(3.500) which will be compared to findings from first and second follow up in a later 
section. 
Interviews were only conducted as part of the evaluation after the intervention was 
delivered, however, when approaching potential participants and inviting them to take 
part in this study, the majority of participants showed great interest in the study. 
2. The Motivation/Satisfaction (Appendix 4) 
The second outcome measured in this study was the participants' level of satisfaction 
with five main aspects of their treatment. This outcome includes their satisfaction with 
effectiveness of treatment, side effects of eye drops, eye appearance, convenience of 
use and satisfaction with ease of administration. A validated scale questionnaire was 
used and rating was given by each patient. The higher the score the more satisfied 
they were. The mean on baseline was (54.6) and SD was (7.85812) which will be 
compared to the findings from first follow up and second follow up. 
3. Adherence and Concordance (Appendix 5) 
To reflect whether improvement in knowledge will subsequently lead to improvement 
in the concordance amongst participants, I examined the level of adherence to the eye 
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drops used by asking participants how many times they missed their eye drops over 
the last four weeks. One may question the reliability of self-report in the tool used. Here 
the result serves as a guide rather than an accurate measurement. The mean on 
baseline was (1.8). 
5.3.2.3 Post-Intervention Findings 
1. The Learning Process (Knowledge) 
One of the outcomes measured to assess the effectiveness of this study, was the level 
of knowledge assessed prior to receiving the intervention and on 1 st follow up and 2nd 
follow up using a true and false validated questionnaire (Hoevenaars et ai, 2006). 
*Comparing the knowledge on baseline with the first follow up. 
The result showed a statistically significant improvement on the level of knowledge of 
participants when compared to baseline results (mean 20.40, SO 3.500) with those of 
the 1st follow up (mean 23.28, SO 2.55799) and a p-value of (0.000) using Wilcoxon 
Signed Ranks Test. 
*Comparing the knowledge on first follow up with the second follow up. 
To assess the sustainability of this intervention another comparison between the first 
follow up and the second follow up on the level of knowledge was undertaken. The 
results were not disappointing, as participants seem to retain the knowledge they have 
gained during this intervention. There was no further improvement, as the results were 
similar as shown in the mean and SO values. With first follow up results (mean 23.28, 
SO 2.55799) and the second follow up (mean 22.88, SO 2.75862) and a p-value 
<0.005 using the Wilcoxon Signed Rank Test which reflects a significant result in 
retention of knowledge. 
*Comparing the knowledge on three data sets (Baseline, first and second 
follow up). 
For a more comprehensive test of the sustainability of this gain in knowledge, further 
test that compares the results on baseline with results from the first follow up and 
second follow up using Friedman Test was conducted. The Mean for this comparison 
was (20.40 on baseline, 23.28 on first follow up and 22.88 on second follow up) whilst 
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the SO was (3.500, 2.55799 and 2.75862) respectively. The p-value was calculated at 
0.000 using Friedman Test and Kendall's W Test. 
For a better illustration of this comparison, the following figure (5.10) provides an 
indication of the knowledge gain on each episode: 
Figure (5.10): Line Chart of Intervention Group Knowledge 
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As can be seen from the above chart there was an obvious improvement on 
participants' level of knowledge quantitatively. Interviews conducted reflected similar 
trends. 
On the terminology and jargon used in the treatment of glaucoma for example, 
participants said: 
It ••• You know some of the terms and words they use ... 1 didn 't really 
understand everything they told me ... but now that someone explained it to 
me it makes more sense ... " (IG03). 
It ••• as I said I knew a bit about glaucoma, but there is always more for you 
to learn ... 1 learned useful things from her (Expert Patient) ... " (IG02). 
When asked what difference this research made for them, participants 
commented: 
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" ... You could say I am more confident now and more familiar with all the 
stuff they say, how to use the drops, where to get a repeat prescription and 
all that ... You know it puts your mind at rest" (IG05). 
"I think it helped me in many ways ... You know the more you know it puts 
your mind at rest instead of keep worrying about it and not knowing what to 
do ... " (IG07). 
" ... they do explain things here, but for example, I didn't know that I have to 
use my eye drops all the time and to get a repeat prescription from the 
GP ... She (Expert Patient) told me that I have to do that ... but how would I 
know ... no one told me" (IG09). 
" ... It is difficult for a non-medical person to understand the words they 
use .. . though she (Expert Patient) explained this and that.. ./t is good to 
understand what is going on with my eyes and stuff ... " (IG1 0). 
2. The Motivation/Satisfaction (Appendix 4) 
The second outcome measured in this study was the participants' level of satisfaction 
with five main aspects of their treatment. This outcome includes their satisfaction with 
effectiveness of treatment, side effects of eye drops, eye appearance, convenience of 
use and satisfaction with ease of administration. A validated scale questionnaire (Day 
et ai, 2006) was used and rating was given by each participant. The higher the score 
the more satisfied they were. 
*Comparing the level of satisfaction on baseline with the first follow up. 
In order to reflect any improvement on satisfaction, a comparison of the baseline 
results was made with first follow up. The results were encouraging as the baseline 
results were (mean 54.6, SD 7.85812) as compared to 1st follow up (mean 57.8, SD 
9.16515), using Wilcoxon Signed Ranks Test which showed a p-value 0.133. Although 
there was an improvement in the level of satisfaction, the improvement was relatively 
small to make any statistical difference. 
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*Comparing the level of satisfaction on first follow up with the second follow 
up. 
To examine whether this small improvement was sustainable over time, a further 
comparison was made between first follow up and second follow up. The results 
revealed relatively similar means (1 st follow up 57.8, 2nd follow up 56.72) and the SD 
(1 st follow up 9.19515, 2nd follow up 7.46949) and a p-value 0.078 using Wilcoxon 
Signed Ranks Test, which is not significant indicating that satisfaction remained pretty 
stable over time. 
*Comparing the satisfaction on three times (Baseline, first follow up and 
second follow up). 
This comparison provided an overall perspective of the changes of participants' level 
of satisfaction when comparing the three level of satisfaction using Friedman Test 
which revealed a mean of (Baseline 1.8, 1 st follow up 1.94, 2nd follow up 2.26). Although 
there was a small improvement as reflected by the mean results, the improvement was 
relatively small and was reflected in the p-value 0.224. Refer to chart (5.11). 
Figure (5.11): Line Chart of Intervention Group Motivation/Satisfaction 
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Participants' satisfaction with the above mentioned five aspects of their treatment were 
also measured in semi-structured interviews and responses were as following: 
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a. Effectiveness of Treatment 
When asked how effective they thought their eye drops were in controlling their 
glaucoma, responses were varied. Some participants based their judgment on the side 
effects of the eye drops and commented: 
" .. .1 am not sure these eye drops are doing me any good or agreeing with 
my eyes ... ever since I started using them my eyes, as you can see, are very 
red and gritty ... " (I GO?). 
" ... they said the drops will solve the problem ... but look how red and crusty 
my eyes are ... " (IG08). 
"I am still doing the drops but I am not sure if it is doing much to be 
honest.. .as they make my eyes very gritty crusty and red especially in the 
morning which is something I never had before" (IG02). 
"I didn't have any symptoms at al/ until I started using the eye drops ... That's 
why I was not very convinced at the beginning" (IG01). 
Other participants based their responses on how effective the drops were in controlling 
the lOPs and glaucoma as indicated by following responses: 
"Every time I come here they check the pressures and say Mr X your 
pressures today are normal ... 1 guess they are doing the job ... " (IG06). 
" .. .1 am lucky they caught it early so I have not suffered much damage ... and 
it seems the drops are doing the trick" (IG1 0). 
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b. Side Effects of Eye Drops 
As one of the major barriers of glaucoma is concordance, the side effects of eye drops 
prescribed remained a challenge for participants; although now they understand the 
need for these drops. 
" .. . knowing the drops are working for you ... and when I come to the clinic 
and they check my pressures and say your pressures are okay and all 
good ... 1 guess it is worth it at the end ... " (IG04). 
Though not all participants reported having side effects, some participants were 
entirely not bothered with the side effects caused by the drops as one commented: 
" ... They never caused me any problem really ... 1 just do what I am told ... 1 
put the drops in every night and that's it ... " (I GOg). 
c. Eye Appearance 
Eye appearance was consistently expressed as one of the main themes in these 
interviews. Even some of the Expert Patients expressed concerns on the appearance 
of their eyes. This was particularly a concern amongst the younger participants who 
were always asked by colleagues or family why their eyes were always red as 
expressed by this participant: 
" .. . As you can see my eyes are always gritty and red. You know my 
colleagues at work keep asking what's wrong with your eyes? Or are you 
alright? It is really annoying" (IG06). 
For other participants, understanding the necessity of using the eye drops was a 
motivation and an encouragement for them to overcome these concerns as one 
commented: 
"Whenever I look in the mirror and see my eyes red it upsets me ... but once 
you understand these drops actually are saving your sight it makes it easier 
to accept it and you get on with your life ... " (IG04). 
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d. Convenience of Use 
Participants' responses also varied based on the treatment regimen followed. For 
some participants one eye drop to be used every night was enough to control the lOP 
and so it was more convenient for them in comparison with other participants who have 
to use additional eye drop(s) two or three times a day to control the pressure. 
IG01 commented: 
" ... They started me on G.Xalatan to use eve/}' night which was okay ... but 
then she said the pressure was still high .. . so she gave another drop to use 
twice a day which stings when I put it in ... and you know I work and 
sometimes I leave in the morning and forget to put the drop in ... " (IG01). 
" ... It doesn't really bother me ... Eve/}' night I put the drop in and that's it 
really ... and I am quite good I don't miss them at all ... My wife also reminds 
me 'did you do your drops' ... " (IGOS). 
" ... 1 travel a lot ... and before I was not really that good I always forget 
them ... but when I came here they told me your pressures are still high and 
stuff ... then she (Expert Patient) told me you can keep them in your bag so 
even if you travel or don't come home you have them with you ... which so 
far ;s working ... but you see when I run out of them that's the problem" 
(IG14). 
e. Ease of Administration 
As explained earlier the majority of COAG patients are elderly and have other health 
conditions like arthritis. Mastering the skill of dropping drops can be challenging. As 
drop instillation was the main aspect of this intervention, responses were generally 
positive. Expert Patients explained to all participants the technique of instilling eye 
drops and asked them to demonstrate using the drops. The responses were generally 
encouraging as indicated in the following narrative: 
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" .. . At the beginning it was difficult to get the drop exactly in the 
eye ... Sometimes it drops on my cheek or eyelid ... but I was doing it 
blindly ... She told me to look in the mirror which really made it easier ... 1 am 
much better now ... at least the bottle last me for all the month ... before they 
always run out and not lasted long enough ... " (IG14). 
"She gave me this little dropper which I attach to the bottle and it is much 
easier to use them now ... " (IG09). 
3. Adherence and Concordance (Appendix 5) 
To reflect whether improvement in knowledge will subsequently lead to improvement 
in concordance amongst the participants, I examined the level of adherence to the eye 
drops used by asking participants how many times they missed their eye drops over 
the last four weeks. One may question the reliability of self-report in the tool used, but 
here the result will serve as a guide reflecting a semblance of adherence and 
concordance. 
*Comparing the level of adherence on baseline with first follow up. 
This comparison revealed a 1.8 mean on baseline and 2.0 on 1 st follow up using the 
Wilcoxon Signed Ranks Test, and a p-value 0.059. Which showed some improvement 
but again not large enough to be deemed significant. 
*Comparing adherence on first follow with second follow up. 
Again this comparison has provided similar results to the previous comparison, with a 
relatively small improvement that is not statistically significant. The Wilcoxon Signed 
Ranks Test showed a Mean of 2.0 on 1 st follow up and 2.2 on 2nd follow up respectively 
anda p-value of 0.208 which again is not statistically significant. 
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*Comparing the adherence level on baseline and first follow up and second 
follow up. 
A more comprehensive look at the trend over the three episodes was made by thrs 
comparison and results showed a Mean (1.8 baseline, 2.0 1st follow up, 2.2 on 
2nd follow up) and a p-value 0.189 using the Friedman Test. The following figure (5.12) 
provides a better illustration over the entire period. 
Fi ure (5.12 : Line Chart of Intervention Group Level of Adhere_nc_e ____ _ 
12 ~--------------------------------
10 +----------------~-------,---------------
8 +-------------------~------~+_-------------
(II 
o 6 +-------------~--~~----~~~------------- - Besline 
u 
\II 
1 2 3 4 5 6 7 8 9 10111213 1415 16 17 18 19 20 21 22 23 24 25 
Number of Patient 
- FU1 
- FU2 
The above chart shows a small overall improvement in terms of concordance, 
however, individual participants who had major issues with either accepting the 
condition or how to use eye drops or in fact the necessity of these eye drops, is where 
the GEPP has made the difference. Given the subjectivity of the self-report 
questionnaire used and the relatively small sample size the t-test results were not 
expected to be of high significance. Therefore, semi-structured interviews were 
conducted to give an insightful evaluation of the difference the GEPP made. 
The participant, who was presented as a case study in section (5.1.3.3), might be 
remembered as a participant that missed her appointments twice and was not 
interested in attending her appointments. She commented: 
"I am really glad I was given this opportunity ... She (Expert Patient) was so 
lovely and helpful ... ff anything I feel much happier coming to the clinic and 
less guilty of not doing the right thing you know ... and most of aliI don't keep 
244 
worrying that I am going to go blind and who is going to look after me and 
you know these thoughts are no longer there ... " {IG14}. 
Other participants thought of the GEPP as: 
lilt really helped me accept things ... She (Expert Patient) was very 
informative and kind ... listening to her just made me think 'maybe she has 
got a point you know and I should do something about it' .. .1 learned a lot 
from her ... " {IG15}. 
" ... She was very informative and very reasonable ... 1f someone has been 
through this and telling me at the end of the day they are the one who lost 
their sight ... 1 think I buy that and listen to what she said ... although I don't 
believe what the doctors are telling me here ... but I don't want to go blind 
either ... " {IG13}. 
"I really dread coming to the clinic ... but since I started coming to "Loxford 
Clinic" with the staff here ... and this project .. .1 feel a lot more relaxed and 
happier to attend the clinic ... Personally I feel more confident and 
knowledgeable than before I would say ... " {IG16}. 
Other participants thought the idea of having a patient sharing their experience and 
knowledge with another patient was: 
" .. . 1 like the idea that this project is run by patients .. .just made me think why 
someone would waste their time explaining things to me unless it is worth 
listening to ... " {IG19}. 
Other participants were less appreciative of the GEPP and thought efforts should be 
focused on staffing issues and reducing waiting times. 
" ... She was okay ... you know she explained things to me ... but I think the 
problem is with how this clinic is run ... It is always busy and you probably 
have to spend three hours before you get to be seen" (IG21). 
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5.3.3 Control Group 
This is a group of participants who were recruited non-contemporaneously from the 
same clinic on the completion of the intervention evaluation of the intervention group. 
25 newly diagnosed patients in their first 2 years of life with glaucoma were 
purposefully sampled to carefully match the demographics of the intervention group. 
5.3.3.1 Demographic Data 
This group comprised 25 participants from three ethnic backgrounds. Of which 60% 
were of white ethnic background as opposed to 48% in the intervention group, 24% of 
black ethnic origin as compared to 40% in the intervention group and 16% of Asian 
origin in comparison to 12% of the intervention group, as illustrated in the following 
figure (5.13). 
Figure (5.13): Control Group by Ethnicity 
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The education level was similar to the intervention group as illustrated in figure (5.14). 
16% of control group were below high school compared to 10% in the intervention. 
68% of control group have a high school qualification in comparison to 60% in the 
intervention group. 12% of the control group have an undergraduate qualification as 
compared to 25% in the intervention group. Both groups have 5% of participants with 
a postgraduate education level. 
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Figure (5.14): Control Group by Education 
Control Group (Education Level) 
• below high school 
• high school 
• undergraduate 
• postgraduate 
The following figure (5.15) shows that only one fifth of the participants in this group 
have a family history of glaucoma as opposed to two fifths in the intervention group. 
Figure (5.15): Control Group by Family History 
Control Group (Family History) 
Almost half of the participants in this group were in their first year of being diagnosed 
whilst the other half were in their second year of diagnosis is explained in the following 
figure (5.16). 
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Figure (5.16): Control Group by Years of Diagnosis 
- --- ---
Control Group (Glaucoma Diagnosis) 
5.3.3.2 Pre-Intervention Findings 
1. Knowledge (Appendix 3) 
When a glaucoma patient attends the outpatient clinic there are naturally occurring 
learning opportunities in which a patient will presumably gain knowledge. This is a 
result of frequent attendances in the clinic and conversations held with professionals 
and other sources of learning in life. On baseline the mean of Knowledge was (19.52) 
and SO (3.94884) . 
2. The Motivation/Satisfaction (Appendix 4) 
When conducting a similar assessment of the Control group's level of motivation and 
satisfaction with the five main aspects of their treatment. The Mean on baseline was 
(37.04), whilst the SO was (10.74508). 
3. Adherence and Concordance (Appendix 5) 
Adherence to treatment regimen was also assessed in the same way. The Mean on 
baseline was (2.04) and the SD was (2.590). 
5.3.3.3 Post-Intervention Findings 
1. Knowledge (Appendix 3) 
To assess whether the improved knowledge in the intervention group was a result of 
the intervention delivered or was a naturally occurring event. The level of knowledge 
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amongst this group of patients was compared to the control group. The same set of 
knowledge questionnaire (Hoevenaars et ai, 2006) used with the intervention group on 
three different occasion (prior to recruitment, first follow up and second follow up) 
which took up to six months, were used with the control group. 
*Comparing the knowledge on baseline with the first follow up. 
This comparison examined knowledge gained during the first three months of 
recruitment. There was no intervention apart from the routine care received in the 
clinic. On baseline the Mean was 19.52 and SD 3.94884, whilst on first follow up Mean 
was 19.64 and SD 3.70675, which is almost equal resembling no improvement. Using 
Wilcoxon Signed Ranks Test, p-value was 0.88. When comparing the first follow-up 
with the second follow up, there was no improvement shown with p-value of 0.143. 
*Comparing the knowledge on three data sets (Baseline, first follow up and 
second follow up). 
An overall comparison of the three episodes has revealed very similar results (Mean: 
19.52 on baseline, 19.64 on 1st follow up and 19.96 on 2nd follow up) and (SD: 3.94884 
on baseline, 3.70675 on 1 st follow and 3.86738 on 2nd follow up). These values 
represent very little improvement which is reflected in the p-value of 0.635 using the 
Friedman Test. In comparison with the p-value of the intervention group using the 
same test which was 0.000, clearly it can be seen there is a difference. The following 
figure (5.17) represents the learning curve of the control group over the six months of 
involvement in this research. 
Figure (5.17): Line Chart of Control Group Knowledge 
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This chart shows a small naturally occurring improvement in the level of knowledge 
amongst participants in this group. Semi-structured interviews were conducted to 
elaborate findings. 
The majority of participants whilst valuing the importance of information they received 
whilst attending the clinic, highlighted the frustration, fear and apprehension that is 
associated with a lack of information as presented in the following narrative: 
" .. . It is quite difficult for me to understand things because I am not sure if! 
have glaucoma or not and they are not clear with me. I asked them many 
times, if I don't have it then there must be something else that makes my 
vision so blurry ... llost sight in my right eye ... I am really frightened what 
could happen to me if I lose the other eye" (eGOS). 
" ... 1 don't really know much about glaucoma and I am not sure if I have it or 
not ... " (eG06). 
" ... They explain things to you only if you ask them ... You see my knowledge 
is very limited ... They are the ones who have wide experience with 
glaucoma ... They are the ones who should be telling us more about 
glaucoma rather than we asking stupid questions ... " (CG07). 
" ... 1 don't really understand what glaucoma is or how it is being 
managed ... AII what I know is that I have high pressures in my eyes and I 
should put these drops in my eyes to bring it down ... " (CG08). 
When asked how important knowledge was for them and whether they wanted to know 
more, they rated knowledge highly and commented: 
" .. . Dad went completely blind because of glaucoma ... so I want to know if 
there is anything I can do to stop me from going blind .. .! know I am lonely I 
have not got any children or anyone to look after me ... " (eGOS). 
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"I would like to know more ... It is my body and I would like to know what they 
are doing with it" (CG08). 
" ... 1 want to know more ... 1 really do ... because I am always scared of the 
thought of going blind and I am still young and have children and the thought 
of me going blind and not to be able to see my kids and my grandkids in the 
future frightens me ... 1 am always worried about my eyes ... n (CG07). 
"I think it is necessary to learn more about it .. . Personally I would like to know 
why I am taking these drops and what I am taking them for and for how long 
and the consequences of and the risk associated with it" (CG03). 
When asked what source of information they were likely to use if they did not receive 
the information they wanted from the clinic, they commented: 
" ... 1 joined the IGA (International Glaucoma Association) and read on their 
website which has a lot of information ... but I don't understand everything ... " 
(CG03). 
" ... 1 found a leaflet in the waiting area and took it home and read it at 
home ... " (CG10). 
" ... 1 just go online and google it and read about it ... but sometimes it is very 
confusing and scary the stories you read online ... n (eG07). 
However, some participants were happy with the amount of information that was given 
and thought that was enough to help them manage their condition as commented 
below: 
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lilt was explained to me and they told me what I need to do and how to stop 
the glaucoma ... with all fairness .. . they do explain things to me and try to 
help me with my treatment" (CG01). 
III am quite satisfied with what they explained to me ... I am the type of man 
I just do what I am told ... 1 do the drops ... come to my appointment and just 
get on with my life ... They are the experts and I think they know what they 
are doing ... " (CG02). 
2. The MotivationlSatisfaction (Appendix 4) 
When conducting a similar comparison on control group participant's satisfaction with 
the five main aspects of their treatment, the results were as the following. 
*Comparing the level of satisfaction on baseline with the first follow up. 
The Mean for baseline was 37.04 and for first follow up 38.76, whilst the SD was 
10.74508 and 9.84158 respectively. Applying Wilcoxon Signed Ranks Test has 
revealed a p-value of 0.414, which represents no substantial improvement. 
*Comparing the level of satisfaction on first follow up with the second follow 
up. 
A similar comparison was made between first follow up and second follow up. The 
results were similar to those of the previous comparison with a Mean of (38.76 on first 
follow up and 37.96 on second follow up. The SD was (9.84158 on first follow up and 
8.71053 on second follow up). The p-value was calculated using Wilcoxon Signed 
Ranks Test and was 0.261 demonstrating no significant change. 
*Comparing the satisfaction on three times (Baseline, first follow up and 
second follow up) 
When making this comparison on a larger scale to examine the trends over the three 
episodes, the findings were as following. The Mean was (37.04 on Baseline, 38.76 on 
first follow up and 37.96 on second follow up), whilst the SD was (10.74508, 9.84158 
and 8.71053) respectively. The p-value using Friedman Test was 0.727. For a better 
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perspective of this comparison please refer to figure 5.18 that presents this trend over 
the three episodes. 
Figure (5.18): Line Chart of Control Group Motivation/Satisfaction 
70 ~-------------------------------------------
60 +--------------------------------------------
50 +--------------------------------,~~,,~~~ 
~ 40 ~--~~~~~~~--~~--~~~----~~~~­
- Besline o 
u 
~ 30 +-~~--~~~~~~~~~~~---------------
20 +-----------------~--~---------------------
10 +--------------------------------------------
1 2 3 4 5 6 7 8 9 10111213 1415 16 17 18 19 20 21 22 23 24 25 
Number of Patient 
- FU1 
- FU2 
Control group participants identified information as the main motivator for them and 
likely to make them more satisfied as commented below: 
" .. . by knowing things you accept them quicker ... As I told you, my sister has 
glaucoma and I knew at some point I will get ... that's why I was going to the 
optician frequently to check for glaucoma ... " (CGO?). 
" . .. It is important to know about it as it motivates me and helps me to use 
my drops ... and to know what the consequences of not using them are ... " 
(CG01 ). 
" .. . It is important for me if for example I decided I am not going to take my 
drops now I know what is going to happen to me ... So in a way it motivates 
me to take my eye drops on time knowing what the consequences are .. . Also 
I think the more you know the less you will be worrying about it and what 
could happen to you ... " (CG03). 
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"I suppose it does help you when you know what you going through and 
why you are doing this and that...it stops you from worrying all the time and 
then you can get on with your life instead of just keep worrying about it ... " 
(CGOS). 
" .. . It is very important to know my body and how it is reacting ... So I know 
what things to avoid and what things perhaps I should be doing to help ... " 
(CG08). 
3. Adherence and Concordance (Appendix 5) 
Adherence to treatment regimen was also assessed in the same way as the 
intervention group was assessed by using the same tool. 
*Comparing the level of adherence on baseline with first follow up. 
The results were varied with the Mean (2.04 on baseline and 2.28 on first follow up), 
whilst the SO (2.590 and 2.13151) respectively. The p-value was tested using 
Wilcoxon Signed Ranks Test and was 0.3S. 
*Comparing adherence on first follow with second follow up. 
A similar comparison was made between the first follow up and second follow up. The 
mean was (2.28 on first follow up and 1.88 on second follow up) whilst the SO was 
(2.13151 on first follow up and 2.14709 on second follow up. The p-value was 
calculated using Wilcoxon Signed Ranks Test and was 0.048 that is significant 
demonstrating an increase in perceived adherence and concordance. 
*Comparing the adherence level on baseline and first follow up and second 
follow up 
On a larger scale, this comparison was conducted on the three occasions and results 
were as following. The Mean was (2.04 on baseline, 2.28 on first follow up and 1.88 
on second follow up) the SO was (2.59 on baseline, 2.13151 on first follow up and 
2.14709 on second follow up) and a p-value was 0.270 using Friedman Test as 
illustrated in figure (5.19). 
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Figure (5.19): Line Chart of Control Group Adherence Level 
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Participants showed uncertainty when it comes to the effectiveness of their treatment. 
That may have an impact on their concordance levels as indicated in the following 
narratives: 
tl • •• The pressure has not gone down ... lts rather going up and up ... 1 don 't 
think these drops are doing anything but making my eyes red and gritty ... 1 
stopped using them from last week and I will tell them today ... " (eGO?). 
tl • • • Although I am still working and doing the things I used to do .. . it is only 
the inconvenience of doing these drops for all this time ... especially that I 
am not totally convinced if I should be putting them at all ... " (eG06). 
tl • •• They gave me these drops and they keep checking my eyes and saying 
we will see if things are getting worse or not ... but it is bad enough for me 
and I don 't think they are doing anything ... That's why I don 't like this clinic 
and I don 't think I will come back ... " (eGOS). 
tl • • • Every time I come to this clinic I am seen by some body different ... and 
I find it sort of off putting because you never have the chance to relate to 
the person treating you .. . 1 am much happier when I see the same person 
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who probably knows all my history much better than someone who just 
picked up my notes ... 1 feel like telling them do you actually know me or how 
much do you know about my glaucoma case ... " (CG03). 
"I don't think the drops are doing much to me to be honest ... The trouble is I 
don't have a lot of symptoms in first place so it is veryhard to tell if I am 
doing well or not ... Sometimes I take the drops religiously and I come to the 
clinic and they say the pressures are still high ... Other times I don't take 
them regularly and I come here and they say the pressure is normal ... So I 
really don't know ... " (CG02). 
5.4 Between Groups Comparison 
The following table (5.2) presents the quantitative findings from the three groups 
(Expert Patient Group, Intervention Group and Control Group). It shows the 
scores of each group on each timeline (Baseline, First Follow Up and Second 
follow up). 
When comparing the satisfaction scores from the Intervention Group with those of the 
Control Group, one can notice there was a small improvement that was sustained over 
the 6 months where as in the Control Group it was slightly worse. The same applies to 
knowledge scores where there is a sustainable improvement in the Intervention Group 
compared to no improvement in the Control Group. Adherence scores show similar 
trends when comparing these two groups. Based on these results it can be seen that 
the GEPP has been successful. 
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Table (5.2): Average scores of all groups 
Satisfaet Knowled Adheren Satisfae Knowled Adheren Satisfa Knowled Adhere 
-ion -ge -ee t-ion -ge -ee e-tion -ge n-ee 
Baselin 
e 35.5 23.3 2.0 36.4 20.4 2.0 37.0 19.5 2.0 
First 
Follow 30.5 26.5 0 32.1 23.3 0.8 38.8 19.6 2.3 
33.3 22.9 1.1 37.9 19.9 1.9 
Key: Satisfaction Score: 1) Extremely satisfied, 2) Satisfied, 3) Neither Satisfied nor Dissatisfied, 4) 
Dissatisfied, 5) Extremely Dissatisfied . The lower the score the more satisfied the participant. 
Knowledge Score: True and False question, so the higher the score the more knowledgeable the 
participant. Adherence Score: The number of times a participant didn't take his/her eye drops, so the 
lower the score the more adherence. 
In the Expert Patient Group, although deemed as knowledgeable and generally 
satisfied with the service they received, the scores of knowledge, satisfaction and 
adherence improved when comparing before and after intervention. This can add an 
additional value, where the GEPP is not only successful in the above constructs but 
also for the Expert Patients who delivered the intervention. 
5.5 Thematic Map - Final Results 
The following figure (5.20) presents a thematic map that served as an important 
strategy as it helped focus on the constructs of the 1MB model. It has helped in seeing 
participants' meanings, as well as the connections that participants discussed across 
sub-themes. Additionally, this map has supported the attempt of embedding data onto 
the 1MB model within the ophthalmic context which is an integral part of this analysis. 
In the following section, the results of the questionnaires, interviews and field notes 
are reflected thematically according to the 1MB model. The dynamic nature of the 
model when integrated with the EPP reflects an organismic GEPP. Subsequently 
patients' knowledge, motivation and behaviour evolve into a substantial platform of 
self-management of their COAG. 
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5.6 Summary 
This chapter has explicated the results of the GEPP originating with development, 
extending to implementation and concluding with results demonstrating the outcome 
of the GEPP. It can be concluded that the development and implementation of the 
GEPP does improve knowledge and concordance amongst recently diagnosed 
glaucoma patients. The collaborative approach proposed by this research, as an 
alternative approach to the medical model has been proved effective, less costly and 
empowering to newly diagnosed patients with COAG. This tailored self-management 
programme has the potential to be transferable to other condition in an ophthalmic 
context. 
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CHAPTER SIX 
Discussion 
6.0 Introduction 
The aim of this study was to explore the issues arising from the development and 
implementation of hospital-based lay-led Glaucoma Expert Patient Programme 
(GEPP). The study's objectives were to examine participants' perception of the GEPP, 
to explore the impact of the GEPP on patient care and its sustainability. In this chapter, 
implications of the study findings in relation to study's aims and objectives are 
discussed further and their theoretical and empirical significance explored in relation 
to future self-management policies. This discussion will also highlight limitations of this 
study and possible areas of future research. 
With all the criticism received, EPPs remain central to the government's self-care 
policy and aims to equip people with the knowledge and skills that will enable and 
empower them to assume more responsibility in their care. The literature review 
(Chapter 3) highlighted that very little is known about EPPs amongst health 
professionals. 
Since its development, the EPP has largely been tailored to be more disease specific. 
A number of studies have examined the effectiveness of such programmes in various 
chronic conditions. No work has been identified that designed, implemented or 
evaluated a glaucoma specific EPP in any setting. This review identified issues that 
arise from developing and implementing an EPP in an ophthalmic context. Most of the 
EPPs developed have been conducted in a community setting or General Practice 
Surgeries. No work has been identified that reports on how to implement such a 
programme in a hospital setting. There have been no studies that report the process 
of incorporating an EPP within the daily running of outpatient clinics or how to 
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complement and build on the care provided by health professionals. As this chapter 
will illustrate, this study serves to address some of these important empirical gaps. 
6.1 Reflection on the Methodological Approach 
Many of the strengths and weaknesses of research methods used in this study have 
been discussed in detail in chapter 4. This section reviews the key strengths and 
weaknesses in light of the findings that emerged so the reader can judge the relevance 
of the claims made in the remainder of the chapter. A number of strengths in the design 
of this study give weight to the findings and conclusions drawn. Choosing multiple 
study designs and pairing qualitative and quantitative methods is valuable as they 
capitalise on the respective strengths of each approach. This enabled the design and 
implementation of the GEPP to be examined from a number of different angles and 
added to the richness of the account given of the study context. 
The methodological strength of the ethnographic perspective is in the great importance 
conferred to the observation of events and rituals, which reveal elements regarding 
the rules and the culture of the group under study. Ethnography enabled an in-depth 
view of how ophthalmic care was implemented in a real life clinical setting, therefore, 
further research into this area should incorporate this approach to inquiry. This design 
enabled me to build an intense relationship with professionals running the clinics and 
build a beneficial dialogue. Over a considerable period of time this relationship with 
on-site presence has allowed me access to multiple opportunities for informal 
observations and conversations that would have been unavailable through formal data 
collection techniques alone. These conversations led to new reflections and lines of 
inquiry which were explicated further in the action research phase. Similarly the action 
research approach employed a wide range of methods which allowed the GEPP to be 
implemented and the mixed methods then facilitated evaluation qualitatively and 
quantitatively; thus giving richness to the account of the study. 
The qualitative design allowed the participants' perspectives to be examined. Unlike 
quantitative methods, qualitatively it was possible to explore and uncover outcomes of 
participating in the EPP both positively and negatively. Unlike previous qualitative 
evaluations of self-management programmes which interviewed only participants who 
successfully attended the 6 sessions of such programmes, the current study 
interviewed participants who took part and compared the findings with those from a 
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control group. It also took a critical stance toward the data when assessing the impact 
of the GEPP. Using mixed methods provided the opportunity for triangulation of data 
derived from the quantitative methods used and so provided contextual information 
that helped explain the results of the quantitative tools (questionnaires). 
Furthermore, my role as an "insider". within this study meant I was in a good position 
to be accepted as a collaborative researcher. Indeed this gave me further access to 
knowledge that would not have been available to an external researcher new to the 
organisation. This arguably adds credibility to study findings although one cannot 
ignore the bias of being an insider and too close to the data. The democratic impulse 
in this collaborative form of inquiry is consistent with team working and outcomes 
suggest action research provides an ideal way to engage participants (patients and 
staff) in the shared need for improvement. 
A further methodological strength was the wide range of methods used to evaluate 
this inquiry; in particular the use of semi-structured interviews to examine the personal 
experiences of participants and relating these to findings drawn from the quantitative 
evaluation. 
The sample size used in the quantitative part of this evaluation was relatively small (4 
Expert Patients, and 25 patients in the Intervention Group and 25 patients in the 
Control Group), which is argued to limit the generalizability of the findings. Conversely, 
the in-depth contextual findings generated resonate with others undertaking similar 
inquiries, and the potential for generalisation should not be ignored. Additionally, the 
1MB model tested through the processes of data collection and analysis are more wide 
applicable beyond this particular setting and has been used to enhance understanding 
about current practice in today's health service~ 
6.2 Disease Specific or Generic EPP? 
The EPP has provided a new approach to chronic disease management for the 21 st 
century. Unlike all previous papers and interventions of the Department of Health 
(DoH) the EPP is a user friendly intervention and can be delivered by lay people. 
However, the argument on the best way forward for the EPP, whether to run a generic 
or a disease-specific programme, has been long won in favour of the later. Evaluation 
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of generic programmes revealed that participants did not find it beneficial to attend 
training with participants who don't necessarily suffer from the same condition. 
The DoH has compiled evidence in support of successful examples of disease-specific 
programmes nationally. Since the publication of that evaluation, more successful 
examples of tailored hospital-based disease-specific EPPs have been developed. The 
GEPP is an example of an in house self-management programme and resembles a 
successful attempt to assimilate an EPP into an NHS organisation. In its evaluation of 
the EPP, the DoH was not successful in engaging NHS organisations to adopt this 
EPP. Instead, they were faced with endless bureaucracy and lack of access to acute 
trusts. Being an "insider" and having the support of the leading consultant without a 
doubt was an advantage that helped obtain the approval of the Research and 
Development Committee. 
Other barriers documented in the DoH evaluation were not as problematic, notably, 
the lack of legitimacy of lay-led initiatives by health professionals. Moorfields Eye 
Hospital NHS Foundation Trust is a renowned setting with reputable excellent 
customer care. Almost all of the professionals I met in this study were in favour of the 
idea of the GEPP. 
6.2.1 Expert Patient Programme as a Vehicle for Patient Empowerment Chapter 
three explored theories and policies surrounding long-term conditions and in particular 
those aimed at enabling self-management. The EPP is an example of the commitment 
of the DoH to making the NHS more democratic and patient-centred as well as 
eliminating the no longer acceptable medical dominance. Patient and public 
involvement has been the underpinning of most of the subsequent policies including 
the EPP as opposed to the current emphasis of evidence based medicine. Beyond 
this tension other issues were highlighted in participation and involvement. Experts in 
the field have questioned whether all patients want to participate (Sanders and 
Skevington, 2003) or whether it is a viable option for all especially when health literacy 
levels are low (Pickard et ai, 2002). 
Findings from this study have revealed little if any hesitation from participants in taking 
part in this study. Expert Patients were particularly enthusiastic about the prospect of 
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taking part in this research and receive the training and support to lead this research. 
Participants in both intervention and control groups showed great interest in taking 
part and took this as an opportunity to learn more and make use of the time spent in 
the waiting area. However, collecting follow up data was not always as straight forward 
especially with a few participants in the control group who did not attend their follow 
up appointments. Hesitation in completing the questionnaires could be due to the lack 
of interest in the study, or lack of knowledge to answer the questionnaires, or both. 
Subsequently further reminders were sent to participants to complete and return the 
forms. 
Olthoff et ai's (2005) review revealed the most successful strategy to improve 
concordance is by enhancing levels of knowledge and self-management skills. Such 
strategies are seen as effective mechanisms for self-efficacy and for teaching 
participants how to set realistic goals that are more likely to be achieved. For the 
Expert Patients that participated in this study, the experience was something they 
enjoyed and was an opportunity to gain new knowledge and skills as well. They talked 
of their improving knowledge base, their increased satisfaction and understanding of 
the ophthalmic service provided by the Trust. Most of all they expressed the 
satisfaction they felt from helping and supporting fellow glaucoma patients. It made 
the experience for them worthwhile. 
6.2.2 Common Ground for a Shared Vision 
Improving glaucoma patients' concordance level was central to the creation of the 
GEPP. Despite the large body of published glaucoma concordance literature, the 
focus is continuing to be on paternalistic solutions to improve concordance. The 
findings from this study make an important empirical contribution not only to the 
knowledge it provides, but also to proposing a new collaborative paradigm. This 
paradigm will shift the emphasis from doing things to patients to empower and enable 
patients to make informed decisions about their own care and be an active partner. It 
created a place to bring glaucoma patients and staff to provide a new focus for shared 
vision and a shared practice where Expert Patient can playa central part in providing 
healthcare information/guidance to newly diagnosed fellow glaucoma patients. The 
newly established GEPP has helped to define the core purpose and value of actions 
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to be undertaken by the Expert Patients, and providing common ground for shaping a 
shared understanding as a base for collaborative working. 
6.2.3 NHS Cost-Cutting and Challenge Ahead 
The NHS is facing a tough financial climate, and cost cutting is on everyone's agenda, 
with trusts across the country having little time before the financial axe falls. Although 
it is unclear how much needs to be saved across the NHS, it is inevitable that cost 
cutting will reduce the quality of care. The McKinsey report sets out a range of advice 
to enable NHS organisations to achieve suggested savings. Of which they suggested 
increasing professionals' patient facing time, in other words, reducing the number of 
health professionals and increasing the number of patients seen by professionals per 
day. This means professionals will have even less time to spend with patients and that 
will inevitably impact the quality of glaucoma care and indeed the overall health care 
in the NHS. 
Findings from the Ethnographic phase of this study support theory that states work 
that is not viewed as core work to a profession regardless of the reason, is at risk of 
being marginalised (Sheppard et ai, 2003). Findings showed that professionals were, 
on occasions at least, practicing under large pressure and so were unable to provide 
all information and care they would normally provide. The occasions identified became 
more frequent as numbers of patients referred and reviewed in these outpatients 
clinics are constantly increasing. This lack of time and workload is likely to become a 
norm with the cost cutting measures as discussed earlier and so a key solution needs 
to be unearthed. Does this not substantiate the need for instituting a GEPP? 
Without taking away any of the traditional responsibilities of professionals in being 
informative and engaging with patients, the challenge ahead needs new arrangements 
that can blend professional and patients expectations to set reasonable goals. This 
will require effort and innovation in finding new solutions and strategies for the 
turbulent near term future. The GEPP gives an ideal example of this innovation. It 
provides an affordable and ethical alternative by engaging experienced patient to play 
an essential role in improving the service provided and complement the efforts of the 
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professionals. This will require a more integrated and coordinated services which can 
be achieved through good team work and improving communication. 
As the GEPP provided space for patients to come together for mutual engagement in 
glaucoma care, and in doing so they developed a sense of identity as the 'Expert 
Patient' working with professionals in the clinics. This identity has developed a sense 
of belonging to this community and the outpatient clinics. The Expert Patients that 
participated in this study no longer felt as strangers to the outpatient clinics. 
6.3 The 1MB Model Constructs 
Findings of the three main constructs of the 1MB model were consistent with findings 
from previous studies. There was a statistically significant improvement in level of 
knowledge amongst participants from the intervention group and to lesser extent in 
participants from the control group. This improvement in knowledge correlated with an 
improved level of satisfaction with the five main aspects of their treatment as illustrated 
in previous chapter as well as improved behavioural skills. A relatively weak correlation 
with adherence was demonstrated in the findings using the self-administered 
questionnaire to measure the rate of non-adherence. The self-report has an advantage 
of being relatively simple and inexpensive. The risk of recall bias is minimised in this 
study by asking for non-adherence only in the past 4 weeks. Over-estimation risk was 
dealt with by strict definition of the low cut-off level of non-adherence. 
I tried to explore the relation between participants who have a very poor adherence 
level and their level of knowledge about their glaucoma and their treatment regimen. 
However, because only a few participants did not use their medication more than 10 
times in the last few weeks; therefore analysis on this subject should not be considered 
reliable. But looking at individual cases, participants who were less compliant to their 
glaucoma treatment were generally less knowledgeable and dissatisfied with the 
service and the treatment received. 
The 1MB model suggested that improving the level of knowledge and improving 
behavioural skills and motivation will improve levels of satisfaction and ultimately 
improve concordance levels. Of course, I would prefer to have shown that 
improvement of knowledge would lead to great improvement of concordance with 
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glaucoma treatment. The lack of significant improvement of the concordance level 
amongst participants can be related to many reasons. First, the study sample was 
relatively small and so the improvement was not large enough to be represented in 
the p-value. Secondly, self-report as a tool, as mentioned earlier, has recall bias which 
could have affected the results of this study. Thirdly, participants who are adherent to . 
their medication are more likely to volunteer to take part in the research affecting study 
results. In addition, the likelihood of being patients in the outpatient clinics may mean 
that they are more eager to discuss their condition and take part, or both. 
6.4 Empirical Contributions 
Whilst this study directly builds on the existing knowledge and research literature in 
glaucoma concordance, insights generated by this in-depth inquiry contribute to 
knowledge about designing and implementing a GEPP and provides the first empirical 
account of processes involved in setting up such a programme within a clinical setting. 
Furthermore, findings related to the central role of the Expert Patient in conducting this 
inquiry add empirical support to the growing recognition of the patient-centred 
collaborative approach for healthcare and health research. Thus this Thesis adds to 
practice based knowledge, the knowing how, of the implementation and delivery of an 
EPP in an ophthalmic context. In addition, findings from this research are significant 
as they provide the first empirical account of how a GEPP was created for delivery in 
a clinical setting by an Expert Patient. 
This Thesis demonstrates that Ethnography and Action Research provide a sound 
mechanism for improving services in the NHS as Greenhalgh et al (2004) have 
indicated. In particular, findings suggest the democratic and collaborative approaches 
of action research are congruent with the development of the GEPP, a concept 
recently i.ntroduced by the DoH as a way to democratise the NHS. 
This research has implications for healthcare policy as the ageing population 
increases and as treatment concordance potentially becomes an increasingly 
challenging and costly problem. This research also provides important information to 
guide the development of interventions to improve glaucoma concordance based on 
the participatory paradigm. 
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6.5 Theoretical Contributions 
This study demonstrated strong theoretical links between the findings and the creation 
of the GEPP based on the 1MB model. This study makes an important new contribution 
to the theories of adherence. It illustrates how to apply the 1MB model in a new context 
like the ophthalmic context which is beyond the point of its establishment of being a 
model for HIV/AIDs intervention. The role of the 1MB model construct in predicting and 
improving concordance was tested in this study. 
Finally, the 1MB model has specified situations in which information is expected to be 
a significant contributor to concordance and when it will not. Further empirical study of 
the 1MB model's conceptualisation of the role of knowledge is necessary. More 
clarification is required concerning the relationship between knowledge and motivation 
constructs which are sometimes independent and sometimes not. The 1MB model 
logic which holds that well-informed people are not necessarily well motivated and vice 
versa is shown, and so it is important to establish conceptually when such a 
relationship mayor may not be anticipated by the theory. 
6.6 Conclusion 
The current financial climate has taken most of the attention on how best to cut the 
cost of the NHS and employ strategies to save more money. With the quality of care 
ultimately on the line, the EPP as an affordable ethical and feasible programme, can 
provide answers to many doubts and concerns regarding the future of the NHS. In a 
time where every penny counts, the EPP can contribute significantly to improving 
patients' satisfaction with the service and treatment they receive in the glaucoma 
outpatient clinics. It also could give patients more say on how the service is run and 
how best to improve it. The GEPP has been the first of its kind in an ophthalmic 
context; it proves a success and has the potential to be incorporated into other services 
at Moorfields Eye Hospital NHS Foundation Trust and other ophthalmic facilities where 
adherence is an issue. 
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CHAPTER SEVEN 
Conclusion 
7.0 Summary 
The aim of this ethnography, action research and mixed methods study reported in 
this Thesis was to develop, implement and evaluate a GEPP. This programme was 
initiated in four glaucoma outpatient clinics and delivered by Expert Patients who 
played a central role in its design and delivery. The study aimed to describe critically 
the processes involved in such an initiative and examine the effectiveness of the 
GEPP in improving knowledge and concordance amongst newly diagnosed glaucoma 
patients. 
This study achieved most of its objectives. During the Exploratory phase of the study, 
using an ethnographic approach, it set out to understand and explore the practices 
followed in the clinic. Great consideration was given to incorporate input from various 
key players and the expressed needs of patients into the GEPP design. As a result, 
two major action cycles were implemented using a collaborative approach to 
implement the GEPP. This approach has ranged from "technical collaborative" in the 
early stages of this study and progressed to a "mutual collaborative" approach at later 
stages. Expert Patients were encouraged and coached into taking a central role in this 
inquiry by collaborating with the research team and patient participants. The study 
has been evaluated using a mixed methods approach. 
7.1 Key Findings 
This section highlights some of the key findings reported more fully in previous 
Chapters' 5 and 6. 
7.1.1 Ethnography Phase 
During the exploratory phase of the study, the research highlighted that an increasing 
workload and time constraints impacted on the quality of care provided to glaucoma 
patients. Many staff were interested and committed to the provision of high quality 
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care, but a lack of time and space within the glaucoma outpatient clinics meant that 
care provided, at times, fell short of the usual and desired standard. 
7.1.2 Action Phase 
The EPP in its generic form has little if any relevance to patients with chronic eye 
conditions such as glaucoma. The generic form failed to engage 'hard to reach' groups 
whom policy makers wished to target. Action research emphasised a collaborative 
approach and allowed problems and their respective solutions to be identified. Action 
research revealed solutions that made the EPP format more palatable. It encouraged, 
facilitated and ultimately engaged participants in helping to shape the GEPP in a way 
that is responsive to their needs and provides the self-care support required. The 
GEPP developed in this study is an example of a modified EPP that has the potential 
to play a major part in helping people live with glaucoma. Unlike the DoH plan of 
providing the EPP as a part of community social network, I argued that disease specific 
self-management programmes like the GEPP can be incorporated as part of the 
clinical setting to complement the care provided by professionals and fill the gaps 
where they have failed. The GEPP provides a successful example of how such a 
programme can be entwined within the NHS and how the envisaged value of a self-
care approach can be achieved. 
7.1.3 Evaluative Phase 
The GEPP can be described as a complex intervention where it is difficult to work out 
cause and effect mechanisms. Unlike other EPPs, this programme has a technical 
and practical focus, in the sense that participants have been exposed to technical 
terms and procedures, relevant information and practical and essential skills to help 
them self-care. The GEPP has significantly improved the level of knowledge amongst 
participants and, to an extent, improved their level of satisfaction with the service and 
the care they receive in the clinic. 
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7.2 Implications of this Research 
This study has raised some important issues which are worthy of future consideration. 
The issues raised are related to future practice and research and likely to be of specific 
interest to health professionals, researchers, educationalists, managers and policy 
makers in the ophthalmic field and more generally in chronic disease self-
management. 
7.2.1 Future Practice 
1. The EPP, in its generic form, needs to move away from rigid material delivery and 
demonstrate more flexibility and responsiveness to the particular needs of participants. 
2. The EPP can be tailored into a more flexible form such as the GEPP and so 
potentially be incorporated into clinical settings where it becomes a routine part of the 
service. This can ultimately improve patient and public involvement. 
3. After a number of years since being launched, health professionals seem to have 
very little knowledge of the EPP initiative and the notion of Expert Patients. Providing 
a disease-specific EPP in the clinical setting would potentially expose health 
professionals to this concept. 
4. There is a need for health professionals (nurses, optometrists and ophthalmologists) 
to recognise and value the vast experience gained by patients along their journey and 
life with glaucoma. Finding innovative strategies and ways to involve experienced 
patients to be part of this service would appeal to commissioners and the general 
public, simply because it is ethical, democratic and affordable. 
5. In the event of implementation of the GEPP, careful reviews need to be undertaken 
to ensure that important aspects of nursing and medical responsibilities toward patient 
care are not marginalised. 
6. Nurse specialists involved in this research felt !ess challenged by the Expert 
Patients and were consequently able to enter into an appropriate therapeutic 
relationship with them. The nurse specialists showed confidence in their knowledge, 
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which created a sense of openness and encouragement when patients did question 
treatment options. 
7. Nurse Managers involved in this study showed a firm commitment and appreciation 
of the idea of the GEPP and demonstrated a preparedness to continue playing the 
facilitator role if this programme were to be implemented more comprehensively in the 
future. 
8. This study proposes a new collaborative approach to the management of COAG 
with a move away from the paternalistic approach traditionally followed. The traditional 
approach has historically failed to provide answers to the challenge of concordance 
in the management of COAG. 
9. Despite the efforts made by the medical profession to adapting the medical 
curriculum to incorporate more emphasis on communication skills and partnership 
relationships with patients, there appears to be a continuing adoption of the acute care 
model which does not facilitate patient involvement. Such an approach compromises 
the opportunity for concordance to develop. 
7.2.2 Future Research 
1. Understanding the issues of concordance in conditions like glaucoma indicates that 
subsequent interventions should be bas~d on solid theoretical underpinning. This 
. 
study used the Information-Motivation-Behavioural Skills model which worked 
successfully in explaining the adherence behaviour and supporting the development 
of the GEPP and its evaluation. 
2. Evaluation of complex interventions like glaucoma concordance requires an 
increase in the use of practice based and action orientated approaches that take into 
account processes and the wider socio-economic and contextual factors, such as 
ethnography and action research. 
3. Increased funding opportunities to encourage healthcare professionals to undertake 
qualitative practice based research should be considered. Funding bodies need to 
recognise the value and importance of the context that can be gained by using 
qualitative or mixed methods. 
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4. Findings from this study suggest that patients can playa central role in research 
and be successful co-researchers. More effort should be made to engage patients not 
only as subjects but as part of the research team. 
5. There is a need for further research to explore whether results achieved in this study 
can be replicated in different settings and with conditions other than glaucoma. 
7.3 Conclusion 
The research explicated in this Thesis has identified issues that influence and affect 
patients with COAG self-management skills. The unique priorities and needs of 
patients living with COAG include, but rarely limited to, problems with medication use. 
The GEPP developed in this study provided information, motivation, and behaviour 
skills support for medication use and adherence within a broader patient-centred 
system of care delivery that "activates" patients and improves their health outcomes. 
Findings from this study also highlight that efforts to support effective self-
management require patient motivation and should begin with a collaborative 
approach to help patients determine their unique needs and concerns. Importantly, the 
findings highlight that the EPP can contribute to improving the lives of people who are 
living with a long-term condition such as COAG. It is only by moving away from the 
inflexible generic programme and adapting a more flexible approach like the GEPP 
that service delivery can be more responsive to patients' needs. 
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• GLAUCOMA: 
What is glaucoma? 
Was treatment given? 
If yes: 
Why they were given? 
F or how long to be used? 
Appendix (1) 
Observation Data 
Patient Information 
Where to get a repeat prescription if needed? 
Self-management and self-care? 
• FUTURE VISITS: 
Yes D 
Yes D 
Yes D 
Yes D 
Yes D 
Yes D 
Prognosis of glaucoma if untreated? Yes D 
Tests and procedures to be carried out on future visit? Yes D 
• OTHER ISSUES: 
Family screening? Yes D 
Driving? Yes D 
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NoD 
NoD 
NoD 
NoD· 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
Appendix (2) 
Expert Patient: Checklist 
This list is intended to help us decide your suitability for this role. Please take 
the time to think about them or discuss with us before you take any further steps 
to volunteer for the COAG Self-Management Programme. 
1. What is my motivation? 
2. Am I a good listener? 
3. Can I commit to training sessions regularly and reliably? 
4. How much experience do I have in self-managing my own glaucoma? 
5. Can I work with a small group of people and build a rapport with them? 
6. Have I already explored / dealt with my own feelings about having a 
chronic glaucoma? 
7. Will I be able to accept and build on feedback from others? 
8. Am I ready to learn new ways of approaching long-term health 
conditions? 
9. Can I facilitate rather than dominate? 
10. Do I feel I am an effective communicator? 
11. Do I have the time available for the training programme? 
12. Am I willing to travel out of my home area as necessary? 
13. Am I adaptable to working with different people? 
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Appendix (3) 
Moorfields Eye Hospital NHS Foundation Trust 
Glaucoma Patients' Knowledge Questionnaire 
Patient ID for Study: ____ _ 
Visit: Baseline / 1-3 months / 6 months (circle as appropriate) 
The following are statements about glaucoma; please circle (T) if you think it is 
TRUE or (F) if you think it is FALSE. 
Statement 
1. If the visual field is impaired, this can be repaired. 
2. Young people more often have glaucoma than older people. 
3. Glaucoma often causes impaired reading. 
4. Glaucoma affects the visual field. 
5. The optic nerve is damaged in glaucoma. 
6. It is possible to have glaucoma without knowing. 
7. Without treatment, glaucoma is a FAST progressing condition. 
8. Nutrition influences glaucoma. 
9. The chance of getting glaucoma is higher if a family member has 
glaucoma. 
10. The intraocular pressure is increased if it exceeds 25. 
11. The chance of getting glaucoma is higher if the intraocular pressure is 
increased. 
12. The patient should tell the ophthalmologist which other diseases she/he 
has or medicines shelhe is using. 
True 
T 
T 
T 
T 
T 
T 
T 
T 
T 
T 
T 
T 
False 
F 
F 
F 
F 
F 
F 
F 
F 
F 
F 
F 
F 
13. Glaucoma causes reduction of visual acuity. T F 
14. African people have a higher chance of getting glaucoma. T F 
15. Being very short-sighted or long-sighted gives a higher chance of getting T F 
glaucoma. 
16. The intraocular pressure is always increased in glaucoma. T F 
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The following are statements about glaucoma treatment; please circle (T) if you 
think it is TRUE or (F) if you think it is FALSE. 
atement True False 
Early detection and treatment will NOT slow down the course of glaucoma. T F 
Laser treatment or surgery for glaucoma can repair the damage caused by T F 
aucoma. 
Some eye drops should not be used by cardiac patients or asthma patients. T F 
A slower heart rate could be an adverse effect of eye drops. T F 
Shortness of breath could be an adverse effect of eye drops. T F 
Each treatment is equally good for everyone. T F 
Stinging or burning of the eyes could be an adverse effect of eye drops. T F 
Eye drops can be replaced by tablets. T F 
The course of the disease can be slowed down by eye drops. T F 
). A high intraocular pressure must always be treated. T F 
l. Discoloration of the iris may be an adverse effect of eye drops. T F 
~. Blurred vision after using eye drops could be an adverse effect of the T F 
,edication. 
3. Even if the intraocular pressure is under control, the visual field has to be T F 
lecked. 
Moorfields Glaucoma Expert Patient Study 
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Appendix (4) 
Moorfields Eye Hospital NHS Foundation Trust 
Glaucoma Patient's Medication Use 
Patient ID for Study: ____ _ 
Visit: Baseline / 1-3 months / 6 months (circle as appropriate) 
How many times you have not used your glaucoma medication in the past 
four weeks as instructed? Please circle the correct answer. 
o 1 2 3 4 5 6 7 8 9 10 >10 
OI do not take any eye drops. 
Moorfields Glaucoma Expert Patient Study 
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Appendix (5) 
Moorfields Eye Hospital NHS Foundation Trust 
Glaucoma Patients' Treatment Satisfaction Questionnaire 
Patient ID for Study: 
Visit: Baseline / 1-3 months / 6 months (circle as appropriate) 
Please indicate your degree of agreement with the following statements by placing a circle on the appropriate 
nUmber representing your answer. There are no right or wrong answers - we are simply interested in your views. 
oo~ 00 ~ooZ ~ ~oo 
= ~ = .... = ~ .... ~. ::;-~::;- ~ ~~::.: fIl fIl fIl Q fIl ~ fIl = fIl =- = = = ~9 ~ 0; ~ ~ ~ ~(JQ ~ ~ n> fIl' ~ ., fIl fIl -Q.- Q. ~Q. ~ ~'< 
'< n> ........ n> ~ Statement Q. Q. Q. 
Effectiveness: 
1. How satisfied or dissatisfied are you that the eye drops are 
preventing future vision problems? 1 2 3 4 5 
2. How satisfied or dissatisfied are you that your eye drops 
are reducing current vision problems? 1 2 3 4 5 
Convenience of use: 
3. How satisfied or dissatisfied are you with the number of 1 2 3 4 5 
times per day you are required to use your eye drops? 
4. How satisfied or dissatisfied are you with the time of day 
that you are required to use your eye drops? 1 2 3 4 5 
5. How easy or difficult is it to remember to use your eye 
drops at the time of the day they should be used? 1 2 3 4 5 
Ease of administration: 
6. How easy or difficult is it to deliver the required amount 1 2 3 4 5 
of eye drops to the eye without missing or applying too 
much medication? 
7. When standing up, how easy or difficult is it to correctly 
angle your head to accurately apply the eye drops? 1 2 3 4 5 
8. How confident are you in your ability to consistently get 
~xactly the right amount of eye drop medication (one drop) 4 5 
In your eye each time you use it? 
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.... q .... ~ .......... .... .... ""I =-~ =- t:I:J;; t:I:J =-Q ~ 8 ~ ~ = ""I Q ""I ~ Q ""I(JQ 
~ ~ ~ .... ~ ""I .... ~ -Q..-< Q.. =-Q.. =- Q.."< ~ -- ~ ~ Statement ""I ""I ~ ~ Q Q.. Q.. .... 
Side effects: 
9. How much are you bothered by prolonged burning or 
stinging as a result of using your eye drops? 1 2 3 4 5 
10. How much are you bothered by grittiness or sandiness in 
your eyes as a result of using eye drops? 1 2 3 4 5 
11. How much are you bothered by unpleasant feelings of 
stickiness or crustiness in or around your eyes due to using 1 2 3 4 5 
eye drops? 
12. How much are you bothered by dry eyes due to using 
your eye drops? 1 2 3 4 5 
Eye appearance: 
13. How much are you bothered by people's reaction or 1 2 3 4 5 
comments about the redness of your eyes caused by using 
your eye drops? 
14. How self-conscious have you been of eye redness caused 
by your eye drops? 1 2 3 4 5 
15. How concerned have you been by changes to the overall 
cosmetic appearance of your eyes due to redness caused by 1 2 3 4 5 
using your eye drops? 
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Scenario" (Compliance) 
Patient: 
Appendix (6) 
A 58 years old taxi driver was diagnosed with glaucoma 3 months ago; he was 
given a beta-blocker to be applied topically twice a day. On the next his wife says 
he is not taking the medications regularly. The patient does not think it is 
important to do so and thinks it is enough to do it once a day or even twice a 
week. 
Expert Patient: 
Drug non-compliance is a common problem. Avoid confronting the patient as the 
patient may deny it. Instead begin by asking ifhe had problems with the eye drops 
such as breathlessness and any problems applying them such as rheumatoid 
hands. Then explain to him the deterioration of visual field and the risk of 
blindness and losing his driving license. Suggest discussing alternatives with the 
doctor rather than not using the drops. 
Scenario2: (Side Effects) 
Patient: 
A 62 years old lady with a strong family history of glaucoma was diagnosed with 
glaucoma five months ago. It was a bit of shock for her as the case with mo~t 
glaucoma patients as she was asymptomatic. As she understood the risks 
accompanied with glaucoma she was very religious in applying the eye drops on 
time as prescribed. However, she started experiencing burning and red eye as a 
result. She thinks her eyes were fine until she start using the drops which gave 
her a lot of discomfort. 
Expert Patient: 
Most glaucoma patients will experience side effects to their eye drops, however, 
that should not stop them from taking the drops. Explain to this lady the 
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importance of taking these eye drops and encourage her to discuss the side effects 
with the doctors as she might be allergic to them. 
Scenario3: (No Problems Subjectively) 
Patient: 
A 52 years old man has been referred by his (Optician then GP) to the clinic as 
glaucoma suspected. After extensive testing and examination the diagnosis was 
confirmed as open angle glaucoma. The patient never experienced any problems 
subjectively and always has had good eye sight. 
Expert Patient: 
The difficulty with glaucoma is that in the vast majority of cases patients do not 
notice anything at all "asymptomatic". Explain to the patient that glaucoma 
patient most of the times do not experienced any symptoms as the deterioration 
of vision is in the periphery more than central, it is gradual in onset and painless 
that it can go easily unnoticed. 
Scenario4: (What is Glaucoma?). 
Patient: 
A 68 years old man was recently diagnosed with glaucoma. Although it was 
previously explained to him but he does not seem to understand what glaucoma 
is. He is taking his drops regularly and his pressure is brought under control. 
Expert Patient: 
Terminology and amount of information given to patient once the diagnosis has 
been confirmed could be overwhelming. In simple language describe to this man 
what glaucoma is, what the purpose of the treatment, what are the risks of 
glaucoma, what are the targets when treating glaucoma. 
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Appendix (7) 
INFORMATION SHEET 
FOR EXPERT PATIENT VOLUNTEERS 
Implementation and evaluation of an Expert Patient Programme 
for patients with chronic primary open angle glaucoma 
You are being invited to take part in a research study. Please read the following 
information carefully and do not hesitate to ask if anything is unclear or you need 
more information. 
This study has been reviewed and approved by the Moorfields & Whittington 
Research Ethics Committee. 
What is the purpose of the study? 
The purpose of this study is to understand the impact of involving expert patients 
with glaucoma to help other glaucoma patients to better understand their eye 
condition and to learn how to live with a lifelong condition. 
You will be welcome to offer suggestions or input from your own experience 
with the illness and with the service that you have been receiving on how to 
improve the Expert Patient's role in helping other newly diagnosed glaucoma 
patients. 
Why have I been chosen? 
You have been invited to take part as you have been diagnosed and living with 
glaucoma for the past few years. We will be inviting three other Expert Patients 
to draw on their experience on how to make the service a better one. 
Do I have to take part? 
No. it is voluntary and up to you to decide whether or not to take part. If you do, 
you will be given this information sheet to keep and will be asked to sign a 
consent form. You are still free to withdraw from the study at any time without 
giving a reason. Should you decide not to take part or withdraw your standard of 
care will not be affected. 
What will happen if I participate? 
You will be asked to complete a short questionnaire on some background 
information on yourself prior to taking part in the project, and then you will be 
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invited to take part in an interview and a focus group to explore issues related to 
self management and the service you are receiving. 
You will need to make one visit to the hospital for training, which will take 4-6 
hours. You will receive training and all the information and support you need to 
enable you to teach other patients about their condition in sessions of 20-30 
minutes. 
You will also be invited at the end of the study in another focus group meeting to 
give us feedback on your experience and your evaluation of the entire experience. 
All expenses (e.g. travel and refreshments) will be paid for throughout the study 
plus £25 in gift tokens, as a "thank-you" gift at the end of the study. 
How long will it all take? 
The questionnaire should take approximately five to ten minutes to complete. 
Focus groups will be held twice; one at the beginning of the study on an agreed 
date in which we will explore with you different issues regarding your illness, 
self-management as well as issues regarding the service and care you are 
receiving in the Glaucoma Clinic. The other focus group will be toward the end 
of the study in which we will welcome any feedback on your experience. If you 
prefer a one-to-one interview with the researcher over focused groups, we will 
arrange for an agreed date between you and the researcher. 
Each session with patients will take anything from 20-30 minutes. The number 
of patients receiving the training will depend on how many patients agree to take 
part in the study. We aim to recruit 5 patients for each Expert Patient. 
What are the possible benefits of taking part? 
This experience will: 
• Offer you greater awareness of the principles of self management of 
glaucoma 
• Make a valuable contribution to the way we run the service and to the self-
management agenda. 
• Allow you to work closely with health professionals who are caring for you 
and other glaucoma patients. 
• Increase your awareness and confidence in relationships between patients 
with glaucoma and staff involved in patient self-management. 
What if you have a complaint? 
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Any complaint about the way you have been dealt with during the study will be 
addressed. You should contact Sue Lydeard, Research Manager on 
Will my taking part in this study be kept confidential? 
Yes, all information collected and views given in the course of this study will be 
recorded onto forms for analysis and kept securely under the terms of Data 
Protection Act 1998. All information which is collected about you during the 
course of the research will be kept strictly confidential. If you agree to take part 
in the study, your GP will be informed of this. 
What will happen to the results of the research study? 
Theoretical contributions of this study will be disseminated to academic 
audiences. Evidence from this study will be published on the requirements and 
the implications of self management training. The learning from practice will be 
fed back to inform the future development of policies and practices. 
Contact: if you have any questions please call Raed Amro at Moorfields Eye 
Hospital on 
Please note that participation in this study is entirely 
voluntary and you will not be at any disadvantage if you 
decide not to take part .. 
Appendix (8) 
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INFORMATION SHEET 
FOR CLINIC PATIENT PARTICIPANTS 
Implementation and evaluation of an Expert Patient Programme for 
patients with chronic primary open angle glaucoma 
You are being invited to take part in a research study. Please read the following 
information carefully and do not hesitate to ask if anything is unclear or you need 
more information. 
This study has been reviewed and approved by the Moorfields & Whittington 
Hospitals Research Ethics Committee. 
What is the purpose of the study? 
The purpose of this study is to understand the impact of involving Expert Patients 
with glaucoma to help other glaucoma patients to better understand their eye 
condition and to learn how to live with a lifelong condition. 
You will be welcome to offer your feedback on the performance of the Expert 
Patients and how effective you think they are in helping you to make the most of 
your clinic visits and your time at the hospital. 
Why have I been chosen? 
You have been invited to take part as you have been diagnosed with glaucoma. 
We will be inviting approximately 20 patients to take part. 
Do I have to take part? 
No. it is voluntary and up to you to decide whether or not to take part. If you do, 
you will be given this information sheet to keep and will be asked to sign a 
consent form. You are still free to withdraw from the study at any time without 
giving a reason. Should you decide not to take part or withdraw your standard of 
·care will not be affected. 
What will happen if I participate? 
If you agree to take part in the study, you will be asked to complete 3 short 
questionnaires whilst you waiting to see your doctor or receive your medications. 
These questionnaires will take about 20 minutes in total to complete and will 
address issues such as: knowledge of your condition; compliance with 
medication; and satisfaction with the care you are receiving. 
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You will then be introduced to an Expert Patient, who will tell you more about 
your condition, answer any questions you may have, and give you advice on how 
to manage your symptoms. This session with the Expert Patient should last 
between 20-30 minutes. 
Approximately 1-3 months after this session with the Expert Patient, and then 
again at 6 months, we will ask you to repeat the same 3 questionnaires you will 
have completed at recruitment. The information you give us will help us to 
ascertain the effectiveness of involving Expert Patients in the service. 
What are the possible benefits of taking part? 
You will have the chance to informally talk with a patient who is suffering the 
same illness as you and an expert in managing their condition. 
What if you have a complaint? 
Any complaint about the way you have been dealt with during the study will be 
addressed. You should contact Sue Lydeard, Research Manager on 
Will my taking part in this study be kept confidential? 
Yes, all information collected and views given in the course of this study will be 
recorded onto forms for analysis and kept securely under the terms of Data 
Protection Act 1998. All information, which is collected, about you during the 
course of the research will be kept strictly confidential. If you agree to take part 
in the study, your GP will be informed of this. 
What will happen to the results of the research study? 
Theoretical contributions of this study will be disseminated to academic 
audiences. Evidence from this study will be published on the requirements and 
the implications of self-management training. The learning from practice will be 
fed back to inform the future development of policies and practices. 
Contact: if you have any questions please call Raed Amro at Moorfields Eye 
Hospital on 
Please note that participation in this study is entirely 
voluntary and you will not be at any disadvantage if you 
decide not to take part. 
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Appendix (9) 
CONSENT FORM 
FOR CLINIC PATIENT PARTICIPANTS 
Title of Project: Implementation and evaluation of an Expert 
Patient Programme for patients with chronic primary open angle 
glaucoma 
Name of Researchers: Raed Amro, Dilani Siriwardena, Carol Cox 
Please initial box 
1. I confirm that I have read and understood the 
information sheet dated 04.06.2009 (Version 1.1} for the above D 
study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am D 
free to withdraw at any time, without giving any reason, without 
my medical care or legal rights being affected. 
3. I understand that relevant sections of any of my medical notes 
and data collected during the study may be looked at by 
responsible individuals from this Hospital, from regulatory D 
authorities or from the NHS Trust, where it is relevant to my 
taking part in this research. I give permission for these 
individuals to have access to my records. 
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CONSENT FORM (continued) 
FOR CLINIC PATIENT PARTICIPANTS 
Title of Project: Implementation and evaluation of an Expert Patient 
Programme for patients with chronic primary open angle glaucoma 
Name of Researchers: Raed Amro, Dilani Siriwardena, Carol Cox 
Please initial box 
4. I agree that my GP can be informed about my participation in D 
the study. 
5. I agree to take part in the above study. D 
Patient Name Signature Date 
Researcher Signature Date 
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Glaucoma expert patient 
programme 
Abstract 
Expert patient programmes (EPPs) are becoming an increasingly important aspect 
of chronic disease management, resulting in improved health outcomes for patients. 
Patients with chronic open angle glaucoma (COAG) require lifelong therapy. However, to 
date, no EPPs have been designed specifically for patients with chronic eye conditions 
like COAG. This article describes the development and implementation of the Glaucoma 
Expert Patient Programme (GEPP), a glaucoma-specific educational self-management 
Programme which aims to improve glaucoma patients' knowledge, self-management 
skills, expectations and adherence to treatment. A review of theoretical frameworks 
and models which underpin the design, use and conduct of EPPs was undertaken, and 
the GEPP was designed based on the model by Kate Lorig (2003). The result is an 
educational programme which offers COAG patients a different perspective on their 
Condition and supports them with knowledge, skills and strategies to better manage 
their condition on a daily basis. 
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atients with chronic open angle glaucoma 
(COAG) require lifelong therapy. Successful 
treatment outcomes require the daily instil-
lation of ocular hypotensive eye drops to prevent 
the occurrence of glaucoma, if intraocular pres-
sure is high, and to delay the progression of visual 
fields loss (Olthoff et aI, 2005). More than ever 
before, patients are assuming greater responsibility 
for their care , becoming experts in managing their 
symptoms, daily administration of their medica-
tion , and communicating their needs and concerns 
with health professionals. However, asymptomatic 
diseases like COAG are prone to poor patient adher-
ence in following treatment plans (DiMatteo et aI, 
2002). 
A number of authors have suggested that the nature 
of COAG fosters non-adherence , with minimal 
chances of maintaining eyesight among patients who 
adhere poorly to treatment (Stewart et aI, 1993). Poor 
adherence not only leads to poor health outcomes, 
but also unnecessarily increases healthcare costs 
(Haynes et aI , 2002). 
Discussions of adherence often detract from the 
reality of patient independence in self-managing 
their condition (Gifford and Groessl, 2002). By 
focusing attention on the power held by health 
professionals, there is a risk of discouraging collabo-
rative problem solving that addresses patient motiva-
tion and barriers to the taking of medication (Steiner 
and Earnest, 2000). 
Self management and expert 
patient programmes 
Self-management programmes for patients with 
COAG are rare. It is postulated here that learning 
from the experiences of patients with other chronic 
conditions who have been through an expert 
patient programme (EPP) can provide useful guid-
ance in establishing a glaucoma self-management 
programme. The concept of patient self-manage-
ment first emerged in the 1960s and 1970s as a 
method for finding better solutions to living with 
chronic illness. The first structured self-management 
programme was developed by Lorig and colleagues 
(1999). In this scheme, self management is seen as 
an integral , even central, part of the system of care 
provided to people with chronic diseases (Depart-
ment of Health (DoH). 1999). This approach to the 
management of chronic disease, or long-term condi-
tions, has been taken up in many countries around 
the world, including Australia , China, South Africa , 
Canada, and many European countries, including 
the UK. 
Based on Lorig's model , the DoH established the 
Expert Patient Programme as a lay-person-Ied self-
management programme designed specifically for 
people living with long-term conditions (Depart-
ment of Health, 1999). The aim of this programme 
is to support people by increasing their confidence, 
better managing their condition and subsequently 
improving their quality of life. The DoH identified 
the most common chronic diseases that have a signif-
icant impact on a person's quality of life and on their 
family among the UK population. These are arthritis , 
asthma, back pain , diabetes mellitus , epilepsy, 
heart failure and multiple sclerosis (Department of 
Health, 2002). Having been successfully piloted, the 
EPPs for arthritis and some other chronic diseases 
currently offer around 12000 course places every 
year. These are made available through NHS trusts 
in primary care and partner organizations (Depart-
ment of Health, 2009). Internal evaluation data 
from approximately 1000 EPP participants, who 
completed a course between January 2003 and 
January 2005, indicates that the programmes are 
achieving improved health outcomes for patients 
and reduce the degree to which these patients use 
healthcare services (Department of Health, 2005). 
OPTHALMOLOGY 
Glaucoma expert patient programme 
and ocular hypotensive treatment 
Raed Amro, Carol L Cox, Kathryn Waddington, Dilani Siriwardena 
Patients with chronic open angle glaucoma (COAG) require lifelong therapy. Successful treatment outco~es require the daily instillation of ocular hypotensive eye drops to prevent the occurrence 
of glaucoma, if intraocular pressure is high, and to delay 
the progression of visual fields loss (Olthoff et aI, 2005) . 
More than ever before, patients are assuming greater 
responsibility for their care, becoming experts in managing 
their symptoms, daily administration of their medication, 
and communicating their needs and concerns with health 
professionals . However, asymptomatic diseases like COAG 
are prone to poor patient adherence in following treatment 
plans (DiMatteo et aI, 2002). A number of authors have 
suggested that the nature of COAG fosters non-adherence, 
With minimal chances of maintaining eyesight among 
patients who adhere poorly to treatment (Stewart et aI, 
1993) . Poor adherence not only leads to poor health 
Outcomes, but also unnecessarily increases healthcare costs 
(Haynes et aI , 2002). 
Discussions of adherence often detract from the reality 
of patient independence in self-managing their condition 
(Gifford and Groessl , 2002) . By focusing attention on 
the power held by health professionals, there is a risk of 
discouraging collaborative problem-solving that addresses 
patient motivation and barriers to the taking of medication 
(Steiner and Earnest, 2000) . 
Self-management and expert patient 
programmes 
Self-management programmes for patients with COAG 
are rare. It is postulated here that learning from the 
experiences of patients with other chronic conditions who 
have been through an expert patient programme (EPP) 
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Abstract 
Expert patient progranunes (EPPs) are becoming an increasingly 
important aspect of chronic disease management, resulting in 
improved health outcomes for patients. Patients with chronic open 
angle glaucoma (COAG) require lifelong therapy. However, to date, 
no EPPs have been designed specifically for patients with chronic eye 
conditions like COAG. This article describes the development and 
implementation of the Glaucoma Expert Patient Progranune (GEPP), 
a glaucoma-specific educational self-management progranune which 
aims to itnprove glaucoma patients' knowledge, self-management 
skills, expectations and adherence to treatment. A review of theoretical 
frameworks and models which underpin the design, use and conduct 
of EPPs was undertaken, and the GEPP was designed based on the 
model by Kate Lorig (2003). The result is an educational progranune 
which offers COAG patients a different perspective on their condition 
and supports them with knowledge, skills and strategies to better 
manage their condition on a daily basis. 
Key words: Expert patient programme • Glaucoma expert patient 
programme • Self-management programme 
• Information-motivation-behavioural skills model 
can ptovide useful guidance in establishing a glaucoma 
self-management programme. The concept of patient self-
management first emerged in the 1960s and 1970s as a 
method for finding better solu tions to living with chronic 
illness. The first structured self-management prograrrune was 
developed by Lorig and colleagues (1999) . In this scheme, 
self-management is seen as an integral, even central , part of 
the system of care provided to people with chronic diseases 
(Department of Health (DH), 1999). This approach to the 
management of chronic disease, or long-term conditions, 
has been taken up in many countries around the world, 
including Australia, China, South Africa, Canada, and many 
European countries, including the UK. 
Based on Lorig's model, the DH established the Expert 
Patient Programme as a lay-person-led self-management 
programme designed specifically for people living with 
long-term conditions (DH, 1999).The aim of this programme 
is to support people by increasing their confidence, better 
managing their condi~on and subsequently improving their 
quality oflife. The DH identified the most common chronic 
diseases that have a significant impact on a person's quality 
oflife and on their family among the UK population. These 
are arthritis , asthma, back pain, diabetes mellitus, epilepsy, 
heart failure and multiple sclerosis (DH, 2002). Having been 
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Adherence: compliance, persistence and 
concordance in the management of 
glaucoma. Part 1 
Abstract 
... ...... .............. .... .... .......... .. .. ..... ..... ... ........ .... .......... ...... .................... 
Adherence is laden with difficulties in relation to the management of glaucoma. 
Perhaps a significant issue associated with a lack of the aforementioned is 
associated with the patient's failure to recognize there is a need to administer 
their eye drops as prescribed. Undoubtedly the greatest issue is that patients 
experience no pain with their debilitating eye disease. It is not until there is 
considerable loss of vision that awareness of the need to administer eye drops 
becomes a reality. Understanding the complexities of adherence and its association 
with compliance, persistence and concordance as discussed in this article can 
assist the healthcare practitioner in developing models of care that help the patient 
in self management of their glaucoma. This article is published in two parts. Part 
I addresses the background to issues associated with adherence in glaucoma 
management including definition of terms, assessing adherence and barriers and 
interventions to improve adherence. Part 2 addresses the theory of adherence 
and self management of chronic open angle glaucoma (COAG). It provides 
perspectives, theories and models that can be employed to improve adherence in 
the self-management of glaucoma. 
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dherence is a term that is frequently 
discussed by healthcare practitioners 
in relation to patients managing their 
health. It is recognized by healthcare practitioners 
that adherence to long-term intraocular pressure 
(lOP) lowering medication , in particular, is poor 
in patients with glaucoma, which is a significant 
factor in disease progression. The concept of adher-
ence is recognized by healthcare practitioners 
as being laden with difficulties in relation to the 
management of glaucoma. A significant problem 
associated with adherence is the patient's failure 
to recognize there is a need to administer their 
eye drops as prescribed . Undoubtedly the greatest 
issue is that patients experience no pain with their 
debilitating eye disease (Amro et ai, 2011). It is not 
until there is considerable loss of vision that aware-
ness of the need to administer eye drops becomes a 
reality. This article addresses the concept of adher-
ence in association with compliance, persistence 
and concordance in the management of glaucoma: 
It provides the background associated with adher-
ence in chronic conditions, explains the concepts 
of adherence, compliance, persistence and concord -
ance , describes various mechanisms for assessing 
the concepts and delineates barriers and interven-
tions to improve adherence. 
Background 
Patient adherence with medical treatments for 
chronic conditions is knm.\Tn to be far from ideal 
(Schwartz and Quigley, 2008). Approximately 9% 
of all prescriptions written across all therapeutic 
areas are never filled ; especially at initial stage of 
treatment (Lash and Harding, 1995). The scope of 
this issue is enormous throughout chronic condi-
tion literature. Diseases that are asymptomatic in-
nature like chronic open angle glaucoma (COAG) are 
more prone to poor adherence (DiMatteo et ai , 2002) 
with studies suggesting it could be as high as 80% 
(Olthoff et ai , 2005). 
Ocular hypotensive drugs are prescribed to 
patients with COAG to minimize the visual field 
loss by slowing the progression rate of the disease 
in individuals with elevated lOPs and so preserving 
their vision (Nordstrom et ai , 2005). It is important 
that these drops are administered regularly on a daily 
basis for life (Gray et ai , 2009). Failing to do so, could 
result in additional risks and costs because of the 
need for more hospital appointments and diagnostic 
tests , having to switch to other medications and/ 
or wastage of unfinished pharmaceutical supplies , 
and ultimately needing to advance to surgical inter-
vention (Bissell et ai , 2004; Hoevenaars et ai , 2008; 
Gray et ai, 2009). It is important to note here that, 
according to some medical literature, medication 
such as nitroglycerin may increase lOP and should 
be used with caution in patients that have glaucoma. 
However the effect of organic nitrates and nitrites on 
lOP has been found to be variable and there is no 
evidence that these drugs cause narrow angle glau-
coma (Drugs. Com, 2011). 
The literature addressing glaucoma treatment 
adherence is vast, reflecting the variation in termi-
nology used to describe it (such as compliance, 
persistence and concordance), its interventions 
and strategies designed to tackle poor adherence, 
barriers, and the way it is measured. Vermiere et al 
(2001) observed that during three decades of quan-
titative research into adherence 'non-compliance' , 
more than 200 variables have been studied. However 
none can be considered as consistently predictive. 
Terminology 
The term adherence means to be consistent - to 
stick to a regimen. Therefore from an ophthalmic 
CPD article 
Adherence: compliance, persistence and 
concordance in the management of 
glaucoma. Part 2 . 
Abstract 
........... .. ................. .. ..... ... ..... .. .... .. .............. .... ...... .... ........ .... ........ .. ... 
Adherence was noted in Part I of this series as a concept laden with difficulties 
in relation to the management of glaucoma. A significant issue associated with a 
lack of adherence is the patient's failure to recognize there is a need to administer 
their eye drops as prescribed. Part I identified that the greatest issue is that 
patients experience no pain with their debilitating eye disease. It is not until there 
is considerable loss of vision that awareness of the need to administer eye drops 
becomes a reality. It was further noted that understanding the complexities of 
adherence and its association with persistence, compliance and concordance 
can assist the healthcare practitioner in developing models of care that help the 
patient in self management of their glaucoma. This article addresses the theory of 
adherence and self management of chronic open angle glaucoma and discusses 
perspectives, theories and models that help the patient in self management of their 
glaucoma. 
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s noted in the previous article, Adherence: 
Compliance, Persistence and Concord-
ance in the Management of Glaucoma, Part 
1, adherence is a term that is frequently discussed 
by healthcare practitioners in relation to patients 
managing their health (Amro and Cox, 2011). It was 
further noted that it is recognized by healthcare 
practitioners that adherence to long-term intraocular 
pressure (lOP) lowering medication, in particular, is 
poor in patients with glaucoma, which is a signifi-
cant factor in disease progression. A significant 
problem associated with adherence is the patient's 
failure to recognize there is a need to administer eye 
drops as prescribed . This is associated with the fact 
that patients experience no pain with their debili-
tating eye disease (Amro et aI, 2011). It is not until 
there is considerable loss of vision that awareness of 
the need to administer eye drops becomes a reality. 
This article addresses the theory of adherence and 
self management of chronic open angle glaucoma 
(COAG) and discusses perspectives, theories and 
models that help the patient in self management of 
their glaucoma. 
Theory of adherence and 
self management of COAG 
Theories are essential in promoting an under-
standing of human behaviour, directing research 
and facilitating transferability from one health issue, 
geographical area or healthcare setting to another 
(Michie et aI , 2005). However, early programmes 
related to self management of different chronic 
conditions frequently lack an explicit theoretical 
basis. The problem of adherence remains a challenge 
as it relates to human behaviour and self manage-
ment of COAG. 
Munro et al (2007) examined the empirical 
evidence and theories applied in changing behav-
iour interventions in relation to long-term disease' 
self management and treatment regimen adherence. 
Their review revealed that certain theories have the 
potential to both improve understanding of behav-
iour change and contribute to the design of more 
effective interventions that promote collaborative 
partnerships and adherence. Several interventions 
have been designed to improve patients' treatment 
adherence, but few theories describe the processes 
involved in doing so (Michie et aI, 2005; Olthoff 
et aI , 2005) . With more than 30 theories of health 
behaviour change available, chOOSing the most 
appropriate theory when designing an intervention 
is far from an easy task (Munro et aI , 2007). This 
is particularly problematic in the field of adher-
ence to long-term medications, such as medications 
required to manage COAG where the cost of non 
adherence is quite severe with an ultimate eye sight 
loss. 
Leventhal and Cameron (1987) initially classi-
fied five theoretical perspectives (models) related to 
long-term treatment adherence: biomedical; behav-
ioural ; communication; cognitive; and self regula-
tory. Recently a sixth domain, stage perspective, has 
emerged. Each perspective (model) includes several 
theories, where the most commonly used theo-
ries are those within the cognitive perspective and 
the transtheoretical model of the perspective stage 
(Redding et ai, 2000) . Each of these perspectives will 
be reviewed in the narrative that follows. 
Biomedical perspective 
A patient in the biomedical perspective is viewed 
as a passive recipient of the doctors ' instructions, 
where a patient who fails to adhere is understood 
to be caused by patient characteristics like age and 
gender (Blackwell, 1992). Technological innovations 
to monitor adherence to medications, such as the 
'unobtrusive eye drops monitor' are rooted in this 
perspective . 
..................... ............................................................................ ........... ........ .... .............. ... .............. ... ...................... ... .. 
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